{
    "5e6157cb1af46fc13000000e_1": [
        {
            "start_logit": 9.25,
            "end_logit": 9.0703125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.3681640625,
            "text": "Ret",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -1.5830078125,
            "end_logit": 9.0703125,
            "text": "syndrome",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 9.0703125,
            "text": "t syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.03125,
            "text": "Rett syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.1953125,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.0703125,
            "text": "with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.0703125,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.0703125,
            "text": "-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.0703125,
            "text": "(MECP2) are commonly associated with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.0703125,
            "text": "associated with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.0703125,
            "text": "commonly associated with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.0703125,
            "text": "CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5830078125,
            "end_logit": -7.03125,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -1.3681640625,
            "text": "with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -1.3681640625,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -1.3681640625,
            "text": "-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -1.3681640625,
            "text": "(MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.3681640625,
            "text": "associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -1.3681640625,
            "text": "commonly associated with Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_2": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.09375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.5146484375,
            "end_logit": 9.09375,
            "text": "syndrome",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.5986328125,
            "text": "Ret",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -6.125,
            "end_logit": 9.09375,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.8515625,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.11328125,
            "text": "Rett syndrome (RS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.26953125,
            "text": "Rett syndrome (RS)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.27734375,
            "text": "Rett syndrome (RS) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.3203125,
            "text": "Rett syndrome (RS) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.33984375,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.390625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.41015625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.44921875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein MeCP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.453125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.4609375,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.47265625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.47265625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.47265625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein MeC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.48046875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.48046875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6157cb1af46fc13000000e_3": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.1015625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.3642578125,
            "text": "Ret",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": 9.1015625,
            "text": "syndrome",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": -6.12890625,
            "end_logit": 9.1015625,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.7109375,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.00390625,
            "text": "Rett syndrome (RTT).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.01953125,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.0390625,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (RT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.16796875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.171875,
            "end_logit": 9.1015625,
            "text": "disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 9.1015625,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.1015625,
            "text": "in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6875,
            "end_logit": 9.1015625,
            "text": "the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 9.1015625,
            "text": "Mutations in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.1015625,
            "text": "gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.1015625,
            "text": "cause the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -6.7109375,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -7.00390625,
            "text": "syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -7.01953125,
            "text": "syndrome (RTT",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_4": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.3466796875,
            "text": "Ret",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.458984375,
            "end_logit": 9.125,
            "text": "syndrome",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -6.02734375,
            "end_logit": 9.125,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.578125,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.74609375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.94921875,
            "text": "Rett syndrome is a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.0390625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.05859375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.06640625,
            "text": "Rett syndrome is a severe",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.19140625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.19140625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1953125,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.19921875,
            "text": "Rett syndrome is a severe neurodevelopmental",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.203125,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.22265625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.23828125,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2578125,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.296875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.30078125,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6157cb1af46fc13000000e_5": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.046875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.3798828125,
            "text": "Ret",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": 9.046875,
            "text": "syndrome",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 9.046875,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.921875,
            "text": "Rett syndrome,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.03515625,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.24609375,
            "text": "Rett syndrome, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.25390625,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.34375,
            "text": "Rett syndrome, a progressive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.359375,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3828125,
            "text": "Rett syndrome, a progressive neurodevelopmental",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.046875,
            "text": "Mutations in the MeCP2 gene cause Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -6.921875,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.03515625,
            "text": "syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.24609375,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.34375,
            "text": "syndrome, a progressive",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.359375,
            "text": "syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.3828125,
            "text": "syndrome, a progressive neurodevelopmental",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -1.3798828125,
            "text": "Mutations in the MeCP2 gene cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -7.03515625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_6": [
        {
            "start_logit": 9.2734375,
            "end_logit": 9.125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -1.2880859375,
            "text": "Ret",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.4345703125,
            "end_logit": 9.125,
            "text": "syndrome",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 9.125,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -6.82421875,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -6.890625,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.02734375,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.07421875,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.11328125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (RTT) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.171875,
            "text": "Rett syndrome (RTT) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.17578125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.21484375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MECP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.23046875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.23828125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (MEC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.2421875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.2578125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.26953125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2734375,
            "end_logit": -7.26953125,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4345703125,
            "end_logit": -6.82421875,
            "text": "syndrome (",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_7": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.23046875,
            "text": "Ret",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.43359375,
            "end_logit": 9.125,
            "text": "syndrome",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -6.03125,
            "end_logit": 9.125,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.65234375,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.7265625,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.875,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.8828125,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.984375,
            "text": "Rett syndrome (RTT) is associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.0,
            "text": "Rett syndrome (RTT) is associated with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.01953125,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.03515625,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.04296875,
            "text": "Rett syndrome (RTT) is associated with mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.0546875,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.09375,
            "text": "Rett syndrome (RTT) is associated with mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.11328125,
            "text": "Rett syndrome (RTT) is associated with mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.1171875,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.16015625,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.24609375,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.25390625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6157cb1af46fc13000000e_8": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.046875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.3798828125,
            "text": "Ret",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": 9.046875,
            "text": "syndrome",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 9.046875,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.921875,
            "text": "Rett syndrome,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.03515625,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.24609375,
            "text": "Rett syndrome, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.25390625,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.34375,
            "text": "Rett syndrome, a progressive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.359375,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3828125,
            "text": "Rett syndrome, a progressive neurodevelopmental",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.046875,
            "text": "Mutations in the MeCP2 gene cause Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -6.921875,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.03515625,
            "text": "syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.24609375,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.34375,
            "text": "syndrome, a progressive",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.359375,
            "text": "syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.6455078125,
            "end_logit": -7.3828125,
            "text": "syndrome, a progressive neurodevelopmental",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -1.3798828125,
            "text": "Mutations in the MeCP2 gene cause Ret",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -7.03515625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_9": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.046875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.494140625,
            "text": "Ret",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": 9.046875,
            "text": "syndrome",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 9.046875,
            "text": "t syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.0859375,
            "text": "Rett syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.26953125,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.046875,
            "text": "in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.046875,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.046875,
            "text": "disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.046875,
            "text": "-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.046875,
            "text": "(MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.046875,
            "text": "protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.046875,
            "text": "CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.046875,
            "text": "binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -1.494140625,
            "text": "in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -1.6630859375,
            "end_logit": -7.0859375,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -1.494140625,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -1.494140625,
            "text": "disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -1.494140625,
            "text": "-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -1.494140625,
            "text": "(MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_10": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.443359375,
            "text": "Ret",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": 9.125,
            "text": "syndrome",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -6.046875,
            "end_logit": 9.125,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.93359375,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.0390625,
            "text": "Rett syndrome (RTT), the second",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.08984375,
            "text": "Rett syndrome (RTT), the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.1015625,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.12890625,
            "text": "Rett syndrome (RTT), the second most",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.1328125,
            "text": "Rett syndrome (RT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.15234375,
            "text": "Rett syndrome (RTT)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (RTT),",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.21875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -6.93359375,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -7.0390625,
            "text": "syndrome (RTT), the second",
            "probability": 0.0
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -7.08984375,
            "text": "syndrome (RTT), the",
            "probability": 0.0
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -7.1015625,
            "text": "syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -7.12890625,
            "text": "syndrome (RTT), the second most",
            "probability": 0.0
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -7.1328125,
            "text": "syndrome (RT",
            "probability": 0.0
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": -7.15234375,
            "text": "syndrome (RTT)",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_11": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.1015625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.3369140625,
            "text": "Ret",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -1.4990234375,
            "end_logit": 9.1015625,
            "text": "syndrome",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 9.1015625,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.80078125,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.83203125,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.02734375,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.0625,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1484375,
            "text": "Rett syndrome (RTT) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.171875,
            "text": "Rett syndrome (RTT) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.21484375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2265625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.23046875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.25390625,
            "text": "Rett syndrome (RTT) is a severe",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.265625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MEC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.27734375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2890625,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.296875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4990234375,
            "end_logit": -6.80078125,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.4990234375,
            "end_logit": -6.83203125,
            "text": "syndrome (RTT",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_12": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.2421875,
            "text": "Ret",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.4326171875,
            "end_logit": 9.125,
            "text": "syndrome",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 9.125,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.82421875,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.890625,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -6.9765625,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.05078125,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.0703125,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.0859375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.10546875,
            "text": "Rett syndrome (RTT) is caused by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.10546875,
            "text": "Rett syndrome (RTT) is caused by mutations in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.12109375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.14453125,
            "text": "Rett syndrome (RTT) is caused by mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.15234375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MEC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.15234375,
            "text": "Rett syndrome (RTT) is caused",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (RTT) is caused by mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.171875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -7.1875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2).",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6157cb1af46fc13000000e_13": [
        {
            "start_logit": 9.234375,
            "end_logit": 9.09375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.3974609375,
            "text": "Ret",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": 9.09375,
            "text": "syndrome",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 9.09375,
            "text": "t syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.703125,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.97265625,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0078125,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.015625,
            "text": "Rett syndrome (RTT).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.1171875,
            "text": "Rett",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (RT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 9.09375,
            "text": "disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.09375,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.09375,
            "text": "the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": 9.09375,
            "text": "in MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -6.703125,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -6.97265625,
            "text": "syndrome (RTT)",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.0078125,
            "text": "syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -7.015625,
            "text": "syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -7.16015625,
            "end_logit": -1.3974609375,
            "text": "disorder Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.22265625,
            "end_logit": -1.3974609375,
            "text": "neurodevelopmental disorder Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_14": [
        {
            "start_logit": 9.25,
            "end_logit": 9.09375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.357421875,
            "text": "Ret",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -1.5390625,
            "end_logit": 9.09375,
            "text": "syndrome",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 9.09375,
            "text": "t syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.9296875,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting young females .",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.953125,
            "text": "Rett syndrome ,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.0390625,
            "text": "Rett syndrome , an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.1328125,
            "text": "Rett syndrome , an autism spectrum disorder mainly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.1328125,
            "text": "Rett syndrome , an autism spectrum disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.16015625,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.27734375,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting young",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.30078125,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.3125,
            "text": "Rett syndrome , an autism spectrum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.09375,
            "text": "methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.09375,
            "text": "of Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.09375,
            "text": "cause of Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.09375,
            "text": "-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5390625,
            "end_logit": -6.9296875,
            "text": "syndrome , an autism spectrum disorder mainly affecting young females .",
            "probability": 0.0
        },
        {
            "start_logit": -1.5390625,
            "end_logit": -6.953125,
            "text": "syndrome ,",
            "probability": 0.0
        },
        {
            "start_logit": -1.5390625,
            "end_logit": -7.0390625,
            "text": "syndrome , an",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_15": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.09375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.314453125,
            "text": "Ret",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -1.5126953125,
            "end_logit": 9.09375,
            "text": "syndrome",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 9.09375,
            "text": "t syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.9140625,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.953125,
            "text": "Rett syndrome ( RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.09765625,
            "text": "Rett syndrome ( RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1640625,
            "text": "Rett syndrome ( RTT )",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1953125,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.2578125,
            "text": "Rett syndrome ( RTT ) is a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.265625,
            "text": "Rett syndrome ( RTT ) is a severe",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.2890625,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.29296875,
            "text": "Rett syndrome ( RTT ) is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.328125,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.3515625,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.3671875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5126953125,
            "end_logit": -6.9140625,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.5126953125,
            "end_logit": -6.953125,
            "text": "syndrome ( RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.5126953125,
            "end_logit": -7.09765625,
            "text": "syndrome ( RT",
            "probability": 0.0
        },
        {
            "start_logit": -1.5126953125,
            "end_logit": -7.1640625,
            "text": "syndrome ( RTT )",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_16": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.3271484375,
            "text": "Ret",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": 9.1171875,
            "text": "syndrome",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 9.1171875,
            "text": "t syndrome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.7109375,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.86328125,
            "text": "Rett syndrome (RTT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.91015625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.00390625,
            "text": "Rett syndrome (RT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.08984375,
            "text": "Rett syndrome (RTT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.10546875,
            "text": "Rett syndrome (RTT) is an X",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.12109375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.125,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.171875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1953125,
            "text": "Rett syndrome (RTT) is an X-linked",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.2109375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.21484375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.234375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.234375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.23828125,
            "text": "Rett syndrome (RTT) is an",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6157cb1af46fc13000000e_17": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.1015625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.3037109375,
            "text": "Ret",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -1.498046875,
            "end_logit": 9.1015625,
            "text": "syndrome",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 9.1015625,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.546875,
            "text": "Rett syndrome (RTT).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.0390625,
            "text": "Rett syndrome (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.1015625,
            "text": "as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.171875,
            "text": "Rett syndrome (RTT",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1796875,
            "text": "Rett syndrome (RTT)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.27734375,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.1015625,
            "text": "known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.1015625,
            "text": "disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.1015625,
            "text": "a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.1015625,
            "text": "neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.1015625,
            "text": "methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.1015625,
            "text": "onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.1015625,
            "text": "-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.1015625,
            "text": "-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.1015625,
            "text": "delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.498046875,
            "end_logit": -6.546875,
            "text": "syndrome (RTT).",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_18": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.3818359375,
            "text": "Ret",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": 9.1171875,
            "text": "syndrome",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 9.1171875,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.578125,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.0390625,
            "text": "Rett syndrome is a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.05859375,
            "text": "Rett syndrome is a neurodevelopmental disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1484375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.16015625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1640625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1640625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1796875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2 (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.19140625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.203125,
            "text": "Rett syndrome is a neurodevelopmental",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.20703125,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.2265625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.234375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": -6.578125,
            "text": "syndrome is",
            "probability": 0.0
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": -7.0390625,
            "text": "syndrome is a",
            "probability": 0.0
        },
        {
            "start_logit": -1.4794921875,
            "end_logit": -7.05859375,
            "text": "syndrome is a neurodevelopmental disorder",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_19": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.078125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.45703125,
            "text": "Ret",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.568359375,
            "end_logit": 9.078125,
            "text": "syndrome",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 9.078125,
            "text": "t syndrome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.9609375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL5 genes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.01171875,
            "text": "Rett syndrome is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.0859375,
            "text": "Rett syndrome is a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.13671875,
            "text": "Rett syndrome is a monogenic disease due to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.16015625,
            "text": "Rett syndrome is a monogenic disease due",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.19921875,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.25,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.2578125,
            "text": "Rett syndrome is a mono",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.2734375,
            "text": "Rett syndrome is a monogenic disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.27734375,
            "text": "Rett syndrome is a monogenic disease due to de",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.27734375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.27734375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.2890625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.29296875,
            "text": "Rett syndrome is a monogenic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.29296875,
            "text": "Rett",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.296875,
            "text": "Rett syndrome is a monogenic disease due to de novo",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b6bd2622d300530900000c_1": [
        {
            "start_logit": 9.1875,
            "end_logit": 2.8828125,
            "text": "ApoE2",
            "probability": 0.97607421875
        },
        {
            "start_logit": 9.1875,
            "end_logit": -0.90673828125,
            "text": "ApoE",
            "probability": 0.0220794677734375
        },
        {
            "start_logit": 9.1875,
            "end_logit": -4.4921875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 0.0006117820739746094
        },
        {
            "start_logit": 9.1875,
            "end_logit": -4.91796875,
            "text": "ApoE2 polymorphism",
            "probability": 0.00039958953857421875
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.40625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is",
            "probability": 9.02414321899414e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.43359375,
            "text": "ApoE2 polymorphism is well known",
            "probability": 8.815526962280273e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.46484375,
            "text": "ApoE2 polymorphism is well",
            "probability": 8.541345596313477e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.4921875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia,",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.546875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R1",
            "probability": 7.838010787963867e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.578125,
            "text": "ApoE2 polymorphism is",
            "probability": 7.599592208862305e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.609375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R158C",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.7265625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by",
            "probability": 6.55055046081543e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.74609375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the",
            "probability": 6.449222564697266e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.78515625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded",
            "probability": 6.151199340820312e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.828125,
            "text": "ApoE2 polymorphism is well known for",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.8359375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common",
            "probability": 5.8710575103759766e-05
        },
        {
            "start_logit": -7.046875,
            "end_logit": 2.8828125,
            "text": "2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.578125,
            "end_logit": -3.90625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -3.90625,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -4.4921875,
            "text": "apoE2 isoform",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_2": [
        {
            "start_logit": 9.1875,
            "end_logit": 2.8828125,
            "text": "ApoE2",
            "probability": 0.97607421875
        },
        {
            "start_logit": 9.1875,
            "end_logit": -0.90673828125,
            "text": "ApoE",
            "probability": 0.0220794677734375
        },
        {
            "start_logit": 9.1875,
            "end_logit": -4.4921875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 0.0006117820739746094
        },
        {
            "start_logit": 9.1875,
            "end_logit": -4.91796875,
            "text": "ApoE2 polymorphism",
            "probability": 0.00039958953857421875
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.40625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is",
            "probability": 9.02414321899414e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.43359375,
            "text": "ApoE2 polymorphism is well known",
            "probability": 8.815526962280273e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.46484375,
            "text": "ApoE2 polymorphism is well",
            "probability": 8.541345596313477e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.4921875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia,",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.546875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R1",
            "probability": 7.838010787963867e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.578125,
            "text": "ApoE2 polymorphism is",
            "probability": 7.599592208862305e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.609375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R158C",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.7265625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by",
            "probability": 6.55055046081543e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.74609375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the",
            "probability": 6.449222564697266e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.78515625,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded",
            "probability": 6.151199340820312e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.828125,
            "text": "ApoE2 polymorphism is well known for",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.8359375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common",
            "probability": 5.8710575103759766e-05
        },
        {
            "start_logit": -7.046875,
            "end_logit": 2.8828125,
            "text": "2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.578125,
            "end_logit": -3.90625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -3.90625,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 0.0
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -4.4921875,
            "text": "apoE2 isoform",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_1": [
        {
            "start_logit": 6.8203125,
            "end_logit": 7.6328125,
            "text": "SERCA",
            "probability": 1.0
        },
        {
            "start_logit": 6.8203125,
            "end_logit": -5.0078125,
            "text": "SERCA)",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -6.46875,
            "end_logit": 7.6328125,
            "text": "(SERCA",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.6328125,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.46875,
            "end_logit": -5.0078125,
            "text": "(SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -5.0078125,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.73828125,
            "text": "sarcoplasmic reticulum (SR) calcium pump",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.74609375,
            "text": "sarcoplasmic reticulum",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.83984375,
            "text": "sarcoplasmic reticulum (SR)",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.87109375,
            "text": "sarcoplasmic reticulum (SR) calcium",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.89453125,
            "text": "sarcoplasmic reticulum (SR",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.99609375,
            "text": "sarcoplasmic reticulum (",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_2": [
        {
            "start_logit": 2.435546875,
            "end_logit": 7.90625,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.98291015625
        },
        {
            "start_logit": 2.435546875,
            "end_logit": 3.21875,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 0.0090484619140625
        },
        {
            "start_logit": -3.1640625,
            "end_logit": 7.90625,
            "text": "ATPase",
            "probability": 0.0036296844482421875
        },
        {
            "start_logit": 1.1767578125,
            "end_logit": 3.21875,
            "text": "SERCA",
            "probability": 0.0025615692138671875
        },
        {
            "start_logit": -4.4453125,
            "end_logit": 7.90625,
            "text": "the sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.001007080078125
        },
        {
            "start_logit": -5.859375,
            "end_logit": 7.90625,
            "text": "Ca(2+)-ATPase",
            "probability": 0.00024509429931640625
        },
        {
            "start_logit": 2.435546875,
            "end_logit": -0.69775390625,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 0.000179290771484375
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 7.90625,
            "text": "reticulum Ca(2+)-ATPase",
            "probability": 0.0001112818717956543
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 7.90625,
            "text": "+)-ATPase",
            "probability": 8.600950241088867e-05
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.90625,
            "text": "-ATPase",
            "probability": 8.600950241088867e-05
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.90625,
            "text": "(2+)-ATPase",
            "probability": 7.241964340209961e-05
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 7.90625,
            "text": ")-ATPase",
            "probability": 6.80088996887207e-05
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.90625,
            "text": "o/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": 1.1767578125,
            "end_logit": -0.69775390625,
            "text": "SERCA)",
            "probability": 5.0961971282958984e-05
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.90625,
            "text": "2+)-ATPase",
            "probability": 4.464387893676758e-05
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.90625,
            "text": "endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 4.464387893676758e-05
        },
        {
            "start_logit": -3.1640625,
            "end_logit": 3.21875,
            "text": "ATPase (SERCA",
            "probability": 3.337860107421875e-05
        },
        {
            "start_logit": -4.21484375,
            "end_logit": 3.21875,
            "text": "(SERCA",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": -4.4453125,
            "end_logit": 3.21875,
            "text": "the sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -5.859375,
            "end_logit": 3.21875,
            "text": "Ca(2+)-ATPase (SERCA",
            "probability": 2.2649765014648438e-06
        }
    ],
    "54db62a3034aea571d000001_3": [
        {
            "start_logit": 7.3984375,
            "end_logit": 5.13671875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.",
            "probability": 0.98388671875
        },
        {
            "start_logit": 7.3984375,
            "end_logit": 1.0009765625,
            "text": "SERCA",
            "probability": 0.015777587890625
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -2.857421875,
            "text": "SERCA,",
            "probability": 0.0003325939178466797
        },
        {
            "start_logit": -1.8544921875,
            "end_logit": 5.13671875,
            "text": ".",
            "probability": 9.453296661376953e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -4.234375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump,",
            "probability": 8.410215377807617e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.01953125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.03515625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.08203125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER",
            "probability": 3.5881996154785156e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.19140625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.28125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into",
            "probability": 2.950429916381836e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.3046875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.31640625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible",
            "probability": 2.8371810913085938e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.5234375,
            "text": "SERCA, an endoplasmic reticulum (ER)",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.7109375,
            "text": "SERCA, an endoplasmic reticulum",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.734375,
            "text": "SERCA, an endoplasmic reticulum (",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.7578125,
            "text": "SERCA, an endoplasmic reticulum (ER",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.78125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely",
            "probability": 1.7881393432617188e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.78515625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.8359375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.9296875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium",
            "probability": 1.5437602996826172e-05
        }
    ],
    "54db62a3034aea571d000001_4": [
        {
            "start_logit": 7.51171875,
            "end_logit": 9.3515625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase",
            "probability": 1.0
        },
        {
            "start_logit": -0.377197265625,
            "end_logit": 9.3515625,
            "text": "ATPase",
            "probability": 0.0003771781921386719
        },
        {
            "start_logit": -3.44140625,
            "end_logit": 9.3515625,
            "text": "Ca(2+)-ATPase",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -2.00390625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -3.111328125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -3.13671875,
            "text": "Sarcoplasmic",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 9.3515625,
            "text": "reticulum Ca(2+)-ATPase",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.15625,
            "end_logit": 9.3515625,
            "text": ")-ATPase",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 9.3515625,
            "text": "-ATPase",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -4.765625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 9.3515625,
            "text": "+)-ATPase",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.3515625,
            "text": "(2+)-ATPase",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -5.39453125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.3515625,
            "text": "2+)-ATPase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -5.70703125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -6.02734375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -6.1875,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -6.19921875,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -6.35546875,
            "text": "Sarcoplasmic reticulum Ca(2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.51171875,
            "end_logit": -6.44140625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54db62a3034aea571d000001_5": [
        {
            "start_logit": 7.87109375,
            "end_logit": 4.48828125,
            "text": "SERCA",
            "probability": 0.97265625
        },
        {
            "start_logit": 7.87109375,
            "end_logit": 0.8291015625,
            "text": "SERCA enzymes).",
            "probability": 0.025115966796875
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -1.7939453125,
            "text": "SERCA enzymes",
            "probability": 0.001819610595703125
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -4.015625,
            "text": "SERCA enzymes)",
            "probability": 0.00019788742065429688
        },
        {
            "start_logit": -5.765625,
            "end_logit": 4.48828125,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 4.48828125,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": 4.48828125,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 4.48828125,
            "text": "(SERCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -3.49609375,
            "end_logit": 0.8291015625,
            "text": ".",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 4.48828125,
            "text": "o/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 4.48828125,
            "text": "in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 4.48828125,
            "text": "actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 4.48828125,
            "text": "the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.765625,
            "end_logit": 0.8291015625,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 0.8291015625,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": 0.8291015625,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 0.8291015625,
            "text": "(SERCA enzymes).",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 0.8291015625,
            "text": "o/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 0.8291015625,
            "text": "in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": 0.8291015625,
            "text": "enzymes).",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_6": [
        {
            "start_logit": 6.79296875,
            "end_logit": 7.27734375,
            "text": "SERCA",
            "probability": 1.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": 7.27734375,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 9.244680404663086e-05
        },
        {
            "start_logit": 6.79296875,
            "end_logit": -4.01171875,
            "text": "SERCA)",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.27734375,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.27734375,
            "text": "(SERCA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -4.01171875,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -5.77734375,
            "text": "sarco(endo)plasmic reticulum",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -5.8828125,
            "text": "sarco(endo)plasmic reticulum calcium pump",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -5.99609375,
            "text": "sarco(endo)plasmic",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -6.01953125,
            "text": "sarco(endo)plasm",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -6.29296875,
            "text": "sarco(endo)",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -6.5078125,
            "text": "sarco(endo",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -6.51171875,
            "text": "sarco(endo)plasmic reticulum calcium",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -6.57421875,
            "text": "sarco(",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -6.921875,
            "text": "sarco(endo)plasmic reticulum calcium pump (",
            "probability": 0.0
        },
        {
            "start_logit": -2.494140625,
            "end_logit": -7.0859375,
            "text": "sarco",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -4.01171875,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -4.01171875,
            "text": "(SERCA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -5.77734375,
            "text": "o(endo)plasmic reticulum",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -5.8828125,
            "text": "o(endo)plasmic reticulum calcium pump",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_7": [
        {
            "start_logit": 8.2734375,
            "end_logit": 4.7265625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 0.9912109375
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.364990234375,
            "text": "SERCA",
            "probability": 0.006107330322265625
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -2.267578125,
            "text": "SERCA is",
            "probability": 0.0009107589721679688
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -3.2421875,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and",
            "probability": 0.00034308433532714844
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.08984375,
            "text": "SERCA is a membrane protein that",
            "probability": 0.0001475811004638672
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.28125,
            "text": "SERCA is a membrane",
            "probability": 0.00012135505676269531
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.359375,
            "text": "SERCA is a",
            "probability": 0.00011223554611206055
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.59765625,
            "text": "SERCA is a membrane protein that belongs to the family",
            "probability": 8.809566497802734e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.859375,
            "text": "SERCA is a membrane protein that belongs to the",
            "probability": 6.80685043334961e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.859375,
            "text": "SERCA is a membrane protein that belongs to the family of P",
            "probability": 6.80685043334961e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.87890625,
            "text": "SERCA is a membrane protein",
            "probability": 6.651878356933594e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.8984375,
            "text": "SERCA is a membrane protein that belongs to the family of",
            "probability": 6.54458999633789e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -4.9296875,
            "text": "SERCA is a membrane protein that belongs to",
            "probability": 6.347894668579102e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -5.01171875,
            "text": "SERCA is a membrane protein that belongs",
            "probability": 5.8650970458984375e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -5.16015625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -5.203125,
            "text": "SERCA is a membrane protein that belongs to the family of P-type",
            "probability": 4.8279762268066406e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -5.23046875,
            "text": "SERCA is a membrane protein that belongs to the family of P-",
            "probability": 4.7147274017333984e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -5.43359375,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": -1.9345703125,
            "end_logit": 4.7265625,
            "text": ".",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -5.546875,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion transloc",
            "probability": 3.421306610107422e-05
        }
    ],
    "54db62a3034aea571d000001_8": [
        {
            "start_logit": 9.296875,
            "end_logit": 9.03125,
            "text": "SERCA2a",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -0.7763671875,
            "text": "SERCA2a isoform in the heart.",
            "probability": 5.519390106201172e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.0244140625,
            "text": "SERCA",
            "probability": 4.297494888305664e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.39453125,
            "text": "SERCA2a isoform",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.4443359375,
            "end_logit": 9.03125,
            "text": "2a",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.9130859375,
            "text": "SERCA2a isoform in the heart",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -2.703125,
            "end_logit": 9.03125,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -4.671875,
            "end_logit": 9.03125,
            "text": ". SERCA is mainly represented by the SERCA2a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.26953125,
            "text": "SERCA2a isoform in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 9.03125,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 9.03125,
            "text": "-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.03125,
            "text": "Three different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.03125,
            "text": "the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.03125,
            "text": "different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.03125,
            "text": ", SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.03125,
            "text": "identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4443359375,
            "end_logit": -0.7763671875,
            "text": "2a isoform in the heart.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4443359375,
            "end_logit": -1.39453125,
            "text": "2a isoform",
            "probability": 0.0
        },
        {
            "start_logit": -1.4443359375,
            "end_logit": -1.9130859375,
            "text": "2a isoform in the heart",
            "probability": 0.0
        },
        {
            "start_logit": -2.703125,
            "end_logit": -0.7763671875,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a isoform in the heart.",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_9": [
        {
            "start_logit": 9.1015625,
            "end_logit": 0.28955078125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase",
            "probability": 0.447998046875
        },
        {
            "start_logit": 9.1015625,
            "end_logit": 0.15185546875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA)",
            "probability": 0.38916015625
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.4287109375,
            "text": "The",
            "probability": 0.080322265625
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -2.017578125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is",
            "probability": 0.044708251953125
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -3.68359375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump",
            "probability": 0.0084381103515625
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.05078125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a",
            "probability": 0.005840301513671875
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.37109375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane",
            "probability": 0.004241943359375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.58984375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (",
            "probability": 0.003406524658203125
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.85546875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-",
            "probability": 0.002613067626953125
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -4.8828125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that",
            "probability": 0.00254058837890625
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.0859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to",
            "probability": 0.0020751953125
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.13671875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound",
            "probability": 0.001972198486328125
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.26171875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive",
            "probability": 0.0017404556274414062
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.59765625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the",
            "probability": 0.00124359130859375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.703125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte",
            "probability": 0.0011196136474609375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.75,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP",
            "probability": 0.001068115234375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.9140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against",
            "probability": 0.0009064674377441406
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.96484375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from",
            "probability": 0.0008611679077148438
        },
        {
            "start_logit": -2.412109375,
            "end_logit": 2.775390625,
            "text": ".",
            "probability": 5.358457565307617e-05
        },
        {
            "start_logit": -3.423828125,
            "end_logit": 2.775390625,
            "text": "SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 1.9550323486328125e-05
        }
    ],
    "550739cf3b8a5dc045000002_1": [
        {
            "start_logit": 8.734375,
            "end_logit": 7.9140625,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 8.734375,
            "end_logit": -0.78125,
            "text": "AAUAAA hexamer",
            "probability": 0.00016605854034423828
        },
        {
            "start_logit": 8.734375,
            "end_logit": -2.419921875,
            "text": "AA",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -3.37890625,
            "end_logit": 7.9140625,
            "text": "AA",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 8.734375,
            "end_logit": -5.375,
            "text": "AAUAAA hexa",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -5.25390625,
            "end_logit": 7.9140625,
            "text": "UAAA",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.9140625,
            "text": "canonical AAUAAA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -0.78125,
            "text": "AA hexamer",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -0.78125,
            "text": "UAAA hexamer",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -0.78125,
            "text": "hexamer",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -0.78125,
            "text": "canonical AAUAAA hexamer",
            "probability": 0.0
        },
        {
            "start_logit": -3.37890625,
            "end_logit": -5.375,
            "text": "AA hexa",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -2.419921875,
            "text": "canonical AA",
            "probability": 0.0
        },
        {
            "start_logit": -5.25390625,
            "end_logit": -5.375,
            "text": "UAAA hexa",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -5.375,
            "text": "hexa",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.375,
            "text": "canonical AAUAAA hexa",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -7.04296875,
            "text": "canonical",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_2": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.734375,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.2734375,
            "text": "AA",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": -2.3046875,
            "end_logit": 8.734375,
            "text": "AA",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 8.734375,
            "text": "UAAA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.734375,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -2.2734375,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.390625,
            "text": "polyadenylation",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_3": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.734375,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.2734375,
            "text": "AA",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": -2.3046875,
            "end_logit": 8.734375,
            "text": "AA",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 8.734375,
            "text": "UAAA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.734375,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -2.2734375,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.390625,
            "text": "polyadenylation",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_4": [
        {
            "start_logit": 9.0625,
            "end_logit": 8.9765625,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.734375,
            "text": "AA",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -1.6796875,
            "end_logit": 8.9765625,
            "text": "AA",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -3.015625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A) synthesis.",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -4.64453125,
            "end_logit": 8.9765625,
            "text": "UAAA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.0234375,
            "text": "AAUAAA)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.16015625,
            "text": "AAUAAA) nearby the 3' end of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.171875,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.32421875,
            "text": "AAUAAA) nearby the 3' end",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.35546875,
            "text": "AAUAAA) nearby the 3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.36328125,
            "text": "AAUAAA) nearby the 3' end of pre",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.41015625,
            "text": "AAUAAA) nearby",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.6015625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.6015625,
            "text": "AAUAAA) nearby the 3'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.65625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.71484375,
            "text": "AAUAAA) nearby the 3' end of pre-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.72265625,
            "text": "AAUAAA) nearby the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.8359375,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.89453125,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A) synthesis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 8.9765625,
            "text": "A polyadenylation signal (AAUAAA",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e764647c6a8763d23000016_1": [
        {
            "start_logit": 7.87109375,
            "end_logit": 8.5625,
            "text": "The oral live cholera vaccine CVD 103-HgR",
            "probability": 1.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": 8.5625,
            "text": "R",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -2.39453125,
            "end_logit": 8.5625,
            "text": "CVD 103-HgR",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -2.275390625,
            "text": "The",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -4.09375,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol)",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -4.47265625,
            "text": "The oral live cholera vaccine",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 8.5625,
            "text": "HgR",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.0625,
            "text": "The oral live cholera",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -5.8359375,
            "end_logit": 8.5625,
            "text": "-HgR",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.62890625,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol), the first genetically modified organism",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.6328125,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol), the first",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.68359375,
            "text": "The oral live cholera vaccine CVD 103",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.8125,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.1171875,
            "text": "The oral",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -6.1640625,
            "text": "The oral live cholera vaccine CVD 103-HgR (Orochol",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 8.5625,
            "text": "103-HgR",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 8.5625,
            "text": "cholera vaccine CVD 103-HgR",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -4.09375,
            "text": "R (Orochol, Mutachol)",
            "probability": 0.0
        },
        {
            "start_logit": -2.39453125,
            "end_logit": -4.09375,
            "text": "CVD 103-HgR (Orochol, Mutachol)",
            "probability": 0.0
        },
        {
            "start_logit": -2.3203125,
            "end_logit": -5.62890625,
            "text": "R (Orochol, Mutachol), the first genetically modified organism",
            "probability": 0.0
        }
    ],
    "5319a7d2b166e2b806000029_1": [
        {
            "start_logit": 8.7578125,
            "end_logit": 8.6640625,
            "text": "hsc70-interacting protein",
            "probability": 1.0
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -0.74267578125,
            "text": "hsc70-interacting protein (CHIP)",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -2.158203125,
            "end_logit": 8.6640625,
            "text": "protein",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -2.451171875,
            "text": "hsc",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -4.14453125,
            "text": "hsc70-interacting protein (CHIP) can",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -5.734375,
            "text": "hsc70-interacting protein (CHIP",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.3359375,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.453125,
            "text": "hsc70-interacting protein (CHIP) can remod",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.625,
            "text": "hsc70-interacting protein (CHIP) can remodel",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.71484375,
            "text": "hsc70",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 8.6640625,
            "text": "interacting protein",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.75,
            "text": "hsc70-interacting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.765625,
            "text": "hsc70-interacting protein (CHIP) can remodel mature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.8515625,
            "text": "hsc70-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 8.6640625,
            "text": "70-interacting protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.86328125,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.8984375,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.9296875,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 8.6640625,
            "text": "-interacting protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.6640625,
            "text": "of hsc70-interacting protein",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5313058de3eabad02100000e_1": [
        {
            "start_logit": 8.1796875,
            "end_logit": 7.8203125,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -2.765625,
            "text": "lumbosacral",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": -3.38671875,
            "end_logit": 7.8203125,
            "text": "vertebrae",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 7.8203125,
            "text": "transitional vertebrae",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.51171875,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in young patients.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.60546875,
            "text": "lumbosacral transitional vertebrae,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.72265625,
            "text": "lumbosacral transitional",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.390625,
            "end_logit": 7.8203125,
            "text": "in lumbosacral transitional vertebrae",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 7.8203125,
            "text": "lumbago in lumbosacral transitional vertebrae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.0703125,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.28515625,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.3203125,
            "text": "lumbosacral transitional vertebrae, is an important",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.328125,
            "text": "lumbosacral transitional vertebrae, is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.8203125,
            "text": "form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.8203125,
            "text": ", a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.8203125,
            "text": "Bertolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.8203125,
            "text": "of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.8203125,
            "text": "a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.8203125,
            "text": "tolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.8203125,
            "text": "(BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5313058de3eabad02100000e_2": [
        {
            "start_logit": 7.90234375,
            "end_logit": 7.2265625,
            "text": "lumbosacral",
            "probability": 1.0
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.42578125,
            "text": "lumbosacral anomalies",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.03125,
            "text": "lumbosacral anomalies and often have severe sciatica.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.13671875,
            "text": "lumbosacral anomalies and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.34765625,
            "text": "lumbosacral anomalies and often",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 7.2265625,
            "text": "with Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.2265625,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.2265625,
            "text": "characteristic lumbosacral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.2265625,
            "text": "have characteristic lumbosacral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.2265625,
            "text": "Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.2265625,
            "text": "tolotti's syndrome have characteristic lumbosacral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.2265625,
            "text": "'s syndrome have characteristic lumbosacral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.2265625,
            "text": "lotti's syndrome have characteristic lumbosacral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.171875,
            "end_logit": -7.03125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -6.42578125,
            "text": "with Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.42578125,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -6.42578125,
            "text": "characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -6.42578125,
            "text": "have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -6.42578125,
            "text": "Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -6.42578125,
            "text": "tolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_3": [
        {
            "start_logit": 8.765625,
            "end_logit": 8.75,
            "text": "lumbosacral junction",
            "probability": 0.9892578125
        },
        {
            "start_logit": 8.765625,
            "end_logit": 4.2265625,
            "text": "lumbosacral junction pseudarticulation",
            "probability": 0.01073455810546875
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": 8.75,
            "text": "junction",
            "probability": 2.3305416107177734e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -2.21875,
            "text": "lumbosacral",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.41796875,
            "text": "lumbosacral junction pseudartic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": 4.2265625,
            "text": "junction pseudarticulation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.6953125,
            "text": "lumbosacral junction pseud",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.94921875,
            "text": "lumbosacral junction pseudarticulation (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.96484375,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case report.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 8.75,
            "text": "unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.32421875,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case report",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.359375,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.75,
            "text": "symptomatic unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.515625,
            "end_logit": 4.2265625,
            "text": "pseudarticulation",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 4.2265625,
            "text": "ulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": 4.2265625,
            "text": "unilateral lumbosacral junction pseudarticulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 4.2265625,
            "text": "symptomatic unilateral lumbosacral junction pseudarticulation",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -6.41796875,
            "text": "junction pseudartic",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -6.6953125,
            "text": "junction pseud",
            "probability": 0.0
        },
        {
            "start_logit": -1.8857421875,
            "end_logit": -6.94921875,
            "text": "junction pseudarticulation (",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_4": [
        {
            "start_logit": 0.64208984375,
            "end_logit": 6.84765625,
            "text": "spine",
            "probability": 0.85205078125
        },
        {
            "start_logit": 3.767578125,
            "end_logit": 1.7978515625,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra",
            "probability": 0.12469482421875
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -0.63525390625,
            "text": "Lumbosacral transitional vertebra",
            "probability": 0.01093292236328125
        },
        {
            "start_logit": -4.203125,
            "end_logit": 6.84765625,
            "text": ". The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0067138671875
        },
        {
            "start_logit": -5.609375,
            "end_logit": 6.84765625,
            "text": "lumbar spine",
            "probability": 0.001644134521484375
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 6.84765625,
            "text": "The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0005617141723632812
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 6.84765625,
            "text": "association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0005316734313964844
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 6.84765625,
            "text": "low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0005197525024414062
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 6.84765625,
            "text": "the lumbar spine",
            "probability": 0.0004820823669433594
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 6.84765625,
            "text": "variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0004208087921142578
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 6.84765625,
            "text": "with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0004191398620605469
        },
        {
            "start_logit": -2.060546875,
            "end_logit": 1.7978515625,
            "text": "fifth lumbar vertebra",
            "probability": 0.0003669261932373047
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -4.49609375,
            "text": "Lumbosacral transitional vertebra is",
            "probability": 0.00022971630096435547
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -5.8515625,
            "text": "Lumbosacral",
            "probability": 5.9485435485839844e-05
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -6.29296875,
            "text": "Lumbosacral transitional vertebra is an",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -6.6015625,
            "text": "Lumbosacral transitional vertebra is an anatomical variation",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -6.6640625,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in which an enlarged transverse process can",
            "probability": 2.6345252990722656e-05
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -6.8359375,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in which an enlarged transverse process",
            "probability": 2.2172927856445312e-05
        },
        {
            "start_logit": 3.767578125,
            "end_logit": -6.91796875,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -4.95703125,
            "end_logit": 1.7978515625,
            "text": "lumbar vertebra",
            "probability": 2.0205974578857422e-05
        }
    ],
    "5313058de3eabad02100000e_5": [
        {
            "start_logit": 5.94921875,
            "end_logit": 6.75390625,
            "text": "lumbosacral vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": 6.75390625,
            "text": "Transitional lumbosacral vertebrae",
            "probability": 0.00034332275390625
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 6.75390625,
            "text": "vertebrae",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -5.09375,
            "text": "lumbosacral",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -6.04296875,
            "text": "lumbosacral vertebrae and",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -6.47265625,
            "text": "lumbosacral vertebrae and low back pain",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -6.7578125,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -6.9140625,
            "text": "lumbosacral vertebrae and low back pain:",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -7.28125,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -5.09375,
            "text": "Transitional lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -6.04296875,
            "text": "Transitional lumbosacral vertebrae and",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -6.47265625,
            "text": "Transitional lumbosacral vertebrae and low back pain",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -6.7578125,
            "text": "Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -6.9140625,
            "text": "Transitional lumbosacral vertebrae and low back pain:",
            "probability": 0.0
        },
        {
            "start_logit": -2.02734375,
            "end_logit": -7.28125,
            "text": "Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -6.04296875,
            "text": "vertebrae and",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -6.47265625,
            "text": "vertebrae and low back pain",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -6.7578125,
            "text": "vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -6.9140625,
            "text": "vertebrae and low back pain:",
            "probability": 0.0
        },
        {
            "start_logit": -4.5859375,
            "end_logit": -6.7578125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_6": [
        {
            "start_logit": 5.7421875,
            "end_logit": 7.609375,
            "text": "facet joint",
            "probability": 0.998046875
        },
        {
            "start_logit": 5.7421875,
            "end_logit": 1.048828125,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation",
            "probability": 0.0014095306396484375
        },
        {
            "start_logit": 3.947265625,
            "end_logit": 1.048828125,
            "text": "lumbosacral articulation",
            "probability": 0.00023376941680908203
        },
        {
            "start_logit": -3.603515625,
            "end_logit": 7.609375,
            "text": "joint",
            "probability": 8.732080459594727e-05
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.609375,
            "text": "from the facet joint",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -5.2890625,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.609375,
            "text": "low back pain from the facet joint",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.609375,
            "text": "the facet joint",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.609375,
            "text": "Case report of surgically treated mechanical low back pain from the facet joint",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -5.49609375,
            "text": "facet",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.609375,
            "text": "back pain from the facet joint",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.609375,
            "text": "mechanical low back pain from the facet joint",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.609375,
            "text": "treated mechanical low back pain from the facet joint",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -6.22265625,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (Bertolotti's syndrome).",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -6.5859375,
            "text": "facet joint contralateral",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -6.984375,
            "text": "facet joint contralateral to a unilateral",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -7.0,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (Bertolotti's syndrome)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -7.0390625,
            "text": "facet joint contralateral to a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.7421875,
            "end_logit": -7.078125,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 3.947265625,
            "end_logit": -5.2890625,
            "text": "lumbosacral",
            "probability": 4.172325134277344e-07
        }
    ],
    "5313058de3eabad02100000e_7": [
        {
            "start_logit": 8.5625,
            "end_logit": 8.6875,
            "text": "facet joint",
            "probability": 1.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": 8.6875,
            "text": "joint",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 8.5625,
            "end_logit": -2.4765625,
            "text": "facet",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 8.5625,
            "end_logit": -4.6484375,
            "text": "facet joint contralateral",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.5625,
            "end_logit": -4.9765625,
            "text": "facet joint contralateral to an anomalous lumbosacral articulation.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.5625,
            "end_logit": -5.99609375,
            "text": "facet joint contralateral to an anomalous lumbosacral articulation",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 8.6875,
            "text": "L6-S1 facet joint",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 8.6875,
            "text": "S1 facet joint",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.5625,
            "end_logit": -6.5234375,
            "text": "facet joint contralateral to an anomalous lumbosacral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5625,
            "end_logit": -6.76953125,
            "text": "facet joint contralateral to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 8.6875,
            "text": "symptomatic L6-S1 facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.6875,
            "text": "-S1 facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.6875,
            "text": "a symptomatic L6-S1 facet joint",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.6875,
            "text": "Repeated fluoroscopically guided injections implicated a symptomatic L6-S1 facet joint",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -4.6484375,
            "text": "joint contralateral",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -4.9765625,
            "text": "joint contralateral to an anomalous lumbosacral articulation.",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -5.99609375,
            "text": "joint contralateral to an anomalous lumbosacral articulation",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -6.5234375,
            "text": "joint contralateral to an anomalous lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -2.4765625,
            "text": "L6-S1 facet",
            "probability": 0.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": -6.76953125,
            "text": "joint contralateral to",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_8": [
        {
            "start_logit": 7.87890625,
            "end_logit": 5.7265625,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -3.0859375,
            "text": "lumbosacral",
            "probability": 0.00014889240264892578
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -5.64453125,
            "text": "lumbosacral transitional vertebrae.",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.58984375,
            "text": "lumbosacral transitional",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 5.7265625,
            "text": "vertebrae",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.15625,
            "end_logit": 5.7265625,
            "text": "back pain with lumbosacral transitional vertebrae",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 5.7265625,
            "text": "Bertolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 5.7265625,
            "text": "transitional vertebrae",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 5.7265625,
            "text": "with lumbosacral transitional vertebrae",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 5.7265625,
            "text": "association of back pain with lumbosacral transitional vertebrae",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 5.7265625,
            "text": "tolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 5.7265625,
            "text": "of back pain with lumbosacral transitional vertebrae",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 5.7265625,
            "text": "the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 5.7265625,
            "text": "lotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 5.7265625,
            "text": "syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 5.7265625,
            "text": "pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 5.7265625,
            "text": "to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 5.7265625,
            "text": "'s syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 5.7265625,
            "text": "s syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.15625,
            "end_logit": -3.0859375,
            "text": "back pain with lumbosacral",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_1": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.0859375,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": 9.0859375,
            "text": "DB",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.708984375,
            "text": "mpM",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -5.10546875,
            "end_logit": 9.0859375,
            "text": "oRFsDB",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.71875,
            "end_logit": 9.0859375,
            "text": "FsDB",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -5.94921875,
            "text": "mpMoRFsDB:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.44140625,
            "text": "mpMoRFsDB: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.75,
            "text": "mpMoRFsDB: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.8046875,
            "text": "mpMoRFs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.12109375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.16015625,
            "text": "mpMoRFsDB: a database of molecular recognition features",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.20703125,
            "text": "mpMoRFsDB: a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.2109375,
            "text": "mpMoRFsDB: a database of molecular recognition features in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.234375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.2578125,
            "text": "mpMoRFsDB: a database of molecular",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.28125,
            "text": "mpMoRFsDB: a database of molecular recognition",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -5.94921875,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -6.44140625,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -6.75,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -1.552734375,
            "end_logit": -7.12109375,
            "text": "DB: a database of molecular recognition features in membrane",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_2": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.09375,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.4853515625,
            "text": "mpM",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -1.517578125,
            "end_logit": 9.09375,
            "text": "DB",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -5.4296875,
            "end_logit": 9.09375,
            "text": "oRFsDB",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.71875,
            "end_logit": 9.09375,
            "text": "FsDB",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.25390625,
            "text": "mpMoRFsDB provides",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.76953125,
            "text": "mpMoRFsDB provides valuable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.796875,
            "text": "mpMoRFsDB provides valuable information related to disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.8515625,
            "text": "mpMoRFs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.14453125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.18359375,
            "text": "mpMoRFsDB provides valuable information related to disorder-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.1953125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.19921875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.28515625,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.296875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.30078125,
            "text": "mpMoRFsDB provides valuable information related to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.3203125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.328125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.33203125,
            "text": "mpMoRFsDB provides valuable information related",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.517578125,
            "end_logit": -6.25390625,
            "text": "DB provides",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_3": [
        {
            "start_logit": 9.1875,
            "end_logit": 9.125,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": 9.1875,
            "end_logit": -1.4970703125,
            "text": "mpM",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.4423828125,
            "end_logit": 9.125,
            "text": "DB",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.0859375,
            "end_logit": 9.125,
            "text": "oRFsDB",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.5625,
            "end_logit": 9.125,
            "text": "FsDB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.15234375,
            "text": "mpMoRFsDB:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.59375,
            "text": "mpMoRFsDB: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.69140625,
            "text": "mpMoRFs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.7890625,
            "text": "mpMoRFsDB: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -6.8359375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.1171875,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.140625,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.14453125,
            "text": "mpMoRFsDB: a database of molecular recognition features",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.203125,
            "text": "mpMoRFsDB: a database of molecular recognition features in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.2109375,
            "text": "mpMoRFsDB: a database of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.26171875,
            "text": "mpMoRFsDB: a database of molecular",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1875,
            "end_logit": -7.296875,
            "text": "mpMoRFsDB: a database of molecular recognition",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4423828125,
            "end_logit": -6.15234375,
            "text": "DB:",
            "probability": 0.0
        },
        {
            "start_logit": -1.4423828125,
            "end_logit": -6.59375,
            "text": "DB: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.4423828125,
            "end_logit": -6.7890625,
            "text": "DB: a database",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_1": [
        {
            "start_logit": 8.5625,
            "end_logit": 9.078125,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -0.53955078125,
            "end_logit": 9.078125,
            "text": "of magnetic resonance imaging",
            "probability": 0.00011152029037475586
        },
        {
            "start_logit": -1.4287109375,
            "end_logit": 9.078125,
            "text": "imaging",
            "probability": 4.57763671875e-05
        },
        {
            "start_logit": 8.5625,
            "end_logit": -2.63671875,
            "text": "magnetic",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -3.9453125,
            "end_logit": 9.078125,
            "text": ". Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 9.078125,
            "text": "resonance imaging",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.5625,
            "end_logit": -5.171875,
            "text": "magnetic resonance imaging and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.76953125,
            "end_logit": 9.078125,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": 9.078125,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 9.078125,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 9.078125,
            "text": "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 9.078125,
            "text": "approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 9.078125,
            "text": "a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 9.078125,
            "text": "report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5625,
            "end_logit": -6.7578125,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5625,
            "end_logit": -7.01171875,
            "text": "magnetic resonance imaging and we",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.53955078125,
            "end_logit": -2.63671875,
            "text": "of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -0.53955078125,
            "end_logit": -5.171875,
            "text": "of magnetic resonance imaging and",
            "probability": 0.0
        },
        {
            "start_logit": -3.9453125,
            "end_logit": -2.63671875,
            "text": ". Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -1.4287109375,
            "end_logit": -5.171875,
            "text": "imaging and",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_2": [
        {
            "start_logit": 8.6171875,
            "end_logit": 9.1015625,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -1.4189453125,
            "end_logit": 9.1015625,
            "text": "imaging",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -2.53125,
            "text": "magnetic",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -4.73046875,
            "end_logit": 9.1015625,
            "text": "of magnetic resonance imaging",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 9.1015625,
            "text": "resonance imaging",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -5.47265625,
            "text": "magnetic resonance imaging and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.5625,
            "end_logit": 9.1015625,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 9.1015625,
            "text": "approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 9.1015625,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 9.1015625,
            "text": "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 9.1015625,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.1015625,
            "text": ", we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 9.1015625,
            "text": "report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.75,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of this syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.99609375,
            "text": "magnetic resonance imaging and we",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.125,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.15625,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.18359375,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.21484375,
            "text": "magnetic resonance imaging and we conduct a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.2421875,
            "text": "magnetic resonance imaging and we conduct a systematic review of all",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e3129c32c812009000002_1": [
        {
            "start_logit": 9.0390625,
            "end_logit": 8.84375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.8662109375,
            "text": "tra",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -2.140625,
            "end_logit": 8.84375,
            "text": "R",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -5.73828125,
            "end_logit": 8.84375,
            "text": "seR",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.08203125,
            "text": "traseR: an",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.34375,
            "text": "traseR:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.91796875,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.0546875,
            "text": "traseR: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.15625,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.234375,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.234375,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.24609375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.2734375,
            "text": "traseR: an R package for performing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.2890625,
            "text": "traseR: an R package for performing trait-associated SNP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.32421875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.3671875,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.421875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.42578125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.43359375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.140625,
            "end_logit": -6.08203125,
            "text": "R: an",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_2": [
        {
            "start_logit": 9.109375,
            "end_logit": 8.8828125,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.66015625,
            "text": "tra",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -2.044921875,
            "end_logit": 8.8828125,
            "text": "R",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": -5.578125,
            "end_logit": 8.8828125,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.265625,
            "text": "traseR, an easy-to-use",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.4765625,
            "text": "traseR,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.6796875,
            "text": "traseR, an easy-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.78515625,
            "text": "traseR, an easy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.96484375,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.16015625,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.18359375,
            "text": "traseR, an easy-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 8.8828125,
            "text": "present traseR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.234375,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.2890625,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.34765625,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.37109375,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.3828125,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.8828125,
            "text": "Here, we present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.8828125,
            "text": ", we present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.8828125,
            "text": "we present traseR",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e3129c32c812009000002_3": [
        {
            "start_logit": 9.0859375,
            "end_logit": 8.84375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.716796875,
            "text": "tra",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -2.1328125,
            "end_logit": 8.84375,
            "text": "R",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": -5.5625,
            "end_logit": 8.84375,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.48046875,
            "text": "traseR, an easy-to-use",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.796875,
            "text": "traseR,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.859375,
            "text": "traseR, an easy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.8984375,
            "text": "traseR, an easy-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.0078125,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.19140625,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.2890625,
            "text": "traseR, an easy-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.29296875,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.3671875,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.4140625,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.453125,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.46875,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.51171875,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.84375,
            "text": "present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -6.48046875,
            "text": "R, an easy-to-use",
            "probability": 0.0
        },
        {
            "start_logit": -2.1328125,
            "end_logit": -6.796875,
            "text": "R,",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_4": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.9296875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.591796875,
            "text": "tra",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": 8.9296875,
            "text": "R",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 8.9296875,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.40625,
            "text": "traseR, an easy-to-use",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.58203125,
            "text": "traseR,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.703125,
            "text": "traseR, an easy-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.84765625,
            "text": "traseR, an easy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.984375,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 8.9296875,
            "text": "present traseR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.171875,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1875,
            "text": "traseR, an easy-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.234375,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2890625,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.3125,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.3359375,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.34765625,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.9296875,
            "text": "Here, we present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.9296875,
            "text": ", we present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -6.40625,
            "text": "R, an easy-to-use",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_5": [
        {
            "start_logit": 9.140625,
            "end_logit": 8.921875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.6103515625,
            "text": "tra",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.9677734375,
            "end_logit": 8.921875,
            "text": "R",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 8.921875,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.28125,
            "text": "traseR: an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3046875,
            "text": "traseR:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.94140625,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.94921875,
            "text": "traseR: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.09375,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1328125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1328125,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.15625,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.16796875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.19921875,
            "text": "traseR: an R package for performing trait-associated SNP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.203125,
            "text": "traseR: an R package for performing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.26953125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.30078125,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.30859375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.31640625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e3129c32c812009000002_6": [
        {
            "start_logit": 9.140625,
            "end_logit": 8.921875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.6103515625,
            "text": "tra",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -1.9677734375,
            "end_logit": 8.921875,
            "text": "R",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": -5.5546875,
            "end_logit": 8.921875,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.28125,
            "text": "traseR: an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3046875,
            "text": "traseR:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.94140625,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.94921875,
            "text": "traseR: an R package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.09375,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1328125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1328125,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.15625,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.16796875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.19921875,
            "text": "traseR: an R package for performing trait-associated SNP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.203125,
            "text": "traseR: an R package for performing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.26953125,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.30078125,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.30859375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.31640625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e3129c32c812009000002_7": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.9296875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.591796875,
            "text": "tra",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": 8.9296875,
            "text": "R",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 8.9296875,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.40625,
            "text": "traseR, an easy-to-use",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.58203125,
            "text": "traseR,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.703125,
            "text": "traseR, an easy-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.84765625,
            "text": "traseR, an easy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.984375,
            "text": "traseR, an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 8.9296875,
            "text": "present traseR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.171875,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1875,
            "text": "traseR, an easy-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.234375,
            "text": "traseR, an easy-to-use R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2890625,
            "text": "trase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.3125,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.3359375,
            "text": "traseR, an easy-to-use R Bioconduc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.34765625,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.9296875,
            "text": "Here, we present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.9296875,
            "text": ", we present traseR",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.9462890625,
            "end_logit": -6.40625,
            "text": "R, an easy-to-use",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_8": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.8671875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.5830078125,
            "text": "tra",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -2.08203125,
            "end_logit": 8.8671875,
            "text": "R",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": -5.63671875,
            "end_logit": 8.8671875,
            "text": "seR",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.16015625,
            "text": "traseR R",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.8203125,
            "text": "traseR R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.203125,
            "text": "traseR R package preloaded with up-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2109375,
            "text": "traseR R package preloaded with up",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.21484375,
            "text": "traseR R package preloaded",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.23046875,
            "text": "traseR R package preloaded with up-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.23828125,
            "text": "traseR R package preloaded with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.265625,
            "text": "traseR R package preload",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.265625,
            "text": "traseR R package preloaded with up-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.30859375,
            "text": "traseR R package preloaded with up-to-date collection of trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.30859375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.328125,
            "text": "traseR R package preloaded with up-to-date collection of trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.328125,
            "text": "traseR R package preloaded with up-to-date collection of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.08203125,
            "end_logit": -6.16015625,
            "text": "R R",
            "probability": 0.0
        },
        {
            "start_logit": -2.08203125,
            "end_logit": -6.8203125,
            "text": "R R package",
            "probability": 0.0
        },
        {
            "start_logit": -2.08203125,
            "end_logit": -7.203125,
            "text": "R R package preloaded with up-to",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_1": [
        {
            "start_logit": 8.890625,
            "end_logit": 9.0234375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.7294921875,
            "end_logit": 9.0234375,
            "text": "e",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 8.890625,
            "end_logit": -2.208984375,
            "text": "GBs",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": -5.6875,
            "end_logit": 9.0234375,
            "text": "hape",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -6.13671875,
            "text": "GBshape:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -6.33203125,
            "text": "GBshape: a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.0078125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.0234375,
            "text": "GBshape: a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.07421875,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.08203125,
            "text": "GBshape: a genome brow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.1171875,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.2265625,
            "text": "GBshape: a genome browser database",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.32421875,
            "text": "GBshape: a genome browser database for DNA shape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.3359375,
            "text": "GBshape: a genome browser database for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.40625,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.890625,
            "end_logit": -7.4375,
            "text": "GBshape: a genome browser database for DNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7294921875,
            "end_logit": -6.13671875,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7294921875,
            "end_logit": -6.33203125,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7294921875,
            "end_logit": -7.0234375,
            "text": "e: a genome",
            "probability": 0.0
        },
        {
            "start_logit": -1.7294921875,
            "end_logit": -7.07421875,
            "text": "e: a genome browser",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_2": [
        {
            "start_logit": 8.6484375,
            "end_logit": 9.0546875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": 9.0546875,
            "text": "e",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -2.537109375,
            "text": "GBs",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -4.58203125,
            "end_logit": 9.0546875,
            "text": "hape",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 9.0546875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -5.85546875,
            "text": "GBshape;",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 9.0546875,
            "text": "(GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.68359375,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.76171875,
            "text": "GBshape; freely available at http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.7890625,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.796875,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.85546875,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.90625,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.9453125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -6.96484375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -7.078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -7.0859375,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -7.16796875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -5.85546875,
            "text": "e;",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_3": [
        {
            "start_logit": 9.0078125,
            "end_logit": 9.0703125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": 9.0703125,
            "text": "e",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.953125,
            "text": "GBs",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 9.0703125,
            "text": "hape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.265625,
            "text": "GBshape:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.34375,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.953125,
            "text": "GBshape: a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.01953125,
            "text": "GBshape: a genome brow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.0234375,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.03125,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.078125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.10546875,
            "text": "GBshape: a genome browser database for DNA shape annotations.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.11328125,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.2265625,
            "text": "GBshape: a genome browser database for DNA shape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.2578125,
            "text": "GBshape: a genome browser database for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.28515625,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.42578125,
            "text": "GBshape: a genome browser database for DNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.265625,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.34375,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.953125,
            "text": "e: a genome",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_4": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.09375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.546875,
            "end_logit": 9.09375,
            "text": "e",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -2.037109375,
            "text": "GBs",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -5.12890625,
            "end_logit": 9.09375,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -5.921875,
            "text": "GBshape can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.4453125,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.7734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.79296875,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.859375,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.02734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.08984375,
            "text": "GBshape can be used to visualize",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.1015625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.15625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.15625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.171875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.18359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.21875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.546875,
            "end_logit": -5.921875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.546875,
            "end_logit": -6.4453125,
            "text": "e can be",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_5": [
        {
            "start_logit": 9.046875,
            "end_logit": 9.0625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.5986328125,
            "end_logit": 9.0625,
            "text": "e",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.80859375,
            "text": "GBs",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 9.0625,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.0234375,
            "text": "GBshape;",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.609375,
            "text": "GBshape; freely available at http:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.6328125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.703125,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.7109375,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.7578125,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.81640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.82421875,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.84765625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.93359375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9921875,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 9.0625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.12109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.125,
            "text": "GBshape; freely",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_6": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.09375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.546875,
            "end_logit": 9.09375,
            "text": "e",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -2.037109375,
            "text": "GBs",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -5.12890625,
            "end_logit": 9.09375,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -5.921875,
            "text": "GBshape can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.4453125,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.7734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.79296875,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.859375,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.02734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.08984375,
            "text": "GBshape can be used to visualize",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.1015625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.15625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.15625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.171875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.18359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.21875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.546875,
            "end_logit": -5.921875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.546875,
            "end_logit": -6.4453125,
            "text": "e can be",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_7": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.09375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.546875,
            "end_logit": 9.09375,
            "text": "e",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -2.037109375,
            "text": "GBs",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -5.12890625,
            "end_logit": 9.09375,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -5.921875,
            "text": "GBshape can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.4453125,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.7734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.79296875,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.859375,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.02734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.08984375,
            "text": "GBshape can be used to visualize",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.1015625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.15625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.15625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.171875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.18359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.21875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.2421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.546875,
            "end_logit": -5.921875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.546875,
            "end_logit": -6.4453125,
            "text": "e can be",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_8": [
        {
            "start_logit": 9.0078125,
            "end_logit": 9.0703125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": 9.0703125,
            "text": "e",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.953125,
            "text": "GBs",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 9.0703125,
            "text": "hape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.265625,
            "text": "GBshape:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.34375,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.953125,
            "text": "GBshape: a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.01953125,
            "text": "GBshape: a genome brow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.0234375,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.03125,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.078125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.10546875,
            "text": "GBshape: a genome browser database for DNA shape annotations.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.11328125,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.2265625,
            "text": "GBshape: a genome browser database for DNA shape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.2578125,
            "text": "GBshape: a genome browser database for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.28515625,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.42578125,
            "text": "GBshape: a genome browser database for DNA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.265625,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.34375,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.6201171875,
            "end_logit": -6.953125,
            "text": "e: a genome",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_9": [
        {
            "start_logit": 9.046875,
            "end_logit": 9.0625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.5986328125,
            "end_logit": 9.0625,
            "text": "e",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.80859375,
            "text": "GBs",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 9.0625,
            "text": "hape",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.0234375,
            "text": "GBshape;",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.609375,
            "text": "GBshape; freely available at http:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.6328125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.703125,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.7109375,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.7578125,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.81640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.82421875,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.84765625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.93359375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9921875,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 9.0625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.12109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.125,
            "text": "GBshape; freely",
            "probability": 1.1920928955078125e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_1": [
        {
            "start_logit": 5.86328125,
            "end_logit": 7.26953125,
            "text": "epidural blood patch",
            "probability": 0.9541015625
        },
        {
            "start_logit": 5.86328125,
            "end_logit": 4.10546875,
            "text": "epidural blood patch.",
            "probability": 0.04034423828125
        },
        {
            "start_logit": 0.55419921875,
            "end_logit": 7.26953125,
            "text": "CSF leak using an epidural blood patch",
            "probability": 0.00472259521484375
        },
        {
            "start_logit": 0.55419921875,
            "end_logit": 4.29296875,
            "text": "CSF leak",
            "probability": 0.0002416372299194336
        },
        {
            "start_logit": 0.55419921875,
            "end_logit": 4.10546875,
            "text": "CSF leak using an epidural blood patch.",
            "probability": 0.00020039081573486328
        },
        {
            "start_logit": -3.9609375,
            "end_logit": 7.26953125,
            "text": "patch",
            "probability": 5.14984130859375e-05
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 7.26953125,
            "text": "she was treated for CSF leak using an epidural blood patch",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 7.26953125,
            "text": "blood patch",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 7.26953125,
            "text": "was treated for CSF leak using an epidural blood patch",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -5.765625,
            "end_logit": 7.26953125,
            "text": "treated for CSF leak using an epidural blood patch",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -6.3125,
            "end_logit": 7.26953125,
            "text": "for CSF leak using an epidural blood patch",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 7.26953125,
            "text": "leak using an epidural blood patch",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": 5.86328125,
            "end_logit": -4.97265625,
            "text": "epidural",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -3.58984375,
            "end_logit": 4.10546875,
            "text": ".",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 4.29296875,
            "text": "she was treated for CSF leak",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -3.9609375,
            "end_logit": 4.10546875,
            "text": "patch.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -4.0234375,
            "end_logit": 4.10546875,
            "text": "she was treated for CSF leak using an epidural blood patch.",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.26953125,
            "text": "an epidural blood patch",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.26953125,
            "text": "using an epidural blood patch",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 5.86328125,
            "end_logit": -6.984375,
            "text": "epidural blood",
            "probability": 5.960464477539062e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_2": [
        {
            "start_logit": 8.7734375,
            "end_logit": 8.703125,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -2.2265625,
            "text": "epidural",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -2.28125,
            "end_logit": 8.703125,
            "text": "patch",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 8.703125,
            "text": "blood patch",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -5.23828125,
            "text": "epidural blood patch providing",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 8.703125,
            "text": "invasive measures with epidural blood patch",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.37890625,
            "text": "epidural blood patch providing the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.6171875,
            "text": "epidural blood patch providing the cornerstone",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.06640625,
            "text": "epidural blood patch providing the cornerstone of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.13671875,
            "text": "epidural blood patch providing the cornerstone of the invasive measures",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.19140625,
            "text": "epidural blood patch providing the cornerstone of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.23046875,
            "text": "epidural blood patch providing the cornerstone of the invasive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.703125,
            "text": "with epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.703125,
            "text": "measures with epidural blood patch",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.28125,
            "end_logit": -5.23828125,
            "text": "patch providing",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -2.2265625,
            "text": "invasive measures with epidural",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -6.37890625,
            "text": "patch providing the",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -6.6171875,
            "text": "patch providing the cornerstone",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -7.06640625,
            "text": "patch providing the cornerstone of",
            "probability": 0.0
        },
        {
            "start_logit": -2.28125,
            "end_logit": -7.13671875,
            "text": "patch providing the cornerstone of the invasive measures",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_3": [
        {
            "start_logit": 8.34375,
            "end_logit": 7.80078125,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": 8.34375,
            "end_logit": -2.908203125,
            "text": "epidural",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -3.53125,
            "end_logit": 7.80078125,
            "text": "patch",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.04296875,
            "text": "epidural blood patch should",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.515625,
            "text": "epidural blood patch should be performed",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.0625,
            "end_logit": 7.80078125,
            "text": "blood patch",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.75390625,
            "text": "epidural blood patch should be",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.80078125,
            "text": "epidural blood",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 7.80078125,
            "text": ", epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.80078125,
            "text": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.80078125,
            "text": "needle puncture, epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.80078125,
            "text": "puncture, epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.80078125,
            "text": "risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.80078125,
            "text": "postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.80078125,
            "text": ", for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.80078125,
            "text": "patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.53125,
            "end_logit": -6.04296875,
            "text": "patch should",
            "probability": 0.0
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -2.908203125,
            "text": ", epidural",
            "probability": 0.0
        },
        {
            "start_logit": -3.53125,
            "end_logit": -6.515625,
            "text": "patch should be performed",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -2.908203125,
            "text": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_4": [
        {
            "start_logit": 7.97265625,
            "end_logit": 7.3125,
            "text": "acupuncture",
            "probability": 1.0
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -4.796875,
            "text": "acupuncture rather than an epidural blood patch.",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -6.1015625,
            "text": "acupuncture rather",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -6.73046875,
            "text": "acupuncture rather than an epidural blood patch",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -6.90625,
            "text": "acupuncture rather than",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.0390625,
            "text": "acupuncture rather than an",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.09765625,
            "text": "acupuncture rather than an epidural blood",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.2578125,
            "text": "acupuncture rather than an epidural",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.3125,
            "text": "Both parturients were successfully managed using acupuncture",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.3125,
            "text": "using acupuncture",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.3125,
            "text": "parturients were successfully managed using acupuncture",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.3125,
            "text": "managed using acupuncture",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.3125,
            "text": "successfully managed using acupuncture",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.3125,
            "text": "ients were successfully managed using acupuncture",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.3125,
            "text": "urients were successfully managed using acupuncture",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.3125,
            "text": "were successfully managed using acupuncture",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.109375,
            "end_logit": -4.796875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.73828125,
            "end_logit": -4.796875,
            "text": "Both parturients were successfully managed using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -4.796875,
            "text": "using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -4.796875,
            "text": "parturients were successfully managed using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_5": [
        {
            "start_logit": 4.09375,
            "end_logit": 6.77734375,
            "text": "epidural blood patch",
            "probability": 0.998046875
        },
        {
            "start_logit": -2.9453125,
            "end_logit": 6.77734375,
            "text": "blood patch",
            "probability": 0.0008716583251953125
        },
        {
            "start_logit": -3.880859375,
            "end_logit": 6.77734375,
            "text": "after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.0003426074981689453
        },
        {
            "start_logit": -4.31640625,
            "end_logit": 6.77734375,
            "text": "In this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.00022125244140625
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 6.77734375,
            "text": "patch",
            "probability": 0.00021123886108398438
        },
        {
            "start_logit": -4.99609375,
            "end_logit": 6.77734375,
            "text": "case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": -5.12890625,
            "end_logit": 6.77734375,
            "text": "LP shunt placement alleviated by an epidural blood patch",
            "probability": 9.822845458984375e-05
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 6.77734375,
            "text": "shunt placement alleviated by an epidural blood patch",
            "probability": 9.590387344360352e-05
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 6.77734375,
            "text": "this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 6.341934204101562e-05
        },
        {
            "start_logit": 4.09375,
            "end_logit": -3.1953125,
            "text": "epidural blood patch.",
            "probability": 4.6372413635253906e-05
        },
        {
            "start_logit": -3.880859375,
            "end_logit": 4.72265625,
            "text": "after LP shunt placement",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 6.77734375,
            "text": "placement alleviated by an epidural blood patch",
            "probability": 3.641843795776367e-05
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 6.77734375,
            "text": "a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 3.641843795776367e-05
        },
        {
            "start_logit": -4.31640625,
            "end_logit": 4.72265625,
            "text": "In this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 2.8371810913085938e-05
        },
        {
            "start_logit": -6.6875,
            "end_logit": 6.77734375,
            "text": ", a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 2.0742416381835938e-05
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.77734375,
            "text": "low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 6.77734375,
            "text": "an epidural blood patch",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -4.99609375,
            "end_logit": 4.72265625,
            "text": "case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 6.77734375,
            "text": "17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement alleviated by an epidural blood patch",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 6.77734375,
            "text": "by an epidural blood patch",
            "probability": 1.2636184692382812e-05
        }
    ],
    "53262cdcd6d3ac6a34000003_6": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.296875,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": -2.9140625,
            "end_logit": 8.296875,
            "text": "patch",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -3.095703125,
            "text": "epidural",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.3125,
            "text": "epidural blood",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 8.296875,
            "text": "blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.296875,
            "text": "(within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.296875,
            "text": "offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.296875,
            "text": "within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.296875,
            "text": "dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.296875,
            "text": "patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.296875,
            "text": "of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": -3.095703125,
            "text": "(within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -3.095703125,
            "text": "offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -3.095703125,
            "text": "within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -3.095703125,
            "text": "dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -3.095703125,
            "text": "patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -3.095703125,
            "text": "of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -6.9140625,
            "end_logit": -6.3125,
            "text": "blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.3125,
            "text": "(within 24-48 h of dural puncture) epidural blood",
            "probability": 0.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": -6.3125,
            "text": "offered early (within 24-48 h of dural puncture) epidural blood",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_1": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.71875,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.6162109375,
            "text": "DSM",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -2.322265625,
            "end_logit": 8.71875,
            "text": "NC",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.59375,
            "text": "DSMNC:",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.0703125,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.4765625,
            "text": "DSMNC: a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.80078125,
            "text": "DSMNC: a database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.9140625,
            "text": "DSMNC: a database of somatic mutations in normal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.9296875,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.98828125,
            "text": "DSMNC: a database of somatic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.015625,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.0546875,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.12109375,
            "text": "DSMNC: a database of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -5.59375,
            "text": "NC:",
            "probability": 0.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -6.0703125,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -6.4765625,
            "text": "NC: a",
            "probability": 0.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -6.80078125,
            "text": "NC: a database",
            "probability": 0.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -6.9140625,
            "text": "NC: a database of somatic mutations in normal",
            "probability": 0.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -6.9296875,
            "text": "NC: a database of somatic mutations in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": -2.322265625,
            "end_logit": -6.98828125,
            "text": "NC: a database of somatic",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_2": [
        {
            "start_logit": 8.4453125,
            "end_logit": 8.9296875,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": 8.9296875,
            "text": "NC",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -2.365234375,
            "end_logit": 8.9296875,
            "text": ". Here, we established DSMNC",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -2.76171875,
            "text": "DSM",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -3.728515625,
            "end_logit": 8.9296875,
            "text": "established DSMNC",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -4.3046875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.0625,
            "end_logit": 8.9296875,
            "text": "Here, we established DSMNC",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -6.16796875,
            "text": "DSMNC:",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -6.17578125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -6.25,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.365234375,
            "end_logit": -2.76171875,
            "text": ". Here, we established DSM",
            "probability": 0.0
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": -4.3046875,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -3.728515625,
            "end_logit": -2.76171875,
            "text": "established DSM",
            "probability": 0.0
        },
        {
            "start_logit": -2.365234375,
            "end_logit": -4.30078125,
            "text": ". In the current version, the database collected \u223c",
            "probability": 0.0
        },
        {
            "start_logit": -2.365234375,
            "end_logit": -4.3046875,
            "text": ". Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 0.0
        },
        {
            "start_logit": -2.365234375,
            "end_logit": -4.6796875,
            "text": ". In the current version, the database collected \u223c0.8",
            "probability": 0.0
        },
        {
            "start_logit": -2.365234375,
            "end_logit": -5.328125,
            "text": ". In the current version, the database collected \u223c0",
            "probability": 0.0
        },
        {
            "start_logit": -5.0625,
            "end_logit": -2.76171875,
            "text": "Here, we established DSM",
            "probability": 0.0
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": -6.16796875,
            "text": "NC:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": -6.17578125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_3": [
        {
            "start_logit": 9.0546875,
            "end_logit": 8.8984375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.7880859375,
            "text": "DSM",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.9306640625,
            "end_logit": 8.8984375,
            "text": "NC",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.3828125,
            "text": "DSMNC:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.6953125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 8.8984375,
            "text": "established DSMNC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.80078125,
            "text": "DSMNC: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98828125,
            "text": "DSMNC: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98828125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.0234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.8984375,
            "text": "Here, we established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.06640625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.15625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 8.8984375,
            "text": ", we established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.20703125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "DSMNC: a database of somatic mutations in normal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.24609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/),",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.8984375,
            "text": "we established DSMNC",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_4": [
        {
            "start_logit": 9.203125,
            "end_logit": 8.765625,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.42578125,
            "text": "DSM",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -2.21875,
            "end_logit": 8.765625,
            "text": "NC",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.87109375,
            "text": "DSMNC:",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.16796875,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.41796875,
            "text": "DSMNC: a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.7734375,
            "text": "DSMNC: a database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.0,
            "text": "DSMNC: a database of somatic mutations in normal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.06640625,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.0703125,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.078125,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.08203125,
            "text": "DSMNC: a database of somatic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.09765625,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.09765625,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.1484375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.21875,
            "end_logit": -5.87109375,
            "text": "NC:",
            "probability": 0.0
        },
        {
            "start_logit": -2.21875,
            "end_logit": -6.16796875,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -2.21875,
            "end_logit": -6.41796875,
            "text": "NC: a",
            "probability": 0.0
        },
        {
            "start_logit": -2.21875,
            "end_logit": -6.7734375,
            "text": "NC: a database",
            "probability": 0.0
        },
        {
            "start_logit": -2.21875,
            "end_logit": -7.0,
            "text": "NC: a database of somatic mutations in normal",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_5": [
        {
            "start_logit": 9.0546875,
            "end_logit": 8.8984375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.7880859375,
            "text": "DSM",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.9306640625,
            "end_logit": 8.8984375,
            "text": "NC",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.3828125,
            "text": "DSMNC:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.6953125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 8.8984375,
            "text": "established DSMNC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.80078125,
            "text": "DSMNC: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98828125,
            "text": "DSMNC: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98828125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.0234375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.8984375,
            "text": "Here, we established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.06640625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.15625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 8.8984375,
            "text": ", we established DSMNC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.20703125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "DSMNC: a database of somatic mutations in normal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.24609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/),",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 8.8984375,
            "text": "we established DSMNC",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a690487b750ff445500001f_1": [
        {
            "start_logit": 9.1171875,
            "end_logit": 8.765625,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -0.364501953125,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 0.00010889768600463867
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.640625,
            "text": "Epstein",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -2.060546875,
            "end_logit": 8.765625,
            "text": "virus",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -2.462890625,
            "text": "Epstein-Barr virus (EBV",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 8.765625,
            "text": "Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 8.765625,
            "text": "-Barr virus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.5234375,
            "text": "Epstein-Barr virus (EBV) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.85546875,
            "text": "Epstein-Barr virus (EBV) is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.953125,
            "text": "Epstein-Barr virus (EBV) is a highly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.12890625,
            "text": "Epstein-Barr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.3408203125,
            "end_logit": -0.364501953125,
            "text": "EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -2.060546875,
            "end_logit": -0.364501953125,
            "text": "virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3408203125,
            "end_logit": -2.462890625,
            "text": "EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.060546875,
            "end_logit": -2.462890625,
            "text": "virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -5.24609375,
            "end_logit": -0.364501953125,
            "text": "(EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -5.83984375,
            "end_logit": -0.364501953125,
            "text": "Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -6.15234375,
            "end_logit": -0.364501953125,
            "text": "-Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3408203125,
            "end_logit": -5.828125,
            "text": "EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents.",
            "probability": 0.0
        },
        {
            "start_logit": -5.24609375,
            "end_logit": -2.462890625,
            "text": "(EBV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_2": [
        {
            "start_logit": 7.8671875,
            "end_logit": 7.00390625,
            "text": "cytomegalovirus",
            "probability": 1.0
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -5.875,
            "text": "cytomegalovirus (CMV",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -5.05078125,
            "end_logit": 7.00390625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.0234375,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.4375,
            "text": "cytomegalovirus (CMV)",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.7421875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.0546875,
            "text": "cytomegalovirus (CMV) IgM and IgG were",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.00390625,
            "text": "her cytomegalovirus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.00390625,
            "text": "Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.00390625,
            "text": "-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -3.380859375,
            "text": ". Further investigation showed the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -5.05078125,
            "end_logit": -3.380859375,
            "text": "Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -5.2265625,
            "end_logit": -3.380859375,
            "text": "positive monospot test result. Further investigation showed the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -3.380859375,
            "text": "a positive monospot test result. Further investigation showed the Epstein-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -3.380859375,
            "text": "Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -3.380859375,
            "text": "-Barr virus",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -6.25,
            "text": ". Further investigation showed the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to",
            "probability": 0.0
        },
        {
            "start_logit": -4.47265625,
            "end_logit": -6.7421875,
            "text": ". Initial investigations revealed atypical lymphocytosis, thrombocytopenia, elevated liver enzymes, and a positive monospot test result.",
            "probability": 0.0
        },
        {
            "start_logit": -4.47265625,
            "end_logit": -6.7421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.4765625,
            "end_logit": -6.7421875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_3": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.71875,
            "text": "Epstein-Barr virus infection",
            "probability": 1.0
        },
        {
            "start_logit": 0.9560546875,
            "end_logit": 8.71875,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 0.0003859996795654297
        },
        {
            "start_logit": -1.9375,
            "end_logit": 8.71875,
            "text": "infection",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.326171875,
            "text": "Epstein",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -3.982421875,
            "end_logit": 8.71875,
            "text": ". The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -4.5078125,
            "text": "Epstein-Barr virus",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 0.9560546875,
            "end_logit": 2.54296875,
            "text": "infectious mononucleosis",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 8.71875,
            "text": "Barr virus infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 8.71875,
            "text": "virus infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.71875,
            "text": "-Barr virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.4921875,
            "text": "Epstein-Barr virus infection.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 8.71875,
            "text": "to Epstein-Barr virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.89453125,
            "text": "Epstein-Barr",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 8.71875,
            "text": "mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.71875,
            "text": "osis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.9560546875,
            "end_logit": -2.326171875,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -3.982421875,
            "end_logit": 2.54296875,
            "text": ". He was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": -3.982421875,
            "end_logit": 2.54296875,
            "text": ". The unifying diagnosis was infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": -3.984375,
            "end_logit": 2.54296875,
            "text": ". This had likely caused referred pain through diaphragmatic irritation. He was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis",
            "probability": 0.0
        },
        {
            "start_logit": 0.9560546875,
            "end_logit": -4.5078125,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_4": [
        {
            "start_logit": 9.125,
            "end_logit": 8.7265625,
            "text": "Epstein-Barr virus",
            "probability": 0.9970703125
        },
        {
            "start_logit": 9.125,
            "end_logit": 2.7734375,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 0.0026111602783203125
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.638671875,
            "text": "Epstein",
            "probability": 3.159046173095703e-05
        },
        {
            "start_logit": -2.138671875,
            "end_logit": 8.7265625,
            "text": "virus",
            "probability": 1.2874603271484375e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -3.52734375,
            "text": "Epstein-Barr virus (EBV",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 8.7265625,
            "text": "Barr virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.859375,
            "end_logit": 8.7265625,
            "text": "-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.76953125,
            "text": "Epstein-Barr virus (EBV) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 8.7265625,
            "text": "with Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 8.7265625,
            "text": "Infection with Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 8.7265625,
            "text": "BACKGROUND: Infection with Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5810546875,
            "end_logit": 2.7734375,
            "text": "EBV)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.138671875,
            "end_logit": 2.7734375,
            "text": "virus (EBV)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.27734375,
            "end_logit": 2.7734375,
            "text": "(EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 2.7734375,
            "text": "Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -5.859375,
            "end_logit": 2.7734375,
            "text": "-Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 2.7734375,
            "text": "with Epstein-Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 2.7734375,
            "text": "Infection with Epstein-Barr virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": 2.7734375,
            "text": ")",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 2.7734375,
            "text": "BACKGROUND: Infection with Epstein-Barr virus (EBV)",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_5": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.1015625,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -1.3720703125,
            "end_logit": 9.1015625,
            "text": "virus",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.5791015625,
            "text": "Epstein",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 9.1015625,
            "text": "Barr virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 9.1015625,
            "text": "-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.7109375,
            "text": "Epstein-Barr virus viral load",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.83984375,
            "text": "Epstein-Barr virus viral load (EBV-VL",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 9.1015625,
            "text": "of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.953125,
            "text": "Epstein-Barr virus viral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.01953125,
            "text": "Epstein-Barr virus viral load (EBV-VL)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.06640625,
            "text": "Epstein-Barr virus viral load (EBV",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1171875,
            "text": "Epstein-Barr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.13671875,
            "text": "Epstein-Barr virus viral load (EBV-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.171875,
            "text": "Epstein-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.1015625,
            "text": "measurement of Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.1015625,
            "text": "antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.1015625,
            "text": "IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3720703125,
            "end_logit": -6.7109375,
            "text": "virus viral load",
            "probability": 0.0
        },
        {
            "start_logit": -1.3720703125,
            "end_logit": -6.83984375,
            "text": "virus viral load (EBV-VL",
            "probability": 0.0
        },
        {
            "start_logit": -1.3720703125,
            "end_logit": -6.953125,
            "text": "virus viral",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_6": [
        {
            "start_logit": 9.1015625,
            "end_logit": 9.09375,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": 9.09375,
            "text": "virus",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.701171875,
            "text": "Epstein",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -3.3359375,
            "text": "Epstein-Barr virus-related infectious mononucleosis",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -4.609375,
            "end_logit": 9.09375,
            "text": ". The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -4.609375,
            "end_logit": 9.09375,
            "text": ". Epstein-Barr virus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.75,
            "end_logit": 9.09375,
            "text": "Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 9.09375,
            "text": "-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.4296875,
            "text": "Epstein-Barr virus-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.72265625,
            "text": "Epstein-Barr virus-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.80859375,
            "text": "Epstein-Barr virus-related infectious mononucleosis was",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.9375,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the most likely diagnosis for our patient.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.0625,
            "text": "Epstein-Barr virus-related infectious mononucle",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.13671875,
            "text": "Epstein-Barr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.19140625,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.20703125,
            "text": "Epstein-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.265625,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.09375,
            "text": "his rash. Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.09375,
            "text": "peripheral smear, and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -3.3359375,
            "text": "virus-related infectious mononucleosis",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_7": [
        {
            "start_logit": 7.9296875,
            "end_logit": 8.2578125,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.6591796875,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis",
            "probability": 0.00013339519500732422
        },
        {
            "start_logit": -2.673828125,
            "end_logit": 8.2578125,
            "text": "virus",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 2.57421875,
            "end_logit": 2.443359375,
            "text": "Cytomegalovirus (CMV) infection",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -2.994140625,
            "text": "Epstein",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -4.1328125,
            "text": "Epstein-Barr virus (EBV",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -4.9296875,
            "end_logit": 8.2578125,
            "text": "Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -4.76953125,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -5.0625,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 8.2578125,
            "text": "against Epstein-Barr virus",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.6484375,
            "end_logit": 8.2578125,
            "text": "both viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.015625,
            "end_logit": 8.2578125,
            "text": "Barr virus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -5.71875,
            "text": "Epstein-Barr virus (",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -5.765625,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested for anti-CMV",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 8.2578125,
            "text": "-Barr virus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 8.2578125,
            "text": "viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.44921875,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested for anti-CMV (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.998046875,
            "end_logit": 2.443359375,
            "text": "acute infectious mononucleosis and tested for anti-CMV (IgM) by ELISA technique for the diagnosis of acute Cytomegalovirus (CMV) infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.57421875,
            "end_logit": -2.591796875,
            "text": "Cytomegalovirus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.5078125,
            "end_logit": 2.443359375,
            "text": "infectious mononucleosis and tested for anti-CMV (IgM) by ELISA technique for the diagnosis of acute Cytomegalovirus (CMV) infection",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a690487b750ff445500001f_8": [
        {
            "start_logit": 9.140625,
            "end_logit": 9.1171875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": 9.1171875,
            "text": "virus",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.59375,
            "text": "Epstein",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -5.640625,
            "end_logit": 9.1171875,
            "text": "Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.37890625,
            "text": "Epstein-Barr virus.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 9.1171875,
            "text": "-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 9.1171875,
            "text": "for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.78515625,
            "text": "Epstein-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.8203125,
            "text": "Epstein-Barr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 9.1171875,
            "text": ", but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.1171875,
            "text": "positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.1171875,
            "text": "had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 9.1171875,
            "text": "a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.328125,
            "end_logit": 9.1171875,
            "text": "His septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.1171875,
            "text": "but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.1171875,
            "text": "he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.1171875,
            "text": "septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.1171875,
            "text": "immunoglobulin G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.1171875,
            "text": "G for Epstein-Barr virus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": -6.37890625,
            "text": "virus.",
            "probability": 0.0
        }
    ],
    "5c89623bf9c2ba6b28000004_1": [
        {
            "start_logit": -1.923828125,
            "end_logit": -0.8212890625,
            "text": "(c.19G>A, p.Val7Met",
            "probability": 0.4580078125
        },
        {
            "start_logit": -2.61328125,
            "end_logit": -0.8212890625,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.2303466796875
        },
        {
            "start_logit": -3.169921875,
            "end_logit": -0.8212890625,
            "text": "Val7Met",
            "probability": 0.1317138671875
        },
        {
            "start_logit": -4.078125,
            "end_logit": -0.8212890625,
            "text": ", p.Val7Met",
            "probability": 0.05322265625
        },
        {
            "start_logit": -4.25390625,
            "end_logit": -0.8212890625,
            "text": "novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.044647216796875
        },
        {
            "start_logit": -5.01171875,
            "end_logit": -0.8212890625,
            "text": "p.Val7Met",
            "probability": 0.0209197998046875
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -4.1171875,
            "text": "(c.19G>A, p.Val7Met) of CFL2 was identified in both siblings.",
            "probability": 0.0170135498046875
        },
        {
            "start_logit": -5.6640625,
            "end_logit": -0.8212890625,
            "text": "missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.010894775390625
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -0.8212890625,
            "text": "mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0088958740234375
        },
        {
            "start_logit": -3.169921875,
            "end_logit": -4.1171875,
            "text": "Val7Met) of CFL2 was identified in both siblings.",
            "probability": 0.00487518310546875
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -5.625,
            "text": "(c.19G>A, p.Val7Met)",
            "probability": 0.0037670135498046875
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -6.19921875,
            "text": "(c.19G>A, p",
            "probability": 0.0021114349365234375
        },
        {
            "start_logit": -4.078125,
            "end_logit": -4.1171875,
            "text": ", p.Val7Met) of CFL2 was identified in both siblings.",
            "probability": 0.0019683837890625
        },
        {
            "start_logit": -2.61328125,
            "end_logit": -5.625,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met)",
            "probability": 0.0018939971923828125
        },
        {
            "start_logit": -4.15625,
            "end_logit": -4.1171875,
            "text": ".",
            "probability": 0.0018205642700195312
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -6.38671875,
            "text": "(c",
            "probability": 0.001750946044921875
        },
        {
            "start_logit": -4.25390625,
            "end_logit": -4.1171875,
            "text": "novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met) of CFL2 was identified in both siblings.",
            "probability": 0.0016460418701171875
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -6.4609375,
            "text": "(c.19G>A, p.Val7Met) of CFL2 was identified",
            "probability": 0.0016326904296875
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -6.484375,
            "text": "(c.19G>A, p.Val7",
            "probability": 0.00159454345703125
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -6.734375,
            "text": "(c.19G",
            "probability": 0.0012416839599609375
        }
    ],
    "56c85ed65795f9a73e000012_1": [
        {
            "start_logit": 8.09375,
            "end_logit": 4.27734375,
            "text": "inhibits",
            "probability": 1.0
        },
        {
            "start_logit": 8.09375,
            "end_logit": -4.2578125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.00019562244415283203
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.375,
            "text": "inhibits TCR-",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.39453125,
            "text": "inhibits TCR-mediated signal transduction,",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.4921875,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.6015625,
            "text": "inhibits TCR",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.6328125,
            "text": "inhibits TCR-mediated",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.6484375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.8984375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production,",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.94921875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation,",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.03515625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.09765625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.11328125,
            "text": "inhibits TCR-mediated signal",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": -4.37109375,
            "end_logit": 4.27734375,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 4.27734375,
            "text": ", we show that dasatinib inhibits",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.9375,
            "end_logit": 4.27734375,
            "text": "we show that dasatinib inhibits",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 4.27734375,
            "text": "that dasatinib inhibits",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 4.27734375,
            "text": "show that dasatinib inhibits",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 4.27734375,
            "text": "dasatinib inhibits",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.05859375,
            "end_logit": -4.2578125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "56c85ed65795f9a73e000012_2": [
        {
            "start_logit": 6.859375,
            "end_logit": 4.33984375,
            "text": "inhibits",
            "probability": 1.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": 4.33984375,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -6.4921875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -6.6796875,
            "text": "inhibits TCR",
            "probability": 1.633167266845703e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -6.6953125,
            "text": "inhibits TCR-mediated",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -6.6953125,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -6.734375,
            "text": "inhibits TCR-",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -6.76171875,
            "text": "inhibits TCR-mediated signal transduction,",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -7.00390625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation,",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -7.078125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -7.08984375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 6.859375,
            "end_logit": -7.1171875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -5.30078125,
            "end_logit": 4.33984375,
            "text": ", we show that dasatinib inhibits",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -6.328125,
            "end_logit": 4.33984375,
            "text": "we show that dasatinib inhibits",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 4.33984375,
            "text": "that dasatinib inhibits",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 4.33984375,
            "text": "show that dasatinib inhibits",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 4.33984375,
            "text": "dasatinib inhibits",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -6.4921875,
            "text": "Herein, we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -6.6796875,
            "text": "Herein, we show that dasatinib inhibits TCR",
            "probability": 0.0
        },
        {
            "start_logit": -3.685546875,
            "end_logit": -6.6953125,
            "text": "Herein, we show that dasatinib inhibits TCR-mediated",
            "probability": 0.0
        }
    ],
    "56c85ed65795f9a73e000012_3": [
        {
            "start_logit": -0.38818359375,
            "end_logit": -5.7578125,
            "text": "inhibits",
            "probability": 0.2392578125
        },
        {
            "start_logit": -0.38818359375,
            "end_logit": -5.984375,
            "text": "inhibits T-cell activation and proliferation",
            "probability": 0.1907958984375
        },
        {
            "start_logit": -0.38818359375,
            "end_logit": -6.34765625,
            "text": "inhibits T-cell activation",
            "probability": 0.132568359375
        },
        {
            "start_logit": -0.38818359375,
            "end_logit": -6.39453125,
            "text": "inhibits T-cell activation and",
            "probability": 0.12646484375
        },
        {
            "start_logit": -0.38818359375,
            "end_logit": -6.47265625,
            "text": "inhibits T-cell",
            "probability": 0.1170654296875
        },
        {
            "start_logit": -0.38818359375,
            "end_logit": -6.78125,
            "text": "inhibits T",
            "probability": 0.08599853515625
        },
        {
            "start_logit": -0.38818359375,
            "end_logit": -6.921875,
            "text": "inhibits T-",
            "probability": 0.07470703125
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -5.46875,
            "text": "protein tyrosine kinase",
            "probability": 0.006500244140625
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -5.7578125,
            "text": "protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.00490570068359375
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -5.984375,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 0.0038814544677734375
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1953125,
            "text": "protein tyrosine kinase inhibitor",
            "probability": 0.0031681060791015625
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.34765625,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation",
            "probability": 0.0027103424072265625
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.39453125,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and",
            "probability": 0.00258636474609375
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.47265625,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.002391815185546875
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.78125,
            "text": "protein tyrosine kinase inhibitor, inhibits T",
            "probability": 0.0017499923706054688
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.921875,
            "text": "protein tyrosine kinase inhibitor, inhibits T-",
            "probability": 0.0015201568603515625
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -7.35546875,
            "text": "protein tyrosine",
            "probability": 0.0009889602661132812
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -5.46875,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.0009293556213378906
        },
        {
            "start_logit": -6.37890625,
            "end_logit": -5.46875,
            "text": "molecule protein tyrosine kinase",
            "probability": 0.0008015632629394531
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -5.7578125,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.0006957054138183594
        }
    ],
    "56c85ed65795f9a73e000012_4": [
        {
            "start_logit": 7.46875,
            "end_logit": 1.462890625,
            "text": "inhibits",
            "probability": 0.9658203125
        },
        {
            "start_logit": 7.46875,
            "end_logit": -1.9326171875,
            "text": "inhibits T-cell activation and proliferation.",
            "probability": 0.032440185546875
        },
        {
            "start_logit": 7.46875,
            "end_logit": -6.3359375,
            "text": "inhibits T-cell activation and",
            "probability": 0.00039696693420410156
        },
        {
            "start_logit": 7.46875,
            "end_logit": -6.44921875,
            "text": "inhibits T-cell activation and proliferation",
            "probability": 0.00035452842712402344
        },
        {
            "start_logit": 7.46875,
            "end_logit": -6.6328125,
            "text": "inhibits T-cell activation",
            "probability": 0.0002949237823486328
        },
        {
            "start_logit": 7.46875,
            "end_logit": -6.76953125,
            "text": "inhibits T-cell",
            "probability": 0.0002562999725341797
        },
        {
            "start_logit": 7.46875,
            "end_logit": -7.19921875,
            "text": "inhibits T",
            "probability": 0.00016808509826660156
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 1.462890625,
            "text": "protein tyrosine kinase inhibitor, inhibits",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 1.462890625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 1.462890625,
            "text": "tyrosine kinase inhibitor, inhibits",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 1.462890625,
            "text": "molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 1.462890625,
            "text": "small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 1.462890625,
            "text": "atinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 1.462890625,
            "text": ", a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 1.462890625,
            "text": "kinase inhibitor, inhibits",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 1.462890625,
            "text": "a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 1.462890625,
            "text": "-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 1.462890625,
            "text": ", inhibits",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.41796875,
            "end_logit": -1.9326171875,
            "text": ".",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4453125,
            "end_logit": -1.9326171875,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c85ed65795f9a73e000012_5": [
        {
            "start_logit": 8.8515625,
            "end_logit": 4.68359375,
            "text": "inhibits",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -2.4453125,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.0008034706115722656
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -2.470703125,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.0007848739624023438
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.39453125,
            "text": "inhibits the",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.41015625,
            "text": "inhibits the proliferation and",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.5546875,
            "text": "inhibits the proliferation",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.59765625,
            "text": "inhibits the proliferation and function of",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.65625,
            "text": "inhibits the proliferation and function of CD4+CD25",
            "probability": 1.1920928955078125e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.74609375,
            "text": "inhibits the proliferation and function",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.8359375,
            "text": "inhibits the proliferation and function of CD4+CD25+",
            "probability": 9.953975677490234e-06
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -6.96875,
            "text": "inhibits the proliferation and function of CD4",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -7.1484375,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -7.171875,
            "text": "inhibits the proliferation and function of CD4+",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 4.68359375,
            "text": "Dasatinib inhibits",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 4.68359375,
            "text": "atinib inhibits",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.56640625,
            "end_logit": -2.4453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": -2.4453125,
            "text": "T cells.",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": -2.470703125,
            "text": "T cells",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -2.4453125,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -2.470703125,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_1": [
        {
            "start_logit": 6.1640625,
            "end_logit": 3.787109375,
            "text": "Liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.1640625,
            "end_logit": -5.8046875,
            "text": "Liver Injury",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 6.1640625,
            "end_logit": -6.015625,
            "text": "Liver Injury Network.",
            "probability": 5.519390106201172e-05
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 3.787109375,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 3.787109375,
            "text": ", prospective U.S. Drug-Induced Liver",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 3.787109375,
            "text": "prospective U.S. Drug-Induced Liver",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 3.787109375,
            "text": "of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 3.787109375,
            "text": "need for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 3.787109375,
            "text": "Induced Liver",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -3.154296875,
            "end_logit": -6.015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": -5.90234375,
            "text": "drug-induced hepatocellular jaundice",
            "probability": 0.0
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -5.8046875,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -5.90234375,
            "text": "of drug-induced hepatocellular jaundice",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": -6.4296875,
            "text": "drug-induced hepatocellular jaundice causing a case-fatality rate or need for transplant of",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -5.90234375,
            "text": "Hy's Law of drug-induced hepatocellular jaundice",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -5.8046875,
            "text": ", prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -5.8046875,
            "text": "prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -5.8046875,
            "text": "of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -5.8046875,
            "text": "Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": -6.61328125,
            "text": "drug-induced hepatocellular jaundice causing a case-fatality rate or need for transplant of 10",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_2": [
        {
            "start_logit": 7.27734375,
            "end_logit": 7.98046875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.98046875,
            "text": "with liver",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -6.98046875,
            "text": "liver injury patterns were found",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.0234375,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy's Law criteria.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.0703125,
            "text": "liver injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.08984375,
            "text": "liver injury patterns",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.2421875,
            "text": "liver injury patterns were found to affect potential severity as measured",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.25390625,
            "text": "liver injury patterns were",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.30078125,
            "text": "liver injury patterns were found to affect potential severity as",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.30078125,
            "text": "liver injury patterns were found to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.31640625,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.3359375,
            "text": "liver injury patterns were found to affect potential severity as measured by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.890625,
            "end_logit": -7.0234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -6.98046875,
            "text": "with liver injury patterns were found",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.0234375,
            "text": "with liver injury patterns were found to affect potential severity as measured by Hy's Law criteria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.0703125,
            "text": "with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.08984375,
            "text": "with liver injury patterns",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.2421875,
            "text": "with liver injury patterns were found to affect potential severity as measured",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.0234375,
            "text": "severity as measured by Hy's Law criteria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.25390625,
            "text": "with liver injury patterns were",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_3": [
        {
            "start_logit": 7.21875,
            "end_logit": 7.83984375,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": 7.83984375,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.48046875,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.83984375,
            "text": ", liver",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.83984375,
            "text": "DILI from 2004 through 2010, liver",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.83984375,
            "text": ",353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.83984375,
            "text": "with DILI from 2004 through 2010, liver",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.21875,
            "end_logit": -7.03515625,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.03125,
            "end_logit": -6.0625,
            "text": ".We conducted a retrospective cohort study of 15",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -6.48046875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -6.48046875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -6.90234375,
            "text": ".We conducted a retrospective cohort study of 15,35",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -6.9453125,
            "text": ".We conducted a retrospective cohort study of 15,",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -6.94921875,
            "text": ".We",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -7.00390625,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -7.01171875,
            "text": ".We conducted a retrospective",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -7.12890625,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanent",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -7.1328125,
            "text": ".We conducted",
            "probability": 0.0
        },
        {
            "start_logit": -4.03125,
            "end_logit": -7.1484375,
            "text": ".We conducted a retrospective cohort",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -6.0625,
            "text": "alanine aminotransferase or aspartate aminotransferase and total bilirubin, and validated the model in a separate sample.We conducted a retrospective cohort study of 15",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_4": [
        {
            "start_logit": 7.8359375,
            "end_logit": 7.46484375,
            "text": "Liver",
            "probability": 1.0
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.60546875,
            "text": "Liver Failure",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.8828125,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -6.9375,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.1328125,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury:",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.19140625,
            "text": "Liver Failure in Patients With Drug-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.24609375,
            "text": "Liver Failure in Patients",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.25390625,
            "text": "Liver Failure in",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.25390625,
            "text": "Liver Failure in Patients With Drug-Induced",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.2734375,
            "text": "Liver Failure in Patients With",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.2734375,
            "text": "Liver Failure in Patients With Drug",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -7.2890625,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.46484375,
            "text": "Acute Liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.46484375,
            "text": "Risk of Acute Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.296875,
            "end_logit": -6.8828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.60546875,
            "text": "Acute Liver Failure",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -6.60546875,
            "text": "Risk of Acute Liver Failure",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.8828125,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.9375,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -6.8828125,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_5": [
        {
            "start_logit": 7.50390625,
            "end_logit": 7.6796875,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -6.94921875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF).",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.0546875,
            "text": "liver injury",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.125,
            "text": "liver injury (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.12890625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.1328125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.1328125,
            "text": "liver injury (DILI",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.1484375,
            "text": "liver injury (DILI)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.16015625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.17578125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.18359375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.19921875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.2109375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.26953125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.6796875,
            "text": "hepatocellular drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.6796875,
            "text": "that hepatocellular drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.6796875,
            "text": "states that hepatocellular drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.6796875,
            "text": "drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.859375,
            "end_logit": -6.94921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -6.94921875,
            "text": "acute liver failure (ALF).",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_6": [
        {
            "start_logit": 7.4609375,
            "end_logit": 7.70703125,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -6.921875,
            "text": "liver injury",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.16796875,
            "text": "liver injury (DILI",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.23828125,
            "text": "liver injury (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.28125,
            "text": "liver injury (DILI)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.70703125,
            "text": "identify drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.38671875,
            "text": "liver injury (DIL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -6.921875,
            "text": "identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.16796875,
            "text": "identify drug-induced liver injury (DILI",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.23828125,
            "text": "identify drug-induced liver injury (",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.28125,
            "text": "identify drug-induced liver injury (DILI)",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.38671875,
            "text": "identify drug-induced liver injury (DIL",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_7": [
        {
            "start_logit": 7.47265625,
            "end_logit": 7.828125,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.20703125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.21875,
            "text": "liver injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.828125,
            "text": "severe liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.2734375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.2890625,
            "text": "liver injury is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.3125,
            "text": "liver injury is identified",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.32421875,
            "text": "liver injury is identified in clinical trials by ALT>3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.3359375,
            "text": "liver injury is identified in clinical trials by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.33984375,
            "text": "liver injury is identified in clinical trials by ALT>",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.33984375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.34765625,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.34765625,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.47265625,
            "end_logit": -7.35546875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (UL",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.05859375,
            "end_logit": -7.23828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.20703125,
            "text": "in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -7.234375,
            "text": "'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -7.23828125,
            "text": "'Hy's Law' by the US FDA.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.20703125,
            "text": "clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN, and",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.20703125,
            "text": ", and",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_8": [
        {
            "start_logit": 7.48046875,
            "end_logit": 7.8203125,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.03125,
            "text": "liver injury",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.15234375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.19921875,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.203125,
            "text": "liver injury is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.8203125,
            "text": "Severe liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.21875,
            "text": "liver injury is identified",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.22265625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.22265625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.2265625,
            "text": "liver injury is identified by the liver chemistry threshold",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.23828125,
            "text": "liver injury is identified by",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.24609375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.2734375,
            "text": "liver injury is identified by the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.28125,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.85546875,
            "end_logit": -7.17578125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.03125,
            "text": "Severe liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.15234375,
            "text": "Severe liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.15234375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.19921875,
            "text": "Severe liver injury is identified by the liver chemistry threshold of alanine aminotransferase (",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.203125,
            "text": "Severe liver injury is",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_1": [
        {
            "start_logit": 7.44921875,
            "end_logit": 7.83984375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.44921875,
            "end_logit": -6.83984375,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.83984375,
            "text": "DOACs i.e., dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.83984375,
            "text": ", dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.83984375,
            "text": ", idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.83984375,
            "text": "ACs i.e., dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.83984375,
            "text": "idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 7.83984375,
            "text": "Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.83984375,
            "text": "one of the DOACs i.e., dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.83984375,
            "text": "by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.83984375,
            "text": "for one of the DOACs i.e., dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.83984375,
            "text": "rucizumab for one of the DOACs i.e., dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -6.83984375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -6.83984375,
            "text": "DOACs i.e., dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -6.96484375,
            "text": "DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -6.96875,
            "text": "DOACs i",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -6.83984375,
            "text": ", dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.0,
            "text": "DOACs i.e",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -6.83984375,
            "text": ", idarucizumab for one of the DOACs i.e., dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -6.90234375,
            "text": "So far",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_2": [
        {
            "start_logit": 8.5234375,
            "end_logit": 8.6328125,
            "text": "vitamin K antagonists",
            "probability": 1.0
        },
        {
            "start_logit": -2.2890625,
            "end_logit": 8.6328125,
            "text": "antagonists",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -2.6796875,
            "text": "vitamin",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -4.25390625,
            "end_logit": 8.6328125,
            "text": "dabigatran may be preferred to vitamin K antagonists",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -4.83984375,
            "end_logit": 8.6328125,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -5.6328125,
            "text": "vitamin K",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 8.6328125,
            "text": "K antagonists",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.640625,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.734375,
            "text": "vitamin K antagonists in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 8.6328125,
            "text": "apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.8125,
            "text": "vitamin K antagonists in patients without cancer or renal failure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.875,
            "text": "vitamin K antagonists in patients",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 8.6328125,
            "text": "oral anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.9296875,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such as idarucizumab and andexanet",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.93359375,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.9453125,
            "text": "vitamin K antagonists in patients without cancer or renal failure,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.6328125,
            "text": "rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.6328125,
            "text": ", or dabigatran may be preferred to vitamin K antagonists",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 8.6328125,
            "text": "to vitamin K antagonists",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.6328125,
            "text": "New oral anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7237672dc08e987e000008_3": [
        {
            "start_logit": 7.2578125,
            "end_logit": 8.0625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.0625,
            "text": "in immediate, complete and sustained reversal of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.0625,
            "text": "immediate, complete and sustained reversal of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.0625,
            "text": "Idarucizumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.0625,
            "text": "of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.0625,
            "text": "rucizumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0625,
            "text": ", complete and sustained reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.0625,
            "text": "complete and sustained reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.0625,
            "text": "reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.0625,
            "text": "izumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.0625,
            "text": "resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.0625,
            "text": "sustained reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -6.9921875,
            "text": "dabigatran anticoagulant",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.015625,
            "text": "dabigatran anticoagulant activity",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.08203125,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renally impaired volunteers.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.125,
            "text": "dabigatran anticoagulant activity, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.21875,
            "text": "dabigatran anticoagulant activity,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.328125,
            "text": "dabigatran anticoagulant activity, and was safe and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.3515625,
            "text": "dabigatran anticoagulant activity, and was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.359375,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged,",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7237672dc08e987e000008_4": [
        {
            "start_logit": 7.29296875,
            "end_logit": 8.0,
            "text": "Dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.44140625,
            "text": "Dabigatran Anticoagulant",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.0,
            "text": "of Dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.6171875,
            "text": "Dabigatran Anticoagulant Activity",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.890625,
            "text": "Dabigatran Anticoagulant Activity in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0,
            "text": "Reversal of Dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.0,
            "text": "rucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.9921875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0,
            "text": "rucizumab-Mediated Reversal of Dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0,
            "text": "Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.99609375,
            "text": "Dabigatran Anticoagulant Activity in a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.0,
            "text": "Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.0,
            "text": "Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.078125,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.08203125,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.0859375,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.12890625,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.1875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.1875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -7.203125,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a7237672dc08e987e000008_5": [
        {
            "start_logit": 7.38671875,
            "end_logit": 7.9140625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -6.63671875,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.9140625,
            "text": "of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.9140625,
            "text": "discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -6.86328125,
            "text": "dabigatran and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.9140625,
            "text": "also discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -6.921875,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.9140625,
            "text": "reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -6.98828125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.9140625,
            "text": "We also discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.9140625,
            "text": ", for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.9140625,
            "text": "reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.9140625,
            "text": ", both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.0390625,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.9140625,
            "text": "for the reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.9140625,
            "text": "for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.9140625,
            "text": "strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.9140625,
            "text": "specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.9140625,
            "text": "the reversal of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.1015625,
            "text": "dabigatran and two agents, andexanet and",
            "probability": 2.980232238769531e-07
        }
    ],
    "5a7237672dc08e987e000008_6": [
        {
            "start_logit": 7.34375,
            "end_logit": 7.984375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 7.984375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.34375,
            "end_logit": -6.65625,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.984375,
            "text": "urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.984375,
            "text": "Idarucizumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.984375,
            "text": "reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.984375,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.984375,
            "text": "of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.984375,
            "text": "rucizumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.984375,
            "text": "targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.984375,
            "text": "for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 7.984375,
            "text": "agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.984375,
            "text": "izumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 7.984375,
            "text": "reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 7.984375,
            "text": "is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.984375,
            "text": "of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.76171875,
            "end_logit": -6.65625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.51171875,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.51953125,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.65625,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_7": [
        {
            "start_logit": 7.34765625,
            "end_logit": 7.94921875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.94921875,
            "text": "with dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 7.94921875,
            "text": "bleeding associated with dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.34765625,
            "end_logit": -6.640625,
            "text": "dabigatran.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.94921875,
            "text": "CONCLUSIONS: The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.94921875,
            "text": "The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.94921875,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.94921875,
            "text": "associated with dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.94921875,
            "text": "initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.94921875,
            "text": "treatment of bleeding associated with dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.94921875,
            "text": "idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.94921875,
            "text": "data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.94921875,
            "text": "of bleeding associated with dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.94921875,
            "text": "rucizumab in treatment of bleeding associated with dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.94921875,
            "text": "izumab in treatment of bleeding associated with dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.94921875,
            "text": "in treatment of bleeding associated with dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.94921875,
            "text": "for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.94921875,
            "text": "suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.76171875,
            "end_logit": -6.640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -6.640625,
            "text": "with dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_8": [
        {
            "start_logit": 7.296875,
            "end_logit": 7.984375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": 7.984375,
            "text": "anticoagulant activity of dabigatran",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.984375,
            "text": "The administration of 5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.984375,
            "text": "administration of 5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -6.77734375,
            "text": "dabigatran as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.984375,
            "text": "reversed the anticoagulant activity of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.984375,
            "text": "the anticoagulant activity of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.984375,
            "text": "intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.19140625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time from",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.203125,
            "text": "dabigatran as assessed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.2421875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time from 92",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.25,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.265625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.28515625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.296875,
            "end_logit": -7.28515625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.95703125,
            "end_logit": -6.46484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": -6.48828125,
            "text": "anticoagulant activity",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": -6.73828125,
            "text": "anticoagulant activity of",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": -6.77734375,
            "text": "anticoagulant activity of dabigatran as",
            "probability": 0.0
        },
        {
            "start_logit": -6.4375,
            "end_logit": -6.9375,
            "text": "anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_9": [
        {
            "start_logit": 7.3828125,
            "end_logit": 7.94140625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -6.921875,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.94140625,
            "text": "binds dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.94140625,
            "text": "that binds dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.94140625,
            "text": "antibody fragment that binds dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.94140625,
            "text": "monoclonal antibody fragment that binds dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.1640625,
            "text": "dabigatran with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.20703125,
            "text": "dabigatran with high affinity, is in development as a specific antidote",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.21875,
            "text": "dabigatran with high affinity, is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.26171875,
            "text": "dabigatran with high affinity, is in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.28125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.3046875,
            "text": "dabigatran with high affinity, is in development",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.31640625,
            "text": "dabigatran with high",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.3203125,
            "text": "dabigatran with high affinity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.33203125,
            "text": "dabigatran with high affinity, is in development as a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.33984375,
            "text": "dabigatran with high affinity, is in development as a specific antid",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.34375,
            "text": "dabigatran with high affinity, is in development as",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.34765625,
            "text": "dabigatran with high affinity,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.32421875,
            "end_logit": -6.921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -6.921875,
            "text": "antidote for dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_10": [
        {
            "start_logit": 7.38671875,
            "end_logit": 7.94140625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.94140625,
            "text": "antidote to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -6.53125,
            "text": "dabigatran.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.94140625,
            "text": "specific antidote to dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.94140625,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.94140625,
            "text": "ote to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.94140625,
            "text": "safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.94140625,
            "text": "to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 7.94140625,
            "text": "a specific antidote to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.17578125,
            "end_logit": -6.53125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -6.53125,
            "text": "antidote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.53125,
            "text": "specific antidote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -7.08984375,
            "text": "antidote to",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.53125,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -6.53125,
            "text": "ote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.65234375,
            "text": "A randomised study in healthy volunteers to",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -6.68359375,
            "text": "A randomised study",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -6.53125,
            "text": "safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -6.53125,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -6.53125,
            "text": "a specific antidote to dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_11": [
        {
            "start_logit": 7.28515625,
            "end_logit": 8.0234375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.53125,
            "end_logit": 8.0234375,
            "text": "anticoagulant activity of dabigatran",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.0234375,
            "text": "To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.0234375,
            "text": "for the anticoagulant activity of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -6.87890625,
            "text": "dabigatran and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.0234375,
            "text": "evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.0234375,
            "text": "specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0234375,
            "text": "humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0234375,
            "text": "reversal agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.0234375,
            "text": "agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.0234375,
            "text": "role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.0234375,
            "text": "monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.05078125,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.19140625,
            "text": "dabigatran and to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.22265625,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.24609375,
            "text": "dabigatran and to review the pharmacology",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.265625,
            "text": "dabigatran and to review the pharmacology,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.2734375,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.28125,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.28515625,
            "end_logit": -7.29296875,
            "text": "dabigatran and to review the",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a7237672dc08e987e000008_12": [
        {
            "start_logit": 9.25,
            "end_logit": 8.9453125,
            "text": "Dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.255859375,
            "text": "Dabigatran",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -1.7626953125,
            "end_logit": 8.9453125,
            "text": "te",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -3.90234375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab.",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -4.703125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.546875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.55859375,
            "text": "Dabigatran etexilate is",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.640625,
            "text": "Dabigatran etexilate is an oral thrombin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.03515625,
            "text": "Dabigatran etexilate is an",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.2734375,
            "text": "Dabigatran et",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.328125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.4609375,
            "text": "Dabigatran etex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 8.9453125,
            "text": "ilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.6484375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.8203125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.8671875,
            "text": "Dabigatran etexilate is an oral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.9453125,
            "text": "Dabigatran etexila",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.06640625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by ida",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.07421875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.140625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idaruc",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7237672dc08e987e000008_13": [
        {
            "start_logit": 7.3046875,
            "end_logit": 8.0078125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 8.0078125,
            "text": "In ICH related to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 8.0078125,
            "text": "to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.0078125,
            "text": "ICH related to dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.0078125,
            "text": "related to dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -6.859375,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.15625,
            "text": "dabigatran, anticoagulation can",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.19921875,
            "text": "dabigatran, anticoagulation can be",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.23046875,
            "text": "dabigatran, anticoagulation can be rapidly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.2734375,
            "text": "dabigatran, anticoagulation can be rapidly reversed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.375,
            "text": "dabigatran, anticoagulation can be rapidly reversed with ida",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.75390625,
            "end_logit": -6.859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -6.859375,
            "text": "In ICH related to dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -7.15625,
            "text": "In ICH related to dabigatran, anticoagulation can",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -7.19921875,
            "text": "In ICH related to dabigatran, anticoagulation can be",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -7.23046875,
            "text": "In ICH related to dabigatran, anticoagulation can be rapidly",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.859375,
            "text": "to dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -7.2734375,
            "text": "In ICH related to dabigatran, anticoagulation can be rapidly reversed",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.859375,
            "text": "ICH related to dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -7.375,
            "text": "In ICH related to dabigatran, anticoagulation can be rapidly reversed with ida",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_14": [
        {
            "start_logit": 9.40625,
            "end_logit": 9.1328125,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.40625,
            "end_logit": -0.85595703125,
            "text": "dabigatran",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": -1.34765625,
            "end_logit": 9.1328125,
            "text": "te",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.40625,
            "end_logit": -6.01953125,
            "text": "dabigatran et",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.40625,
            "end_logit": -6.234375,
            "text": "dabigatran etex",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 9.1328125,
            "text": "ilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.40625,
            "end_logit": -6.70703125,
            "text": "dabigatran etexila",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.40625,
            "end_logit": -6.82421875,
            "text": "dabigatran etexilate.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 9.1328125,
            "text": "exilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.1328125,
            "text": "etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.1328125,
            "text": "for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.1328125,
            "text": "Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.1328125,
            "text": "agent for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 9.1328125,
            "text": "rucizumab is a reversal agent for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.1328125,
            "text": "is a reversal agent for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.34765625,
            "end_logit": -6.82421875,
            "text": "te.",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -0.85595703125,
            "text": "for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -0.85595703125,
            "text": "Idarucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -0.85595703125,
            "text": "agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -0.85595703125,
            "text": "rucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_15": [
        {
            "start_logit": 7.21484375,
            "end_logit": 8.0859375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -6.1171875,
            "text": "dabigatran within minutes.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 8.0859375,
            "text": "anticoagulant effect of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.0859375,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.0859375,
            "text": "the anticoagulant effect of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.0859375,
            "text": "reversed the anticoagulant effect of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0859375,
            "text": "izumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0859375,
            "text": "completely reversed the anticoagulant effect of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.0859375,
            "text": "rucizumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.0859375,
            "text": "effect of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.0859375,
            "text": "of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -6.9453125,
            "text": "dabigatran within",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -7.140625,
            "text": "dabigatran within minutes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.8671875,
            "end_logit": -6.1171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -6.1171875,
            "text": "anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -6.1171875,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.1171875,
            "text": "the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -6.1171875,
            "text": "reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -6.1171875,
            "text": "izumab completely reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -6.1171875,
            "text": "completely reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_16": [
        {
            "start_logit": 9.25,
            "end_logit": 8.9453125,
            "text": "Dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.255859375,
            "text": "Dabigatran",
            "probability": 3.737211227416992e-05
        },
        {
            "start_logit": -1.7626953125,
            "end_logit": 8.9453125,
            "text": "te",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -3.90234375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab.",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -4.703125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.546875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.55859375,
            "text": "Dabigatran etexilate is",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.640625,
            "text": "Dabigatran etexilate is an oral thrombin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.03515625,
            "text": "Dabigatran etexilate is an",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.2734375,
            "text": "Dabigatran et",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.328125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.4609375,
            "text": "Dabigatran etex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 8.9453125,
            "text": "ilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.6484375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.8203125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.8671875,
            "text": "Dabigatran etexilate is an oral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.9453125,
            "text": "Dabigatran etexila",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.06640625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by ida",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.07421875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.140625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idaruc",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7237672dc08e987e000008_17": [
        {
            "start_logit": 9.7734375,
            "end_logit": 8.96875,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.7734375,
            "end_logit": 1.0322265625,
            "text": "dabigatran",
            "probability": 0.0003542900085449219
        },
        {
            "start_logit": -1.716796875,
            "end_logit": 8.96875,
            "text": "te",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -5.8828125,
            "text": "dabigatran et",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -6.37890625,
            "text": "dabigatran etex",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -6.78125,
            "text": "dabigatran etexilate.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.7734375,
            "end_logit": -6.8515625,
            "text": "dabigatran etexila",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.38671875,
            "end_logit": 8.96875,
            "text": "ilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.96875,
            "text": "exilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.96875,
            "text": "for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.96875,
            "text": "etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.96875,
            "text": "Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.96875,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.96875,
            "text": "agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.96875,
            "text": "rucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.96875,
            "text": "reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 1.0322265625,
            "text": "for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": 1.0322265625,
            "text": "Idarucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 1.0322265625,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 1.0322265625,
            "text": "agent for dabigatran",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_18": [
        {
            "start_logit": 7.203125,
            "end_logit": 8.0859375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 8.0859375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.5703125,
            "text": "dabigatran.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.0859375,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.0859375,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.0859375,
            "text": "izumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.0859375,
            "text": "rucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.0859375,
            "text": "of the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0859375,
            "text": "reversal of the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.0859375,
            "text": "effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 8.0859375,
            "text": "humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.0859375,
            "text": "monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.0859375,
            "text": "is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -6.5703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -6.5703125,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -6.671875,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -6.71875,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -7.28125,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -6.5703125,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -6.5703125,
            "text": "the anticoagulant effects of dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_19": [
        {
            "start_logit": 7.45703125,
            "end_logit": 7.89453125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.89453125,
            "text": "to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.89453125,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.13671875,
            "text": "dabigatran.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.89453125,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.89453125,
            "text": "izumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.89453125,
            "text": "antibody fragment specifically targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.89453125,
            "text": "is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.89453125,
            "text": "monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.89453125,
            "text": "targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.13671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.10546875,
            "text": "Ida",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.13671875,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.13671875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.24609375,
            "text": "Idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.2734375,
            "text": "Idarucizumab is a monoclonal antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.13671875,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.28125,
            "text": "Idarucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.2890625,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.2890625,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_20": [
        {
            "start_logit": 7.45703125,
            "end_logit": 7.89453125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.89453125,
            "text": "to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.89453125,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.45703125,
            "end_logit": -7.13671875,
            "text": "dabigatran.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.89453125,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.89453125,
            "text": "izumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.89453125,
            "text": "antibody fragment specifically targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.89453125,
            "text": "is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.89453125,
            "text": "monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.89453125,
            "text": "targeted to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -7.13671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.10546875,
            "text": "Ida",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.13671875,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.13671875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.24609375,
            "text": "Idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.2734375,
            "text": "Idarucizumab is a monoclonal antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.13671875,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.28125,
            "text": "Idarucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.2890625,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.2890625,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_21": [
        {
            "start_logit": 9.4140625,
            "end_logit": 9.125,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -0.7646484375,
            "text": "dabigatran",
            "probability": 5.1021575927734375e-05
        },
        {
            "start_logit": -1.3154296875,
            "end_logit": 9.125,
            "text": "te",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -5.7109375,
            "text": "dabigatran et",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -6.40234375,
            "text": "dabigatran etex",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -6.5859375,
            "text": "dabigatran etexila",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.38671875,
            "end_logit": 9.125,
            "text": "ilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -6.72265625,
            "text": "dabigatran etexilate and neutralizes its activity.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -6.78125,
            "text": "dabigatran etexilate and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 9.125,
            "text": "exilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.3203125,
            "text": "dabigatran etexilate and neutral",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4140625,
            "end_logit": -7.37890625,
            "text": "dabigatran etexilate and neutralizes its activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 9.125,
            "text": "etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.125,
            "text": "binds dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.125,
            "text": ", directly binds dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 9.125,
            "text": "rucizumab, a monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 9.125,
            "text": "Idarucizumab, a monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.125,
            "text": "antibody fragment, directly binds dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3154296875,
            "end_logit": -6.72265625,
            "text": "te and neutralizes its activity.",
            "probability": 0.0
        },
        {
            "start_logit": -1.3154296875,
            "end_logit": -6.78125,
            "text": "te and",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_22": [
        {
            "start_logit": 7.515625,
            "end_logit": 7.828125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.515625,
            "end_logit": -6.9765625,
            "text": "dabigatran with high affinity.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.0234375,
            "text": "dabigatran with",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.16796875,
            "text": "dabigatran with high affinity",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.515625,
            "end_logit": -7.16796875,
            "text": "dabigatran with high",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.828125,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.828125,
            "text": "binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.828125,
            "text": "rucizumab is an antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.828125,
            "text": "izumab is an antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.828125,
            "text": "is an antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.828125,
            "text": "antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.828125,
            "text": "an antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.828125,
            "text": "that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.39453125,
            "end_logit": -6.9765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -6.9765625,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.0234375,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -6.9765625,
            "text": "binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -6.9765625,
            "text": "rucizumab is an antibody fragment that binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.0234375,
            "text": "binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -6.9765625,
            "text": "izumab is an antibody fragment that binds dabigatran with high affinity.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_23": [
        {
            "start_logit": 9.6796875,
            "end_logit": 9.0546875,
            "text": "dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.6796875,
            "end_logit": 0.272216796875,
            "text": "dabigatran",
            "probability": 0.00015354156494140625
        },
        {
            "start_logit": -1.50390625,
            "end_logit": 9.0546875,
            "text": "te",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -6.0,
            "text": "dabigatran et",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -6.7265625,
            "text": "dabigatran etex",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -6.828125,
            "text": "dabigatran etexila",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -6.90234375,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 9.0546875,
            "text": "ilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.14453125,
            "text": "dabigatran etexilate using ida",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.22265625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.30078125,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.3046875,
            "text": "dabigatran etexilate using idarucizumab was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.33984375,
            "text": "dabigatran etexilate using",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.34765625,
            "text": "dabigatran etexilate using idarucizumab was safe and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.3515625,
            "text": "dabigatran etexilate using idarucizumab was safe and successful",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.3515625,
            "text": "dabigatran etexilate using idarucizumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.6796875,
            "end_logit": -7.38671875,
            "text": "dabigatran etexilate using idaruc",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 9.0546875,
            "text": "exilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.0546875,
            "text": "etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.0546875,
            "text": "CONCLUSION Reversal of dabigatran etexilate",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7237672dc08e987e000008_24": [
        {
            "start_logit": 7.5625,
            "end_logit": 7.78515625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.5625,
            "end_logit": -7.015625,
            "text": "dabigatran.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.78515625,
            "text": ", monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.78515625,
            "text": "to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.78515625,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.78515625,
            "text": "Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.78515625,
            "text": "treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.78515625,
            "text": "rucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.78515625,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.78515625,
            "text": "that specifically binds to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.78515625,
            "text": "humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -7.015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.015625,
            "text": ", monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -7.015625,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.015625,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.015625,
            "text": "Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.015625,
            "text": "treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.015625,
            "text": "rucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -7.015625,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -7.015625,
            "text": "that specifically binds to dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_25": [
        {
            "start_logit": 7.24609375,
            "end_logit": 8.0546875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.0546875,
            "text": "anticoagulant effects of dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.0546875,
            "text": "In 2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.24609375,
            "end_logit": -6.72265625,
            "text": "dabigatran.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.0546875,
            "text": "rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.0546875,
            "text": "2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.0546875,
            "text": "of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.0546875,
            "text": ", the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.0546875,
            "text": "the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.0546875,
            "text": "reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 8.0546875,
            "text": "rucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 8.0546875,
            "text": "humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.0546875,
            "text": "izumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.0546875,
            "text": "effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.0546875,
            "text": "approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.0546875,
            "text": "for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.6640625,
            "end_logit": -6.72265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.72265625,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.96875,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -7.00390625,
            "text": "anticoagulant effects",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_26": [
        {
            "start_logit": 7.2890625,
            "end_logit": 8.0,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.0,
            "text": "direct thrombin inhibitor, dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.0,
            "text": ", dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.0,
            "text": "thrombin inhibitor, dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -6.68359375,
            "text": "dabigatran, which was recently approved for use in the USA.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.0,
            "text": "Idarucizumab is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -6.90234375,
            "text": "dabigatran, which was recently",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.0,
            "text": "antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.0,
            "text": "reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.0,
            "text": "the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.0,
            "text": "rucizumab is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.0,
            "text": "specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.0,
            "text": "izumab is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -7.0,
            "text": "dabigatran, which was",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.0,
            "text": "ote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -7.0234375,
            "text": "dabigatran, which was recently approved for use in the USA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -7.03125,
            "text": "dabigatran, which",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.0,
            "text": "is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -7.04296875,
            "text": "dabigatran,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.2890625,
            "end_logit": -7.05859375,
            "text": "dabigatran, which was recently approved",
            "probability": 2.980232238769531e-07
        }
    ],
    "5a7237672dc08e987e000008_27": [
        {
            "start_logit": 7.46484375,
            "end_logit": 7.88671875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -6.9296875,
            "text": "dabigatran, is the first specific antidote for a NOAC",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -6.953125,
            "text": "dabigatran, is the first specific antidote for a NOAC to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.88671875,
            "text": "targeting dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -6.9921875,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is limited.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.15234375,
            "text": "dabigatran, is the first",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.2109375,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.21484375,
            "text": "dabigatran, is the first specific antidote for a NOAC to be",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.21484375,
            "text": "dabigatran, is the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.21875,
            "text": "dabigatran, is the first specific antidote",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.88671875,
            "text": "antibody fragment targeting dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.88671875,
            "text": "an antibody fragment targeting dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.25,
            "text": "dabigatran,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.2578125,
            "text": "dabigatran, is the first specific antid",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.28515625,
            "text": "dabigatran, is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.2890625,
            "text": "dabigatran, is the first specific antidote for a NO",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.46484375,
            "end_logit": -7.32421875,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.23828125,
            "end_logit": -6.9921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.9296875,
            "text": "targeting dabigatran, is the first specific antidote for a NOAC",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.953125,
            "text": "targeting dabigatran, is the first specific antidote for a NOAC to",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_28": [
        {
            "start_logit": 7.3828125,
            "end_logit": 7.92578125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -5.62890625,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -6.453125,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.92578125,
            "text": "Idarucizumab neutralised plasma concentrations of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -6.98828125,
            "text": "dabigatran, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.92578125,
            "text": "plasma concentrations of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.00390625,
            "text": "dabigatran, and reversed the effects of the drug on coagulation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.92578125,
            "text": "of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.92578125,
            "text": "neutralised plasma concentrations of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.92578125,
            "text": "izumab neutralised plasma concentrations of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.92578125,
            "text": "rucizumab neutralised plasma concentrations of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.1640625,
            "text": "dabigatran,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.19921875,
            "text": "dabigatran, and reversed the effects of the drug",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.19921875,
            "text": "dabigatran, and reversed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -7.3125,
            "text": "dabigatran, and reversed the effects of the drug on",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -5.62890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -5.62890625,
            "text": "effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -5.62890625,
            "text": "coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -5.62890625,
            "text": "on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -5.62890625,
            "text": "the effects of the drug on coagulation variables.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_29": [
        {
            "start_logit": 7.21875,
            "end_logit": 8.0703125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 8.0703125,
            "text": "anticoagulant effects of dabigatran",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.234375,
            "text": "dabigatran.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.0703125,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.0703125,
            "text": "reverse the anticoagulant effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.0703125,
            "text": "Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.0703125,
            "text": "antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.0703125,
            "text": "to reverse the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0703125,
            "text": "developed to reverse the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0703125,
            "text": "effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.0703125,
            "text": ", was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.0703125,
            "text": "rucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.0703125,
            "text": "izumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -6.234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -6.234375,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -6.62109375,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -6.70703125,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -6.234375,
            "text": "the anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.234375,
            "text": "reverse the anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -6.234375,
            "text": "Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_30": [
        {
            "start_logit": 7.33984375,
            "end_logit": 7.94921875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.11328125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 7.94921875,
            "text": "effects of dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.94921875,
            "text": "Idarucizumab also reversed the effects of dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.94921875,
            "text": "rucizumab also reversed the effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.94921875,
            "text": "the effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.94921875,
            "text": "reversed the effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.94921875,
            "text": "izumab also reversed the effects of dabigatran",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.94921875,
            "text": "of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.83984375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -6.96484375,
            "text": "dabigatran and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.3046875,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.31640625,
            "text": "dabigatran and, unlike PCCs, was not associated with over",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.3203125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.32421875,
            "text": "dabigatran and, unlike PCCs, was",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.328125,
            "text": "dabigatran and, unlike PCCs, was not",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.33203125,
            "text": "dabigatran and, unlike PCCs, was not associated with",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.359375,
            "text": "dabigatran and, unlike PCCs, was not associated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.3671875,
            "text": "dabigatran and, unlike PCCs,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -6.11328125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_31": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.0625,
            "text": "Dabigatran etexilate",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.1904296875,
            "text": "Dabigatran",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -1.4384765625,
            "end_logit": 9.0625,
            "text": "te",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 9.265625,
            "end_logit": -5.9140625,
            "text": "Dabigatran et",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.28515625,
            "text": "Dabigatran etex",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.3046875,
            "text": "Dabigatran etexilate (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 9.0625,
            "text": "ilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.34765625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by idarucizumab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.3515625,
            "text": "Dabigatran etexilate (DE) dose-dependently",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.59765625,
            "text": "Dabigatran etexilate (DE",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.7890625,
            "text": "Dabigatran etexilate (DE)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.8203125,
            "text": "Dabigatran etexila",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.89453125,
            "text": "Dabigatran etexilate (DE) dose",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.94140625,
            "text": "Dabigatran etexilate (DE) dose-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.97265625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.0703125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.08203125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.12890625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1328125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7237672dc08e987e000008_32": [
        {
            "start_logit": 7.34375,
            "end_logit": 7.96875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 7.96875,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 7.96875,
            "text": "this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.96875,
            "text": "article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.96875,
            "text": ", we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.96875,
            "text": "discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.96875,
            "text": "of dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.96875,
            "text": "safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.96875,
            "text": "rucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.96875,
            "text": "effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.96875,
            "text": "izumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.96875,
            "text": "idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.96875,
            "text": "the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.96875,
            "text": "we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.96875,
            "text": "tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.96875,
            "text": "its efficacy for reversing effect of dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.34375,
            "end_logit": -7.2265625,
            "text": "dabigatran.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.28125,
            "end_logit": -7.2265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.2265625,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.49609375,
            "end_logit": -7.3046875,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_33": [
        {
            "start_logit": 7.4296875,
            "end_logit": 7.9140625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -6.921875,
            "text": "dabigatran.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.9140625,
            "text": "for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.9140625,
            "text": "potential reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.9140625,
            "text": "Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.9140625,
            "text": "reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.9140625,
            "text": "agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.9140625,
            "text": "The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 7.9140625,
            "text": "This was until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.9140625,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.9140625,
            "text": "until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.9140625,
            "text": "was until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 7.9140625,
            "text": "the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.9140625,
            "text": "idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.9140625,
            "text": "and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.625,
            "end_logit": -6.921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -6.921875,
            "text": "for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -6.921875,
            "text": "potential reversal agent for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -6.921875,
            "text": "Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -6.921875,
            "text": "reversal agent for dabigatran.",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_1": [
        {
            "start_logit": 9.2421875,
            "end_logit": 8.21875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.0107421875,
            "text": "lectin",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": -2.931640625,
            "end_logit": 8.21875,
            "text": "pathway",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -4.5625,
            "text": "lectin complement pathway and SLE.",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.671875,
            "text": "lectin complement",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.6875,
            "end_logit": 8.21875,
            "text": "complement pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.890625,
            "text": "lectin complement pathway and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.0,
            "end_logit": 8.21875,
            "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.02734375,
            "text": "lectin complement pathway and SLE",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 8.21875,
            "text": "study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 8.21875,
            "text": "the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.21875,
            "text": "association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 8.21875,
            "text": "between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.21875,
            "text": "aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.21875,
            "text": "ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.21875,
            "text": "investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.21875,
            "text": "whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.21875,
            "text": "of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.21875,
            "text": "to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.21875,
            "text": "an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c1d856ef6e394741000032_2": [
        {
            "start_logit": 9.1953125,
            "end_logit": 8.75,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.1767578125,
            "text": "lectin",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -2.078125,
            "end_logit": 8.75,
            "text": "pathway",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -4.57421875,
            "end_logit": 8.75,
            "text": "complement pathway",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.70703125,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology and outcome.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.9609375,
            "text": "lectin complement pathway (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 8.75,
            "text": "the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.1640625,
            "text": "lectin complement",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.30859375,
            "text": "lectin complement pathway (LCP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.34375,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.34375,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.37109375,
            "text": "lectin complement pathway (LCP), in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.37890625,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 8.75,
            "text": "To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.75,
            "text": "OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.75,
            "text": "of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.75,
            "text": ": To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.75,
            "text": "assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.75,
            "text": "involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.75,
            "text": ", the main initiator of the lectin complement pathway",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c1d856ef6e394741000032_3": [
        {
            "start_logit": 9.0625,
            "end_logit": 8.75,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.455078125,
            "text": "lectin",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -2.095703125,
            "end_logit": 8.75,
            "text": "pathway",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.046875,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 8.75,
            "text": "complement pathway",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.6015625,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.7109375,
            "text": "lectin complement pathway activation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.98046875,
            "text": "lectin complement pathway activation in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.08984375,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.19921875,
            "text": "lectin complement pathway activation in patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.3203125,
            "text": "lectin complement pathway activation in patients with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.33203125,
            "text": "lectin complement pathway activation in patients with subarachnoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.75,
            "text": "Ficolin-3-mediated lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.095703125,
            "end_logit": -6.046875,
            "text": "pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 0.0
        },
        {
            "start_logit": -2.095703125,
            "end_logit": -6.7109375,
            "text": "pathway activation",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -1.455078125,
            "text": "Ficolin-3-mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -2.095703125,
            "end_logit": -6.98046875,
            "text": "pathway activation in",
            "probability": 0.0
        },
        {
            "start_logit": -2.095703125,
            "end_logit": -7.08984375,
            "text": "pathway activation in patients with subarachnoid hemorrhage",
            "probability": 0.0
        },
        {
            "start_logit": -2.095703125,
            "end_logit": -7.19921875,
            "text": "pathway activation in patients",
            "probability": 0.0
        },
        {
            "start_logit": -2.095703125,
            "end_logit": -7.3203125,
            "text": "pathway activation in patients with",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_4": [
        {
            "start_logit": 8.96875,
            "end_logit": 7.94140625,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.96875,
            "end_logit": -1.2431640625,
            "text": "lectin",
            "probability": 0.00010311603546142578
        },
        {
            "start_logit": -3.220703125,
            "end_logit": 7.94140625,
            "text": "pathway",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 8.96875,
            "end_logit": -5.5859375,
            "text": "lectin complement pathway initiators.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.96875,
            "end_logit": -6.1953125,
            "text": "lectin complement",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.96875,
            "end_logit": -7.078125,
            "text": "lectin complement pathway initiator",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.94140625,
            "text": "complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 7.94140625,
            "text": "the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.94140625,
            "text": "among the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.94140625,
            "text": ", Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.94140625,
            "text": "complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.94140625,
            "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.94140625,
            "text": "is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -1.2431640625,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -1.2431640625,
            "text": "among the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -1.2431640625,
            "text": ", Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -3.220703125,
            "end_logit": -5.5859375,
            "text": "pathway initiators.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -1.2431640625,
            "text": "complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -1.2431640625,
            "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -1.2431640625,
            "text": "is the only collagenase proteolytic resistant molecule among the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_5": [
        {
            "start_logit": 8.8671875,
            "end_logit": 6.91015625,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -1.78125,
            "text": "lectin",
            "probability": 0.00016736984252929688
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -5.61328125,
            "text": "lectin complement pathway.",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.04296875,
            "text": "lectin complement",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -4.50390625,
            "end_logit": 6.91015625,
            "text": "pathway",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 6.91015625,
            "text": "the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 6.91015625,
            "text": "complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 6.91015625,
            "text": "in the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 6.91015625,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -1.78125,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -1.78125,
            "text": "in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.78125,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -4.50390625,
            "end_logit": -5.61328125,
            "text": "pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -4.98828125,
            "end_logit": -5.61328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -5.61328125,
            "text": "the lectin complement pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -5.61328125,
            "text": "complement pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -5.61328125,
            "text": "in the lectin complement pathway.",
            "probability": 0.0
        },
        {
            "start_logit": -6.43359375,
            "end_logit": -6.04296875,
            "text": "the lectin complement",
            "probability": 0.0
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -6.04296875,
            "text": "complement",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -6.04296875,
            "text": "in the lectin complement",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_6": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.1796875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.8125,
            "end_logit": -1.947265625,
            "text": "lectin",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -2.978515625,
            "end_logit": 8.1796875,
            "text": "pathway",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -3.318359375,
            "end_logit": 8.1796875,
            "text": "complement pathway",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -5.59765625,
            "end_logit": 8.1796875,
            "text": "the lectin complement pathway",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.40234375,
            "text": "lectin complement pathway and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.56640625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 8.1796875,
            "text": "in the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.12890625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.19921875,
            "text": "lectin complement",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.26953125,
            "text": "lectin complement pathway and form complexes with serine proteases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.28125,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.28515625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.2890625,
            "text": "lectin complement pathway and form complexes with serine proteases named",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.29296875,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.1796875,
            "text": "molecules in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.1796875,
            "text": "recognition molecules in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.1796875,
            "text": "Ficolin-1, -2 and -3 are recognition molecules in the lectin complement pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.59765625,
            "end_logit": -1.947265625,
            "text": "the lectin",
            "probability": 0.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -1.947265625,
            "text": "in the lectin",
            "probability": 0.0
        }
    ],
    "5a7639419e632bc066000005_1": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.0390625,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.1875,
            "text": "Deep",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": 9.0390625,
            "text": "c",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -5.375,
            "end_logit": 9.0390625,
            "text": "Loc",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.90234375,
            "text": "DeepLoc:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.09375,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.10546875,
            "text": "DeepLo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.1875,
            "text": "DeepLoc: prediction of protein subcellular localization",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.25390625,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.27734375,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.30078125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3125,
            "text": "DeepLoc: prediction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -6.90234375,
            "text": "c:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.09375,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.1875,
            "text": "c: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.25390625,
            "text": "c: prediction of protein subcellular localization using deep",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.27734375,
            "text": "c: prediction of protein subcellular localization using deep learning.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.30078125,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.3125,
            "text": "c: prediction",
            "probability": 0.0
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -7.27734375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a7639419e632bc066000005_2": [
        {
            "start_logit": 9.3046875,
            "end_logit": 9.0390625,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -1.1875,
            "text": "Deep",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": 9.0390625,
            "text": "c",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -5.375,
            "end_logit": 9.0390625,
            "text": "Loc",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -6.90234375,
            "text": "DeepLoc:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.09375,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.10546875,
            "text": "DeepLo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.1875,
            "text": "DeepLoc: prediction of protein subcellular localization",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.25390625,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.27734375,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.30078125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3046875,
            "end_logit": -7.3125,
            "text": "DeepLoc: prediction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -6.90234375,
            "text": "c:",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.09375,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.1875,
            "text": "c: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.25390625,
            "text": "c: prediction of protein subcellular localization using deep",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.27734375,
            "text": "c: prediction of protein subcellular localization using deep learning.",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.30078125,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -1.6533203125,
            "end_logit": -7.3125,
            "text": "c: prediction",
            "probability": 0.0
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -7.27734375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_1": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.1796875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.2724609375,
            "text": "interleukin",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": -1.2529296875,
            "end_logit": 9.1796875,
            "text": "17A",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -6.015625,
            "end_logit": 9.1796875,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.12890625,
            "text": "interleukin-17A monoclonal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.15234375,
            "text": "interleukin-17A monoclonal antibody.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.296875,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.1796875,
            "text": "-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.1796875,
            "text": "human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6875,
            "end_logit": 9.1796875,
            "text": ": Secukinumab is a fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 9.1796875,
            "text": "anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.1796875,
            "text": "fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.796875,
            "end_logit": 9.1796875,
            "text": "BACKGROUND: Secukinumab is a fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2529296875,
            "end_logit": -7.12890625,
            "text": "17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -1.2529296875,
            "end_logit": -7.15234375,
            "text": "17A monoclonal antibody.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2529296875,
            "end_logit": -7.296875,
            "text": "17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.2724609375,
            "text": "-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -1.2724609375,
            "text": "human anti-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -1.2724609375,
            "text": ": Secukinumab is a fully human anti-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -1.2724609375,
            "text": "anti-interleukin",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_2": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.1640625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.29296875,
            "end_logit": 9.1640625,
            "text": "17A",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.4462890625,
            "text": "interleukin",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 9.1640625,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.76171875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.08203125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.16796875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.1875,
            "text": "interleukin-17A monoclonal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.20703125,
            "text": "interleukin-17A monoclonal antibody,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.234375,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.1640625,
            "text": "-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.30859375,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.30859375,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.34765625,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.3671875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.375,
            "text": "interleukin-17A monoclonal antibody, demonstrated",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.37890625,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 9.1640625,
            "text": "human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.1640625,
            "text": "anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.1640625,
            "text": "fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        }
    ],
    "54e0d7471388e8454a000015_3": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.1796875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 9.1796875,
            "text": "17A",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.3271484375,
            "text": "interleukin",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": -5.9609375,
            "end_logit": 9.1796875,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.50390625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.9609375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.08203125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.11328125,
            "text": "interleukin-17A monoclonal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.12109375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1484375,
            "text": "interleukin-17A monoclonal antibody, in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.16015625,
            "text": "interleukin-17A monoclonal antibody,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.23046875,
            "text": "interleukin-17A monoclonal antibody, in patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.234375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.1796875,
            "text": "-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.1796875,
            "text": "human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.1796875,
            "text": "anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.1796875,
            "text": "fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.1796875,
            "text": "a fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 9.1796875,
            "text": "secukinumab, a fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 9.1796875,
            "text": ", a fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        }
    ],
    "54e0d7471388e8454a000015_4": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.1875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.232421875,
            "end_logit": 9.1875,
            "text": "17A",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.376953125,
            "text": "interleukin",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 9.1875,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.59765625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.98828125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.01953125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.02734375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.0390625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.04296875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.04296875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.06640625,
            "text": "interleukin-17A monoclonal antibody sec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.09375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.109375,
            "text": "interleukin-17A monoclonal antibody secukinumab in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.1171875,
            "text": "interleukin-17A monoclonal antibody secuk",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.13671875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.1640625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.16796875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.171875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 9.1875,
            "text": "-interleukin-17A",
            "probability": 5.960464477539063e-08
        }
    ],
    "54e0d7471388e8454a000015_5": [
        {
            "start_logit": 9.2109375,
            "end_logit": 9.1953125,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.203125,
            "end_logit": 9.1953125,
            "text": "17A",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.4150390625,
            "text": "interleukin",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -5.91796875,
            "end_logit": 9.1953125,
            "text": "-17A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -6.9609375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 9.1953125,
            "text": "-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.08984375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.12109375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.171875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.17578125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.18359375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.18359375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.19140625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.1953125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.1953125,
            "text": "human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -7.19921875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.1953125,
            "text": "anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.1953125,
            "text": "fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.1953125,
            "text": "a fully human anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        }
    ],
    "54e0d7471388e8454a000015_6": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.1953125,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": 9.1953125,
            "text": "17A",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.431640625,
            "text": "interleukin",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -6.03125,
            "end_logit": 9.1953125,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.05078125,
            "text": "interleukin-17A blockade, in patients with noninfectious uveitis.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.2734375,
            "text": "interleukin-17A blockade, in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.29296875,
            "text": "interleukin-17A blockade, in patients with noninfectious uveitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.31640625,
            "text": "interleukin-17A blockade",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.33984375,
            "text": "interleukin-17A blockade, in patients with noninfect",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.37890625,
            "text": "interleukin-17A blockade, in patients with noninfe",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.3828125,
            "text": "interleukin-17A blockade, in patients with nonin",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.1953125,
            "text": "targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.1953125,
            "text": "human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.1953125,
            "text": "fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.1953125,
            "text": "To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.1953125,
            "text": ": To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.1953125,
            "text": "for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 9.1953125,
            "text": "determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.1953125,
            "text": "safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.1953125,
            "text": "antibody for targeted interleukin-17A",
            "probability": 5.960464477539063e-08
        }
    ],
    "54e0d7471388e8454a000015_7": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.1796875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": 9.1796875,
            "text": "17A",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.3779296875,
            "text": "interleukin",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 9.1796875,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.23828125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.26171875,
            "text": "interleukin-17A-blocking antibody sec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.30078125,
            "text": "interleukin-17A-blocking",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.33203125,
            "text": "interleukin-17A-blocking antibody secuk",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.33203125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.34765625,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.34765625,
            "text": "interleukin-17A-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.36328125,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.37109375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.1796875,
            "text": "the interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": -7.23828125,
            "text": "17A-blocking antibody secukinumab does not interfere with the",
            "probability": 0.0
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": -7.2578125,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label",
            "probability": 0.0
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": -7.26171875,
            "text": "17A-blocking antibody sec",
            "probability": 0.0
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": -7.30078125,
            "text": "17A-blocking",
            "probability": 0.0
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": -7.31640625,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label,",
            "probability": 0.0
        },
        {
            "start_logit": -1.2666015625,
            "end_logit": -7.33203125,
            "text": "17A-blocking antibody secuk",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_8": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.328125,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -0.80615234375,
            "end_logit": 9.328125,
            "text": "17A",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -1.0751953125,
            "text": "interleukin",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": -5.921875,
            "end_logit": 9.328125,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.47265625,
            "text": "interleukin-17A (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.87890625,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 9.328125,
            "text": "-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.078125,
            "end_logit": 9.328125,
            "text": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.10546875,
            "text": "interleukin-17A (IL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.19921875,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.203125,
            "text": "interleukin-17A (IL-17A",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.25390625,
            "text": "interleukin-17A (IL-17A) monoclonal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.27734375,
            "text": "interleukin-17A (IL-17A)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.3046875,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.30859375,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) sec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.3125,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.31640625,
            "text": "interleukin-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.328125,
            "text": "interleukin-17A (IL-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.33203125,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) secuk",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -7.3359375,
            "text": "interleukin-17A (IL-17A) monoclonal antibody",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b6978822d300530900000a_1": [
        {
            "start_logit": 7.8671875,
            "end_logit": 9.078125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.4482421875,
            "end_logit": 9.078125,
            "text": "disease",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -3.205078125,
            "text": "Alzheimer",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -5.33984375,
            "end_logit": 9.078125,
            "text": "'s disease",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.078125,
            "text": "s disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 9.078125,
            "text": "The novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 9.078125,
            "text": "novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.078125,
            "text": "paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.078125,
            "text": "in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.078125,
            "text": "approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.05078125,
            "text": "Alzheimer's disease mouse model.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.5,
            "text": "Alzheimer's disease mouse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -6.67578125,
            "text": "Alzheimer's disease mouse model",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.8671875,
            "end_logit": -7.203125,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4482421875,
            "end_logit": -6.05078125,
            "text": "disease mouse model.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4482421875,
            "end_logit": -6.5,
            "text": "disease mouse",
            "probability": 0.0
        },
        {
            "start_logit": -1.4482421875,
            "end_logit": -6.67578125,
            "text": "disease mouse model",
            "probability": 0.0
        },
        {
            "start_logit": -3.451171875,
            "end_logit": -6.05078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -3.205078125,
            "text": "The novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -3.205078125,
            "text": "novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_2": [
        {
            "start_logit": 9.140625,
            "end_logit": 9.0703125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.4560546875,
            "end_logit": 9.0703125,
            "text": "disease",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.5625,
            "text": "Alzheimer",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.7626953125,
            "text": "Alzheimer's disease (AD)",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.64453125,
            "text": "Alzheimer's disease (AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.6640625,
            "text": "Alzheimer's disease (AD) is the massive loss of synapses that occurs at an early clinical stage of the disease.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 9.0703125,
            "text": "'s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 9.0703125,
            "text": "s disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 9.0703125,
            "text": "of Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.4560546875,
            "end_logit": -1.7626953125,
            "text": "disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -4.63671875,
            "end_logit": -1.7626953125,
            "text": "AD)",
            "probability": 0.0
        },
        {
            "start_logit": -1.4560546875,
            "end_logit": -5.64453125,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -1.4560546875,
            "end_logit": -5.6640625,
            "text": "disease (AD) is the massive loss of synapses that occurs at an early clinical stage of the disease.",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -1.7626953125,
            "text": "'s disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -5.921875,
            "end_logit": -1.7626953125,
            "text": "(AD)",
            "probability": 0.0
        },
        {
            "start_logit": -6.30078125,
            "end_logit": -1.5625,
            "text": "of Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -1.7626953125,
            "text": "s disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -6.30078125,
            "end_logit": -1.7626953125,
            "text": "of Alzheimer's disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -3.28125,
            "end_logit": -5.13671875,
            "text": ". The density of mushroom-type spines was reduced by 34",
            "probability": 0.0
        },
        {
            "start_logit": -3.28125,
            "end_logit": -5.33984375,
            "text": ". The density of mushroom-type spines was reduced by 34%",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_3": [
        {
            "start_logit": 8.8828125,
            "end_logit": 9.1328125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": 9.1328125,
            "text": "disease",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -2.166015625,
            "text": "Alzheimer",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 9.1328125,
            "text": "onset Alzheimer's disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 9.1328125,
            "text": "'s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.234375,
            "end_logit": 9.1328125,
            "text": "s disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 9.1328125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -6.296875,
            "text": "Alzheimer's disease.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 9.1328125,
            "text": "with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 9.1328125,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 9.1328125,
            "text": "early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.1328125,
            "text": "two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.1328125,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.1328125,
            "text": "-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.1328125,
            "text": "in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.1328125,
            "text": "families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.08984375,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.2578125,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": -6.296875,
            "text": "disease.",
            "probability": 0.0
        },
        {
            "start_logit": -5.66796875,
            "end_logit": -2.166015625,
            "text": "onset Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_4": [
        {
            "start_logit": 7.76953125,
            "end_logit": 7.53515625,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -6.90234375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 7.53515625,
            "text": "In 1 family, this mutation was responsible for AD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.0546875,
            "text": "AD in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 7.53515625,
            "text": ", this mutation was responsible for AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 7.53515625,
            "text": "for AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.18359375,
            "text": "AD in 3 out",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.25,
            "text": "AD in 3 out of 7 siblings and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 7.53515625,
            "text": "mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.53515625,
            "text": "this mutation was responsible for AD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.36328125,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.4296875,
            "text": "AD in 3 out of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.4296875,
            "text": "AD in 3 out of 7 siblings and it is also present",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 7.53515625,
            "text": "1 family, this mutation was responsible for AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 7.53515625,
            "text": "family, this mutation was responsible for AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.44140625,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far. Two subjects",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.53515625,
            "text": "responsible for AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.53515625,
            "text": "was responsible for AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -6.90234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.8203125,
            "end_logit": -6.90234375,
            "text": ". Two subjects of the other family with AD diagnosis were carriers of the same mutation.",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_5": [
        {
            "start_logit": 8.0390625,
            "end_logit": 7.2265625,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.1640625,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP).",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.11328125,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 7.2265625,
            "text": "of an AD",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.2265625,
            "text": "an AD",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ". These mutants facilitate Abeta production.",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ". For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD. These mutants facilitate Abeta production.",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ". For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ". The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)) are examples of these mutants.",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ". Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD.",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.1640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.625,
            "text": ". Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.765625,
            "text": ". The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)) are examples",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.8984375,
            "text": ". Studies have revealed a strong genetic linkage in the early-onset familial form",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.90234375,
            "text": ". The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)) are",
            "probability": 0.0
        },
        {
            "start_logit": -4.27734375,
            "end_logit": -6.9921875,
            "text": ". These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON))",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_6": [
        {
            "start_logit": 7.58203125,
            "end_logit": 7.51171875,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.9140625,
            "text": "AD development.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.828125,
            "end_logit": 7.51171875,
            "text": "study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 7.51171875,
            "text": "in AD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -7.0390625,
            "text": "AD development",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 7.51171875,
            "text": "this study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -5.9140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.94140625,
            "end_logit": -5.9140625,
            "text": "in AD development.",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -6.125,
            "text": "study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -6.125,
            "text": "in this study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -6.125,
            "text": "this study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -6.125,
            "text": "identified in this study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -6.125,
            "text": "The sequences that are effective to silence APP(SW) and APP(LON) as identified in this study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.125,
            "text": "sequences that are effective to silence APP(SW) and APP(LON) as identified in this study may",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -6.125,
            "text": "ence APP(SW) and APP(LON) as identified in this study may",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -7.0390625,
            "text": "study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD development",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -7.046875,
            "text": "study",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": -7.06640625,
            "text": "study may be useful",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -6.76953125,
            "text": "The sequences that are effective to silence APP(SW) and APP(LON) as",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.76953125,
            "text": "sequences that are effective to silence APP(SW) and APP(LON) as",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_7": [
        {
            "start_logit": 9.09375,
            "end_logit": 9.2265625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.171875,
            "end_logit": 9.2265625,
            "text": "disease",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 9.09375,
            "end_logit": -1.7138671875,
            "text": "Alzheimer",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 9.2265625,
            "text": "'s disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -5.96875,
            "text": "Alzheimer's disease using",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 9.2265625,
            "text": "s disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.421875,
            "end_logit": 9.2265625,
            "text": "familial Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.921875,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.2265625,
            "text": "to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.2265625,
            "text": "Here, we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 9.2265625,
            "text": "related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.2265625,
            "text": "amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.26171875,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.265625,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type allelic sequences in their 3'",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.26953125,
            "text": "Alzheimer's disease using two",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.26953125,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.27734375,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.28515625,
            "text": "Alzheimer's disease using two reporter",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.2890625,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.296875,
            "text": "Alzheimer's disease using two reporter alleles encoding the",
            "probability": 5.960464477539063e-08
        }
    ],
    "58b6978822d300530900000a_8": [
        {
            "start_logit": 9.0546875,
            "end_logit": 9.25,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.0888671875,
            "end_logit": 9.25,
            "text": "disease",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.8076171875,
            "text": "Alzheimer",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": -5.85546875,
            "end_logit": 9.25,
            "text": "'s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -5.73828125,
            "text": "Alzheimer's disease (V642I",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9609375,
            "end_logit": 9.25,
            "text": "s disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.33203125,
            "text": "Alzheimer's disease (V64",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.44921875,
            "text": "Alzheimer's disease (V642",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 9.25,
            "text": "with Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.8046875,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.25,
            "text": "associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.25,
            "text": "a mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 9.25,
            "text": "mutation associated with Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.19921875,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and wild-type controls",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.24609375,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.25,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.2578125,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and wild-type controls were",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.0888671875,
            "end_logit": -5.73828125,
            "text": "disease (V642I",
            "probability": 0.0
        },
        {
            "start_logit": -1.0888671875,
            "end_logit": -6.33203125,
            "text": "disease (V64",
            "probability": 0.0
        },
        {
            "start_logit": -1.0888671875,
            "end_logit": -6.44921875,
            "text": "disease (V642",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_9": [
        {
            "start_logit": 9.0234375,
            "end_logit": 9.0234375,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": 9.0234375,
            "text": "disease",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -1.87890625,
            "text": "Alzheimer",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -5.89453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 9.0234375,
            "text": "'s disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 9.0234375,
            "text": "s disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.921875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.99609375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.0,
            "text": "Alzheimer's disease genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.01953125,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.02734375,
            "text": "Alzheimer's",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.0546875,
            "text": "Alzheimer's disease genes: the amyloid precursor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.09765625,
            "text": "Alzheimer's disease genes: the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.16015625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 9.0234375,
            "text": "of Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -5.89453125,
            "text": "disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -6.921875,
            "text": "disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_10": [
        {
            "start_logit": 8.7421875,
            "end_logit": 8.703125,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -2.296875,
            "text": "Alzheimer",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -2.259765625,
            "end_logit": 8.703125,
            "text": "disease",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -4.9453125,
            "text": "Alzheimers disease (AD)",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -5.51171875,
            "text": "Alzheimers disease (AD",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.55859375,
            "end_logit": 8.703125,
            "text": "s disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -6.94140625,
            "text": "Alzheimers disease (AD).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.0234375,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.171875,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7421875,
            "end_logit": -7.30078125,
            "text": "Alzheimers disease (AD).We",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -4.9453125,
            "text": "disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -5.51171875,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -6.51171875,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -6.94140625,
            "text": "disease (AD).",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -7.0234375,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -7.078125,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val71",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -7.171875,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val",
            "probability": 0.0
        },
        {
            "start_logit": -2.259765625,
            "end_logit": -7.30078125,
            "text": "disease (AD).We",
            "probability": 0.0
        },
        {
            "start_logit": -5.21875,
            "end_logit": -4.9453125,
            "text": "AD)",
            "probability": 0.0
        },
        {
            "start_logit": -5.55859375,
            "end_logit": -4.9453125,
            "text": "s disease (AD)",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_11": [
        {
            "start_logit": 8.671875,
            "end_logit": 8.7421875,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": -2.220703125,
            "end_logit": 8.7421875,
            "text": "disease",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 8.671875,
            "end_logit": -2.55859375,
            "text": "Alzheimer",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -5.6953125,
            "end_logit": 8.7421875,
            "text": "s disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 8.7421875,
            "text": "onset Alzheimers disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.671875,
            "end_logit": -7.0703125,
            "text": "Alzheimers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.7421875,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.7421875,
            "text": "with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": -2.55859375,
            "text": "onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -2.55859375,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -2.55859375,
            "text": "with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -5.6953125,
            "end_logit": -7.0703125,
            "text": "s",
            "probability": 0.0
        },
        {
            "start_logit": -6.6484375,
            "end_logit": -7.0703125,
            "text": "onset Alzheimers",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.62890625,
            "text": "Val717",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.9765625,
            "text": "Val717Ile",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.99609375,
            "text": "Val71",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.0703125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.18359375,
            "text": "Val",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.1953125,
            "text": "Val717Ile)",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.2265625,
            "text": "Val717Ile) associated with early",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_12": [
        {
            "start_logit": 9.0234375,
            "end_logit": 9.0234375,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": 9.0234375,
            "text": "disease",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -1.87890625,
            "text": "Alzheimer",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -5.89453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 9.0234375,
            "text": "'s disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 9.0234375,
            "text": "s disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.921875,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9453125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.99609375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.0,
            "text": "Alzheimer's disease genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.01953125,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.02734375,
            "text": "Alzheimer's",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.0546875,
            "text": "Alzheimer's disease genes: the amyloid precursor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.09765625,
            "text": "Alzheimer's disease genes: the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.16015625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 9.0234375,
            "text": "of Alzheimer's disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -5.89453125,
            "text": "disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 0.0
        },
        {
            "start_logit": -1.689453125,
            "end_logit": -6.921875,
            "text": "disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_13": [
        {
            "start_logit": 8.8828125,
            "end_logit": 9.1328125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": 9.1328125,
            "text": "disease",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -2.166015625,
            "text": "Alzheimer",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 9.1328125,
            "text": "onset Alzheimer's disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 9.1328125,
            "text": "'s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.234375,
            "end_logit": 9.1328125,
            "text": "s disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 9.1328125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -6.296875,
            "text": "Alzheimer's disease.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 9.1328125,
            "text": "with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 9.1328125,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 9.1328125,
            "text": "early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.1328125,
            "text": "two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.1328125,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.1328125,
            "text": "-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.1328125,
            "text": "in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.1328125,
            "text": "families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.08984375,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.2578125,
            "text": "Alzheimer's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4150390625,
            "end_logit": -6.296875,
            "text": "disease.",
            "probability": 0.0
        },
        {
            "start_logit": -5.66796875,
            "end_logit": -2.166015625,
            "text": "onset Alzheimer",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_1": [
        {
            "start_logit": 3.224609375,
            "end_logit": 1.6728515625,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.90869140625
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -1.0751953125,
            "text": "single origins,",
            "probability": 0.058074951171875
        },
        {
            "start_logit": -0.72265625,
            "end_logit": 1.6728515625,
            "text": "multiple origins.",
            "probability": 0.01751708984375
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -2.919921875,
            "text": "single",
            "probability": 0.00919342041015625
        },
        {
            "start_logit": -3.484375,
            "end_logit": 1.6728515625,
            "text": ".",
            "probability": 0.00110626220703125
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -5.34765625,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 0.0008091926574707031
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -5.3515625,
            "text": "single origins, whereas",
            "probability": 0.0008091926574707031
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -5.421875,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins",
            "probability": 0.0007543563842773438
        },
        {
            "start_logit": -4.24609375,
            "end_logit": 1.6728515625,
            "text": "from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.0005164146423339844
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -6.00390625,
            "text": "single origins, whereas most archaea and",
            "probability": 0.00041985511779785156
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -6.13671875,
            "text": "single origins, whereas most",
            "probability": 0.0003676414489746094
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -6.3046875,
            "text": "single origins",
            "probability": 0.00031185150146484375
        },
        {
            "start_logit": -4.75390625,
            "end_logit": 1.6728515625,
            "text": "whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.0003108978271484375
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -6.421875,
            "text": "single origins, whereas most archaea and all eukaryotes replicate",
            "probability": 0.00027751922607421875
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -6.4765625,
            "text": "single origins, whereas most archaea and all",
            "probability": 0.0002627372741699219
        },
        {
            "start_logit": 3.224609375,
            "end_logit": -6.59765625,
            "text": "single origins, whereas most archaea",
            "probability": 0.00023174285888671875
        },
        {
            "start_logit": -5.46875,
            "end_logit": 1.6728515625,
            "text": ", whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 0.00015211105346679688
        },
        {
            "start_logit": -5.515625,
            "end_logit": 1.6728515625,
            "text": "using multiple origins.",
            "probability": 0.00014519691467285156
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 1.6728515625,
            "text": "Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 7.241964340209961e-05
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 1.6728515625,
            "text": "most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 5.3763389587402344e-05
        }
    ],
    "52fe58f82059c6d71c00007a_2": [
        {
            "start_logit": 7.109375,
            "end_logit": -0.82275390625,
            "text": "multiple",
            "probability": 0.94970703125
        },
        {
            "start_logit": 7.109375,
            "end_logit": -5.1484375,
            "text": "multiple DNA replication origins are",
            "probability": 0.01258087158203125
        },
        {
            "start_logit": 7.109375,
            "end_logit": -5.19140625,
            "text": "multiple DNA replication origins are a",
            "probability": 0.012054443359375
        },
        {
            "start_logit": 7.109375,
            "end_logit": -5.796875,
            "text": "multiple DNA replication origins are a hallmark",
            "probability": 0.0065765380859375
        },
        {
            "start_logit": 7.109375,
            "end_logit": -5.90234375,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 0.00592041015625
        },
        {
            "start_logit": 7.109375,
            "end_logit": -6.59375,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes",
            "probability": 0.002964019775390625
        },
        {
            "start_logit": 7.109375,
            "end_logit": -6.63671875,
            "text": "multiple DNA replication origins are a hallmark of",
            "probability": 0.0028400421142578125
        },
        {
            "start_logit": 7.109375,
            "end_logit": -6.97265625,
            "text": "multiple DNA replication origins",
            "probability": 0.0020294189453125
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.14453125,
            "text": "multiple DNA replication",
            "probability": 0.001708984375
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.171875,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some",
            "probability": 0.0016632080078125
        },
        {
            "start_logit": 7.109375,
            "end_logit": -7.23046875,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some Archaea",
            "probability": 0.001567840576171875
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -5.1484375,
            "text": "DNA replication origins are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -5.19140625,
            "text": "DNA replication origins are a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -5.796875,
            "text": "DNA replication origins are a hallmark",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -5.90234375,
            "text": "DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -6.59375,
            "text": "DNA replication origins are a hallmark of Eukaryotes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -6.63671875,
            "text": "DNA replication origins are a hallmark of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -6.97265625,
            "text": "DNA replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -7.14453125,
            "text": "DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -7.171875,
            "text": "DNA replication origins are a hallmark of Eukaryotes and some",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_3": [
        {
            "start_logit": 6.453125,
            "end_logit": 0.52197265625,
            "text": "Multiple",
            "probability": 0.9248046875
        },
        {
            "start_logit": 6.453125,
            "end_logit": -2.466796875,
            "text": "Multiple orc/cdc6-associated replication origins were",
            "probability": 0.0465087890625
        },
        {
            "start_logit": 6.453125,
            "end_logit": -4.3515625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all",
            "probability": 0.007061004638671875
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.046875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal genome",
            "probability": 0.0035228729248046875
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.2265625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted",
            "probability": 0.0029449462890625
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.2734375,
            "text": "Multiple orc/cdc6",
            "probability": 0.0028095245361328125
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.58203125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in",
            "probability": 0.0020618438720703125
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.78125,
            "text": "Multiple orc/cdc6-",
            "probability": 0.0016908645629882812
        },
        {
            "start_logit": 6.453125,
            "end_logit": -5.890625,
            "text": "Multiple orc/cdc6-associated replication origins",
            "probability": 0.0015153884887695312
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.23046875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the",
            "probability": 0.0010786056518554688
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.3359375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of",
            "probability": 0.0009713172912597656
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.3828125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal",
            "probability": 0.0009264945983886719
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.48046875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed",
            "probability": 0.0008401870727539062
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.49609375,
            "text": "Multiple orc/cdc",
            "probability": 0.0008268356323242188
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.50390625,
            "text": "Multiple orc/",
            "probability": 0.0008206367492675781
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.53515625,
            "text": "Multiple orc",
            "probability": 0.0007958412170410156
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.76953125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaea",
            "probability": 0.000629425048828125
        },
        {
            "start_logit": -3.955078125,
            "end_logit": -2.466796875,
            "text": "orc/cdc6-associated replication origins were",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -3.955078125,
            "end_logit": -4.3515625,
            "text": "orc/cdc6-associated replication origins were predicted in all",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3515625,
            "end_logit": -2.466796875,
            "text": "replication origins were",
            "probability": 1.1920928955078125e-07
        }
    ],
    "52fe58f82059c6d71c00007a_4": [
        {
            "start_logit": 1.0283203125,
            "end_logit": -1.310546875,
            "text": "Sulfolobus chromosome implies",
            "probability": 0.837890625
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -3.9140625,
            "text": "Sulfolobus chromosome",
            "probability": 0.0618896484375
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -5.21875,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve",
            "probability": 0.01678466796875
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -5.609375,
            "text": "Sulfolobus chromosome implies that the multiple replication origins",
            "probability": 0.01136016845703125
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -5.66015625,
            "text": "Sulfolobus",
            "probability": 0.01079559326171875
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -5.97265625,
            "text": "Sulfolobus chromosome implies that the multiple",
            "probability": 0.007904052734375
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -5.984375,
            "text": "Sulfolobus chromosome implies that",
            "probability": 0.00780487060546875
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -6.203125,
            "text": "Sulfolobus chromosome implies that the",
            "probability": 0.006275177001953125
        },
        {
            "start_logit": 0.02313232421875,
            "end_logit": -5.21875,
            "text": "multiple replication origins serve",
            "probability": 0.006153106689453125
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -6.328125,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required",
            "probability": 0.005535125732421875
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -6.33984375,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve purposes other than simply shortening the time required for",
            "probability": 0.005474090576171875
        },
        {
            "start_logit": 1.0283203125,
            "end_logit": -6.37890625,
            "text": "Sulfolobus chromosome implies that the multiple replication origins serve purposes other than",
            "probability": 0.005260467529296875
        },
        {
            "start_logit": 0.02313232421875,
            "end_logit": -5.609375,
            "text": "multiple replication origins",
            "probability": 0.004161834716796875
        },
        {
            "start_logit": 0.02313232421875,
            "end_logit": -5.97265625,
            "text": "multiple",
            "probability": 0.002895355224609375
        },
        {
            "start_logit": 0.02313232421875,
            "end_logit": -6.328125,
            "text": "multiple replication origins serve purposes other than simply shortening the time required",
            "probability": 0.0020275115966796875
        },
        {
            "start_logit": 0.02313232421875,
            "end_logit": -6.33984375,
            "text": "multiple replication origins serve purposes other than simply shortening the time required for",
            "probability": 0.00200653076171875
        },
        {
            "start_logit": -5.01953125,
            "end_logit": -1.310546875,
            "text": "the Sulfolobus chromosome implies",
            "probability": 0.0019817352294921875
        },
        {
            "start_logit": 0.02313232421875,
            "end_logit": -6.37890625,
            "text": "multiple replication origins serve purposes other than",
            "probability": 0.0019292831420898438
        },
        {
            "start_logit": -5.90234375,
            "end_logit": -1.310546875,
            "text": "The strong replication-biased structuring of the Sulfolobus chromosome implies",
            "probability": 0.000820159912109375
        },
        {
            "start_logit": -6.0,
            "end_logit": -1.310546875,
            "text": "chromosome implies",
            "probability": 0.0007410049438476562
        }
    ],
    "52fe58f82059c6d71c00007a_5": [
        {
            "start_logit": 2.11328125,
            "end_logit": -5.0390625,
            "text": "multiple replication origin paradigm",
            "probability": 0.167724609375
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.4140625,
            "text": "multiple replication origin paradigm has",
            "probability": 0.1153564453125
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.4921875,
            "text": "multiple replication origin",
            "probability": 0.10662841796875
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.67578125,
            "text": "multiple replication origin paradigm has also been demonstrated",
            "probability": 0.08868408203125
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.734375,
            "text": "multiple",
            "probability": 0.083740234375
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.89453125,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 0.0712890625
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.9609375,
            "text": "multiple replication origin paradigm has also been demonstrated within",
            "probability": 0.06671142578125
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -5.98828125,
            "text": "multiple replication origin paradigm has also been",
            "probability": 0.06494140625
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -6.171875,
            "text": "multiple replication origin paradigm has also",
            "probability": 0.05401611328125
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -6.375,
            "text": "multiple replication origin paradigm has also been demonstrated within the",
            "probability": 0.044097900390625
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -6.44140625,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain",
            "probability": 0.041259765625
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -6.58203125,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of",
            "probability": 0.035858154296875
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -6.78515625,
            "text": "multiple replication",
            "probability": 0.029266357421875
        },
        {
            "start_logit": 2.11328125,
            "end_logit": -6.8046875,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal",
            "probability": 0.0286865234375
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -5.0390625,
            "text": "the multiple replication origin paradigm",
            "probability": 0.000476837158203125
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -5.4140625,
            "text": "the multiple replication origin paradigm has",
            "probability": 0.0003275871276855469
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -5.4921875,
            "text": "the multiple replication origin",
            "probability": 0.00030303001403808594
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -5.67578125,
            "text": "the multiple replication origin paradigm has also been demonstrated",
            "probability": 0.0002512931823730469
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -5.734375,
            "text": "the multiple",
            "probability": 0.00023794174194335938
        },
        {
            "start_logit": -3.751953125,
            "end_logit": -5.89453125,
            "text": "the multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 0.00020194053649902344
        }
    ],
    "52fe58f82059c6d71c00007a_6": [
        {
            "start_logit": 7.48828125,
            "end_logit": -0.096435546875,
            "text": "multiple",
            "probability": 0.97412109375
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -5.8046875,
            "text": "multiple chromosome replication",
            "probability": 0.0032367706298828125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.07421875,
            "text": "multiple chromosome replication origins in Sulfolobus",
            "probability": 0.002471923828125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.125,
            "text": "multiple chromosome",
            "probability": 0.0023517608642578125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.13671875,
            "text": "multiple chromosome replication origins in Sulfolobus species",
            "probability": 0.002323150634765625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.265625,
            "text": "multiple chromosome replication origins in",
            "probability": 0.0020427703857421875
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.31640625,
            "text": "multiple chromosome replication origins in Sulfolobus species has",
            "probability": 0.0019397735595703125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.3359375,
            "text": "multiple chromosome replication origins",
            "probability": 0.0019025802612304688
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.51171875,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet",
            "probability": 0.0015964508056640625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.546875,
            "text": "multiple chromosome replication origins in Sulfolobus species has added",
            "probability": 0.0015411376953125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.60546875,
            "text": "multiple chromosome replication origins in Sulfolobu",
            "probability": 0.001453399658203125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.68359375,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another",
            "probability": 0.0013446807861328125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.77734375,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait",
            "probability": 0.0012235641479492188
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.79296875,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic",
            "probability": 0.0012054443359375
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.00390625,
            "text": "multiple chromosome replication origins in Sulfo",
            "probability": 0.0009756088256835938
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -5.8046875,
            "text": "chromosome replication",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.07421875,
            "text": "chromosome replication origins in Sulfolobus",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.125,
            "text": "chromosome",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.13671875,
            "text": "chromosome replication origins in Sulfolobus species",
            "probability": 0.0
        },
        {
            "start_logit": -6.7265625,
            "end_logit": -6.265625,
            "text": "chromosome replication origins in",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_7": [
        {
            "start_logit": 2.294921875,
            "end_logit": 1.564453125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.54541015625
        },
        {
            "start_logit": 2.076171875,
            "end_logit": 1.564453125,
            "text": "Sulfolobus solfataricus",
            "probability": 0.4384765625
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -2.935546875,
            "text": "multiple replication origins",
            "probability": 0.006061553955078125
        },
        {
            "start_logit": -3.060546875,
            "end_logit": 1.564453125,
            "text": "In addition, the potential multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.0025768280029296875
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -4.6015625,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are",
            "probability": 0.0011472702026367188
        },
        {
            "start_logit": 2.076171875,
            "end_logit": -4.6015625,
            "text": "Sulfolobus solfataricus are",
            "probability": 0.0009217262268066406
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -5.02734375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve method",
            "probability": 0.0007467269897460938
        },
        {
            "start_logit": 2.076171875,
            "end_logit": -5.02734375,
            "text": "Sulfolobus solfataricus are suggested by the analysis based on the Z curve method",
            "probability": 0.0005998611450195312
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -5.265625,
            "text": "multiple replication origins of",
            "probability": 0.0005903244018554688
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -5.3125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve",
            "probability": 0.0005636215209960938
        },
        {
            "start_logit": -4.66796875,
            "end_logit": 1.564453125,
            "text": "addition, the potential multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.0005173683166503906
        },
        {
            "start_logit": 2.076171875,
            "end_logit": -5.3125,
            "text": "Sulfolobus solfataricus are suggested by the analysis based on the Z curve",
            "probability": 0.00045299530029296875
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -6.01171875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested",
            "probability": 0.0002791881561279297
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -6.0703125,
            "text": "multiple",
            "probability": 0.00026416778564453125
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -6.08203125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by",
            "probability": 0.0002601146697998047
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -6.09765625,
            "text": "multiple replication origins of the archaeon Sulfolobus sol",
            "probability": 0.0002560615539550781
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -6.17578125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfa",
            "probability": 0.00023686885833740234
        },
        {
            "start_logit": 2.294921875,
            "end_logit": -6.22265625,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the",
            "probability": 0.00022590160369873047
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 1.564453125,
            "text": ", the potential multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.00022590160369873047
        },
        {
            "start_logit": 2.076171875,
            "end_logit": -6.01171875,
            "text": "Sulfolobus solfataricus are suggested",
            "probability": 0.00022423267364501953
        }
    ],
    "52fe58f82059c6d71c00007a_8": [
        {
            "start_logit": 8.4765625,
            "end_logit": 2.08203125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.8388671875
        },
        {
            "start_logit": 8.4765625,
            "end_logit": 0.4033203125,
            "text": "multiple",
            "probability": 0.1563720703125
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -4.8203125,
            "text": "multiple replication origins have been observed",
            "probability": 0.0008397102355957031
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.046875,
            "text": "multiple replication origins have been observed in archaea,",
            "probability": 0.0006699562072753906
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.16796875,
            "text": "multiple replication origins have",
            "probability": 0.0005936622619628906
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.6484375,
            "text": "multiple replication origins have been",
            "probability": 0.0003669261932373047
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.76953125,
            "text": "multiple replication origins have been observed in archaea, considerably",
            "probability": 0.00032520294189453125
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.79296875,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about",
            "probability": 0.00031757354736328125
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.8125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known",
            "probability": 0.0003113746643066406
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -5.91015625,
            "text": "multiple replication origins",
            "probability": 0.00028252601623535156
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.1484375,
            "text": "multiple replication origins have been observed in",
            "probability": 0.0002225637435913086
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.1875,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary",
            "probability": 0.00021398067474365234
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.25,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their",
            "probability": 0.00020110607147216797
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.25390625,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes",
            "probability": 0.00019943714141845703
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.40234375,
            "text": "multiple replication origins have been observed in archaea, considerably less",
            "probability": 0.00017333030700683594
        },
        {
            "start_logit": 8.4765625,
            "end_logit": -6.5390625,
            "text": "multiple replication origins have been observed in archaea, considerably less is",
            "probability": 0.00015056133270263672
        },
        {
            "start_logit": -0.218505859375,
            "end_logit": 2.08203125,
            "text": "While multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.0001392364501953125
        },
        {
            "start_logit": -0.218505859375,
            "end_logit": 0.4033203125,
            "text": "While multiple",
            "probability": 2.6166439056396484e-05
        },
        {
            "start_logit": -3.51171875,
            "end_logit": 2.08203125,
            "text": ".",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 2.08203125,
            "text": "replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 8.940696716308594e-07
        }
    ],
    "52fe58f82059c6d71c00007a_9": [
        {
            "start_logit": 6.94140625,
            "end_logit": 1.6318359375,
            "text": "multiple",
            "probability": 0.99609375
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -5.44921875,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal genomes",
            "probability": 0.0008401870727539062
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -5.95703125,
            "text": "multiple orc/cdc6-associated replication origins in",
            "probability": 0.0005054473876953125
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.2265625,
            "text": "multiple orc/cdc6",
            "probability": 0.00038623809814453125
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.33203125,
            "text": "multiple orc/cdc6-",
            "probability": 0.00034737586975097656
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.375,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaea",
            "probability": 0.0003342628479003906
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.38671875,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal",
            "probability": 0.00032901763916015625
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.40625,
            "text": "multiple orc/cdc6-associated replication origins",
            "probability": 0.00032401084899902344
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.70703125,
            "text": "multiple orc/cdc6-associated replication origins in halo",
            "probability": 0.00023877620697021484
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.734375,
            "text": "multiple orc/cdc6-associated replication origins in haloarch",
            "probability": 0.0002332925796508789
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.81640625,
            "text": "multiple orc",
            "probability": 0.00021409988403320312
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.83984375,
            "text": "multiple orc/",
            "probability": 0.0002090930938720703
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.9609375,
            "text": "multiple orc/cdc",
            "probability": 0.00018453598022460938
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.20703125,
            "text": "multiple orc/cdc6-associated",
            "probability": 0.00014483928680419922
        },
        {
            "start_logit": -5.765625,
            "end_logit": -5.44921875,
            "text": "orc/cdc6-associated replication origins in haloarchaeal genomes",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -5.95703125,
            "text": "orc/cdc6-associated replication origins in",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -6.2265625,
            "text": "orc/cdc6",
            "probability": 0.0
        },
        {
            "start_logit": -6.6015625,
            "end_logit": -5.44921875,
            "text": "replication origins in haloarchaeal genomes",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -6.33203125,
            "text": "orc/cdc6-",
            "probability": 0.0
        },
        {
            "start_logit": -5.765625,
            "end_logit": -6.375,
            "text": "orc/cdc6-associated replication origins in haloarchaea",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_1": [
        {
            "start_logit": 5.91796875,
            "end_logit": 7.6796875,
            "text": "cytokines",
            "probability": 1.0
        },
        {
            "start_logit": -2.232421875,
            "end_logit": 7.6796875,
            "text": "pro-inflammatory cytokines",
            "probability": 0.0002892017364501953
        },
        {
            "start_logit": -4.90625,
            "end_logit": 7.6796875,
            "text": "adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 7.6796875,
            "text": "inflammatory cytokines",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -4.6796875,
            "text": "cytokines (IL-1\u03b2, IL-6 and IL-8).",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 7.6796875,
            "text": "human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -6.796875,
            "end_logit": 7.6796875,
            "text": "obesity and expression of pro-inflammatory cytokines",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 7.6796875,
            "text": "-inflammatory cytokines",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 7.6796875,
            "text": "of pro-inflammatory cytokines",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 7.6796875,
            "text": "relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -5.40625,
            "text": "cytokines (IL-1\u03b2",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.6796875,
            "text": "of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.6796875,
            "text": "used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.6796875,
            "text": "MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.6796875,
            "text": "We used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.7109375,
            "text": "cytokines (IL-1\u03b2, IL-6 and IL-8)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.7890625,
            "text": "cytokines (IL-1\u03b2,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.86328125,
            "text": "cytokines (IL-1\u03b2, IL",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.86328125,
            "text": "cytokines (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.95703125,
            "text": "cytokines (IL-1\u03b2, IL-6 and IL",
            "probability": 4.172325134277344e-07
        }
    ],
    "5fe31317a43ad31278000044_2": [
        {
            "start_logit": 9.109375,
            "end_logit": 8.75,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": -0.1456298828125,
            "end_logit": 8.75,
            "text": "adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.435546875,
            "text": "IL",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -2.1484375,
            "end_logit": 8.75,
            "text": "1\u03b2",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": -5.65625,
            "end_logit": 8.75,
            "text": "Together, the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.06640625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but does not seem to have systemic effects on insulin resistance.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.1456298828125,
            "end_logit": 2.8046875,
            "text": "adipose tissue",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 8.75,
            "text": "-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.47265625,
            "text": "IL-1\u03b2 and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.49609375,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 8.75,
            "text": "tissue inflammation, specifically for IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 8.75,
            "text": "data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 8.75,
            "text": "the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.890625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but does not seem to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.90625,
            "text": "IL-1\u03b2 and its",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 8.75,
            "text": "local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.94921875,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but does not seem",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.05078125,
            "text": "IL-1\u03b2 and its responsive cytokines IL",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.0625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 8.75,
            "text": "inflammation, specifically for IL-1\u03b2",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5fe31317a43ad31278000044_3": [
        {
            "start_logit": 3.935546875,
            "end_logit": 2.94921875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.60546875
        },
        {
            "start_logit": 3.5,
            "end_logit": 2.94921875,
            "text": "TNF\u03b1",
            "probability": 0.392333984375
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -3.798828125,
            "text": "tumor progression locus 2",
            "probability": 0.0007119178771972656
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -4.9296875,
            "text": "tumor progression locus",
            "probability": 0.0002301931381225586
        },
        {
            "start_logit": -4.27734375,
            "end_logit": 2.94921875,
            "text": "of TNF\u03b1",
            "probability": 0.00016438961029052734
        },
        {
            "start_logit": 3.5,
            "end_logit": -4.91796875,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3",
            "probability": 0.00015103816986083984
        },
        {
            "start_logit": 3.5,
            "end_logit": -4.97265625,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0001418590545654297
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -5.578125,
            "text": "tumor progression",
            "probability": 0.00012034177780151367
        },
        {
            "start_logit": 3.5,
            "end_logit": -5.16015625,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 0.0001175999641418457
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -5.890625,
            "text": "tumor progression locus 2 (",
            "probability": 8.809566497802734e-05
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -5.8984375,
            "text": "tumor",
            "probability": 8.732080459594727e-05
        },
        {
            "start_logit": -5.1328125,
            "end_logit": 2.94921875,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 7.021427154541016e-05
        },
        {
            "start_logit": -5.3125,
            "end_logit": 2.94921875,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 5.817413330078125e-05
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -6.421875,
            "text": "tumor progression locus 2 (Tp",
            "probability": 5.173683166503906e-05
        },
        {
            "start_logit": -5.65625,
            "end_logit": 2.94921875,
            "text": "as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 4.124641418457031e-05
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -6.66796875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that",
            "probability": 4.029273986816406e-05
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -6.703125,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator",
            "probability": 3.910064697265625e-05
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -6.70703125,
            "text": "tumor progression locus 2 (Tpl2,",
            "probability": 3.8743019104003906e-05
        },
        {
            "start_logit": 3.935546875,
            "end_logit": -6.76171875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a",
            "probability": 3.6716461181640625e-05
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 2.94921875,
            "text": "kinase tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 3.528594970703125e-05
        }
    ],
    "5fe31317a43ad31278000044_4": [
        {
            "start_logit": 3.552734375,
            "end_logit": 2.92578125,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.54345703125
        },
        {
            "start_logit": 3.373046875,
            "end_logit": 2.92578125,
            "text": "TNF\u03b1",
            "probability": 0.4541015625
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -4.15234375,
            "text": "tumor progression locus 2",
            "probability": 0.0004584789276123047
        },
        {
            "start_logit": 3.373046875,
            "end_logit": -4.3125,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.0003275871276855469
        },
        {
            "start_logit": 3.373046875,
            "end_logit": -4.546875,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3",
            "probability": 0.00025916099548339844
        },
        {
            "start_logit": -4.2265625,
            "end_logit": 2.92578125,
            "text": "of TNF\u03b1",
            "probability": 0.00022780895233154297
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -5.2265625,
            "text": "tumor progression locus",
            "probability": 0.00015723705291748047
        },
        {
            "start_logit": 3.373046875,
            "end_logit": -5.46875,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 0.00010305643081665039
        },
        {
            "start_logit": -5.03515625,
            "end_logit": 2.92578125,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.00010144710540771484
        },
        {
            "start_logit": -5.09375,
            "end_logit": 2.92578125,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -5.83203125,
            "text": "tumor progression",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -5.91015625,
            "text": "tumor progression locus 2 (",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -6.0234375,
            "text": "tumor",
            "probability": 7.081031799316406e-05
        },
        {
            "start_logit": -5.49609375,
            "end_logit": 2.92578125,
            "text": "as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -5.7890625,
            "end_logit": 2.92578125,
            "text": "production of TNF\u03b1",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -6.453125,
            "text": "tumor progression locus 2 (Tp",
            "probability": 4.607439041137695e-05
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 2.92578125,
            "text": "kinase tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 4.571676254272461e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -6.5546875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -6.6015625,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": 3.552734375,
            "end_logit": -6.65625,
            "text": "tumor progression locus 2 (Tpl2,",
            "probability": 3.7610530853271484e-05
        }
    ],
    "5fe31317a43ad31278000044_5": [
        {
            "start_logit": 9.0234375,
            "end_logit": 8.90625,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -1.8291015625,
            "text": "IL",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": -1.90625,
            "end_logit": 8.90625,
            "text": "1\u03b2",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 8.90625,
            "text": "-1\u03b2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -6.9609375,
            "text": "IL-1\u03b2 reporter activity.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.046875,
            "text": "IL-1\u03b2 reporter",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0234375,
            "end_logit": -7.140625,
            "text": "IL-1\u03b2 reporter activity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.90625,
            "text": "(tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.90625,
            "text": "for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.90625,
            "text": "tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.90625,
            "text": ", MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.90625,
            "text": "that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.90625,
            "end_logit": -6.9609375,
            "text": "1\u03b2 reporter activity.",
            "probability": 0.0
        },
        {
            "start_logit": -1.90625,
            "end_logit": -7.046875,
            "text": "1\u03b2 reporter",
            "probability": 0.0
        },
        {
            "start_logit": -1.90625,
            "end_logit": -7.140625,
            "text": "1\u03b2 reporter activity",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -1.8291015625,
            "text": "(tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.8291015625,
            "text": "for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -1.8291015625,
            "text": "tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.8291015625,
            "text": ", MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -1.8291015625,
            "text": "that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_6": [
        {
            "start_logit": 7.9453125,
            "end_logit": 6.45703125,
            "text": "TNF -\u03b1",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -2.94140625,
            "text": "TNF",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -3.099609375,
            "text": "TNF -\u03b1, in human adipose tissue",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -3.853515625,
            "text": "TNF -\u03b1, in human adipose tissue were associated with higher expression of MAP3K8.",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.265625,
            "text": "TNF -\u03b1, in human adipose tissue were",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": -4.05859375,
            "end_logit": 6.45703125,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -4.69140625,
            "end_logit": 6.45703125,
            "text": "\u03b1",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.54296875,
            "text": "TNF -\u03b1, in human adipose tissue were associated with higher",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 6.45703125,
            "text": "not TNF -\u03b1",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.703125,
            "text": "TNF -\u03b1,",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.8515625,
            "text": "TNF -\u03b1, in human adipose",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 6.45703125,
            "text": "Additionally, high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 6.45703125,
            "text": ", but not TNF -\u03b1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 6.45703125,
            "text": "but not TNF -\u03b1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 6.45703125,
            "text": "high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 6.45703125,
            "text": "-\u03b1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 6.45703125,
            "text": ", high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 6.45703125,
            "text": "of IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.05859375,
            "end_logit": -2.94140625,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF",
            "probability": 0.0
        },
        {
            "start_logit": -4.05859375,
            "end_logit": -3.099609375,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1, in human adipose tissue",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_7": [
        {
            "start_logit": 8.8046875,
            "end_logit": 8.8125,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -0.207275390625,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue",
            "probability": 0.00011962652206420898
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -1.806640625,
            "text": "IL",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.892578125,
            "end_logit": 8.8125,
            "text": "1\u03b2",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -4.48046875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -4.53515625,
            "text": "IL-1\u03b2, IL-6 and CXCL1",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.4921875,
            "end_logit": 8.8125,
            "text": "-1\u03b2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.02734375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.078125,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.109375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.125,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.38671875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.8125,
            "text": "of IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.40234375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.40625,
            "text": "IL-1\u03b2,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.49609375,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 8.8125,
            "text": "lower mRNA expression levels of IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8046875,
            "end_logit": -6.671875,
            "text": "IL-1\u03b2, IL",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.8125,
            "text": ", yet displayed lower mRNA expression levels of IL-1\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 8.8125,
            "text": "mRNA expression levels of IL-1\u03b2",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_1": [
        {
            "start_logit": 8.7890625,
            "end_logit": 7.484375,
            "text": "SARS-CoV-2",
            "probability": 1.0
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -2.25390625,
            "text": "SARS",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -3.052734375,
            "text": "SARS-CoV-2.",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -4.140625,
            "text": "SARS-CoV",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -3.28515625,
            "end_logit": 7.484375,
            "text": "2",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -4.60546875,
            "text": "SARS-CoV-",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 7.484375,
            "text": ". In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.28125,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antiviral",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.421875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.578125,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.66796875,
            "text": "SARS-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 7.484375,
            "text": "In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.82421875,
            "end_logit": 7.484375,
            "text": "against SARS-CoV-2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 7.484375,
            "text": "COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 7.484375,
            "text": "the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 7.484375,
            "text": "-CoV-2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.484375,
            "text": "race for drugs to be effective against SARS-CoV-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.484375,
            "text": "there has been a race for drugs to be effective against SARS-CoV-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.484375,
            "text": "drugs to be effective against SARS-CoV-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.484375,
            "text": "era, there has been a race for drugs to be effective against SARS-CoV-2",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_2": [
        {
            "start_logit": 8.4375,
            "end_logit": 8.9296875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": 8.9296875,
            "text": "19",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -2.9375,
            "text": "COV",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 8.4375,
            "end_logit": -5.36328125,
            "text": "COVID-19 (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 8.9296875,
            "text": "ID-19",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -5.8984375,
            "text": "COVID-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.4296875,
            "text": "COVID-19 (lopinavir",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.46484375,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir),",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.60546875,
            "text": "COVID-19 (lopinavir, ritonavir",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.62890625,
            "text": "COVID-19 (lo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.66015625,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.67578125,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.71875,
            "text": "COVID",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.765625,
            "text": "COVID-19 (lopin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.78515625,
            "text": "COVID-19 (lopinavir,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.9296875,
            "text": "-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.9296875,
            "text": "treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -5.36328125,
            "text": "19 (",
            "probability": 0.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -6.4296875,
            "text": "19 (lopinavir",
            "probability": 0.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -6.46484375,
            "text": "19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir),",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_3": [
        {
            "start_logit": 8.4375,
            "end_logit": 9.015625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -1.5703125,
            "end_logit": 9.015625,
            "text": "19",
            "probability": 4.506111145019531e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -2.865234375,
            "text": "COV",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -6.46875,
            "end_logit": 9.015625,
            "text": "ID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -5.90234375,
            "text": "COVID-19 patients",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.3046875,
            "text": "COVID-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 9.015625,
            "text": "To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.015625,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.015625,
            "text": "treat COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.015625,
            "text": ": To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.015625,
            "text": "Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.9765625,
            "text": "COVID",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -5.90234375,
            "text": "19 patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -2.865234375,
            "text": "To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -2.865234375,
            "text": "treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -2.865234375,
            "text": ": To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -2.865234375,
            "text": "Arbidol) to treat COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": -5.90234375,
            "text": "ID-19 patients",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": -6.3046875,
            "text": "ID-",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -5.90234375,
            "text": "To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19 patients",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_4": [
        {
            "start_logit": 8.5078125,
            "end_logit": 9.078125,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -1.361328125,
            "end_logit": 9.078125,
            "text": "19",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -2.763671875,
            "text": "COV",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 9.078125,
            "text": "ID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 9.078125,
            "text": "possible COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -6.39453125,
            "text": "COVID-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -6.44921875,
            "text": "COVID-19 treatments",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 9.078125,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.078125,
            "text": "Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5078125,
            "end_logit": -6.96484375,
            "text": "COVID",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.361328125,
            "end_logit": -6.44921875,
            "text": "19 treatments",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -2.763671875,
            "text": "possible COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -2.763671875,
            "text": "Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -6.39453125,
            "text": "ID-",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -6.44921875,
            "text": "ID-19 treatments",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -6.39453125,
            "text": "possible COVID-",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -6.44921875,
            "text": "possible COVID-19 treatments",
            "probability": 0.0
        },
        {
            "start_logit": -6.27734375,
            "end_logit": -6.96484375,
            "text": "ID",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.39453125,
            "text": "-",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -6.44921875,
            "text": "-19 treatments",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_5": [
        {
            "start_logit": 8.0390625,
            "end_logit": 8.625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.4296875,
            "end_logit": 8.625,
            "text": "19",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -3.435546875,
            "text": "COV",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -4.05859375,
            "text": "COVID-19 in many countries.",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -4.60546875,
            "text": "COVID-19 in",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 8.625,
            "text": "Favipiravir (FVP) has been used for treatment of COVID-19",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 8.625,
            "text": "treatment of COVID-19",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 8.625,
            "text": "ID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.00390625,
            "text": "COVID-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.078125,
            "text": "COVID-19 in many",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 8.625,
            "text": "of COVID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.40234375,
            "text": "COVID-19 in many countries",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.625,
            "text": "ipiravir (FVP) has been used for treatment of COVID-19",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.625,
            "text": "for treatment of COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.625,
            "text": "iravir (FVP) has been used for treatment of COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.76171875,
            "text": "COVID",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.625,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.625,
            "text": "used for treatment of COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.625,
            "text": "vir (FVP) has been used for treatment of COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.625,
            "text": "FVP) has been used for treatment of COVID-19",
            "probability": 1.7881393432617188e-07
        }
    ],
    "621ebb733a8413c65300005c_6": [
        {
            "start_logit": 8.6953125,
            "end_logit": 9.296875,
            "text": "COVID-19 infection",
            "probability": 1.0
        },
        {
            "start_logit": -0.89990234375,
            "end_logit": 9.296875,
            "text": "infection",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -2.46875,
            "text": "COV",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -5.22265625,
            "end_logit": 9.296875,
            "text": "severe COVID-19 infection",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -5.6328125,
            "text": "COVID-19 infection.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 9.296875,
            "text": "To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.296875,
            "text": "ID-19 infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 9.296875,
            "text": "19 infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 9.296875,
            "text": "-19 infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.296875,
            "text": "treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.62890625,
            "text": "COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.296875,
            "text": "patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.72265625,
            "text": "COVID",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.75390625,
            "text": "COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.296875,
            "text": "assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.296875,
            "text": "Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.89990234375,
            "end_logit": -5.6328125,
            "text": "infection.",
            "probability": 0.0
        },
        {
            "start_logit": -5.22265625,
            "end_logit": -2.46875,
            "text": "severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.40625,
            "end_logit": -2.46875,
            "text": "To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -2.46875,
            "text": "treating patients with severe COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_7": [
        {
            "start_logit": 6.94140625,
            "end_logit": 8.7109375,
            "text": "COVID-19 infections",
            "probability": 1.0
        },
        {
            "start_logit": -2.18359375,
            "end_logit": 8.7109375,
            "text": "infections",
            "probability": 0.00010889768600463867
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 8.7109375,
            "text": "severe COVID-19 infections",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -4.55859375,
            "text": "COV",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 8.7109375,
            "text": "Favipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 8.7109375,
            "text": "ID-19 infections",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 8.7109375,
            "text": "-19 infections",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.7109375,
            "text": "19 infections",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.7109375,
            "text": "with severe COVID-19 infections",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.7109375,
            "text": "patients with severe COVID-19 infections",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.7109375,
            "text": "ipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.7109375,
            "text": "iravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.27734375,
            "text": "COVID-19",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.70703125,
            "text": "COVID",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.77734375,
            "text": "COVID-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -4.55859375,
            "text": "severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.7421875,
            "end_logit": -4.55859375,
            "text": "Favipiravir versus standard of care in patients with severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -4.55859375,
            "text": "with severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -5.5234375,
            "end_logit": -6.27734375,
            "text": "severe COVID-19",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -4.55859375,
            "text": "patients with severe COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_8": [
        {
            "start_logit": 8.4453125,
            "end_logit": 8.7421875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.216796875,
            "end_logit": 8.7421875,
            "text": "19",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -2.9140625,
            "text": "COV",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 8.7421875,
            "text": "ID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -6.15625,
            "text": "COVID-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 8.7421875,
            "text": "treatment of COVID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -6.4921875,
            "text": "COVID-19.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.7421875,
            "text": "in the treatment of COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.7421875,
            "text": "of COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.4453125,
            "end_logit": -6.9140625,
            "text": "COVID",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.7421875,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.7421875,
            "text": "Molnupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.7421875,
            "text": "Favipiravir in the treatment of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.7421875,
            "text": "nupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.7421875,
            "text": "the treatment of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.7421875,
            "text": "iravir in the treatment of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.7421875,
            "text": "vir in the treatment of COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.216796875,
            "end_logit": -6.4921875,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": -2.9140625,
            "text": "treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -2.9140625,
            "text": "in the treatment of COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_9": [
        {
            "start_logit": 9.140625,
            "end_logit": 6.7421875,
            "text": "influenza infections",
            "probability": 1.0
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.064453125,
            "text": "influenza",
            "probability": 0.00040793418884277344
        },
        {
            "start_logit": 9.140625,
            "end_logit": -3.517578125,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated.",
            "probability": 3.510713577270508e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.71875,
            "text": "influenza infections,",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.11328125,
            "text": "influenza infections, has been suggested",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.140625,
            "text": "influenza infections, has been",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3125,
            "text": "influenza infections, has been suggested to",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.38671875,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.390625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.5,
            "text": "influenza infections, has been suggested to be effective against SARS",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.54296875,
            "text": "influenza infections, has",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.5703125,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2,",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.5859375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.58984375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.59765625,
            "text": "influenza infections, has been suggested to be",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.61328125,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.6328125,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -4.3984375,
            "end_logit": 6.7421875,
            "text": "infections",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.38671875,
            "end_logit": 6.7421875,
            "text": "treatment of new and re-emerging influenza infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 6.7421875,
            "text": "emerging influenza infections",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_10": [
        {
            "start_logit": 8.4296875,
            "end_logit": 8.515625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.517578125,
            "end_logit": 8.515625,
            "text": "19",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -2.9375,
            "text": "COV",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -3.125,
            "text": "COVID-19 patients",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -4.85546875,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -5.3671875,
            "text": "COVID-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.05859375,
            "text": "COVID-19 patients treated",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 8.515625,
            "text": "ICU admission rates of mild/moderate COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 8.515625,
            "text": "moderate COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 8.515625,
            "text": "mild/moderate COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.3515625,
            "text": "COVID-19 patients treated with hydroxychloroquine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": 8.515625,
            "text": "ID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.4765625,
            "text": "COVID",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.55078125,
            "text": "COVID-19 patients treated with hydroxychloroquine,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.6328125,
            "text": "COVID-19 patients treated with",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.734375,
            "end_logit": 8.515625,
            "text": "Comparing ICU admission rates of mild/moderate COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.76171875,
            "text": "COVID-19 patients treated with hydroxychlor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 8.515625,
            "text": "of mild/moderate COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.517578125,
            "end_logit": -3.125,
            "text": "19 patients",
            "probability": 0.0
        },
        {
            "start_logit": -2.517578125,
            "end_logit": -4.85546875,
            "text": "19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_11": [
        {
            "start_logit": 7.6640625,
            "end_logit": -3.669921875,
            "text": "influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 0.2066650390625
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -3.728515625,
            "text": "influenza",
            "probability": 0.19482421875
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -3.845703125,
            "text": "influenza A",
            "probability": 0.17333984375
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -4.98828125,
            "text": "influenza A/California",
            "probability": 0.0552978515625
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.0078125,
            "text": "influenza A/",
            "probability": 0.054229736328125
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.05859375,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in",
            "probability": 0.051513671875
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.140625,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice",
            "probability": 0.047454833984375
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.22265625,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice.",
            "probability": 0.043731689453125
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.4375,
            "text": "influenza A/California/04",
            "probability": 0.0352783203125
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.6015625,
            "text": "influenza A/California/04/2009",
            "probability": 0.029937744140625
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.65625,
            "text": "influenza A/California/",
            "probability": 0.028350830078125
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.7890625,
            "text": "influenza A/California/04/",
            "probability": 0.024810791015625
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.19921875,
            "text": "influenza A/California/04/2009 (H1N1",
            "probability": 0.0164642333984375
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.27734375,
            "text": "influenza A/California/04/2009 (H1N1) virus",
            "probability": 0.01523590087890625
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.51171875,
            "text": "influenza A/California/04/2009 (H1N1)",
            "probability": 0.01204681396484375
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.5859375,
            "text": "influenza A/California/04/2009 (",
            "probability": 0.0111846923828125
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -5.22265625,
            "text": ".",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -3.669921875,
            "text": "treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -3.728515625,
            "text": "treatment of pandemic influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.10546875,
            "end_logit": -3.845703125,
            "text": "treatment of pandemic influenza A",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_12": [
        {
            "start_logit": 8.5234375,
            "end_logit": 8.6796875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.373046875,
            "end_logit": 8.6796875,
            "text": "19",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -2.80078125,
            "text": "COV",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.1953125,
            "text": "COVID-19.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": 8.6796875,
            "text": "ID-19",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.31640625,
            "text": "COVID-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 8.6796875,
            "text": "treating patients with COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 8.6796875,
            "text": "with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.6796875,
            "text": "Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 8.6796875,
            "text": "patients with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5234375,
            "end_logit": -6.95703125,
            "text": "COVID",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.6796875,
            "text": "-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.6796875,
            "text": ": Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.6796875,
            "text": "BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.6796875,
            "text": "ipiravir possesses high utility for treating patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.373046875,
            "end_logit": -6.1953125,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -2.80078125,
            "text": "treating patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -2.80078125,
            "text": "with COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -2.80078125,
            "text": "Favipiravir possesses high utility for treating patients with COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -2.80078125,
            "text": "patients with COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_13": [
        {
            "start_logit": 9.234375,
            "end_logit": -0.360107421875,
            "text": "influenza",
            "probability": 0.8525390625
        },
        {
            "start_logit": 9.234375,
            "end_logit": -2.384765625,
            "text": "influenza viruses",
            "probability": 0.11273193359375
        },
        {
            "start_logit": 9.234375,
            "end_logit": -4.07421875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus.",
            "probability": 0.0207672119140625
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.1796875,
            "text": "influenza viruses,",
            "probability": 0.002529144287109375
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.49609375,
            "text": "influenza viruses, including",
            "probability": 0.0018444061279296875
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.54296875,
            "text": "influenza viruses, including A(H1N1)pdm09",
            "probability": 0.0017595291137695312
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.70703125,
            "text": "influenza viruses, including A(H1N1",
            "probability": 0.0014925003051757812
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.77734375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1",
            "probability": 0.0013914108276367188
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.8203125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and",
            "probability": 0.0013322830200195312
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.82421875,
            "text": "influenza viruses, including A(H1N1)pdm09,",
            "probability": 0.0013275146484375
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently",
            "probability": 0.0012617111206054688
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.87890625,
            "text": "influenza viruses, including A(H1N1)pd",
            "probability": 0.0012569427490234375
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -0.360107421875,
            "text": "Favipiravir is active against a broad range of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -0.360107421875,
            "text": "of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": -0.360107421875,
            "text": "against a broad range of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": -0.360107421875,
            "text": "ipiravir is active against a broad range of influenza",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.32421875,
            "end_logit": -4.07421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -2.384765625,
            "text": "Favipiravir is active against a broad range of influenza viruses",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -2.384765625,
            "text": "of influenza viruses",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -2.384765625,
            "text": "against a broad range of influenza viruses",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_14": [
        {
            "start_logit": 8.9765625,
            "end_logit": 8.6875,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -1.84375,
            "text": "influenza",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -2.228515625,
            "end_logit": 8.6875,
            "text": "infections",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -5.32421875,
            "text": "influenza virus infections and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -5.77734375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse model.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 8.6875,
            "text": "virus infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -6.73046875,
            "text": "influenza virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 8.6875,
            "text": "Favipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 8.6875,
            "text": "treatment of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.03515625,
            "text": "influenza virus infections and has shown",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.05078125,
            "text": "influenza virus infections and has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.07421875,
            "text": "influenza virus infections and has shown promise",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.16015625,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9765625,
            "end_logit": -7.1640625,
            "text": "influenza virus infections and has shown promise against other",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 8.6875,
            "text": "of influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.6875,
            "text": "ipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.6875,
            "text": "for the treatment of influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -5.32421875,
            "text": "infections and",
            "probability": 0.0
        },
        {
            "start_logit": -2.228515625,
            "end_logit": -5.77734375,
            "text": "infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse model.",
            "probability": 0.0
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -1.84375,
            "text": "Favipiravir is approved in Japan for the treatment of influenza",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_15": [
        {
            "start_logit": 8.4296875,
            "end_logit": 8.2265625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -1.9228515625,
            "end_logit": 8.2265625,
            "text": "antiviral drug, is being used for COVID-19",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -2.927734375,
            "text": "COV",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -2.931640625,
            "text": "COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": -3.041015625,
            "end_logit": 8.2265625,
            "text": "19",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -4.25390625,
            "text": "COVID-19 treatment",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -4.57421875,
            "text": "COVID-19 treatment,",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -5.8828125,
            "text": "COVID-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 8.2265625,
            "text": "Favipiravir, an antiviral drug, is being used for COVID-19",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 8.2265625,
            "text": "ID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.6484375,
            "text": "COVID-19 treatment, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -6.8046875,
            "text": "COVID",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.078125,
            "text": "COVID-19 treatment, and we currently have limited information regarding",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.4296875,
            "end_logit": -7.08984375,
            "text": "COVID-19 treatment, and we currently",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 8.2265625,
            "text": "an antiviral drug, is being used for COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.2265625,
            "text": "ipiravir, an antiviral drug, is being used for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.9228515625,
            "end_logit": -2.927734375,
            "text": "antiviral drug, is being used for COV",
            "probability": 0.0
        },
        {
            "start_logit": -1.9228515625,
            "end_logit": -2.931640625,
            "text": "antiviral drug, is being used for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 0.0
        },
        {
            "start_logit": -3.041015625,
            "end_logit": -2.931640625,
            "text": "19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 0.0
        },
        {
            "start_logit": -1.9228515625,
            "end_logit": -4.25390625,
            "text": "antiviral drug, is being used for COVID-19 treatment",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_16": [
        {
            "start_logit": 7.91796875,
            "end_logit": 7.37109375,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.4609375,
            "text": "influenza in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.48046875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-2.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.93359375,
            "text": "influenza in Japan",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.96875,
            "text": "influenza in Japan in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -6.97265625,
            "text": "influenza in Japan in 2014 and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.05859375,
            "text": "influenza in Japan in 2014",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.1015625,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.10546875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.125,
            "text": "influenza in Japan in 2014 and has shown",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.16796875,
            "text": "influenza in Japan in 2014 and has",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.17578125,
            "text": "influenza in Japan in 2014 and has shown potent",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.17578125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.18359375,
            "text": "influenza in Japan in 2014 and has shown potent in vitro",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.91796875,
            "end_logit": -7.1875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.37109375,
            "text": "drug that was approved for new and reemerging pandemic influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.37109375,
            "text": "oral drug that was approved for new and reemerging pandemic influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.37109375,
            "text": "pandemic influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.37109375,
            "text": "Favipiravir is one such oral drug that was approved for new and reemerging pandemic influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.37109375,
            "text": "for new and reemerging pandemic influenza",
            "probability": 1.7881393432617188e-07
        }
    ],
    "621ebb733a8413c65300005c_17": [
        {
            "start_logit": 7.21875,
            "end_logit": 6.28125,
            "text": "influenza",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.21875,
            "end_logit": -0.289794921875,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19.",
            "probability": 0.0013980865478515625
        },
        {
            "start_logit": 7.21875,
            "end_logit": -4.9609375,
            "text": "influenza and Ebola,",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": 7.21875,
            "end_logit": -4.98828125,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -4.31640625,
            "end_logit": 6.28125,
            "text": "Favipiravir is an antiviral previously indicated for influenza",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -5.78125,
            "text": "influenza and",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.0546875,
            "text": "influenza and Ebola, which has",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.08203125,
            "text": "influenza and Ebola, which",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.15234375,
            "text": "influenza and Ebola",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.375,
            "text": "influenza and Ebola, which has shown",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.50390625,
            "text": "influenza and Ebola, which has shown some",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.5625,
            "text": "influenza and Ebola, which has shown some promise in early trials",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.60546875,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.62109375,
            "text": "influenza and Ebola, which has shown some promise",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.21875,
            "end_logit": -6.6796875,
            "text": "influenza and Ebola, which has shown some promise in early",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.40625,
            "end_logit": 6.28125,
            "text": "for influenza",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 6.28125,
            "text": "antiviral previously indicated for influenza",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.96875,
            "end_logit": 6.28125,
            "text": "ipiravir is an antiviral previously indicated for influenza",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 6.28125,
            "text": "vir is an antiviral previously indicated for influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 6.28125,
            "text": "an antiviral previously indicated for influenza",
            "probability": 4.76837158203125e-07
        }
    ],
    "621ebb733a8413c65300005c_18": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.2109375,
            "text": "Ebola virus infection",
            "probability": 1.0
        },
        {
            "start_logit": -1.162109375,
            "end_logit": 9.2109375,
            "text": "infection",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -1.79296875,
            "end_logit": 9.2109375,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.7041015625,
            "text": "Ebola",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -3.84765625,
            "text": "Ebola virus infection.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 9.2109375,
            "text": "virus infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 9.2109375,
            "text": "of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 9.2109375,
            "text": "treating Ebola virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 9.2109375,
            "text": "treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.2109375,
            "text": "antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.2109375,
            "text": "novel antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.2109375,
            "text": "drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.2109375,
            "text": "been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.2109375,
            "text": "the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.2109375,
            "text": "was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.2109375,
            "text": "demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.2109375,
            "text": "in treating Ebola virus infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.79296875,
            "end_logit": -1.7041015625,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola",
            "probability": 0.0
        },
        {
            "start_logit": -1.79296875,
            "end_logit": -2.40234375,
            "text": "influenza",
            "probability": 0.0
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -3.84765625,
            "text": "infection.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_19": [
        {
            "start_logit": 7.67578125,
            "end_logit": 8.6796875,
            "text": "influenza virus",
            "probability": 1.0
        },
        {
            "start_logit": -0.454833984375,
            "end_logit": 8.6796875,
            "text": "infections with the influenza virus",
            "probability": 0.000293731689453125
        },
        {
            "start_logit": -2.251953125,
            "end_logit": 8.6796875,
            "text": "virus",
            "probability": 4.869699478149414e-05
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -3.353515625,
            "text": "influenza virus]",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -3.55859375,
            "text": "influenza",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -3.79296875,
            "text": "influenza virus] inhibits in vitro murine norovirus replication.",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 8.6796875,
            "text": "with the influenza virus",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -5.40625,
            "text": "influenza virus] inhibits in vitro murine norovirus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 8.6796875,
            "text": "treatment of infections with the influenza virus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -5.4453125,
            "text": "influenza virus] inhibits in vitro murine norovirus replication",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.51953125,
            "end_logit": 8.6796875,
            "text": "of infections with the influenza virus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 8.6796875,
            "text": "the influenza virus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.6796875,
            "text": "drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -5.84765625,
            "text": "influenza virus] inhibits",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 8.6796875,
            "text": "for the treatment of infections with the influenza virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -6.12890625,
            "text": "influenza virus] inhibits in vitro",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -6.2421875,
            "text": "influenza virus] inhibits in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.454833984375,
            "end_logit": -3.353515625,
            "text": "infections with the influenza virus]",
            "probability": 0.0
        },
        {
            "start_logit": -0.454833984375,
            "end_logit": -3.55859375,
            "text": "infections with the influenza",
            "probability": 0.0
        },
        {
            "start_logit": -0.454833984375,
            "end_logit": -3.79296875,
            "text": "infections with the influenza virus] inhibits in vitro murine norovirus replication.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_20": [
        {
            "start_logit": 7.8828125,
            "end_logit": 8.7421875,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.177734375,
            "end_logit": 8.7421875,
            "text": "19",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -3.666015625,
            "text": "COV",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 8.7421875,
            "text": "with COVID-19",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 8.7421875,
            "text": "ID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -6.1875,
            "text": "COVID-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.7421875,
            "text": "-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -6.90625,
            "text": "COVID",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -3.666015625,
            "text": "with COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -6.1875,
            "text": "with COVID-",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -6.1875,
            "text": "ID-",
            "probability": 0.0
        },
        {
            "start_logit": -6.45703125,
            "end_logit": -6.90625,
            "text": "with COVID",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -6.90625,
            "text": "ID",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -6.1875,
            "text": "-",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_21": [
        {
            "start_logit": 8.6328125,
            "end_logit": 8.734375,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.1953125,
            "end_logit": 8.734375,
            "text": "19",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -2.599609375,
            "text": "COV",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -5.59375,
            "text": "COVID-19.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.015625,
            "text": "COVID-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.734375,
            "text": "ID-19",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.359375,
            "text": "COVID-19. Recent",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.7890625,
            "text": "COVID",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 8.734375,
            "text": "vir, Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 8.734375,
            "text": "for COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.734375,
            "text": ", Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.734375,
            "text": "-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.734375,
            "text": "Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.734375,
            "text": "ipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.734375,
            "text": "Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -5.59375,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.359375,
            "text": "19. Recent",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -2.599609375,
            "text": "vir, Favipiravir and Ribavirin might be a safer therapeutic option for COV",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -2.599609375,
            "text": "for COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -2.599609375,
            "text": ", Favipiravir and Ribavirin might be a safer therapeutic option for COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_22": [
        {
            "start_logit": 8.3125,
            "end_logit": 8.5546875,
            "text": "Covid-19",
            "probability": 1.0
        },
        {
            "start_logit": -2.578125,
            "end_logit": 8.5546875,
            "text": "19",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 8.3125,
            "end_logit": -3.138671875,
            "text": "Cov",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 8.3125,
            "end_logit": -5.19921875,
            "text": "Covid-19:",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.5546875,
            "text": "id-19",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.24609375,
            "text": "Covid-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 8.5546875,
            "text": "of Covid-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.359375,
            "text": "Covid-19: A Retrospective Study.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.7578125,
            "text": "Covid-19: A Retrospective",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.79296875,
            "text": "Covid-19: A Retrospective Study",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.89453125,
            "text": "Covid-19: A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.9453125,
            "text": "Covid",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 8.5546875,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 8.5546875,
            "text": "Management of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.5546875,
            "text": "Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.5546875,
            "text": "Hydroxychloroquine for Management of Covid-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.5546875,
            "text": "ipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.578125,
            "end_logit": -5.19921875,
            "text": "19:",
            "probability": 0.0
        },
        {
            "start_logit": -2.578125,
            "end_logit": -6.359375,
            "text": "19: A Retrospective Study.",
            "probability": 0.0
        },
        {
            "start_logit": -2.578125,
            "end_logit": -6.7578125,
            "text": "19: A Retrospective",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_23": [
        {
            "start_logit": 7.94140625,
            "end_logit": 7.0546875,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -4.86328125,
            "text": "influenza inf",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 7.94140625,
            "end_logit": -6.39453125,
            "text": "influenza infec",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.0546875,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -4.86328125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza inf",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.39453125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza infec",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.078125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.1015625,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.15625,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.203125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.21484375,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.24609375,
            "text": ": Favipiravir and oseltamivir are antiviral",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.28125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.296875,
            "text": ": Fav",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.31640625,
            "text": ": Favipira",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.33203125,
            "text": ": Favipiravir and oseltamivir are",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.34375,
            "text": ": Favipiravir and",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.3515625,
            "text": ": Favipiravir and oseltamivir",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_24": [
        {
            "start_logit": 8.7734375,
            "end_logit": 8.9375,
            "text": "coronavirus disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -0.376708984375,
            "text": "coronavirus disease 2019",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -1.8076171875,
            "end_logit": 8.9375,
            "text": "disease",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -2.3359375,
            "text": "coronavirus",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 8.9375,
            "text": "managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.0,
            "text": "coronavirus disease 2019 (COVID",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.01953125,
            "text": "coronavirus disease 2019 (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.01953125,
            "text": "coronavirus disease 2019 (COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.0625,
            "text": "coronavirus disease 2019 (COVID-19)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.0859375,
            "text": "coronavirus disease 2019 (COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.10546875,
            "text": "coronavirus disease 2019 (COV",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.9375,
            "text": "IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.9375,
            "text": "Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.9375,
            "text": "WHAT IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8076171875,
            "end_logit": -0.376708984375,
            "text": "disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -0.376708984375,
            "text": "managing coronavirus disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -0.376708984375,
            "text": "IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -0.376708984375,
            "text": "Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -0.376708984375,
            "text": "WHAT IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -1.8076171875,
            "end_logit": -7.0,
            "text": "disease 2019 (COVID",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_25": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.01953125,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -3.521484375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.3125,
            "text": "influenza,",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.4609375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.53515625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.5703125,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.640625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.65234375,
            "text": "influenza, the next pandemic influenza strain, and",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.66015625,
            "text": "influenza, the",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.7265625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.76171875,
            "text": "influenza, the next pandemic influenza strain, and other",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.76953125,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.796875,
            "text": "influenza, the next pandemic influenza strain,",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.859375,
            "text": "influenza, the next pandemic influenza",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.93359375,
            "text": "influenza, the next pandemic",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -6.94921875,
            "text": "influenza, the next",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.0,
            "end_logit": 7.01953125,
            "text": "severe influenza",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 7.01953125,
            "text": "Favipiravir is expected to be an important therapeutic agent for severe influenza",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.01953125,
            "text": "expected to be an important therapeutic agent for severe influenza",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.01953125,
            "text": "ipiravir is expected to be an important therapeutic agent for severe influenza",
            "probability": 2.384185791015625e-07
        }
    ],
    "621ebb733a8413c65300005c_26": [
        {
            "start_logit": 8.90625,
            "end_logit": 9.0,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": -1.611328125,
            "end_logit": 9.0,
            "text": "infections",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": 8.90625,
            "end_logit": -1.9677734375,
            "text": "influenza",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 8.90625,
            "end_logit": -4.24609375,
            "text": "influenza virus infections.",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 9.0,
            "text": "pandemic influenza virus infections",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 9.0,
            "text": "virus infections",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 9.0,
            "text": "treat pandemic influenza virus infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 9.0,
            "text": "antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.90625,
            "end_logit": -6.96484375,
            "text": "influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.0,
            "text": "drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.0,
            "text": "2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 9.0,
            "text": "also known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.0,
            "text": "known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.0,
            "text": "Japan to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.0,
            "text": "to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.0,
            "text": "in Japan to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.0,
            "text": "T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.0,
            "text": "ipiravir, also known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.611328125,
            "end_logit": -4.24609375,
            "text": "infections.",
            "probability": 0.0
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -1.9677734375,
            "text": "pandemic influenza",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_27": [
        {
            "start_logit": 8.2109375,
            "end_logit": 7.0234375,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.69140625,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States and Europe.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.98828125,
            "text": "influenza strains; and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.07421875,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.08984375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.12109375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.125,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.13671875,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.14453125,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.14453125,
            "text": "influenza strains",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.1640625,
            "text": "influenza strains; and several phase 2 and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.1640625,
            "text": "influenza strains;",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.1640625,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States and Europe",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.18359375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.18359375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.0234375,
            "text": "use in Japan against emerging influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.0234375,
            "text": "purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.0234375,
            "text": "Favipiravir (T-705) is a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.0234375,
            "text": "against emerging influenza",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.0234375,
            "text": "emerging influenza",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_28": [
        {
            "start_logit": 7.95703125,
            "end_logit": 7.28515625,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -5.515625,
            "text": "influenza and many other RNA viral diseases for which there are no approved therapies.",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.39453125,
            "text": "influenza and",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.6328125,
            "text": "influenza and many other RNA viral diseases",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.83203125,
            "text": "influenza and many other RNA viral diseases for which there are",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.85546875,
            "text": "influenza and many other RNA viral diseases for which there are no approved",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.8828125,
            "text": "influenza and many other RNA viral diseases for which",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.8984375,
            "text": "influenza and many other RNA viral diseases for",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.90234375,
            "text": "influenza and many other RNA viral diseases for which there",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.91015625,
            "text": "influenza and many other RNA viral diseases for which there are no",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -6.97265625,
            "text": "influenza and many other",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.00390625,
            "text": "influenza and many",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.95703125,
            "end_logit": -7.015625,
            "text": "influenza and many other RNA viral diseases for which there are no approved therapies",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.28515625,
            "text": "With its unique mechanism of action and broad range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.28515625,
            "text": "favipiravir is a promising drug candidate for influenza",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.625,
            "end_logit": -5.515625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -5.515625,
            "text": "RNA viral diseases for which there are no approved therapies.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -5.515625,
            "text": "favipiravir is a promising drug candidate for influenza and many other RNA viral diseases for which there are no approved therapies.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -5.515625,
            "text": "viral diseases for which there are no approved therapies.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.39453125,
            "text": "With its unique mechanism of action and broad range of antiviral activity, favipiravir is a promising drug candidate for influenza and",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_1": [
        {
            "start_logit": 8.828125,
            "end_logit": 8.8515625,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": 8.8515625,
            "text": "Epilepticus",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 8.828125,
            "end_logit": -2.185546875,
            "text": "Noncon",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -4.35546875,
            "end_logit": 8.8515625,
            "text": "Status Epilepticus",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.046875,
            "text": "Nonconvulsive Status Epilepticus by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.28125,
            "text": "Nonconvulsive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.5859375,
            "text": "Nonconv",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.6484375,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.734375,
            "text": "Nonconvulsive Status",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 8.8515625,
            "text": "Reevaluation of the Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 8.8515625,
            "text": "Patients With Nonconvulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 8.8515625,
            "text": "With Nonconvulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.94140625,
            "text": "Nonconvulsive Status Epilepticus by Using",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 8.8515625,
            "text": "ulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.01171875,
            "text": "Nonconvulsive Status Epilepticus by Using Salz",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.04296875,
            "text": "Nonconvulsive Status Epilepticus by Using Sal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 8.8515625,
            "text": "vulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": 8.8515625,
            "text": "Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.8515625,
            "text": "Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.09375,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e48bf5ed14c9f295d000019_2": [
        {
            "start_logit": 8.875,
            "end_logit": 9.0546875,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -1.484375,
            "end_logit": 9.0546875,
            "text": "epilepticus",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 8.875,
            "end_logit": -1.9873046875,
            "text": "noncon",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -4.8984375,
            "end_logit": 9.0546875,
            "text": "with nonconvulsive status epilepticus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 9.0546875,
            "text": "status epilepticus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.3359375,
            "text": "nonconvulsive status",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.40625,
            "text": "nonconvulsive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.4140625,
            "text": "nonconvulsive status epilepticus (NCSE).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.4609375,
            "text": "nonconvulsive status epilepticus (NCSE)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 9.0546875,
            "text": "aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 9.0546875,
            "text": "ulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 9.0546875,
            "text": "vulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.5546875,
            "text": "nonconvulsive status epilepticus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 9.0546875,
            "text": "the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.71875,
            "text": "nonconv",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.7734375,
            "text": "nonconvulsive status epilepticus (NCSE",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 9.0546875,
            "text": "We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 9.0546875,
            "text": "prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.0546875,
            "text": "patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.0546875,
            "text": "Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e48bf5ed14c9f295d000019_3": [
        {
            "start_logit": 8.875,
            "end_logit": 8.90625,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -1.966796875,
            "end_logit": 8.90625,
            "text": "Epilepticus",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.875,
            "end_logit": -2.1484375,
            "text": "Noncon",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -4.85546875,
            "end_logit": 8.90625,
            "text": "Status Epilepticus",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.546875,
            "text": "Nonconvulsive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.79296875,
            "text": "Nonconv",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.91796875,
            "text": "Nonconvulsive Status Epilepticus: Validating",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.94140625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.03125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.05078125,
            "text": "Nonconvulsive Status Epilepticus:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.078125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.1484375,
            "text": "Nonconvulsive Status",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.90625,
            "text": "ulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.19140625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.19921875,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.2109375,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 8.90625,
            "text": "vulsive Status Epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.265625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.32421875,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.966796875,
            "end_logit": -6.91796875,
            "text": "Epilepticus: Validating",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_4": [
        {
            "start_logit": 9.140625,
            "end_logit": 9.0703125,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.5166015625,
            "text": "noncon",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -1.4765625,
            "end_logit": 9.0703125,
            "text": "epilepticus",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.84375,
            "end_logit": 9.0703125,
            "text": "To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 9.0703125,
            "text": "status epilepticus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.34765625,
            "text": "nonconvulsive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3984375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.40625,
            "text": "nonconvulsive status",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 9.0703125,
            "text": "for nonconvulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.5703125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.59765625,
            "text": "nonconvulsive status epilepticus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.0703125,
            "text": "vulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.765625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.78125,
            "text": "nonconv",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.734375,
            "end_logit": 9.0703125,
            "text": "ulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.91796875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.0703125,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1015625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.12890625,
            "text": "nonconvulsive status epilepticus (NCSE)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.15234375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e48bf5ed14c9f295d000019_5": [
        {
            "start_logit": 9.140625,
            "end_logit": 9.0703125,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.5166015625,
            "text": "noncon",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -1.4765625,
            "end_logit": 9.0703125,
            "text": "epilepticus",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -5.84375,
            "end_logit": 9.0703125,
            "text": "To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 9.0703125,
            "text": "status epilepticus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.34765625,
            "text": "nonconvulsive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3984375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.40625,
            "text": "nonconvulsive status",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 9.0703125,
            "text": "for nonconvulsive status epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.5703125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.59765625,
            "text": "nonconvulsive status epilepticus (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.0703125,
            "text": "vulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.765625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.78125,
            "text": "nonconv",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.734375,
            "end_logit": 9.0703125,
            "text": "ulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.91796875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.0703125,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1015625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.12890625,
            "text": "nonconvulsive status epilepticus (NCSE)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.15234375,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the",
            "probability": 5.960464477539063e-08
        }
    ],
    "623e02e0f0baec9a1b000005_1": [
        {
            "start_logit": 6.17578125,
            "end_logit": -0.5126953125,
            "text": "ER",
            "probability": 0.505859375
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -0.58056640625,
            "text": "ER retention sequence",
            "probability": 0.4716796875
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -4.109375,
            "text": "ER retention sequence (KDEL)",
            "probability": 0.01385498046875
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -5.0859375,
            "text": "ER retention sequence (KDEL",
            "probability": 0.005218505859375
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -6.4609375,
            "text": "ER retention sequence (",
            "probability": 0.0013189315795898438
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -6.73046875,
            "text": "ER retention",
            "probability": 0.001007080078125
        },
        {
            "start_logit": 6.17578125,
            "end_logit": -6.73046875,
            "text": "ER retention sequence (KD",
            "probability": 0.001007080078125
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -4.109375,
            "text": "KDEL)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -4.109375,
            "text": "(KDEL)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -5.0859375,
            "text": "KDEL",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -5.0859375,
            "text": "(KDEL",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6171875,
            "end_logit": -6.73046875,
            "text": "KD",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -6.4609375,
            "text": "(",
            "probability": 0.0
        },
        {
            "start_logit": -5.47265625,
            "end_logit": -6.73046875,
            "text": "(KD",
            "probability": 0.0
        }
    ],
    "53617eeb7d100faa0900000a_1": [
        {
            "start_logit": 8.2109375,
            "end_logit": 7.890625,
            "text": "Anorexia Athletica",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.29296875,
            "text": "Anorexia Athletica.",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.958984375,
            "text": "Anorexia",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -3.279296875,
            "end_logit": 7.890625,
            "text": "a",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -4.96875,
            "end_logit": 7.890625,
            "text": "Athletica",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.78125,
            "end_logit": 7.890625,
            "text": "developing Anorexia Athletica",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.515625,
            "text": "Anorexia Athletic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.484375,
            "end_logit": 7.890625,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 7.890625,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 7.890625,
            "text": "to developing Anorexia Athletica",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.279296875,
            "end_logit": -2.29296875,
            "text": "a.",
            "probability": 0.0
        },
        {
            "start_logit": -3.65625,
            "end_logit": -2.29296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": -2.29296875,
            "text": "Athletica.",
            "probability": 0.0
        },
        {
            "start_logit": -5.78125,
            "end_logit": -2.29296875,
            "text": "developing Anorexia Athletica.",
            "probability": 0.0
        },
        {
            "start_logit": -5.78125,
            "end_logit": -2.958984375,
            "text": "developing Anorexia",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -2.29296875,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -2.29296875,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -2.29296875,
            "text": "to developing Anorexia Athletica.",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -2.958984375,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -2.958984375,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia",
            "probability": 0.0
        }
    ],
    "53617eeb7d100faa0900000a_2": [
        {
            "start_logit": 7.73828125,
            "end_logit": 8.3046875,
            "text": "anorexia athletica",
            "probability": 1.0
        },
        {
            "start_logit": -2.9140625,
            "end_logit": 8.3046875,
            "text": "a",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -3.703125,
            "text": "anorexia",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -5.55859375,
            "end_logit": 8.3046875,
            "text": "athletica",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -5.28515625,
            "text": "anorexia athletica (",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.4140625,
            "text": "anorexia athletica (AA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 8.3046875,
            "text": "with anorexia athletica",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.3046875,
            "text": "studied 13 female juvenile elite gymnasts with anorexia athletica",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.875,
            "text": "anorexia athletic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.9140625,
            "end_logit": -5.28515625,
            "text": "a (",
            "probability": 0.0
        },
        {
            "start_logit": -2.9140625,
            "end_logit": -6.4140625,
            "text": "a (AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -3.703125,
            "text": "with anorexia",
            "probability": 0.0
        },
        {
            "start_logit": -5.55859375,
            "end_logit": -5.28515625,
            "text": "athletica (",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -3.703125,
            "text": "studied 13 female juvenile elite gymnasts with anorexia",
            "probability": 0.0
        },
        {
            "start_logit": -5.55859375,
            "end_logit": -6.4140625,
            "text": "athletica (AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -5.28515625,
            "text": "with anorexia athletica (",
            "probability": 0.0
        },
        {
            "start_logit": -5.55859375,
            "end_logit": -6.875,
            "text": "athletic",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -5.28515625,
            "text": "studied 13 female juvenile elite gymnasts with anorexia athletica (",
            "probability": 0.0
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -6.4140625,
            "text": "with anorexia athletica (AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -6.4140625,
            "text": "studied 13 female juvenile elite gymnasts with anorexia athletica (AA",
            "probability": 0.0
        }
    ],
    "5c900b9eecadf2e73f000004_1": [
        {
            "start_logit": 9.2421875,
            "end_logit": 9.078125,
            "text": "Alnylam Pharmaceuticals",
            "probability": 1.0
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -1.291015625,
            "text": "Al",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -1.34765625,
            "end_logit": 9.078125,
            "text": "Pharmaceuticals",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.05078125,
            "text": "Alnylam Pharmaceuticals;",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9375,
            "end_logit": 9.078125,
            "text": "nylam Pharmaceuticals",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.25390625,
            "text": "Alnylam",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 9.078125,
            "text": "am Pharmaceuticals",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 9.078125,
            "text": "ylam Pharmaceuticals",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -6.7734375,
            "text": "Alnyl",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 9.078125,
            "text": "by Alnylam Pharmaceuticals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.1953125,
            "text": "Aln",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.25,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.078125,
            "text": "Patisiran has been developed by Alnylam Pharmaceuticals",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.32421875,
            "text": "Alnylam Pharmaceuticals; it was recently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.33984375,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.34765625,
            "text": "Alnylam Pharmaceuticals; it was",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3671875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3671875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2421875,
            "end_logit": -7.3828125,
            "text": "Alnylam Pharmaceuticals; it",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.078125,
            "text": "developed by Alnylam Pharmaceuticals",
            "probability": 5.960464477539063e-08
        }
    ],
    "58c27b7102b8c60953000021_1": [
        {
            "start_logit": 8.984375,
            "end_logit": 8.75,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.9072265625,
            "text": "Enhancer",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -2.248046875,
            "end_logit": 8.75,
            "text": "Sharing",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -5.609375,
            "text": "Enhancer Sharing Promotes",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.046875,
            "text": "Enhancer Sharing Promotes Neighborhoods",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.140625,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.15234375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.15625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.15625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.19921875,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -5.609375,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -7.046875,
            "text": "Sharing Promotes Neighborhoods",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -7.140625,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -7.15234375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -7.15625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -7.15625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -2.248046875,
            "end_logit": -7.19921875,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_2": [
        {
            "start_logit": 9.3671875,
            "end_logit": 9.1171875,
            "text": "enhancer sharing",
            "probability": 1.0
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -0.86181640625,
            "text": "enhancer",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.3037109375,
            "end_logit": 9.1171875,
            "text": "sharing",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -3.919921875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -4.25390625,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -5.64453125,
            "text": "enhancer sharing is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.765625,
            "end_logit": 9.1171875,
            "text": "We propose that enhancer sharing",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.08984375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.2421875,
            "text": "enhancer sharing is commonplace among eukaryotes, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.54296875,
            "text": "enhancer sharing is commonplace among eukaryotes,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.6328125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.734375,
            "text": "enhancer sharing is common",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.73828125,
            "text": "enhancer sharing is commonplace",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.83984375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.8828125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 9.1171875,
            "text": "propose that enhancer sharing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 9.1171875,
            "text": "that enhancer sharing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -6.9921875,
            "text": "enhancer sharing is commonplace among",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.08984375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3671875,
            "end_logit": -7.09765625,
            "text": "enhancer sharing is commonplace among eukaryotes, and that",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58c27b7102b8c60953000021_3": [
        {
            "start_logit": 9.234375,
            "end_logit": 8.9375,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.3037109375,
            "text": "Enhancer",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": 8.9375,
            "text": "Sharing",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 9.234375,
            "end_logit": -5.4609375,
            "text": "Enhancer Sharing Promotes",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0390625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0859375,
            "text": "Enhancer Sharing Promotes Neighborhoods",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.08984375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.109375,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.140625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.15625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -5.4609375,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.0390625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.0625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.0859375,
            "text": "Sharing Promotes Neighborhoods",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.08984375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.109375,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.140625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -1.8564453125,
            "end_logit": -7.15625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -4.73828125,
            "end_logit": -7.0390625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5c8973f3d558e5f232000007_1": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.0859375,
            "text": "Alipogene tiparvovec",
            "probability": 1.0
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.283203125,
            "text": "Ali",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -1.3251953125,
            "end_logit": 9.0859375,
            "text": "c",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -4.5390625,
            "text": "Alipogene tiparvovec (Glybera",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -5.2578125,
            "text": "Alipogene tiparvovec (Glybera\u00ae",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -5.5390625,
            "text": "Alipogene tiparvovec (Glybera\u00ae)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.08984375,
            "text": "Alipogene tiparvovec (Glyber",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 9.0859375,
            "text": "pogene tiparvovec",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.26953125,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.36328125,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.23046875,
            "end_logit": 9.0859375,
            "text": "vec",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.39453125,
            "text": "Alipogene tipar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.42578125,
            "text": "Alipogene tiparvovec (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.484375,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is the first gene therapy to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 9.0859375,
            "text": "gene tiparvovec",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.58984375,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is the first",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.453125,
            "end_logit": 9.0859375,
            "text": "tiparvovec",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 9.0859375,
            "text": "vovec",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.0859375,
            "text": "arvovec",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.046875,
            "end_logit": 0.560546875,
            "text": "Lipoprotein Lipase Deficiency",
            "probability": 0.0
        }
    ],
    "5c929094ecadf2e73f000019_1": [
        {
            "start_logit": 3.849609375,
            "end_logit": 5.046875,
            "text": "activation of retrotransposons.",
            "probability": 0.94921875
        },
        {
            "start_logit": -0.06634521484375,
            "end_logit": 5.046875,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 0.0188751220703125
        },
        {
            "start_logit": 3.849609375,
            "end_logit": 0.423095703125,
            "text": "activation",
            "probability": 0.00930023193359375
        },
        {
            "start_logit": -1.115234375,
            "end_logit": 5.046875,
            "text": ".",
            "probability": 0.006595611572265625
        },
        {
            "start_logit": -1.115234375,
            "end_logit": 5.046875,
            "text": ".",
            "probability": 0.006595611572265625
        },
        {
            "start_logit": -1.708984375,
            "end_logit": 5.046875,
            "text": "lead to the activation of retrotransposons.",
            "probability": 0.003643035888671875
        },
        {
            "start_logit": -2.34375,
            "end_logit": 5.046875,
            "text": "can lead to the activation of retrotransposons.",
            "probability": 0.0019350051879882812
        },
        {
            "start_logit": -3.078125,
            "end_logit": 5.046875,
            "text": "changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 0.0009284019470214844
        },
        {
            "start_logit": -3.091796875,
            "end_logit": 5.046875,
            "text": "alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 0.0009140968322753906
        },
        {
            "start_logit": 3.849609375,
            "end_logit": -2.373046875,
            "text": "activation of retrotransposons",
            "probability": 0.0005674362182617188
        },
        {
            "start_logit": -3.958984375,
            "end_logit": 5.046875,
            "text": "cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 0.0003838539123535156
        },
        {
            "start_logit": -4.7890625,
            "end_logit": 5.046875,
            "text": "the activation of retrotransposons.",
            "probability": 0.00016772747039794922
        },
        {
            "start_logit": -4.91015625,
            "end_logit": 5.046875,
            "text": "that can lead to the activation of retrotransposons.",
            "probability": 0.0001480579376220703
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 5.046875,
            "text": "to the activation of retrotransposons.",
            "probability": 0.0001266002655029297
        },
        {
            "start_logit": -5.17578125,
            "end_logit": 5.046875,
            "text": "retrotransposons.",
            "probability": 0.00011354684829711914
        },
        {
            "start_logit": -1.115234375,
            "end_logit": 0.423095703125,
            "text": ". These include the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 6.467103958129883e-05
        },
        {
            "start_logit": -5.859375,
            "end_logit": 5.046875,
            "text": "loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 5.751848220825195e-05
        },
        {
            "start_logit": -5.921875,
            "end_logit": 5.046875,
            "text": "dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 5.4001808166503906e-05
        },
        {
            "start_logit": -1.708984375,
            "end_logit": 0.423095703125,
            "text": "lead to the activation",
            "probability": 3.5703182220458984e-05
        },
        {
            "start_logit": 3.849609375,
            "end_logit": -5.3984375,
            "text": "activation of",
            "probability": 2.759695053100586e-05
        }
    ],
    "5fe3130da43ad3127800003f_1": [
        {
            "start_logit": 1.5380859375,
            "end_logit": 8.0234375,
            "text": "28 joints",
            "probability": 0.9580078125
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": 8.0234375,
            "text": "joints",
            "probability": 0.03985595703125
        },
        {
            "start_logit": -5.15625,
            "end_logit": 8.0234375,
            "text": "Disease activity score in 28 joints",
            "probability": 0.0011844635009765625
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 8.0234375,
            "text": "in 28 joints",
            "probability": 0.0006122589111328125
        },
        {
            "start_logit": 1.5380859375,
            "end_logit": -4.8359375,
            "text": "28 joints (",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 1.5380859375,
            "end_logit": -5.45703125,
            "text": "28 joints (DAS28)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 1.5380859375,
            "end_logit": -5.734375,
            "text": "28 joints (DAS",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 1.5380859375,
            "end_logit": -5.73828125,
            "text": "28 joints (DAS28",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 1.5380859375,
            "end_logit": -6.3671875,
            "text": "28",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -4.8359375,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -5.45703125,
            "text": "joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -5.734375,
            "text": "joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6416015625,
            "end_logit": -5.73828125,
            "text": "joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.15625,
            "end_logit": -4.8359375,
            "text": "Disease activity score in 28 joints (",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.45703125,
            "text": "Disease activity score in 28 joints (DAS28)",
            "probability": 0.0
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -4.8359375,
            "text": "in 28 joints (",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.734375,
            "text": "Disease activity score in 28 joints (DAS",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -5.73828125,
            "text": "Disease activity score in 28 joints (DAS28",
            "probability": 0.0
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -5.45703125,
            "text": "in 28 joints (DAS28)",
            "probability": 0.0
        },
        {
            "start_logit": -5.15625,
            "end_logit": -6.3671875,
            "text": "Disease activity score in 28",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_2": [
        {
            "start_logit": 2.873046875,
            "end_logit": 6.24609375,
            "text": "28 joints",
            "probability": 0.990234375
        },
        {
            "start_logit": -2.453125,
            "end_logit": 6.24609375,
            "text": "joints",
            "probability": 0.004825592041015625
        },
        {
            "start_logit": -2.9765625,
            "end_logit": 6.24609375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.002857208251953125
        },
        {
            "start_logit": -3.83984375,
            "end_logit": 6.24609375,
            "text": "in 28 joints",
            "probability": 0.0012063980102539062
        },
        {
            "start_logit": -5.96875,
            "end_logit": 6.24609375,
            "text": "(Disease Activity Score in 28 joints",
            "probability": 0.00014281272888183594
        },
        {
            "start_logit": -6.46875,
            "end_logit": 6.24609375,
            "text": "study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 8.666515350341797e-05
        },
        {
            "start_logit": -6.8125,
            "end_logit": 6.24609375,
            "text": "questionnaire designed specifically for the present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 6.145238876342773e-05
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -4.75,
            "text": "28 joints [",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -4.78515625,
            "text": "28",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -5.34765625,
            "text": "28 joints [DAS28]",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -5.46484375,
            "text": "28 joints [DAS28",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -6.06640625,
            "text": "28 joints [DAS28])",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -6.55859375,
            "text": "28 joints [DAS",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -6.9375,
            "text": "28 joints [DAS28]) and",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -2.453125,
            "end_logit": -4.75,
            "text": "joints [",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.9765625,
            "end_logit": -4.75,
            "text": "Disease Activity Score in 28 joints [",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.9765625,
            "end_logit": -4.78515625,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.453125,
            "end_logit": -5.34765625,
            "text": "joints [DAS28]",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.453125,
            "end_logit": -5.46484375,
            "text": "joints [DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.9765625,
            "end_logit": -5.34765625,
            "text": "Disease Activity Score in 28 joints [DAS28]",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_3": [
        {
            "start_logit": 5.37890625,
            "end_logit": 8.0,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.35546875,
            "end_logit": 8.0,
            "text": "28 Joints",
            "probability": 0.0011920928955078125
        },
        {
            "start_logit": -2.498046875,
            "end_logit": 8.0,
            "text": "Joints",
            "probability": 0.00037932395935058594
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 8.0,
            "text": "in 28 Joints",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -3.3515625,
            "text": "Disease Activity Score in 28 Joints (",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -3.552734375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 8.0,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 8.0,
            "text": "Activity Score in 28 Joints",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 8.0,
            "text": "Score in 28 Joints",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 8.0,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -5.21484375,
            "text": "Disease",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -5.796875,
            "text": "Disease Activity Score in 28 Joints (DAS28)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.05078125,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.08203125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.3359375,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.46484375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.47265625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.4921875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -6.51953125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 4.76837158203125e-07
        }
    ],
    "5fe3130da43ad3127800003f_4": [
        {
            "start_logit": 0.6904296875,
            "end_logit": 8.8203125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.73193359375
        },
        {
            "start_logit": -0.9296875,
            "end_logit": 8.8203125,
            "text": "joints",
            "probability": 0.145263671875
        },
        {
            "start_logit": -1.275390625,
            "end_logit": 8.8203125,
            "text": "28 joints",
            "probability": 0.10302734375
        },
        {
            "start_logit": -3.19140625,
            "end_logit": 8.8203125,
            "text": "a Disease Activity Score in 28 joints",
            "probability": 0.01513671875
        },
        {
            "start_logit": -5.03125,
            "end_logit": 8.8203125,
            "text": "in 28 joints",
            "probability": 0.00240325927734375
        },
        {
            "start_logit": -6.3203125,
            "end_logit": 8.8203125,
            "text": "by a Disease Activity Score in 28 joints",
            "probability": 0.0006623268127441406
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.8203125,
            "text": "rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.0005960464477539062
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 8.8203125,
            "text": "Activity Score in 28 joints",
            "probability": 0.0004062652587890625
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 8.8203125,
            "text": ", in patients with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.0003714561462402344
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -3.638671875,
            "text": "Disease Activity Score in 28 joints (DAS28) score greater",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -0.9296875,
            "end_logit": -3.638671875,
            "text": "joints (DAS28) score greater",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -5.27734375,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.275390625,
            "end_logit": -3.638671875,
            "text": "28 joints (DAS28) score greater",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -5.828125,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -6.12109375,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -6.35546875,
            "text": "Disease Activity Score in 28 joints (DAS28) score",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -6.765625,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.9296875,
            "end_logit": -5.27734375,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.6904296875,
            "end_logit": -6.9375,
            "text": "Disease Activity Score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.275390625,
            "end_logit": -5.27734375,
            "text": "28 joints (",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_5": [
        {
            "start_logit": 4.06640625,
            "end_logit": 8.8828125,
            "text": "28 joints",
            "probability": 0.9912109375
        },
        {
            "start_logit": -0.74267578125,
            "end_logit": 8.8828125,
            "text": "joints",
            "probability": 0.008056640625
        },
        {
            "start_logit": -5.3359375,
            "end_logit": 8.8828125,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 8.147954940795898e-05
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 8.8828125,
            "text": "on 28 joints",
            "probability": 8.022785186767578e-05
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 8.8828125,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 8.8828125,
            "text": "based on 28 joints",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.8828125,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.8828125,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -4.9609375,
            "text": "28 joints (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -5.7109375,
            "text": "28",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.14453125,
            "text": "28 joints (DAS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.54296875,
            "text": "28 joints (DAS28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.6953125,
            "text": "28 joints (DAS28)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.8984375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.9453125,
            "text": "28 joints (DAS28) has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.96875,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -6.9921875,
            "text": "28 joints (DAS28) has been increasingly used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -7.11328125,
            "text": "28 joints (DAS28) has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.06640625,
            "end_logit": -7.1484375,
            "text": "28 joints (DAS28) has been increasingly used in clinical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.74267578125,
            "end_logit": -4.9609375,
            "text": "joints (",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_6": [
        {
            "start_logit": 3.91796875,
            "end_logit": 8.8359375,
            "text": "28 joints",
            "probability": 0.9912109375
        },
        {
            "start_logit": -0.88134765625,
            "end_logit": 8.8359375,
            "text": "joints",
            "probability": 0.00818634033203125
        },
        {
            "start_logit": -4.9765625,
            "end_logit": 8.8359375,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.00013649463653564453
        },
        {
            "start_logit": -5.4375,
            "end_logit": 8.8359375,
            "text": "on 28 joints",
            "probability": 8.606910705566406e-05
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 8.8359375,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 8.8359375,
            "text": "based on 28 joints",
            "probability": 2.771615982055664e-05
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.8359375,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 8.8359375,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -4.95703125,
            "text": "28 joints (",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -5.80859375,
            "text": "28",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.19921875,
            "text": "28 joints (DAS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.56640625,
            "text": "28 joints (DAS28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.71875,
            "text": "28 joints (DAS28)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.88671875,
            "text": "28 joints (DAS28) has been widely",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.9140625,
            "text": "28 joints (DAS28) has been widely used in clinical practice",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.953125,
            "text": "28 joints (DAS28) has been widely used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -6.9765625,
            "text": "28 joints (DAS28) has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -7.1484375,
            "text": "28 joints (DAS28) has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 3.91796875,
            "end_logit": -7.16796875,
            "text": "28 joints (DAS28) has been widely used in clinical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.88134765625,
            "end_logit": -4.95703125,
            "text": "joints (",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_7": [
        {
            "start_logit": 1.005859375,
            "end_logit": 8.2421875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.80712890625
        },
        {
            "start_logit": -0.72265625,
            "end_logit": 8.2421875,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.14306640625
        },
        {
            "start_logit": -2.330078125,
            "end_logit": 8.2421875,
            "text": "joints",
            "probability": 0.028717041015625
        },
        {
            "start_logit": -2.75,
            "end_logit": 8.2421875,
            "text": "28 joints",
            "probability": 0.018829345703125
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 8.2421875,
            "text": "in 28 joints",
            "probability": 0.001369476318359375
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 8.2421875,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0002961158752441406
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 8.2421875,
            "text": "Activity Score in 28 joints",
            "probability": 0.0002465248107910156
        },
        {
            "start_logit": -7.09375,
            "end_logit": 8.2421875,
            "text": "Score in 28 joints",
            "probability": 0.0002446174621582031
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.2421875,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.00024259090423583984
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -3.548828125,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -0.72265625,
            "end_logit": -3.548828125,
            "text": "The Disease Activity Score in 28 joints (",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -5.703125,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.08203125,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.1015625,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.25390625,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.55859375,
            "text": "Disease Activity Score in 28 joints (DAS28),",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.68359375,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.75,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.828125,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 1.005859375,
            "end_logit": -6.8359375,
            "text": "Disease Activity Score in 28 joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a composite score comprising",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe3130da43ad3127800003f_8": [
        {
            "start_logit": 2.130859375,
            "end_logit": 7.328125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.97998046875
        },
        {
            "start_logit": -2.419921875,
            "end_logit": 7.328125,
            "text": "component Disease Activity Score in 28 joints",
            "probability": 0.01030731201171875
        },
        {
            "start_logit": -2.939453125,
            "end_logit": 7.328125,
            "text": "joints",
            "probability": 0.006153106689453125
        },
        {
            "start_logit": -4.6171875,
            "end_logit": 7.328125,
            "text": "28 joints",
            "probability": 0.0011472702026367188
        },
        {
            "start_logit": -4.78125,
            "end_logit": 7.328125,
            "text": "better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0009737014770507812
        },
        {
            "start_logit": -4.96484375,
            "end_logit": 7.328125,
            "text": ", the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0008101463317871094
        },
        {
            "start_logit": -5.109375,
            "end_logit": 7.328125,
            "text": "the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0007014274597167969
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 7.328125,
            "text": "in 28 joints",
            "probability": 0.0001552104949951172
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.328125,
            "text": "2-component Disease Activity Score in 28 joints",
            "probability": 0.00012183189392089844
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 7.328125,
            "text": "reweighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.00010842084884643555
        },
        {
            "start_logit": 2.130859375,
            "end_logit": -2.76171875,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 4.0531158447265625e-05
        },
        {
            "start_logit": 2.130859375,
            "end_logit": -4.03515625,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 2.130859375,
            "end_logit": -4.81640625,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 2.130859375,
            "end_logit": -6.09765625,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 2.130859375,
            "end_logit": -6.26171875,
            "text": "Disease Activity Score",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 2.130859375,
            "end_logit": -6.49609375,
            "text": "Disease",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -2.419921875,
            "end_logit": -2.76171875,
            "text": "component Disease Activity Score in 28 joints (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.939453125,
            "end_logit": -2.76171875,
            "text": "joints (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.419921875,
            "end_logit": -4.03515625,
            "text": "component Disease Activity Score in 28 joints (DAS28",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.939453125,
            "end_logit": -4.03515625,
            "text": "joints (DAS28",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_9": [
        {
            "start_logit": -1.4462890625,
            "end_logit": 6.8359375,
            "text": "28 joints",
            "probability": 0.55029296875
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": 6.8359375,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.329833984375
        },
        {
            "start_logit": -3.734375,
            "end_logit": 6.8359375,
            "text": "joints",
            "probability": 0.0557861328125
        },
        {
            "start_logit": -3.82421875,
            "end_logit": 6.8359375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.050994873046875
        },
        {
            "start_logit": -5.609375,
            "end_logit": 6.8359375,
            "text": "in 28 joints",
            "probability": 0.00855255126953125
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 6.8359375,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.0027866363525390625
        },
        {
            "start_logit": -7.078125,
            "end_logit": 6.8359375,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0019683837890625
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -4.50390625,
            "text": "28 joints (",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -4.50390625,
            "text": "The Disease Activity Score in 28 joints (",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.21875,
            "text": "28 joints (DAS",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.33203125,
            "text": "28 joints (DAS28)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.4375,
            "text": "28 joints (DAS28",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.67578125,
            "text": "28 joints (DAS28) is",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.703125,
            "text": "28 joints (DAS28) is a",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -6.21875,
            "text": "The Disease Activity Score in 28 joints (DAS",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -3.734375,
            "end_logit": -4.50390625,
            "text": "joints (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -6.33203125,
            "text": "The Disease Activity Score in 28 joints (DAS28)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.4462890625,
            "end_logit": -6.87890625,
            "text": "28 joints (DAS28) is a key measure in clinical practice",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -3.82421875,
            "end_logit": -4.50390625,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.9580078125,
            "end_logit": -6.4375,
            "text": "The Disease Activity Score in 28 joints (DAS28",
            "probability": 5.364418029785156e-07
        }
    ],
    "5fe3130da43ad3127800003f_10": [
        {
            "start_logit": 0.92578125,
            "end_logit": 7.84375,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.81640625
        },
        {
            "start_logit": -0.7490234375,
            "end_logit": 7.84375,
            "text": "28 Joints",
            "probability": 0.1534423828125
        },
        {
            "start_logit": -2.4921875,
            "end_logit": 7.84375,
            "text": "Joints",
            "probability": 0.0268707275390625
        },
        {
            "start_logit": -5.234375,
            "end_logit": 7.84375,
            "text": "in 28 Joints",
            "probability": 0.00173187255859375
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 7.84375,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.0005688667297363281
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 7.84375,
            "text": "Activity Score in 28 Joints",
            "probability": 0.000370025634765625
        },
        {
            "start_logit": -6.921875,
            "end_logit": 7.84375,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.00032019615173339844
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.84375,
            "text": "Score in 28 Joints",
            "probability": 0.0002532005310058594
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -4.8203125,
            "text": "Disease Activity Score in 28 Joints (",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.2578125,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.30078125,
            "text": "Disease Activity Score in 28 Joints (DAS28)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.3828125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.45703125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.45703125,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.7490234375,
            "end_logit": -4.8203125,
            "text": "28 Joints (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.5,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.6015625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.60546875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.60546875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.92578125,
            "end_logit": -6.640625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 4.172325134277344e-07
        }
    ],
    "5fe3130da43ad3127800003f_11": [
        {
            "start_logit": 3.658203125,
            "end_logit": 0.5400390625,
            "text": "28 joints with ESR",
            "probability": 0.79052734375
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -0.91357421875,
            "text": "28 joints",
            "probability": 0.1845703125
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -4.3203125,
            "text": "28",
            "probability": 0.006134033203125
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -4.46484375,
            "text": "28 joints with ESR (",
            "probability": 0.00528717041015625
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -4.75390625,
            "text": "28 joints with ESR (DAS28)",
            "probability": 0.00395965576171875
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -5.05078125,
            "text": "28 joints with ESR (DAS",
            "probability": 0.0029430389404296875
        },
        {
            "start_logit": -2.07421875,
            "end_logit": 0.5400390625,
            "text": "joints with ESR",
            "probability": 0.00255584716796875
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -5.4453125,
            "text": "28 joints with ESR (DAS28",
            "probability": 0.00199127197265625
        },
        {
            "start_logit": -2.07421875,
            "end_logit": -0.91357421875,
            "text": "joints",
            "probability": 0.0005974769592285156
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -6.7578125,
            "text": "28 joints with ESR (DAS28),",
            "probability": 0.0005359649658203125
        },
        {
            "start_logit": -3.166015625,
            "end_logit": -0.347900390625,
            "text": "rheumatoid arthritis",
            "probability": 0.0003542900085449219
        },
        {
            "start_logit": -4.83984375,
            "end_logit": 0.5400390625,
            "text": "with ESR",
            "probability": 0.0001609325408935547
        },
        {
            "start_logit": -4.8828125,
            "end_logit": 0.5400390625,
            "text": "Disease Activity Score in 28 joints with ESR",
            "probability": 0.00015354156494140625
        },
        {
            "start_logit": -5.44140625,
            "end_logit": 0.5400390625,
            "text": "in 28 joints with ESR",
            "probability": 8.815526962280273e-05
        },
        {
            "start_logit": -6.265625,
            "end_logit": 0.5400390625,
            "text": "ESR",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": -4.8828125,
            "end_logit": -0.91357421875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 0.5400390625,
            "text": "Comparison of Disease Activity Score in 28 joints with ESR",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -0.91357421875,
            "text": "in 28 joints",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -2.07421875,
            "end_logit": -4.46484375,
            "text": "joints with ESR (",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": -2.07421875,
            "end_logit": -4.75390625,
            "text": "joints with ESR (DAS28)",
            "probability": 1.2814998626708984e-05
        }
    ],
    "5fe3130da43ad3127800003f_12": [
        {
            "start_logit": -0.281494140625,
            "end_logit": 8.625,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 0.57373046875
        },
        {
            "start_logit": -1.3896484375,
            "end_logit": 8.625,
            "text": "joints",
            "probability": 0.189208984375
        },
        {
            "start_logit": -1.46875,
            "end_logit": 8.625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.1749267578125
        },
        {
            "start_logit": -2.5859375,
            "end_logit": 8.625,
            "text": "28 joints",
            "probability": 0.0572509765625
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 8.625,
            "text": "in 28 joints",
            "probability": 0.0017557144165039062
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 8.625,
            "text": "and the Disease Activity Score in 28 joints",
            "probability": 0.0013208389282226562
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.625,
            "text": ", and the Disease Activity Score in 28 joints",
            "probability": 0.000865936279296875
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.625,
            "text": "Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0007581710815429688
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -3.998046875,
            "text": "the Disease Activity Score in 28 joints (DAS28",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -1.3896484375,
            "end_logit": -3.998046875,
            "text": "joints (DAS28",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.46875,
            "end_logit": -3.998046875,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -5.54296875,
            "text": "the Disease Activity Score in 28 joints (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -5.83203125,
            "text": "the Disease Activity Score in 28 joints (DAS28)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -6.046875,
            "text": "the Disease Activity Score in 28 joints (DAS28) were calculated using data from tocilizumab trials in patients with RA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -6.26953125,
            "text": "the Disease Activity Score in 28 joints (DAS28) were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.5859375,
            "end_logit": -3.998046875,
            "text": "28 joints (DAS28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -6.35546875,
            "text": "the Disease Activity Score",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -6.4296875,
            "text": "the Disease Activity Score in 28 joints (DAS28) were calculated using data from tocilizumab trials in patients with RA in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.3896484375,
            "end_logit": -5.54296875,
            "text": "joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.281494140625,
            "end_logit": -6.71875,
            "text": "the Disease Activity Score in 28 joints (DAS28) were calculated using data from tocilizumab trials in patients with RA in whom disease had",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5fe3130da43ad3127800003f_13": [
        {
            "start_logit": 6.37109375,
            "end_logit": 8.84375,
            "text": "Disease activity score in 28 joints",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.1796875,
            "end_logit": 8.84375,
            "text": "joints",
            "probability": 0.0005230903625488281
        },
        {
            "start_logit": -1.2236328125,
            "end_logit": 8.84375,
            "text": "28 joints",
            "probability": 0.0005011558532714844
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -1.4482421875,
            "text": "Disease activity score in 28 joints (",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": -5.8125,
            "end_logit": 8.84375,
            "text": "in 28 joints",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 8.84375,
            "text": "activity score in 28 joints",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -4.55078125,
            "text": "Disease",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -4.890625,
            "text": "Disease activity score in 28 joints (DAS28)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.046875,
            "text": "Disease activity score in 28 joints (DAS",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.31640625,
            "text": "Disease activity score in 28 joints (DAS28",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -5.6640625,
            "text": "Disease activity score in 28 joints (DAS28)-remission",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.2265625,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.4375,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.61328125,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.671875,
            "text": "Disease activity score",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.671875,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.671875,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.72265625,
            "text": "Disease activity score in 28 joints (DAS28)-remission has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.1796875,
            "end_logit": -1.4482421875,
            "text": "joints (",
            "probability": 0.0
        },
        {
            "start_logit": -1.2236328125,
            "end_logit": -1.4482421875,
            "text": "28 joints (",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_14": [
        {
            "start_logit": 2.91796875,
            "end_logit": 8.046875,
            "text": "C-reactive protein",
            "probability": 0.9384765625
        },
        {
            "start_logit": -0.35595703125,
            "end_logit": 8.046875,
            "text": "28 joints with C-reactive protein",
            "probability": 0.035400390625
        },
        {
            "start_logit": -1.1357421875,
            "end_logit": 8.046875,
            "text": "joints with C-reactive protein",
            "probability": 0.016204833984375
        },
        {
            "start_logit": -1.8994140625,
            "end_logit": 8.046875,
            "text": "with C-reactive protein",
            "probability": 0.007568359375
        },
        {
            "start_logit": -3.03515625,
            "end_logit": 8.046875,
            "text": "protein",
            "probability": 0.002429962158203125
        },
        {
            "start_logit": -6.453125,
            "end_logit": 8.046875,
            "text": "reactive protein",
            "probability": 7.963180541992188e-05
        },
        {
            "start_logit": -6.75,
            "end_logit": 8.046875,
            "text": "-reactive protein",
            "probability": 5.91278076171875e-05
        },
        {
            "start_logit": -0.35595703125,
            "end_logit": 0.06561279296875,
            "text": "28 joints",
            "probability": 1.2159347534179688e-05
        },
        {
            "start_logit": -1.1357421875,
            "end_logit": 0.06561279296875,
            "text": "joints",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -4.1484375,
            "text": "C-reactive protein (DAS)28",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -4.30859375,
            "text": "C-reactive protein (DAS)28-CRP",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -6.0703125,
            "text": "C-reactive protein (DAS)28-CRP)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -6.07421875,
            "text": "C-reactive protein (DAS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -6.375,
            "text": "C-reactive protein (DAS)28-CRP).",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.35595703125,
            "end_logit": -3.359375,
            "text": "28",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -6.66015625,
            "text": "C-reactive protein (DAS)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -6.765625,
            "text": "C",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 2.91796875,
            "end_logit": -6.8203125,
            "text": "C-reactive protein (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.35595703125,
            "end_logit": -4.1484375,
            "text": "28 joints with C-reactive protein (DAS)28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.35595703125,
            "end_logit": -4.30859375,
            "text": "28 joints with C-reactive protein (DAS)28-CRP",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe3130da43ad3127800003f_15": [
        {
            "start_logit": 0.6865234375,
            "end_logit": 7.85546875,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.73681640625
        },
        {
            "start_logit": -0.49609375,
            "end_logit": 7.85546875,
            "text": "28 Joints",
            "probability": 0.2264404296875
        },
        {
            "start_logit": -2.421875,
            "end_logit": 7.85546875,
            "text": "Joints",
            "probability": 0.032989501953125
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 7.85546875,
            "text": "in 28 Joints",
            "probability": 0.0019063949584960938
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 7.85546875,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.00064849853515625
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.85546875,
            "text": "Activity Score in 28 Joints",
            "probability": 0.0004169940948486328
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 7.85546875,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.00037384033203125
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.85546875,
            "text": "Score in 28 Joints",
            "probability": 0.0002865791320800781
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -4.84765625,
            "text": "Disease Activity Score in 28 Joints (",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -0.49609375,
            "end_logit": -4.84765625,
            "text": "28 Joints (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.0546875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.27734375,
            "text": "Disease Activity Score in 28 Joints (DAS28",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.3125,
            "text": "Disease Activity Score in 28 Joints (DAS28)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.4453125,
            "text": "Disease Activity Score in 28 Joints (DAS",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.5234375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.609375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.6484375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.65625,
            "text": "Disease Activity Score in 28 Joints (DAS28) is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.671875,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 0.6865234375,
            "end_logit": -6.70703125,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5fe3130da43ad3127800003f_16": [
        {
            "start_logit": -1.5703125,
            "end_logit": 7.50390625,
            "text": "28 joints",
            "probability": 0.45068359375
        },
        {
            "start_logit": -2.162109375,
            "end_logit": 7.50390625,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.249755859375
        },
        {
            "start_logit": -2.458984375,
            "end_logit": 7.50390625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.185791015625
        },
        {
            "start_logit": -3.083984375,
            "end_logit": 7.50390625,
            "text": "joints",
            "probability": 0.09942626953125
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 7.50390625,
            "text": "in 28 joints",
            "probability": 0.0074005126953125
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 7.50390625,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.0030727386474609375
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.50390625,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.00212860107421875
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.50390625,
            "text": "Activity Score in 28 joints",
            "probability": 0.0014972686767578125
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -4.453125,
            "text": "28 joints (",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -2.162109375,
            "end_logit": -4.453125,
            "text": "The Disease Activity Score in 28 joints (",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -4.453125,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -3.083984375,
            "end_logit": -4.453125,
            "text": "joints (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -6.2890625,
            "text": "28 joints (DAS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -6.39453125,
            "text": "28 joints (DAS28)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -6.48828125,
            "text": "28 joints (DAS28",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -6.75390625,
            "text": "28 joints (DAS28) is a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -6.77734375,
            "text": "28 joints (DAS28) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.5703125,
            "end_logit": -6.87890625,
            "text": "28 joints (DAS28) is a key measure in clinical practice",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.162109375,
            "end_logit": -6.2890625,
            "text": "The Disease Activity Score in 28 joints (DAS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.162109375,
            "end_logit": -6.39453125,
            "text": "The Disease Activity Score in 28 joints (DAS28)",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe3130da43ad3127800003f_17": [
        {
            "start_logit": 2.70703125,
            "end_logit": 8.296875,
            "text": "28 joints",
            "probability": 0.98291015625
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": 8.296875,
            "text": "joints",
            "probability": 0.0160675048828125
        },
        {
            "start_logit": -4.265625,
            "end_logit": 8.296875,
            "text": "including 28 joints",
            "probability": 0.0009245872497558594
        },
        {
            "start_logit": -5.27734375,
            "end_logit": 8.296875,
            "text": "The Disease Activity Score including 28 joints",
            "probability": 0.0003361701965332031
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 8.296875,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.0001417398452758789
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.296875,
            "text": "OBJECTIVE: The Disease Activity Score including 28 joints",
            "probability": 5.638599395751953e-05
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -4.12109375,
            "text": "28 joints (",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -5.828125,
            "text": "28 joints (DAS28)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -6.234375,
            "text": "28",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -6.33984375,
            "text": "28 joints (DAS",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -6.5625,
            "text": "28 joints (DAS28",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -6.80859375,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -6.9609375,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -7.08203125,
            "text": "28 joints (DAS28) and the Clinical Disease Activity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -7.11328125,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -7.1328125,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -7.1328125,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (CDAI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.70703125,
            "end_logit": -7.15234375,
            "text": "28 joints (DAS28) and the Clinical Disease Activity Index (CDAI) were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": -4.12109375,
            "text": "joints (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4111328125,
            "end_logit": -5.828125,
            "text": "joints (DAS28)",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_18": [
        {
            "start_logit": 4.171875,
            "end_logit": 8.8671875,
            "text": "28 joints",
            "probability": 0.9921875
        },
        {
            "start_logit": -0.6982421875,
            "end_logit": 8.8671875,
            "text": "joints",
            "probability": 0.007633209228515625
        },
        {
            "start_logit": -5.28125,
            "end_logit": 8.8671875,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 7.784366607666016e-05
        },
        {
            "start_logit": -5.390625,
            "end_logit": 8.8671875,
            "text": "on 28 joints",
            "probability": 6.979703903198242e-05
        },
        {
            "start_logit": -6.140625,
            "end_logit": 8.8671875,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 3.2961368560791016e-05
        },
        {
            "start_logit": -6.59375,
            "end_logit": 8.8671875,
            "text": "based on 28 joints",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 8.8671875,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 8.8671875,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": 4.171875,
            "end_logit": -5.04296875,
            "text": "28 joints (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -5.57421875,
            "text": "28",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.12109375,
            "text": "28 joints (DAS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.4765625,
            "text": "28 joints (DAS28",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.65234375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.65625,
            "text": "28 joints (DAS28)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.82421875,
            "text": "28 joints (DAS28) has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.8359375,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.84765625,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.859375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.87109375,
            "text": "28 joints (DAS28) has been increasingly used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.02734375,
            "text": "28 joints (DAS28) has been",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5fe3130da43ad3127800003f_19": [
        {
            "start_logit": 4.3203125,
            "end_logit": 9.125,
            "text": "28 joints",
            "probability": 0.97802734375
        },
        {
            "start_logit": 0.5009765625,
            "end_logit": 9.125,
            "text": "joints",
            "probability": 0.0214385986328125
        },
        {
            "start_logit": -3.63671875,
            "end_logit": 9.125,
            "text": "including 28 joints",
            "probability": 0.0003426074981689453
        },
        {
            "start_logit": -4.0546875,
            "end_logit": 9.125,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.00022554397583007812
        },
        {
            "start_logit": -5.55078125,
            "end_logit": 9.125,
            "text": "the Disease Activity Score including 28 joints",
            "probability": 5.030632019042969e-05
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 9.125,
            "text": "rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": -6.953125,
            "end_logit": 9.125,
            "text": "of the Disease Activity Score including 28 joints",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -4.53125,
            "text": "28",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -4.8515625,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -5.26171875,
            "text": "28 joints (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -5.578125,
            "text": "28 joints (DAS28) compared",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -5.6015625,
            "text": "28 joints (DAS28)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.015625,
            "text": "28 joints (DAS28",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.1640625,
            "text": "28 joints (DAS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.34765625,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.3671875,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.4375,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.5625,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.3203125,
            "end_logit": -6.67578125,
            "text": "28 joints (DAS28) compared with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.5009765625,
            "end_logit": -4.8515625,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 0.0
        }
    ],
    "5fe3130da43ad3127800003f_20": [
        {
            "start_logit": 2.30078125,
            "end_logit": 7.2421875,
            "text": "joints",
            "probability": 0.97265625
        },
        {
            "start_logit": -1.517578125,
            "end_logit": 7.2421875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0213165283203125
        },
        {
            "start_logit": -3.087890625,
            "end_logit": 7.2421875,
            "text": "28 joints",
            "probability": 0.00443267822265625
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -1.9755859375,
            "text": "DAS28",
            "probability": 0.0003654956817626953
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 7.2421875,
            "text": "in 28 joints",
            "probability": 0.00026607513427734375
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -2.404296875,
            "text": "DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 0.00023853778839111328
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 7.2421875,
            "text": ": Disease Activity Score in 28 joints",
            "probability": 0.00016927719116210938
        },
        {
            "start_logit": 2.30078125,
            "end_logit": -1.611328125,
            "text": "joints calculated",
            "probability": 0.00013816356658935547
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 7.2421875,
            "text": "OBJECTIVES: Disease Activity Score in 28 joints",
            "probability": 0.00012576580047607422
        },
        {
            "start_logit": -6.75,
            "end_logit": 7.2421875,
            "text": "Activity Score in 28 joints",
            "probability": 0.00011360645294189453
        },
        {
            "start_logit": 2.30078125,
            "end_logit": -1.9755859375,
            "text": "joints calculated with C-reactive protein (DAS28",
            "probability": 9.644031524658203e-05
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -3.474609375,
            "text": "DAS",
            "probability": 8.183717727661133e-05
        },
        {
            "start_logit": 2.30078125,
            "end_logit": -2.404296875,
            "text": "joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 6.276369094848633e-05
        },
        {
            "start_logit": 2.30078125,
            "end_logit": -2.416015625,
            "text": "joints calculated with C-reactive protein",
            "probability": 6.181001663208008e-05
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -4.74609375,
            "text": "DAS28-CRP",
            "probability": 2.288818359375e-05
        },
        {
            "start_logit": 2.30078125,
            "end_logit": -3.474609375,
            "text": "joints calculated with C-reactive protein (DAS",
            "probability": 2.1517276763916016e-05
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -5.29296875,
            "text": "DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": 2.30078125,
            "end_logit": -4.74609375,
            "text": "joints calculated with C-reactive protein (DAS28-CRP",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -6.1796875,
            "text": "DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 3.63671875,
            "end_logit": -6.33984375,
            "text": "DAS28-",
            "probability": 4.649162292480469e-06
        }
    ],
    "5fe3130da43ad3127800003f_21": [
        {
            "start_logit": 4.046875,
            "end_logit": 7.84765625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.994140625
        },
        {
            "start_logit": -2.220703125,
            "end_logit": 7.84765625,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 0.0018892288208007812
        },
        {
            "start_logit": -2.310546875,
            "end_logit": 7.84765625,
            "text": "28 joints",
            "probability": 0.0017337799072265625
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 7.84765625,
            "text": "joints",
            "probability": 0.001628875732421875
        },
        {
            "start_logit": -4.8125,
            "end_logit": 7.84765625,
            "text": "in 28 joints",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": -5.4765625,
            "end_logit": 7.84765625,
            "text": "To optimize use of the Disease Activity Score in 28 joints",
            "probability": 7.325410842895508e-05
        },
        {
            "start_logit": -5.54296875,
            "end_logit": 7.84765625,
            "text": "OBJECTIVE: To optimize use of the Disease Activity Score in 28 joints",
            "probability": 6.824731826782227e-05
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.84765625,
            "text": "Activity Score in 28 joints",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 7.84765625,
            "text": "use of the Disease Activity Score in 28 joints",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.84765625,
            "text": "of the Disease Activity Score in 28 joints",
            "probability": 2.4974346160888672e-05
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 7.84765625,
            "text": "optimize use of the Disease Activity Score in 28 joints",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 7.84765625,
            "text": ": To optimize use of the Disease Activity Score in 28 joints",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 4.046875,
            "end_logit": -3.947265625,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 4.046875,
            "end_logit": -5.703125,
            "text": "Disease Activity Score in 28 joints (DAS28)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 4.046875,
            "end_logit": -5.7109375,
            "text": "Disease",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 4.046875,
            "end_logit": -5.8125,
            "text": "Disease Activity Score in 28 joints (DAS28",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 4.046875,
            "end_logit": -5.91015625,
            "text": "Disease Activity Score in 28 joints (DAS",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 4.046875,
            "end_logit": -6.45703125,
            "text": "Disease Activity Score in 28",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.046875,
            "end_logit": -6.50390625,
            "text": "Disease Activity Score",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.046875,
            "end_logit": -6.60546875,
            "text": "Disease Activity Score in 28 joints (DAS28) in early rheumatoid arthritis (RA) by",
            "probability": 5.364418029785156e-07
        }
    ],
    "5710a592cf1c32585100002a_1": [
        {
            "start_logit": 6.1171875,
            "end_logit": 8.6484375,
            "text": "bicarbonate/CO2",
            "probability": 0.78271484375
        },
        {
            "start_logit": 4.83984375,
            "end_logit": 8.6484375,
            "text": "CO2",
            "probability": 0.21728515625
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -0.521484375,
            "text": "bicarbonate",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 8.6484375,
            "text": "elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -6.171875,
            "end_logit": 8.6484375,
            "text": "temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -3.666015625,
            "text": "bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 8.6484375,
            "text": "and bicarbonate/CO2",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 8.6484375,
            "text": "/CO2",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 8.6484375,
            "text": "Upon infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.6484375,
            "text": "to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.6484375,
            "text": "Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.6484375,
            "text": "infection of a mammalian host, Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 4.83984375,
            "end_logit": -3.666015625,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.6484375,
            "text": "particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -6.24609375,
            "text": "bicarbonate/CO2 concentrations,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -6.3046875,
            "text": "bicarbonate/CO2 concentrations",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -6.6015625,
            "text": "bicarbonate/CO2 concentrations, with increased expression of virulence factors",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -6.69921875,
            "text": "bicarbonate/CO2 concentrations, with increased expression of virulence factors that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -6.78515625,
            "text": "bicarbonate/CO2 concentrations, with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.1171875,
            "end_logit": -6.8828125,
            "text": "bicarbonate/CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_2": [
        {
            "start_logit": 8.7109375,
            "end_logit": 9.234375,
            "text": "CO(2) /bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 0.330078125,
            "end_logit": 9.234375,
            "text": "bicarbonate",
            "probability": 0.00023055076599121094
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -2.228515625,
            "text": "CO",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.01953125,
            "text": "CO(2)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 9.234375,
            "text": "/bicarbonate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.2421875,
            "text": "CO(2) /bicarbonate exhibited",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.78125,
            "text": "CO(",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.234375,
            "text": "2) /bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.78515625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.79296875,
            "text": "CO(2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.234375,
            "text": "(2) /bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.88671875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.90625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.9921875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.234375,
            "text": "elevated CO(2) /bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 9.234375,
            "text": "cultures grown with elevated CO(2) /bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.330078125,
            "end_logit": -6.2421875,
            "text": "bicarbonate exhibited",
            "probability": 0.0
        },
        {
            "start_logit": 0.330078125,
            "end_logit": -6.78515625,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to",
            "probability": 0.0
        },
        {
            "start_logit": 0.330078125,
            "end_logit": -6.88671875,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and",
            "probability": 0.0
        },
        {
            "start_logit": 0.330078125,
            "end_logit": -6.90625,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_3": [
        {
            "start_logit": 6.9609375,
            "end_logit": 8.2109375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -5.27734375,
            "text": "CO2, a signal mimicking the host environment.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.2109375,
            "text": "by CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.2109375,
            "text": "Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.2109375,
            "text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.2109375,
            "text": "anthracis virulence genes is triggered by CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -6.8046875,
            "text": "CO2,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -6.88671875,
            "text": "CO2, a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -7.0625,
            "text": "CO2, a signal mimicking the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -7.06640625,
            "text": "CO2, a signal mimicking the host environment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -7.07421875,
            "text": "CO2, a signal mimicking",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -7.14453125,
            "text": "CO2, a signal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.9609375,
            "end_logit": -7.1953125,
            "text": "CO2, a signal mimicking the host",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.09375,
            "end_logit": -5.27734375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -5.27734375,
            "text": "by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -5.27734375,
            "text": "Bacillus anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -5.27734375,
            "text": "Transcription of the major Bacillus anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -5.27734375,
            "text": "signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -5.27734375,
            "text": "host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -5.27734375,
            "text": "anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_4": [
        {
            "start_logit": 6.96484375,
            "end_logit": 8.2109375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.2109375,
            "text": ", in vitro in presence of CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.2109375,
            "text": "in vitro in presence of CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.2109375,
            "text": "in presence of CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.2109375,
            "text": "of CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.2109375,
            "text": "Furthermore, in vitro in presence of CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.2109375,
            "text": "presence of CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.2109375,
            "text": "vitro in presence of CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -6.4296875,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.0234375,
            "text": "CO2 and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.203125,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.2109375,
            "text": "CO2 and in vivo, AtxA is part",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.23046875,
            "text": "CO2 and in vivo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.2421875,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.2890625,
            "text": "CO2 and in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.296875,
            "text": "CO2 and in vivo, AtxA is part of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.296875,
            "text": "CO2 and in vivo, AtxA is part of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.296875,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.96484375,
            "end_logit": -7.37109375,
            "text": "CO2 and in vivo,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.76953125,
            "end_logit": -6.4296875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_5": [
        {
            "start_logit": 9.6953125,
            "end_logit": 4.28515625,
            "text": "CO2/bicarbonate",
            "probability": 0.87353515625
        },
        {
            "start_logit": 9.6953125,
            "end_logit": 2.35546875,
            "text": "CO2",
            "probability": 0.1258544921875
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -5.51171875,
            "text": "CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 4.857778549194336e-05
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -6.19140625,
            "text": "CO2/bicarbonate,",
            "probability": 2.4437904357910156e-05
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -7.04296875,
            "text": "CO2/bicarbonate, affects",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 4.28515625,
            "text": "bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 4.28515625,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 4.28515625,
            "text": "temperature, not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 4.28515625,
            "text": "not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 4.28515625,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 4.28515625,
            "text": "Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 4.28515625,
            "text": ", not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 2.35546875,
            "text": "temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 2.35546875,
            "text": "not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": 2.35546875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 2.35546875,
            "text": "Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 2.35546875,
            "text": ", not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -5.1171875,
            "end_logit": -5.51171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -5.51171875,
            "text": "bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -5.51171875,
            "text": "/bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_6": [
        {
            "start_logit": 9.0703125,
            "end_logit": 4.71875,
            "text": "CO2/bicarbonate",
            "probability": 0.994140625
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -0.71630859375,
            "text": "CO2",
            "probability": 0.004322052001953125
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.6962890625,
            "text": "CO2/bicarbonate and temperature.",
            "probability": 0.001628875732421875
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -3.431640625,
            "text": "CO2/bicarbonate and temperature",
            "probability": 0.0002875328063964844
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.39453125,
            "text": "CO2/bicarbonate and",
            "probability": 1.4901161193847656e-05
        },
        {
            "start_logit": -5.03125,
            "end_logit": 4.71875,
            "text": "elevated CO2/bicarbonate",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 4.71875,
            "text": "bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 4.71875,
            "text": "/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 4.71875,
            "text": "toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 4.71875,
            "text": "expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 4.71875,
            "text": "by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 4.71875,
            "text": "enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 4.71875,
            "text": "two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 4.71875,
            "text": ", expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.03125,
            "end_logit": -0.71630859375,
            "text": "elevated CO2",
            "probability": 0.0
        },
        {
            "start_logit": -4.08203125,
            "end_logit": -1.6962890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.03125,
            "end_logit": -1.6962890625,
            "text": "elevated CO2/bicarbonate and temperature.",
            "probability": 0.0
        },
        {
            "start_logit": -6.6015625,
            "end_logit": -0.71630859375,
            "text": "toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2",
            "probability": 0.0
        },
        {
            "start_logit": -5.79296875,
            "end_logit": -1.6962890625,
            "text": "temperature.",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -0.71630859375,
            "text": "In atxA+ strains, expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_7": [
        {
            "start_logit": 9.453125,
            "end_logit": 8.84375,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 9.453125,
            "end_logit": -0.45654296875,
            "text": "CO2",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": -1.58203125,
            "end_logit": 8.84375,
            "text": "bicarbonate",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 9.453125,
            "end_logit": -4.30078125,
            "text": "CO2/bicarbonate levels.",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.453125,
            "end_logit": -5.9921875,
            "text": "CO2/bicarbonate levels. However",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.14453125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.25390625,
            "text": "CO2/bicarbonate levels",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.4140625,
            "text": "CO2/bicarbonate levels. However, the steady-state level",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 8.84375,
            "text": "/bicarbonate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.54296875,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.94921875,
            "end_logit": 8.84375,
            "text": "Our data indicate that atxA expression is not influenced by CO2/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.453125,
            "end_logit": -6.69921875,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 8.84375,
            "text": "data indicate that atxA expression is not influenced by CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 8.84375,
            "text": "by CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.84375,
            "text": "that atxA expression is not influenced by CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.84375,
            "text": "xA expression is not influenced by CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.84375,
            "text": "expression is not influenced by CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.58203125,
            "end_logit": -4.30078125,
            "text": "bicarbonate levels.",
            "probability": 0.0
        },
        {
            "start_logit": -5.94921875,
            "end_logit": -0.45654296875,
            "text": "Our data indicate that atxA expression is not influenced by CO2",
            "probability": 0.0
        },
        {
            "start_logit": -6.375,
            "end_logit": -0.45654296875,
            "text": "data indicate that atxA expression is not influenced by CO2",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_8": [
        {
            "start_logit": -5.09375,
            "end_logit": -2.58984375,
            "text": ", CO2",
            "probability": 0.185791015625
        },
        {
            "start_logit": -5.16015625,
            "end_logit": -2.58984375,
            "text": "response to the same signal, CO2",
            "probability": 0.173828125
        },
        {
            "start_logit": -5.51953125,
            "end_logit": -2.58984375,
            "text": "in response to the same signal, CO2",
            "probability": 0.12139892578125
        },
        {
            "start_logit": -5.71484375,
            "end_logit": -2.58984375,
            "text": "the same signal, CO2",
            "probability": 0.099853515625
        },
        {
            "start_logit": -5.921875,
            "end_logit": -2.58984375,
            "text": "to the same signal, CO2",
            "probability": 0.080810546875
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -2.58984375,
            "text": "CO2",
            "probability": 0.07135009765625
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -2.58984375,
            "text": "by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 0.060089111328125
        },
        {
            "start_logit": -6.26171875,
            "end_logit": -2.58984375,
            "text": ", atxA, in response to the same signal, CO2",
            "probability": 0.057769775390625
        },
        {
            "start_logit": -6.3984375,
            "end_logit": -2.58984375,
            "text": "atxA, in response to the same signal, CO2",
            "probability": 0.050567626953125
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -4.98828125,
            "text": ", can be viewed as a regulon,",
            "probability": 0.01519775390625
        },
        {
            "start_logit": -5.453125,
            "end_logit": -4.98828125,
            "text": "viewed as a regulon,",
            "probability": 0.0118255615234375
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -5.39453125,
            "text": ", can be viewed as",
            "probability": 0.0101165771484375
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -4.98828125,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as a regulon,",
            "probability": 0.0091400146484375
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -5.5234375,
            "text": ", can be viewed as a",
            "probability": 0.0089263916015625
        },
        {
            "start_logit": -5.453125,
            "end_logit": -5.39453125,
            "text": "viewed as",
            "probability": 0.00788116455078125
        },
        {
            "start_logit": -5.85546875,
            "end_logit": -4.98828125,
            "text": "can be viewed as a regulon,",
            "probability": 0.00788116455078125
        },
        {
            "start_logit": -5.1953125,
            "end_logit": -5.73046875,
            "text": ", can be viewed as a regulon, in which transcription of all three genes is",
            "probability": 0.007289886474609375
        },
        {
            "start_logit": -5.16015625,
            "end_logit": -5.79296875,
            "text": "response to the same signal",
            "probability": 0.0070648193359375
        },
        {
            "start_logit": -5.453125,
            "end_logit": -5.5234375,
            "text": "viewed as a",
            "probability": 0.006900787353515625
        },
        {
            "start_logit": -5.70703125,
            "end_logit": -5.39453125,
            "text": "Bacillus anthracis toxin genes, cya, lef, and pag, can be viewed as",
            "probability": 0.0060882568359375
        }
    ],
    "5710a592cf1c32585100002a_9": [
        {
            "start_logit": 6.71875,
            "end_logit": 8.3125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 8.3125,
            "text": "elevated CO2",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 6.71875,
            "end_logit": -4.625,
            "text": "CO2 and the toxin gene regulator, atxA.",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 8.3125,
            "text": "Comparison of the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.3125,
            "text": "protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.3125,
            "text": "toxin proteins is influenced by growth in elevated CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.3125,
            "text": "in elevated CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.3125,
            "text": "resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.3125,
            "text": "of the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.3125,
            "text": "the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.8125,
            "text": "CO2 and the toxin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.82421875,
            "text": "CO2 and the toxin gene regulator",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.71875,
            "end_logit": -6.95703125,
            "text": "CO2 and the toxin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.71875,
            "end_logit": -7.03125,
            "text": "CO2 and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4453125,
            "end_logit": -4.625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.89453125,
            "end_logit": -4.625,
            "text": "elevated CO2 and the toxin gene regulator, atxA.",
            "probability": 0.0
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -4.625,
            "text": "Comparison of the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2 and the toxin gene regulator, atxA.",
            "probability": 0.0
        },
        {
            "start_logit": -7.03125,
            "end_logit": -4.625,
            "text": "toxin gene regulator, atxA.",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -4.625,
            "text": "the toxin gene regulator, atxA.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -4.625,
            "text": "protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2 and the toxin gene regulator, atxA.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_10": [
        {
            "start_logit": 7.3828125,
            "end_logit": 7.87890625,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -4.15234375,
            "text": "bicarbonate.",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.87890625,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.87890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.87890625,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.87890625,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.87890625,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.87890625,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.87890625,
            "text": "by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.87890625,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9453125,
            "end_logit": -4.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -4.15234375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -4.15234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -4.15234375,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -4.15234375,
            "text": ", and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -4.15234375,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -4.15234375,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -4.15234375,
            "text": "by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -4.15234375,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -6.4765625,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA,",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_11": [
        {
            "start_logit": 6.921875,
            "end_logit": 8.2578125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.2578125,
            "text": "to CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.2578125,
            "text": "respond to CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.2578125,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.2578125,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.2578125,
            "text": "anthracis genes that respond to CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.2578125,
            "text": "that respond to CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.2578125,
            "text": "genes that respond to CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -6.73046875,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -7.0390625,
            "text": "CO2 through",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -7.11328125,
            "text": "CO2 through an AtxA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -7.2421875,
            "text": "CO2 through an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -7.26171875,
            "text": "CO2 through an AtxA-dependent",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -7.36328125,
            "text": "CO2 through an At",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.921875,
            "end_logit": -7.375,
            "text": "CO2 through an AtxA-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -6.73046875,
            "text": "to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -6.73046875,
            "text": "respond to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -6.73046875,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.73046875,
            "text": "AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -6.73046875,
            "text": "Bacillus anthracis genes that respond to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_12": [
        {
            "start_logit": 7.3828125,
            "end_logit": 7.87890625,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -4.15234375,
            "text": "bicarbonate.",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.87890625,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.87890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.87890625,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.87890625,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.87890625,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.87890625,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.87890625,
            "text": "by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.87890625,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9453125,
            "end_logit": -4.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -4.15234375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -4.15234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -4.15234375,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -4.15234375,
            "text": ", and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -4.15234375,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -4.15234375,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -4.15234375,
            "text": "by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -4.15234375,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -6.4765625,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA,",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_13": [
        {
            "start_logit": 7.06640625,
            "end_logit": 8.171875,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -6.109375,
            "text": "CO2 through an AtxA-dependent mechanism.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.171875,
            "text": "to CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.171875,
            "text": "respond to CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.171875,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.171875,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.171875,
            "text": "anthracis genes that respond to CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.171875,
            "text": "genes that respond to CO2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.171875,
            "text": "that respond to CO2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.171875,
            "text": "identifies Bacillus anthracis genes that respond to CO2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.171875,
            "text": "is genes that respond to CO2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -6.671875,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -6.9765625,
            "text": "CO2 through an AtxA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -7.02734375,
            "text": "CO2 through",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -7.12890625,
            "text": "CO2 through an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -7.15234375,
            "text": "CO2 through an AtxA-dependent",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -7.22265625,
            "text": "CO2 through an AtxA-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.06640625,
            "end_logit": -7.234375,
            "text": "CO2 through an At",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -6.109375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.109375,
            "text": "to CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_14": [
        {
            "start_logit": 6.93359375,
            "end_logit": 8.2109375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.93359375,
            "end_logit": -5.12109375,
            "text": "CO2.",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.2109375,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.2109375,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.2109375,
            "text": "of CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.2109375,
            "text": "under elevated levels of CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.2109375,
            "text": "growth under elevated levels of CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.2109375,
            "text": "the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.765625,
            "end_logit": -5.12109375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -5.12109375,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -5.12109375,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -5.12109375,
            "text": "of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -5.12109375,
            "text": "under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -5.12109375,
            "text": "growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -5.12109375,
            "text": "the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.76953125,
            "text": "toxin genes by B. anthracis is",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.890625,
            "text": "toxin genes by B. anthracis is enhanced during",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.90234375,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.921875,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.76953125,
            "text": "Expression of the toxin genes by B. anthracis is",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_15": [
        {
            "start_logit": 7.0546875,
            "end_logit": 8.125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -5.2578125,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.125,
            "text": "This CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.68359375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.74609375,
            "text": "CO2 effect is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.88671875,
            "text": "CO2 effect is observed",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.92578125,
            "text": "CO2 effect is observed only in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.93359375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.95703125,
            "text": "CO2 effect is observed only in the presence",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.9765625,
            "text": "CO2 effect",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.984375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.03125,
            "text": "CO2 effect is observed only in the presence of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.0390625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.0390625,
            "text": "CO2 effect is observed only",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.0390625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.0390625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.10546875,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.1328125,
            "text": "CO2 effect is observed only in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -7.16015625,
            "text": "CO2 effect is observed only in the presence of another pX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.703125,
            "end_logit": -5.2578125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_16": [
        {
            "start_logit": 7.1171875,
            "end_logit": 8.109375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -4.61328125,
            "text": "CO2 compared with cells grown in air.",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -6.109375,
            "end_logit": 8.109375,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 8.109375,
            "text": "% CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 8.109375,
            "text": "in cells grown in 5% CO2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.109375,
            "text": "in 5% CO2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.109375,
            "text": "of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.109375,
            "text": "show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.109375,
            "text": "that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.109375,
            "text": "xA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.109375,
            "text": "we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.109375,
            "text": "transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.109375,
            "text": "cells grown in 5% CO2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -6.55078125,
            "text": "CO2 compared",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.109375,
            "text": "atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.109375,
            "text": "appear to differ in cells grown in 5% CO2",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -6.890625,
            "text": "CO2 compared with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.88671875,
            "end_logit": -4.61328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.109375,
            "end_logit": -4.61328125,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2 compared with cells grown in air.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -4.61328125,
            "text": "% CO2 compared with cells grown in air.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_17": [
        {
            "start_logit": 7.3359375,
            "end_logit": 7.82421875,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -3.62890625,
            "text": "bicarbonate.",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -5.02734375,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -5.5,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of 70",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -5.5703125,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -5.69140625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -5.7265625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of 70 bp",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -6.08984375,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 7.82421875,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -6.1875,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of 70 bp extending",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -6.28515625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA required a DNA segment of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 7.82421875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.3359375,
            "end_logit": -6.6171875,
            "text": "bicarbonate. Deletion analysis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 7.82421875,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.82421875,
            "text": "by bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.015625,
            "end_logit": -3.62890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.015625,
            "end_logit": -3.62890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -3.62890625,
            "text": "of the P1 site.",
            "probability": 0.0
        },
        {
            "start_logit": -5.015625,
            "end_logit": -5.02734375,
            "text": ". Deletion analysis of the upstream region of the cap promoter revealed",
            "probability": 0.0
        },
        {
            "start_logit": -6.64453125,
            "end_logit": -3.62890625,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_18": [
        {
            "start_logit": 6.15234375,
            "end_logit": 6.69921875,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": -3.59375,
            "end_logit": 6.69921875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": -3.98046875,
            "end_logit": 6.69921875,
            "text": ". Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -5.109375,
            "end_logit": 6.69921875,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": 6.15234375,
            "end_logit": -5.203125,
            "text": "bicarbonate.",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -6.03125,
            "end_logit": 6.69921875,
            "text": "atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 6.69921875,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 6.69921875,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -6.9375,
            "end_logit": 6.69921875,
            "text": "by bicarbonate",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.69921875,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 6.69921875,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 6.69921875,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 6.69921875,
            "text": "xA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -3.59375,
            "end_logit": -4.859375,
            "text": "acpA",
            "probability": 0.0
        },
        {
            "start_logit": -3.59375,
            "end_logit": -5.203125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -3.98046875,
            "end_logit": -4.859375,
            "text": ". Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": -3.98046875,
            "end_logit": -5.203125,
            "text": ". Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -3.98046875,
            "end_logit": -5.203125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -3.98046875,
            "end_logit": -5.203125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.109375,
            "end_logit": -4.859375,
            "text": "both atxA and acpA",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_19": [
        {
            "start_logit": 7.3828125,
            "end_logit": 7.87890625,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 7.3828125,
            "end_logit": -4.15234375,
            "text": "bicarbonate.",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.87890625,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.87890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.87890625,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.87890625,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.87890625,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.87890625,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.87890625,
            "text": "by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.87890625,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.9453125,
            "end_logit": -4.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -4.15234375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -4.15234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -4.15234375,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -4.15234375,
            "text": ", and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -4.15234375,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -4.15234375,
            "text": "activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -4.15234375,
            "text": "by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -4.15234375,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8984375,
            "end_logit": -6.4765625,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA,",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_20": [
        {
            "start_logit": 9.6953125,
            "end_logit": 4.28515625,
            "text": "CO2/bicarbonate",
            "probability": 0.87353515625
        },
        {
            "start_logit": 9.6953125,
            "end_logit": 2.35546875,
            "text": "CO2",
            "probability": 0.1258544921875
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -5.51171875,
            "text": "CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 4.857778549194336e-05
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -6.19140625,
            "text": "CO2/bicarbonate,",
            "probability": 2.4437904357910156e-05
        },
        {
            "start_logit": 9.6953125,
            "end_logit": -7.04296875,
            "text": "CO2/bicarbonate, affects",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 4.28515625,
            "text": "bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 4.28515625,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 4.28515625,
            "text": "temperature, not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 4.28515625,
            "text": "not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 4.28515625,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 4.28515625,
            "text": "Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 4.28515625,
            "text": ", not CO2/bicarbonate",
            "probability": 0.0
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 2.35546875,
            "text": "temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 2.35546875,
            "text": "not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": 2.35546875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 2.35546875,
            "text": "Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 2.35546875,
            "text": ", not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -5.1171875,
            "end_logit": -5.51171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -5.51171875,
            "text": "bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        },
        {
            "start_logit": -6.28125,
            "end_logit": -5.51171875,
            "text": "/bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        }
    ],
    "5a87ea1861bb38fb2400000d_1": [
        {
            "start_logit": 9.140625,
            "end_logit": 8.75,
            "text": "circularized oligodeoxynucleotides",
            "probability": 1.0
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.4716796875,
            "text": "circular",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": -1.953125,
            "end_logit": 8.75,
            "text": "otides",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.6875,
            "text": "circularized oligodeoxynucleotides (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.97265625,
            "text": "circularized oligodeoxynucleotides (coligos)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.015625,
            "text": "circularized oligodeoxynucleotides (coligos",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.25,
            "text": "circularized oligodeoxynucleotides (coligo",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3125,
            "text": "circularized oligodeoxynucleotides (coli",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.98046875,
            "end_logit": 8.75,
            "text": "ized oligodeoxynucleotides",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.3828125,
            "text": "circularized oligodeoxynucle",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.234375,
            "end_logit": 8.75,
            "text": "oligodeoxynucleotides",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.72265625,
            "text": "circularized oligodeox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 8.75,
            "text": "ynucleotides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.140625,
            "end_logit": -7.1171875,
            "text": "circularized",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.953125,
            "end_logit": -5.6875,
            "text": "otides (",
            "probability": 0.0
        },
        {
            "start_logit": -1.953125,
            "end_logit": -5.97265625,
            "text": "otides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -1.953125,
            "end_logit": -6.015625,
            "text": "otides (coligos",
            "probability": 0.0
        },
        {
            "start_logit": -1.953125,
            "end_logit": -6.25,
            "text": "otides (coligo",
            "probability": 0.0
        },
        {
            "start_logit": -1.953125,
            "end_logit": -6.3125,
            "text": "otides (coli",
            "probability": 0.0
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -5.6875,
            "text": "ized oligodeoxynucleotides (",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_1": [
        {
            "start_logit": 9.0546875,
            "end_logit": 8.9296875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.7587890625,
            "text": "hypertrophic",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.8095703125,
            "end_logit": 8.9296875,
            "text": "cardiomyopathy",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.7109375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.83203125,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.84765625,
            "text": "hypertrophic cardiomyopathy (30",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.99609375,
            "text": "hypertrophic cardiomyopathy (30 %)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.02734375,
            "text": "hypertrophic cardiomyopathy (30 %), followed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.08203125,
            "text": "hypertrophic cardiomyopathy (30 %),",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.0859375,
            "text": "hypertrophic cardiomyopathy (30 %",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.140625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.23828125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.2421875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.27734375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.296875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.3046875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.9296875,
            "text": "death was hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.9296875,
            "text": "The most common cause of death was hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.9296875,
            "text": "was hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        }
    ],
    "530cf4e0c8a0b4a00c000006_2": [
        {
            "start_logit": 9.1796875,
            "end_logit": 8.9609375,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.4404296875,
            "text": "hypertrophic",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -1.720703125,
            "end_logit": 8.9609375,
            "text": "cardiomyopathy",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -5.89453125,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.3203125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.34765625,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.7734375,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.92578125,
            "text": "hypertrophic cardiomyopathy (HCM),",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.92578125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.96484375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.09375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.19921875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.23046875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.25390625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.9609375,
            "text": ", hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.9609375,
            "text": "The most common cause of this, hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -5.89453125,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -6.3203125,
            "text": "cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable.",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -6.34765625,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -1.720703125,
            "end_logit": -6.7734375,
            "text": "cardiomyopathy (",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_3": [
        {
            "start_logit": 9.0703125,
            "end_logit": 8.7578125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.744140625,
            "text": "Hypertrophic",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.921875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -2.08203125,
            "end_logit": 8.7578125,
            "text": "cardiomyopathy",
            "probability": 1.430511474609375e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -5.49609375,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.5859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people, including trained athletes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.640625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.82421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.89453125,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.92578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.94140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.203125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people, including trained athletes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.33984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.34375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.34375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.08203125,
            "end_logit": -1.921875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -5.41796875,
            "end_logit": -1.921875,
            "text": "(HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_4": [
        {
            "start_logit": 9.0390625,
            "end_logit": 8.671875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.8095703125,
            "text": "Hypertrophic",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": 8.671875,
            "text": "cardiomyopathy",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -3.21875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -5.69921875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.00390625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.12890625,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.1796875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.21875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.2890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.5,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.64453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.734375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.79296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.98046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.1015625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.16015625,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.18359375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.1875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.20703125,
            "end_logit": -3.21875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_5": [
        {
            "start_logit": 9.078125,
            "end_logit": 8.734375,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.7333984375,
            "text": "Hypertrophic",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.8056640625,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": -2.12109375,
            "end_logit": 8.734375,
            "text": "cardiomyopathy",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.97265625,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.51171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.59375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.80078125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.9296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.99609375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.01953125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.09765625,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.21484375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.21875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.296875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.12109375,
            "end_logit": -1.8056640625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -5.328125,
            "end_logit": -1.8056640625,
            "text": "(HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_6": [
        {
            "start_logit": 9.1796875,
            "end_logit": 8.921875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.515625,
            "text": "Hypertrophic",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -1.8642578125,
            "end_logit": 8.921875,
            "text": "cardiomyopathy",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.7109375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.74609375,
            "text": "Hypertrophic cardiomyopathy is regarded",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.80078125,
            "text": "Hypertrophic cardiomyopathy is regarded as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.8515625,
            "text": "Hypertrophic cardiomyopathy is regarded as the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.9375,
            "text": "Hypertrophic cardiomyopathy is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.96875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.15625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.203125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.2734375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.2890625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.29296875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.30859375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.3203125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.38671875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.41015625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8642578125,
            "end_logit": -6.7109375,
            "text": "cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 0.0
        },
        {
            "start_logit": -1.8642578125,
            "end_logit": -6.74609375,
            "text": "cardiomyopathy is regarded",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_7": [
        {
            "start_logit": 9.21875,
            "end_logit": 8.9296875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.396484375,
            "text": "hypertrophic",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -1.853515625,
            "end_logit": 8.9296875,
            "text": "cardiomyopathy",
            "probability": 1.5437602996826172e-05
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.11328125,
            "text": "hypertrophic cardiomyopathy.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.9296875,
            "text": "is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.9296875,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.9296875,
            "text": "in athletes is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.9296875,
            "text": "sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.9296875,
            "text": "death in athletes is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.9296875,
            "text": "cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.9296875,
            "text": "athletes is hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -1.396484375,
            "text": "is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -1.396484375,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -1.396484375,
            "text": "in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -1.853515625,
            "end_logit": -7.11328125,
            "text": "cardiomyopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6171875,
            "end_logit": -1.396484375,
            "text": "sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.396484375,
            "text": "death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.396484375,
            "text": "cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -1.396484375,
            "text": "athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -5.16796875,
            "end_logit": -7.11328125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_8": [
        {
            "start_logit": 9.046875,
            "end_logit": 8.265625,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 0.95703125
        },
        {
            "start_logit": 9.046875,
            "end_logit": 5.171875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 0.043365478515625
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.7919921875,
            "text": "Hypertrophic",
            "probability": 4.082918167114258e-05
        },
        {
            "start_logit": -2.845703125,
            "end_logit": 8.265625,
            "text": "cardiomyopathy",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.0703125,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.890625,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.91796875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.2265625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of sudden cardiac death in young athletes.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.38671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.4453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.845703125,
            "end_logit": 5.171875,
            "text": "cardiomyopathy (HCM)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.7890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9609375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.05859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.05859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.07421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.15234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.15625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited",
            "probability": 1.7881393432617188e-07
        }
    ],
    "530cf4e0c8a0b4a00c000006_9": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.796875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": 8.796875,
            "text": "cardiomyopathy",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.212890625,
            "text": "hypertrophic",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -4.23046875,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 8.8125,
            "end_logit": -4.765625,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.03125,
            "end_logit": 8.796875,
            "text": "disorder hypertrophic cardiomyopathy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.1484375,
            "text": "hypertrophic cardiomyopathy (HCM).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.796875,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.09765625,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.796875,
            "text": "individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.796875,
            "text": ", is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.796875,
            "text": "competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.796875,
            "text": "sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.796875,
            "text": "in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.796875,
            "text": "athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.796875,
            "text": ", including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.03125,
            "end_logit": -4.23046875,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": -4.765625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": -6.1484375,
            "text": "cardiomyopathy (HCM).",
            "probability": 0.0
        },
        {
            "start_logit": -6.03125,
            "end_logit": -2.212890625,
            "text": "disorder hypertrophic",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_10": [
        {
            "start_logit": 9.1015625,
            "end_logit": 8.796875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.6865234375,
            "text": "Hypertrophic",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -2.25,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -2.0390625,
            "end_logit": 8.796875,
            "text": "cardiomyopathy",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.16015625,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.58203125,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.59765625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive athletes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.73046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.9609375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.98046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.05859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.12109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.12890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.15625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.19140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive athletes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.2109375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.3046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.30859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.0390625,
            "end_logit": -2.25,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -5.453125,
            "end_logit": -2.25,
            "text": "(HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_11": [
        {
            "start_logit": 9.25,
            "end_logit": 8.984375,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.3173828125,
            "text": "Hypertrophic",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -1.6689453125,
            "end_logit": 8.984375,
            "text": "cardiomyopathy",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.87109375,
            "text": "Hypertrophic cardiomyopathy (HC)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.12109375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.203125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.20703125,
            "text": "Hypertrophic cardiomyopathy (HC) is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.23828125,
            "text": "Hypertrophic cardiomyopathy (HC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.25,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.27734375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.29296875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.3515625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.39453125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youth",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.40625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.453125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.45703125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.46875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6689453125,
            "end_logit": -6.87109375,
            "text": "cardiomyopathy (HC)",
            "probability": 0.0
        },
        {
            "start_logit": -1.6689453125,
            "end_logit": -7.12109375,
            "text": "cardiomyopathy (",
            "probability": 0.0
        },
        {
            "start_logit": -1.6689453125,
            "end_logit": -7.203125,
            "text": "cardiomyopathy (HC) is probably the",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_1": [
        {
            "start_logit": 8.9609375,
            "end_logit": 9.0,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": 9.0,
            "text": "sclerosis",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -1.9677734375,
            "text": "multiple",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.0390625,
            "text": "multiple sclerosis with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.71484375,
            "text": "multiple sclerosis with a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.92578125,
            "text": "multiple sclerosis with a simplified",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.953125,
            "text": "multiple sclerosis with a simplified three-lesion algorithm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.98046875,
            "text": "multiple sclerosis with a simplified three-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.06640625,
            "text": "multiple sclerosis with a simplified three",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.08984375,
            "text": "multiple sclerosis with a simplified three-lesion algorithm.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.12109375,
            "text": "multiple sclerosis with a simplified three-lesion",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.0,
            "text": "for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -6.0390625,
            "text": "sclerosis with",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -6.71484375,
            "text": "sclerosis with a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -6.92578125,
            "text": "sclerosis with a simplified",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -6.953125,
            "text": "sclerosis with a simplified three-lesion algorithm",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -6.98046875,
            "text": "sclerosis with a simplified three-",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -7.06640625,
            "text": "sclerosis with a simplified three",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -7.08984375,
            "text": "sclerosis with a simplified three-lesion algorithm.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7353515625,
            "end_logit": -7.12109375,
            "text": "sclerosis with a simplified three-lesion",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_2": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.0625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 9.0625,
            "text": "sclerosis",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.7587890625,
            "text": "multiple",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.94140625,
            "text": "multiple sclerosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.046875,
            "text": "multiple sclerosis (MS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.09765625,
            "text": "multiple sclerosis (MS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.0625,
            "text": "for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.0625,
            "text": "\"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.0625,
            "text": "* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.0625,
            "text": ": Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.0625,
            "text": "on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 9.0625,
            "text": "magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.0625,
            "text": "(CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 9.0625,
            "text": "central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 9.0625,
            "text": "CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 9.0625,
            "text": "Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 9.0625,
            "text": "imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.0625,
            "text": "FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 9.0625,
            "text": "\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.548828125,
            "end_logit": -6.94140625,
            "text": "sclerosis (",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_3": [
        {
            "start_logit": 9.046875,
            "end_logit": 9.03125,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.65625,
            "end_logit": 9.03125,
            "text": "Sclerosis",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.775390625,
            "text": "Multiple",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.91796875,
            "text": "Multiple Sclerosis from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9609375,
            "text": "Multiple Sclerosis from central nervous system",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9609375,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9765625,
            "text": "Multiple Sclerosis from central nervous system inflammatory vascul",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.03125,
            "text": "Central vein sign differentiates Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 9.03125,
            "text": "s Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 9.03125,
            "text": "differentiates Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.03125,
            "text": "vein sign differentiates Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.65625,
            "end_logit": -6.91796875,
            "text": "Sclerosis from",
            "probability": 0.0
        },
        {
            "start_logit": -1.65625,
            "end_logit": -6.9609375,
            "text": "Sclerosis from central nervous system",
            "probability": 0.0
        },
        {
            "start_logit": -1.65625,
            "end_logit": -6.9609375,
            "text": "Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 0.0
        },
        {
            "start_logit": -1.65625,
            "end_logit": -6.9765625,
            "text": "Sclerosis from central nervous system inflammatory vascul",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -1.775390625,
            "text": "Central vein sign differentiates Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -1.775390625,
            "text": "s Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -1.775390625,
            "text": "differentiates Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.775390625,
            "text": "vein sign differentiates Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -5.5,
            "end_logit": -6.9609375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_4": [
        {
            "start_logit": 8.6328125,
            "end_logit": 8.953125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.5068359375,
            "end_logit": 8.953125,
            "text": "sclerosis",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -2.232421875,
            "text": "multiple",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -4.375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -4.84765625,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -5.6484375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 8.953125,
            "text": "between multiple sclerosis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.2734375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.41796875,
            "text": "multiple sclerosis (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.953125,
            "text": "the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 8.953125,
            "text": "central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.57421875,
            "text": "multiple sclerosis (MS)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6328125,
            "end_logit": -6.6796875,
            "text": "multiple sclerosis (MS) and neuromyelitis optic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 8.953125,
            "text": "To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.953125,
            "text": "OBJECTIVE: To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 8.953125,
            "text": "distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.953125,
            "text": "CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.953125,
            "text": ": To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.953125,
            "text": "assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.953125,
            "text": "clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4601293f54159529000002_5": [
        {
            "start_logit": 8.9140625,
            "end_logit": 8.9765625,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.78125,
            "end_logit": 8.9765625,
            "text": "Sclerosis",
            "probability": 2.2649765014648438e-05
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -2.064453125,
            "text": "Multiple",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": -7.15625,
            "end_logit": 8.9765625,
            "text": "in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.9765625,
            "text": "Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.9765625,
            "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.9765625,
            "text": "Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.9765625,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.9765625,
            "text": "the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.9765625,
            "text": "a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.9765625,
            "text": "Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.9765625,
            "text": "Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.9765625,
            "text": "of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15625,
            "end_logit": -2.064453125,
            "text": "in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -2.064453125,
            "text": "Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -2.064453125,
            "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -2.064453125,
            "text": "Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.8046875,
            "end_logit": -2.064453125,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -2.064453125,
            "text": "the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -2.064453125,
            "text": "a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_6": [
        {
            "start_logit": 9.0390625,
            "end_logit": 9.0703125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": 9.0703125,
            "text": "sclerosis",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -1.80078125,
            "text": "multiple",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.734375,
            "text": "multiple sclerosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.76953125,
            "text": "multiple sclerosis (MS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.84375,
            "text": "multiple sclerosis (MS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -6.92578125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.08984375,
            "text": "multiple sclerosis (MS) and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.109375,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.140625,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.16796875,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultra",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0390625,
            "end_logit": -7.17578125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 9.0703125,
            "text": "between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.0703125,
            "text": "imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.0703125,
            "text": "The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 9.0703125,
            "text": "central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.734375,
            "end_logit": 9.0703125,
            "text": "specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 9.0703125,
            "text": "distinguishing between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 9.0703125,
            "text": "Importance  The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5107421875,
            "end_logit": -6.734375,
            "text": "sclerosis (",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_7": [
        {
            "start_logit": 8.984375,
            "end_logit": 9.0390625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.6513671875,
            "end_logit": 9.0390625,
            "text": "sclerosis",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.97265625,
            "text": "multiple",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.0390625,
            "text": "for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.0390625,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 9.0390625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.0390625,
            "text": "imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.0390625,
            "text": "PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.0390625,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.0390625,
            "text": "BACKGROUND AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 9.0390625,
            "text": "is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.0390625,
            "text": "AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.0390625,
            "text": "vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 9.0390625,
            "text": "promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 9.0390625,
            "text": "biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 9.0390625,
            "text": "diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -1.97265625,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -1.97265625,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.97265625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -1.97265625,
            "text": "imaging diagnostic biomarker for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_8": [
        {
            "start_logit": 8.984375,
            "end_logit": 9.0390625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.6513671875,
            "end_logit": 9.0390625,
            "text": "sclerosis",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.97265625,
            "text": "multiple",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.0390625,
            "text": "for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 9.0390625,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75,
            "end_logit": 9.0390625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 9.0390625,
            "text": "imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.0390625,
            "text": "PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 9.0390625,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.0390625,
            "text": "BACKGROUND AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 9.0390625,
            "text": "is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.0390625,
            "text": "AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.859375,
            "end_logit": 9.0390625,
            "text": "vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 9.0390625,
            "text": "promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 9.0390625,
            "text": "biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 9.0390625,
            "text": "diagnostic biomarker for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -1.97265625,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -1.97265625,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.97265625,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -1.97265625,
            "text": "imaging diagnostic biomarker for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_9": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.0703125,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": 9.0703125,
            "text": "Sclerosis",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.681640625,
            "text": "Multiple",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.078125,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.09765625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.14453125,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.18359375,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.1875,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.19140625,
            "text": "Multiple Sclerosis Lesions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.19921875,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.0703125,
            "text": "in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.0703125,
            "text": "The Central Vein Sign in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 9.0703125,
            "text": "Central Vein Sign in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.078125,
            "text": "Sclerosis Lesions Is Present Irrespective",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.09765625,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.14453125,
            "text": "Sclerosis Lesions Is Present Irrespective of",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.18359375,
            "text": "Sclerosis Lesions Is Present Irrespective of the",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.1875,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.19140625,
            "text": "Sclerosis Lesions",
            "probability": 0.0
        },
        {
            "start_logit": -1.52734375,
            "end_logit": -7.19921875,
            "text": "Sclerosis Lesions Is Present Irrespective of the T2* Sequence at",
            "probability": 0.0
        }
    ],
    "5c8fe7cb0101eac87000000c_1": [
        {
            "start_logit": 8.7578125,
            "end_logit": 8.3203125,
            "text": "Runt related factor-2",
            "probability": 1.0
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -2.34765625,
            "text": "Run",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -2.4296875,
            "end_logit": 8.3203125,
            "text": "2",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -2.91015625,
            "text": "Runt related factor-2 (Runx2)",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -5.0234375,
            "text": "Runt related factor-2 (",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -5.25390625,
            "text": "Runt related factor-2 (Runx2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.140625,
            "text": "Runt related factor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.2421875,
            "text": "Runt related factor-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.6484375,
            "text": "Runt related",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.06640625,
            "text": "Runt",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 8.3203125,
            "text": "t related factor-2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.3203125,
            "text": "related factor-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 8.3203125,
            "text": "factor-2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -2.91015625,
            "text": "2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -5.0234375,
            "text": "2 (",
            "probability": 0.0
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -5.25390625,
            "text": "2 (Runx2",
            "probability": 0.0
        },
        {
            "start_logit": -6.625,
            "end_logit": -2.91015625,
            "text": "(Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -6.76171875,
            "end_logit": -2.91015625,
            "text": "t related factor-2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.05859375,
            "end_logit": -2.91015625,
            "text": "related factor-2 (Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -2.91015625,
            "text": "factor-2 (Runx2)",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_1": [
        {
            "start_logit": 9.0078125,
            "end_logit": 8.9921875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.59765625,
            "end_logit": 8.9921875,
            "text": "receptor",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.9423828125,
            "text": "calcitonin",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.28125,
            "text": "calcitonin gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.296875,
            "text": "calcitonin gene-related peptide receptor occupancy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.39453125,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.40625,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 8.9921875,
            "text": "gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 8.9921875,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.8046875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.8359375,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.8671875,
            "text": "calcitonin gene-related peptide receptor occupancy by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.0703125,
            "text": "calcitonin gene-related peptide receptor occupancy by telca",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.12109375,
            "text": "calcitonin gene-related peptide receptor occupancy by tel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.140625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 8.9921875,
            "text": "related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.15625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.17578125,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.19921875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.9921875,
            "text": "-related peptide receptor",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_2": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.1875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 9.1875,
            "text": "peptide",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.623046875,
            "text": "calcitonin",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.54296875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.22265625,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.33203125,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.41015625,
            "end_logit": 9.1875,
            "text": "novel calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.47265625,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.59765625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.71875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.73046875,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.8203125,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 9.1875,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.97265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 9.1875,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.0625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.0703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.0703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.08984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 9.1875,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_3": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.1796875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.2060546875,
            "end_logit": 9.1796875,
            "text": "peptide",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.689453125,
            "text": "calcitonin",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.15234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine treatment.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.23828125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.25390625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.3203125,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.39453125,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.52734375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.1796875,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.78125,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.87890625,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 9.1796875,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.00390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.04296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.09765625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.1796875,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.1875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine treatment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.26171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_4": [
        {
            "start_logit": 8.9296875,
            "end_logit": 9.0625,
            "text": "Calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.4931640625,
            "end_logit": 9.0625,
            "text": "receptor",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -2.109375,
            "text": "Calcitonin",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.20703125,
            "text": "Calcitonin gene-related",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.31640625,
            "text": "Calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.37109375,
            "text": "Calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 9.0625,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.609375,
            "text": "Calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.97265625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.0625,
            "text": "gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.046875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.12890625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.16015625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.1640625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.171875,
            "text": "Calcitonin gene-related peptide receptor antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.2109375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.22265625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.23046875,
            "text": "Calcitonin gene-related peptide receptor antagonists,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.234375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.2421875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_5": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.1328125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": 9.1328125,
            "text": "peptide",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.759765625,
            "text": "calcitonin",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.65625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.71875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.2890625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.53125,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.1328125,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.72265625,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 9.1328125,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.8125,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.1328125,
            "text": "-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.96484375,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.25,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.30078125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.33203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepan",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.40625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.4140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olce",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (ge",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -5.65625,
            "text": "peptide (CGRP) receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_6": [
        {
            "start_logit": 8.875,
            "end_logit": 8.90625,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.8076171875,
            "end_logit": 8.90625,
            "text": "receptor",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 8.875,
            "end_logit": -2.212890625,
            "text": "calcitonin",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.04296875,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.3046875,
            "text": "calcitonin gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.40234375,
            "text": "calcitonin gene-related",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.40625,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 8.90625,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 8.90625,
            "text": "gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.69921875,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.80859375,
            "text": "calcitonin gene-related peptide receptor antagonist,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.8359375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.90625,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -6.99609375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.03125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.046875,
            "text": "calcitonin gene-related peptide receptor antagonist, is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 8.90625,
            "text": "a calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.90625,
            "text": "related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.11328125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.875,
            "end_logit": -7.234375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_7": [
        {
            "start_logit": 8.9296875,
            "end_logit": 9.0390625,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.5146484375,
            "end_logit": 9.0390625,
            "text": "receptor",
            "probability": 2.9087066650390625e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -2.111328125,
            "text": "calcitonin",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 9.0390625,
            "text": "peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.40234375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.4609375,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 9.0390625,
            "text": "gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.67578125,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 9.0390625,
            "text": "related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.76953125,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.7734375,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.0625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.125,
            "text": "calcitonin gene-related peptide receptor antagonist, tel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.0390625,
            "text": "potent calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.21484375,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.22265625,
            "text": "calcitonin gene-related peptide receptor antagonist, telca",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.2421875,
            "text": "calcitonin gene-related peptide receptor antagonist,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.27734375,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.0390625,
            "text": "-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -7.32421875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_8": [
        {
            "start_logit": 9.125,
            "end_logit": 9.203125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.1689453125,
            "end_logit": 9.203125,
            "text": "peptide",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.658203125,
            "text": "calcitonin",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -4.9296875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.2578125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.03515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual nitroglycerin (NTG).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.578125,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.6328125,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.671875,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 9.203125,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 9.203125,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.10546875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.10546875,
            "text": "calcitonin gene-related peptide (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.203125,
            "text": "To assess the effect of the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 9.203125,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.14453125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.16015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.16015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.203125,
            "text": "AIMS: To assess the effect of the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_9": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.0703125,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.4736328125,
            "end_logit": 9.0703125,
            "text": "receptor",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -2.07421875,
            "text": "calcitonin",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.25390625,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.3125,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.3203125,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 9.0703125,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.5,
            "text": "calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.515625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.9375,
            "text": "calcitonin gene-related peptide receptor antagonist which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.0390625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.0703125,
            "text": "gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.0703125,
            "text": "calcitonin gene-related peptide receptor antagonist which is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.09765625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.12890625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.1328125,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.0703125,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.0703125,
            "text": "related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.26171875,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -7.32421875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_10": [
        {
            "start_logit": 9.1171875,
            "end_logit": 9.1171875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.3681640625,
            "end_logit": 9.1171875,
            "text": "peptide",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.673828125,
            "text": "calcitonin",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -5.28515625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -5.6171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -5.92578125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.36328125,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.60546875,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.67578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very potent drugs.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 9.1171875,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.74609375,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.78125,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 9.1171875,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 9.1171875,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.12109375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olce",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.2109375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.1171875,
            "text": "The calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.25,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists ol",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.25390625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepan",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_11": [
        {
            "start_logit": 9.0,
            "end_logit": 9.0859375,
            "text": "Calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.427734375,
            "end_logit": 9.0859375,
            "text": "peptide",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.9375,
            "text": "Calcitonin",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -3.0078125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -4.0859375,
            "text": "Calcitonin gene-related peptide (CGRP",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.328125,
            "text": "Calcitonin gene-related peptide (CGRP)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.140625,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 9.0859375,
            "text": "gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.67578125,
            "text": "Calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.703125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.73046875,
            "text": "Calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.7421875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 9.0859375,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.87109375,
            "text": "Calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 9.0859375,
            "text": "-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.921875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.9375,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.94921875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.109375,
            "text": "Calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.427734375,
            "end_logit": -3.0078125,
            "text": "peptide (CGRP) receptor",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_12": [
        {
            "start_logit": 9.015625,
            "end_logit": 8.9296875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.7529296875,
            "end_logit": 8.9296875,
            "text": "peptide",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 9.015625,
            "end_logit": -1.890625,
            "text": "calcitonin",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.015625,
            "end_logit": -3.380859375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 9.015625,
            "end_logit": -4.4765625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.09765625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.91796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.359375,
            "text": "calcitonin gene-related peptide (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.5703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.58203125,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.7578125,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 8.9296875,
            "text": "gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.87890625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.89453125,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.9453125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.9609375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 8.9296875,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.12890625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 8.9296875,
            "text": "-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.21484375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_13": [
        {
            "start_logit": 9.078125,
            "end_logit": 9.1953125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.1943359375,
            "end_logit": 9.1953125,
            "text": "peptide",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -1.7802734375,
            "text": "calcitonin",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 9.078125,
            "end_logit": -5.8125,
            "text": "calcitonin gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.59765625,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.078125,
            "end_logit": -6.609375,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 9.1953125,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 9.1953125,
            "text": "In 3 randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 9.1953125,
            "text": "(n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.1953125,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.1328125,
            "text": "calcitonin gene-related peptide antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.1953125,
            "text": "gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.1953125,
            "text": "1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.1953125,
            "text": "randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 9.1953125,
            "text": "the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.1953125,
            "text": "n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.1953125,
            "text": "clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.1953125,
            "text": "3 randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.1953125,
            "text": "trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.078125,
            "end_logit": -7.37890625,
            "text": "calcitonin gene-related peptide antagonist tel",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_14": [
        {
            "start_logit": 8.8125,
            "end_logit": 9.0234375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.55078125,
            "end_logit": 9.0234375,
            "text": "receptor",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.337890625,
            "text": "calcitonin",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.3046875,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.34765625,
            "text": "calcitonin gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 9.0234375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.55859375,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.55859375,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 9.0234375,
            "text": "gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.0234375,
            "text": "related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.0234375,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.0234375,
            "text": "an oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.32421875,
            "text": "calcitonin gene-related peptide receptor antagonist with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.0234375,
            "text": "is an oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.0234375,
            "text": ": Telcagepant is an oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.41015625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.42578125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.4453125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.47265625,
            "text": "calcitonin gene-related peptide receptor antagonist with acute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.4765625,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_15": [
        {
            "start_logit": 9.1640625,
            "end_logit": 9.21875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.123046875,
            "end_logit": 9.21875,
            "text": "peptide",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.556640625,
            "text": "calcitonin",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.3828125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.51953125,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.6484375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.6484375,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.65234375,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.671875,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 9.21875,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.7421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across four attacks.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.765625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 9.21875,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.9140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 9.21875,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.13671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 9.21875,
            "text": "METHODS: This study evaluated the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.26953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_16": [
        {
            "start_logit": 8.9375,
            "end_logit": 9.140625,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.291015625,
            "end_logit": 9.140625,
            "text": "peptide",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -2.07421875,
            "text": "calcitonin",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -5.98828125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.3046875,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.34375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.3671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 9.140625,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 9.140625,
            "text": "the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.78515625,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.8046875,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.81640625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.859375,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 9.140625,
            "text": "-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 9.140625,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.140625,
            "text": "of the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -7.1796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.9375,
            "end_logit": -7.265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.291015625,
            "end_logit": -5.98828125,
            "text": "peptide (CGRP",
            "probability": 0.0
        },
        {
            "start_logit": -1.291015625,
            "end_logit": -6.34375,
            "text": "peptide (CGRP)",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_17": [
        {
            "start_logit": 9.1796875,
            "end_logit": 9.203125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.15234375,
            "end_logit": 9.203125,
            "text": "peptide",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.51171875,
            "text": "calcitonin",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -5.50390625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -5.86328125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.35546875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.4296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.4375,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.6796875,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 9.203125,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.734375,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 9.203125,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.8515625,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 9.203125,
            "text": "-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.1640625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.171875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist tel",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.2578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telca",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.29296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_18": [
        {
            "start_logit": 8.921875,
            "end_logit": 9.0546875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.50390625,
            "end_logit": 9.0546875,
            "text": "receptor",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 8.921875,
            "end_logit": -2.12890625,
            "text": "calcitonin",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -6.53125,
            "end_logit": 9.0546875,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.421875,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.57421875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 9.0546875,
            "text": "gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.75,
            "end_logit": 9.0546875,
            "text": "related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.78125,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.78515625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -6.86328125,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.12890625,
            "text": "calcitonin gene-related peptide receptor antagonist tel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.1328125,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.16796875,
            "text": "calcitonin gene-related peptide receptor antagonist telca",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.2421875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.24609375,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.2734375,
            "text": "calcitonin gene-related peptide receptor antagonist telcage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.2734375,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepan",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.2734375,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.921875,
            "end_logit": -7.2890625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_19": [
        {
            "start_logit": 8.84375,
            "end_logit": 8.9375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.7080078125,
            "end_logit": 8.9375,
            "text": "receptor",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 8.84375,
            "end_logit": -2.265625,
            "text": "calcitonin",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 8.84375,
            "end_logit": -5.63671875,
            "text": "calcitonin gene-related peptide",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.05859375,
            "text": "calcitonin gene-related",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.21484375,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.57421875,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 8.9375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.7265625,
            "text": "calcitonin gene-related peptide receptor blockers.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 8.9375,
            "text": "gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.9375,
            "text": "the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.26953125,
            "text": "calcitonin gene-related peptide receptor blockers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.9375,
            "text": "related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.9375,
            "text": "-the calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.9375,
            "text": "-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.9375,
            "text": "drug-the calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.9375,
            "text": "of antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7080078125,
            "end_logit": -6.7265625,
            "text": "receptor blockers.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7080078125,
            "end_logit": -7.26953125,
            "text": "receptor blockers",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -2.265625,
            "text": "the calcitonin",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_20": [
        {
            "start_logit": 8.78125,
            "end_logit": 8.9453125,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.6875,
            "end_logit": 8.9453125,
            "text": "receptor",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -2.376953125,
            "text": "calcitonin",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -5.484375,
            "end_logit": 8.9453125,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.01171875,
            "text": "calcitonin gene-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.26171875,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 8.9453125,
            "text": "related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.9453125,
            "text": "gene-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 8.9453125,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.91796875,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.94140625,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -6.94140625,
            "text": "calcitonin gene-related peptide receptor antagonist, in adults.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.10546875,
            "text": "calcitonin gene-related peptide receptor antagonist, in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.18359375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.1875,
            "text": "calcitonin gene-related peptide receptor antagonist, in adults",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.9453125,
            "text": "an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.9453125,
            "text": "-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.9453125,
            "text": ", an oral calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.484375,
            "end_logit": -2.376953125,
            "text": "oral calcitonin",
            "probability": 0.0
        },
        {
            "start_logit": -1.6875,
            "end_logit": -6.94140625,
            "text": "receptor antagonist, in adults.",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_21": [
        {
            "start_logit": 8.8671875,
            "end_logit": 8.9921875,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.6396484375,
            "end_logit": 8.9921875,
            "text": "receptor",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -2.23046875,
            "text": "calcitonin",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.03125,
            "text": "calcitonin gene-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.2421875,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.9921875,
            "text": "selective calcitonin gene-related peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.30859375,
            "text": "calcitonin gene-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.40234375,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 8.9921875,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.79296875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -6.8359375,
            "text": "calcitonin gene-related peptide receptor antagonist being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.9921875,
            "text": "related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 8.9921875,
            "text": "gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.16015625,
            "text": "calcitonin gene-related peptide receptor antagonist being developed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.19921875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.21484375,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.234375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.26171875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8671875,
            "end_logit": -7.296875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.9921875,
            "text": ", orally active, and selective calcitonin gene-related peptide receptor",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_22": [
        {
            "start_logit": 9.1796875,
            "end_logit": 9.21875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.099609375,
            "end_logit": 9.21875,
            "text": "peptide",
            "probability": 3.3974647521972656e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -1.509765625,
            "text": "calcitonin",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -4.7890625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.4140625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.515625,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.53125,
            "text": "calcitonin gene-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.5703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.6015625,
            "text": "calcitonin gene",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 9.21875,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.8125,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 9.21875,
            "text": "in human isolated coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -6.93359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 9.21875,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 9.21875,
            "text": "Studies were conducted in human isolated coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.16015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive potential",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1796875,
            "end_logit": -7.1953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.21875,
            "text": "-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 9.21875,
            "text": "human isolated coronary arteries to explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.21875,
            "text": "explore the vascular effects of the calcitonin gene-related peptide",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_23": [
        {
            "start_logit": 9.1328125,
            "end_logit": 9.2109375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": -1.1083984375,
            "end_logit": 9.2109375,
            "text": "peptide",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.63671875,
            "text": "calcitonin",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.63671875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.09375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.34765625,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.3671875,
            "text": "calcitonin gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.4609375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.609375,
            "end_logit": 9.2109375,
            "text": "oral calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.578125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.59375,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.65234375,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.2109375,
            "text": "gene-related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 9.2109375,
            "text": "related peptide",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.95703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1484375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.16796875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6ab4c17c78d6947100001d_1": [
        {
            "start_logit": 7.66015625,
            "end_logit": 8.3984375,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -1.4716796875,
            "end_logit": 8.3984375,
            "text": "under the MATLAB environment",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -0.90625,
            "text": "MATLAB",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -2.525390625,
            "end_logit": 8.3984375,
            "text": "environment",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -3.072265625,
            "end_logit": 8.3984375,
            "text": ".Availability and implementation: SELANSI runs under the MATLAB environment",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -3.6484375,
            "end_logit": 8.3984375,
            "text": "the MATLAB environment",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -4.0,
            "text": "MAT",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -4.9453125,
            "text": "MATLAB environment,",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.3984375,
            "text": "LAB environment",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -6.203125,
            "text": "MATLAB environment, and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -6.41015625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.3984375,
            "text": "Availability and implementation: SELANSI runs under the MATLAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.3984375,
            "text": "SELANSI runs under the MATLAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -6.4765625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.4716796875,
            "end_logit": -0.90625,
            "text": "under the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -3.072265625,
            "end_logit": -0.90625,
            "text": ".Availability and implementation: SELANSI runs under the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -3.6484375,
            "end_logit": -0.90625,
            "text": "the MATLAB",
            "probability": 0.0
        },
        {
            "start_logit": -1.4716796875,
            "end_logit": -4.0,
            "text": "under the MAT",
            "probability": 0.0
        },
        {
            "start_logit": -1.4716796875,
            "end_logit": -4.9453125,
            "text": "under the MATLAB environment,",
            "probability": 0.0
        },
        {
            "start_logit": -1.0771484375,
            "end_logit": -5.86328125,
            "text": "SEmi-LAgrangian SImulation",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_2": [
        {
            "start_logit": 8.8984375,
            "end_logit": 8.8359375,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -1.9267578125,
            "end_logit": 8.8359375,
            "text": "environment",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -2.158203125,
            "text": "MAT",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.8359375,
            "text": "LAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -6.1640625,
            "text": "MATLAB",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -6.328125,
            "text": "MATLAB environment,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2734375,
            "end_logit": 8.8359375,
            "text": "under the MATLAB environment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -6.38671875,
            "text": "MATLAB environment, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -6.9453125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.04296875,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.078125,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.109375,
            "text": "MATLAB environment, and is available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.12890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.140625,
            "text": "MATLAB environment, and is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.140625,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.140625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.15234375,
            "text": "MATLAB environment, and is available under GP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.18359375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.1875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8984375,
            "end_logit": -7.1953125,
            "text": "MATLAB environment, and is available under",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c6ab4c17c78d6947100001d_3": [
        {
            "start_logit": 7.36328125,
            "end_logit": 8.7578125,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -2.0859375,
            "end_logit": 8.7578125,
            "text": "environment",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -2.216796875,
            "end_logit": 8.7578125,
            "text": "the MATLAB environment",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": -3.271484375,
            "end_logit": 8.7578125,
            "text": ".<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -4.74609375,
            "end_logit": 8.7578125,
            "text": "under the MATLAB environment",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -4.34765625,
            "text": "MAT",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.21875,
            "end_logit": 8.7578125,
            "text": "LAB environment",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -5.88671875,
            "text": "MATLAB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.7578125,
            "text": "<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.7578125,
            "text": "simulation options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.7578125,
            "text": "SELANSI runs under the MATLAB environment",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.7578125,
            "text": ": SELANSI runs under the MATLAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.7578125,
            "text": "Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.2578125,
            "text": "MATLAB environment,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.35546875,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.4375,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.56640625,
            "text": "MATLAB environment, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.83984375,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.86328125,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.90234375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c6ab4c17c78d6947100001d_4": [
        {
            "start_logit": 8.703125,
            "end_logit": 8.921875,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -1.7568359375,
            "end_logit": 8.921875,
            "text": "environment",
            "probability": 2.86102294921875e-05
        },
        {
            "start_logit": 8.703125,
            "end_logit": -2.515625,
            "text": "MAT",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 8.703125,
            "end_logit": -5.43359375,
            "text": "MATLAB environment,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.9609375,
            "end_logit": 8.921875,
            "text": "LAB environment",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.09765625,
            "text": "MATLAB environment, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 8.921875,
            "text": "under the MATLAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.921875,
            "text": "the MATLAB environment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.578125,
            "text": "MATLAB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.7578125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.81640625,
            "text": "MATLAB environment, and is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.828125,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.83203125,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.83984375,
            "text": "MATLAB environment, and is available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 8.921875,
            "text": "SELANSI runs under the MATLAB environment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.88671875,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.94140625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.97265625,
            "text": "MATLAB environment, and is available under GP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.0234375,
            "text": "MATLAB environment, and is available under",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -7.07421875,
            "text": "MATLAB environment, and is available under GPLv3 license at https",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a992b371d1251d03b00000a_1": [
        {
            "start_logit": 9.125,
            "end_logit": 8.2734375,
            "text": "Metagenomics of the Human Intestinal Tract",
            "probability": 0.55419921875
        },
        {
            "start_logit": 9.125,
            "end_logit": 8.0703125,
            "text": "Metagenomics",
            "probability": 0.445556640625
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.5732421875,
            "text": "Metagen",
            "probability": 2.8967857360839844e-05
        },
        {
            "start_logit": -2.52734375,
            "end_logit": 8.2734375,
            "text": "Tract",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -2.873046875,
            "end_logit": 8.2734375,
            "text": "omics of the Human Intestinal Tract",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -2.873046875,
            "end_logit": 8.0703125,
            "text": "omics",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -4.66015625,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.6640625,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.9140625,
            "text": "Metagenomics of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.0,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.04296875,
            "text": "Metagenomics of the Human Intestinal Tract (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.09375,
            "text": "Metagenomics of the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.3984375,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.74609375,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.75,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.2734375,
            "text": "and Metagenomics of the Human Intestinal Tract",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 8.0703125,
            "text": "and Metagenomics",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 8.2734375,
            "text": "Human Intestinal Tract",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 8.2734375,
            "text": "Intestinal Tract",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 8.2734375,
            "text": "Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 5.960464477539063e-08
        }
    ],
    "530c7f52970c65fa6b000010_1": [
        {
            "start_logit": 3.0546875,
            "end_logit": 6.359375,
            "text": "Oxantel disrupts polymicrobial biofilm development",
            "probability": 0.9921875
        },
        {
            "start_logit": 3.0546875,
            "end_logit": 0.90478515625,
            "text": "Oxantel disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.00424957275390625
        },
        {
            "start_logit": -3.734375,
            "end_logit": 6.359375,
            "text": "biofilm development",
            "probability": 0.001117706298828125
        },
        {
            "start_logit": -3.896484375,
            "end_logit": 6.359375,
            "text": "disrupts polymicrobial biofilm development",
            "probability": 0.0009479522705078125
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 6.359375,
            "text": "polymicrobial biofilm development",
            "probability": 0.0006413459777832031
        },
        {
            "start_logit": -5.07421875,
            "end_logit": 6.359375,
            "text": "development",
            "probability": 0.000293731689453125
        },
        {
            "start_logit": -5.8203125,
            "end_logit": 6.359375,
            "text": "icrobial biofilm development",
            "probability": 0.00013875961303710938
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 6.359375,
            "text": "ial biofilm development",
            "probability": 7.909536361694336e-05
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 6.359375,
            "text": "ntel disrupts polymicrobial biofilm development",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": 3.0546875,
            "end_logit": -4.99609375,
            "text": "Oxantel disrupts polymicrobial biofilm development of periodontal",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 3.0546875,
            "end_logit": -5.5,
            "text": "Oxantel disrupts polymicrobial biofilm development of",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -3.734375,
            "end_logit": 0.90478515625,
            "text": "biofilm development of periodontal pathogens",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -3.896484375,
            "end_logit": 0.90478515625,
            "text": "disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 0.90478515625,
            "text": "polymicrobial biofilm development of periodontal pathogens",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 3.0546875,
            "end_logit": -7.0078125,
            "text": "Oxantel disrupts polymicrob",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 3.0546875,
            "end_logit": -7.1640625,
            "text": "Oxa",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 3.0546875,
            "end_logit": -7.1796875,
            "text": "Oxantel disrupts polymicrobial",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.07421875,
            "end_logit": 0.90478515625,
            "text": "development of periodontal pathogens",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -5.8203125,
            "end_logit": 0.90478515625,
            "text": "icrobial biofilm development of periodontal pathogens",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 0.90478515625,
            "text": "ial biofilm development of periodontal pathogens",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5540fbce234c5a7c75000001_1": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.828125,
            "text": "Chaperone-mediated autophagy",
            "probability": 0.99609375
        },
        {
            "start_logit": 9.2578125,
            "end_logit": 3.240234375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 0.0037059783935546875
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.048828125,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 5.08427619934082e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2802734375,
            "text": "Chaperone",
            "probability": 4.017353057861328e-05
        },
        {
            "start_logit": -1.580078125,
            "end_logit": 8.828125,
            "text": "autophagy",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -4.33984375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.16015625,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.3671875,
            "text": "Chaperone-mediated autophagy (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.98046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.171875,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.35546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.49609375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.50390625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.828125,
            "text": "mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 8.828125,
            "text": "-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.87109375,
            "text": "Chaperone-mediated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.91796875,
            "text": "Chaperone-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.01171875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.09765625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1640625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5540fbce234c5a7c75000001_2": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.828125,
            "text": "Chaperone-mediated autophagy",
            "probability": 0.99609375
        },
        {
            "start_logit": 9.2578125,
            "end_logit": 3.240234375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 0.0037059783935546875
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.048828125,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 5.08427619934082e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2802734375,
            "text": "Chaperone",
            "probability": 4.017353057861328e-05
        },
        {
            "start_logit": -1.580078125,
            "end_logit": 8.828125,
            "text": "autophagy",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -4.33984375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.16015625,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.3671875,
            "text": "Chaperone-mediated autophagy (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.98046875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.171875,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.35546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.49609375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.50390625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.828125,
            "text": "mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 8.828125,
            "text": "-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.87109375,
            "text": "Chaperone-mediated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.91796875,
            "text": "Chaperone-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.01171875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.09765625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.1640625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5540fbce234c5a7c75000001_3": [
        {
            "start_logit": 9.28125,
            "end_logit": 8.65625,
            "text": "Chaperone-mediated autophagy",
            "probability": 0.9931640625
        },
        {
            "start_logit": 9.28125,
            "end_logit": 3.6171875,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 0.006435394287109375
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.22265625,
            "text": "Chaperone",
            "probability": 5.1081180572509766e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -1.6982421875,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -1.97265625,
            "end_logit": 8.65625,
            "text": "autophagy",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 9.28125,
            "end_logit": -4.52734375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.28125,
            "end_logit": -5.1640625,
            "text": "Chaperone-mediated autophagy (",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 9.28125,
            "end_logit": -5.23046875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -5.8359375,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.3203125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.62109375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.7890625,
            "text": "Chaperone-mediated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.83984375,
            "text": "Chaperone-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.84375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 8.65625,
            "text": "mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.8671875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.93359375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.94140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.28125,
            "end_logit": -6.98828125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 8.65625,
            "text": "-mediated autophagy",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5540fbce234c5a7c75000001_4": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.1796875,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": 9.1796875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.94775390625,
            "text": "chaperone",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -0.9130859375,
            "end_logit": 9.1796875,
            "text": "autophagy",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -3.4375,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 9.34375,
            "end_logit": -4.2578125,
            "text": "chaperone-mediated autophagy (",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.34375,
            "end_logit": -4.82421875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.10546875,
            "text": "chaperone-mediated autophagy (CMA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 9.1796875,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.484375,
            "text": "chaperone-mediated autophagy (CMA), in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 9.1796875,
            "text": "-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.6640625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.1796875,
            "text": "by chaperone-mediated autophagy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.1796875,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -0.94775390625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -3.4375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -4.2578125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -0.9130859375,
            "end_logit": -3.4375,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -4.82421875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        },
        {
            "start_logit": -0.9130859375,
            "end_logit": -4.2578125,
            "text": "autophagy (",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_5": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.1796875,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": 9.1796875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.94775390625,
            "text": "chaperone",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": -0.9130859375,
            "end_logit": 9.1796875,
            "text": "autophagy",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 9.34375,
            "end_logit": -3.4375,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 9.34375,
            "end_logit": -4.2578125,
            "text": "chaperone-mediated autophagy (",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 9.34375,
            "end_logit": -4.82421875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.10546875,
            "text": "chaperone-mediated autophagy (CMA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 9.1796875,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.484375,
            "text": "chaperone-mediated autophagy (CMA), in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 9.1796875,
            "text": "-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.6640625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.1796875,
            "text": "by chaperone-mediated autophagy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.1796875,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -0.94775390625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -3.4375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -4.2578125,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -0.9130859375,
            "end_logit": -3.4375,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -0.083251953125,
            "end_logit": -4.82421875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA),",
            "probability": 0.0
        },
        {
            "start_logit": -0.9130859375,
            "end_logit": -4.2578125,
            "text": "autophagy (",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_6": [
        {
            "start_logit": 9.3125,
            "end_logit": 8.9921875,
            "text": "Chaperone-mediated autophagy",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.3125,
            "end_logit": 1.64453125,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 0.0006361007690429688
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.0966796875,
            "text": "Chaperone",
            "probability": 4.13060188293457e-05
        },
        {
            "start_logit": -1.4345703125,
            "end_logit": 8.9921875,
            "text": "autophagy",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": 9.3125,
            "end_logit": -5.3125,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -5.33984375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -5.5625,
            "text": "Chaperone-mediated autophagy (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.0,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.16796875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 8.9921875,
            "text": "mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 8.9921875,
            "text": "-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.78515625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.82421875,
            "text": "Chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.90234375,
            "text": "Chaperone-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.9453125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.94921875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.953125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.00390625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.05078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.0625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5540fbce234c5a7c75000001_7": [
        {
            "start_logit": 9.25,
            "end_logit": 8.90625,
            "text": "Chaperone-mediated autophagy",
            "probability": 0.998046875
        },
        {
            "start_logit": 9.25,
            "end_logit": 2.65625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 0.001926422119140625
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.2822265625,
            "text": "Chaperone",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": -1.5537109375,
            "end_logit": 8.90625,
            "text": "autophagy",
            "probability": 2.0265579223632812e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -2.787109375,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.34765625,
            "text": "Chaperone-mediated autophagy (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -5.69921875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.0,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.6015625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 8.90625,
            "text": "mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 8.90625,
            "text": "-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.79296875,
            "text": "Chaperone-mediated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.87109375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.91015625,
            "text": "Chaperone-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.9765625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.01953125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.0625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.1015625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.1953125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5537109375,
            "end_logit": 2.65625,
            "text": "autophagy (CMA)",
            "probability": 5.960464477539063e-08
        }
    ],
    "5540fbce234c5a7c75000001_8": [
        {
            "start_logit": 9.3203125,
            "end_logit": 9.1796875,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -1.005859375,
            "text": "chaperone",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -0.92919921875,
            "end_logit": 9.1796875,
            "text": "autophagy",
            "probability": 3.534555435180664e-05
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": 9.1796875,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -3.9609375,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -4.56640625,
            "text": "chaperone-mediated autophagy (",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -5.1640625,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.03125,
            "end_logit": 9.1796875,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.29296875,
            "text": "chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 9.1796875,
            "text": "-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.65234375,
            "text": "chaperone-mediated autophagy (CMA), in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3203125,
            "end_logit": -6.90234375,
            "text": "chaperone-mediated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 9.1796875,
            "text": "by chaperone-mediated autophagy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.1796875,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -1.005859375,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -0.92919921875,
            "end_logit": -3.9609375,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -3.9609375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -0.92919921875,
            "end_logit": -4.56640625,
            "text": "autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -4.56640625,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -0.92919921875,
            "end_logit": -5.1640625,
            "text": "autophagy (CMA),",
            "probability": 0.0
        }
    ],
    "5ac138aa95d0062724000001_1": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.265625,
            "text": "N-arginine dibasic convertase",
            "probability": 1.0
        },
        {
            "start_logit": -0.97607421875,
            "end_logit": 9.265625,
            "text": "ase",
            "probability": 4.297494888305664e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.6201171875,
            "text": "N",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -3.685546875,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.203125,
            "end_logit": 9.265625,
            "text": "-arginine dibasic convertase",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.59765625,
            "end_logit": 9.265625,
            "text": "convertase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -5.515625,
            "text": "N-arginine dibasic convertase;",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -5.7265625,
            "text": "N-arginine dibasic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -5.8125,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 9.265625,
            "text": "Nardilysin (N-arginine dibasic convertase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.05859375,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.171875,
            "text": "N-arginine dib",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 9.265625,
            "text": "arginine dibasic convertase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.328125,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.4921875,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.5,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.5078125,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 9.265625,
            "text": "(N-arginine dibasic convertase",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 9.265625,
            "text": "dibasic convertase",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.265625,
            "text": "asic convertase",
            "probability": 5.960464477539063e-08
        }
    ],
    "5708a845cf1c32585100000f_1": [
        {
            "start_logit": 8.4375,
            "end_logit": 6.7734375,
            "text": "Wnt",
            "probability": 1.0
        },
        {
            "start_logit": 8.4375,
            "end_logit": -1.3203125,
            "text": "Wnt signaling",
            "probability": 0.00030541419982910156
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.484375,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by the proteins Dishevelled and Axin.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.0546875,
            "text": "Wnt signaling is",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.16796875,
            "text": "Wnt signaling is known to",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.234375,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.328125,
            "text": "Wnt signaling is known",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.33203125,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.4375,
            "end_logit": -7.37109375,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": -1.3203125,
            "text": "signaling",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -6.484375,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off.",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -6.484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -6.484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.0625,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.09375,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.203125,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.26953125,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.359375,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.3828125,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled",
            "probability": 0.0
        },
        {
            "start_logit": -5.35546875,
            "end_logit": -7.390625,
            "text": ". Although Dishevelled is activated by Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_2": [
        {
            "start_logit": 8.6171875,
            "end_logit": 5.296875,
            "text": "Wnt",
            "probability": 0.96044921875
        },
        {
            "start_logit": 8.6171875,
            "end_logit": 2.107421875,
            "text": "Wnt signaling",
            "probability": 0.039642333984375
        },
        {
            "start_logit": -2.912109375,
            "end_logit": 5.296875,
            "text": "canonical Wnt",
            "probability": 9.417533874511719e-06
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.109375,
            "text": "Wnt signaling,",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 5.296875,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -2.912109375,
            "end_logit": 2.107421875,
            "text": "canonical Wnt signaling",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 5.296875,
            "text": "via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 5.296875,
            "text": "cell fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 5.296875,
            "text": "fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 5.296875,
            "text": ", within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 2.107421875,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 2.107421875,
            "text": "via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 2.107421875,
            "text": "signaling",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 2.107421875,
            "text": "cell fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": 2.107421875,
            "text": "fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": 2.107421875,
            "text": ", within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -2.912109375,
            "end_logit": -7.109375,
            "text": "canonical Wnt signaling,",
            "probability": 0.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -7.109375,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling,",
            "probability": 0.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -7.28515625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.21484375,
            "end_logit": -7.30859375,
            "text": ". Intriguing",
            "probability": 0.0
        }
    ],
    "5708a845cf1c32585100000f_3": [
        {
            "start_logit": 7.35546875,
            "end_logit": 7.96484375,
            "text": "Wnt",
            "probability": 1.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.96484375,
            "text": "humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.96484375,
            "text": "in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.96484375,
            "text": "have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.35546875,
            "end_logit": -6.7890625,
            "text": "Wnt signaling pathways.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.96484375,
            "text": ", are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.96484375,
            "text": "of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.96484375,
            "text": "which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.96484375,
            "text": "three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.35546875,
            "end_logit": -6.8515625,
            "text": "Wnt signaling",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.96484375,
            "text": ", three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.96484375,
            "text": "been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.96484375,
            "text": "Dishevelled (DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.96484375,
            "text": "canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.96484375,
            "text": "of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.96484375,
            "text": "evelled (DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.35546875,
            "end_logit": -7.1171875,
            "text": "Wnt signaling pathways",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -6.7890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -6.7890625,
            "text": "humans, are highly conserved components of canonical and noncanonical Wnt signaling pathways.",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -6.7890625,
            "text": "in humans, are highly conserved components of canonical and noncanonical Wnt signaling pathways.",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_1": [
        {
            "start_logit": 8.7109375,
            "end_logit": 8.9765625,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.794921875,
            "end_logit": 8.9765625,
            "text": "1",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -2.521484375,
            "text": "ABC",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -6.203125,
            "end_logit": 8.9765625,
            "text": "C11",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.9765625,
            "text": "in ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 8.9765625,
            "text": "A single nucleotide polymorphism (SNP) in ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.12890625,
            "text": "ABCC11 affects",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.1484375,
            "text": "ABCC1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.21875,
            "text": "ABCC11 affects the cerumen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.23046875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.23046875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.23046875,
            "text": "ABCC11 affects the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.2421875,
            "text": "ABCC11 affects the cerumen VOC profiles of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.26953125,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian descent",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.28515625,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.296875,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.794921875,
            "end_logit": -7.12890625,
            "text": "1 affects",
            "probability": 0.0
        },
        {
            "start_logit": -1.794921875,
            "end_logit": -7.21875,
            "text": "1 affects the cerumen",
            "probability": 0.0
        },
        {
            "start_logit": -1.794921875,
            "end_logit": -7.23046875,
            "text": "1 affects the cerumen VOC profiles of individuals from",
            "probability": 0.0
        },
        {
            "start_logit": -1.794921875,
            "end_logit": -7.23046875,
            "text": "1 affects the cerumen VOC profiles of individuals from African,",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_2": [
        {
            "start_logit": 9.046875,
            "end_logit": 9.140625,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": 9.140625,
            "text": "1",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.8408203125,
            "text": "ABC",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -5.73828125,
            "end_logit": 9.140625,
            "text": "C11",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.765625,
            "end_logit": 9.140625,
            "text": "that ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.796875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.859375,
            "text": "ABCC11 genotype alone",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.87890625,
            "text": "ABCC11 genotype",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.0390625,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 9.140625,
            "text": "findings also reveal that ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.08984375,
            "text": "ABCC11 genotype alone does",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.203125,
            "end_logit": 9.140625,
            "text": "Our findings also reveal that ABCC11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1484375,
            "text": "ABCC11 genotype alone does not predict the type and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.18359375,
            "text": "ABCC11 genotype alone does not predict the type and relative",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1875,
            "text": "ABCC1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.19921875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways must",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.2109375,
            "text": "ABCC11 genotype alone does not predict the type and relative levels",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.2265625,
            "text": "ABCC11 genotype alone does not predict",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.23828125,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.2421875,
            "text": "ABCC11 genotype alone does not predict the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5acf74460340b9f058000013_3": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.140625,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.37109375,
            "end_logit": 9.140625,
            "text": "1",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.69140625,
            "text": "ABC",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -5.984375,
            "end_logit": 9.140625,
            "text": "C11",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.8984375,
            "text": "ABCC11 encodes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.91015625,
            "text": "ABCC11 encodes an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.9453125,
            "text": "ABCC1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.01171875,
            "text": "ABCC11 encodes an ATP-driven efflux pump",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.06640625,
            "text": "ABCC11 encodes an ATP-driven",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.08203125,
            "text": "ABCC11 encodes an ATP-driven efflux",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.08203125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.11328125,
            "text": "ABCC11 encodes an ATP-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.11328125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.15234375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.16015625,
            "text": "ABCC11 encodes an ATP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.16796875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.1796875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.234375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.24609375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.26953125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of the auditory canal and the",
            "probability": 5.960464477539063e-08
        }
    ],
    "5acf74460340b9f058000013_4": [
        {
            "start_logit": 8.6171875,
            "end_logit": 9.0,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": 9.0,
            "text": "1",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -2.646484375,
            "text": "ABC",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -6.21875,
            "end_logit": 9.0,
            "text": "C11",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 9.0,
            "text": "(ABCC11",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.28125,
            "text": "ABCC11)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.64453125,
            "text": "ABCC11) to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 9.0,
            "text": "the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.0,
            "text": "link a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.80078125,
            "text": "ABCC1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.0,
            "text": "in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.9140625,
            "text": "ABCC11) to the production of different types of axillary odorants",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 9.0,
            "text": "a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 9.0,
            "text": "adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.0,
            "text": ", member 11 gene (ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.0,
            "text": "gene (ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 9.0,
            "text": ") binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 9.0,
            "text": "ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -6.28125,
            "text": "1)",
            "probability": 0.0
        },
        {
            "start_logit": -1.6806640625,
            "end_logit": -6.64453125,
            "text": "1) to",
            "probability": 0.0
        }
    ],
    "62265b4a3a8413c653000083_1": [
        {
            "start_logit": 8.796875,
            "end_logit": 6.64453125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.796875,
            "end_logit": -0.1429443359375,
            "text": "Runt-related transcription factor 1",
            "probability": 0.001132965087890625
        },
        {
            "start_logit": 8.796875,
            "end_logit": -1.9365234375,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis",
            "probability": 0.00018787384033203125
        },
        {
            "start_logit": 8.796875,
            "end_logit": -2.1484375,
            "text": "Run",
            "probability": 0.00015211105346679688
        },
        {
            "start_logit": -1.4404296875,
            "end_logit": 6.64453125,
            "text": ".",
            "probability": 3.5881996154785156e-05
        },
        {
            "start_logit": 8.796875,
            "end_logit": -4.75,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.30078125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.42578125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.4453125,
            "text": "Runt-related transcription factor",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.4609375,
            "text": "Runt-related transcription factor 1 (RUNX1T1)",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.63671875,
            "text": "Runt-related transcription factor 1 (",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.73046875,
            "text": "Runt-related transcription factor 1 (RUNX1T1",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -5.93359375,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -6.10546875,
            "text": "Runt-related transcription factor 1 (RUNX1",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -6.765625,
            "text": "Runt-",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -6.84375,
            "text": "Runt-related transcription",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.796875,
            "end_logit": -6.89453125,
            "text": "Runt-related",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.10546875,
            "end_logit": 6.64453125,
            "text": "(RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.84765625,
            "end_logit": 6.64453125,
            "text": "t-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 6.64453125,
            "text": "RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 4.172325134277344e-07
        }
    ],
    "54e8c7220fc566b149000002_1": [
        {
            "start_logit": -3.470703125,
            "end_logit": 7.765625,
            "text": "nucleus",
            "probability": 0.79248046875
        },
        {
            "start_logit": -5.80078125,
            "end_logit": 7.765625,
            "text": "in the nucleus",
            "probability": 0.07696533203125
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 7.765625,
            "text": "the nucleus",
            "probability": 0.07666015625
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 7.765625,
            "text": "S100A4 interacts with p53 in the nucleus",
            "probability": 0.04168701171875
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.765625,
            "text": "with p53 in the nucleus",
            "probability": 0.01222991943359375
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -6.83203125,
            "text": "S100A4",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -6.97265625,
            "text": "S100A4 interacts with p53",
            "probability": 0.0
        },
        {
            "start_logit": -6.4140625,
            "end_logit": -6.98828125,
            "text": "S100A4 interacts",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -6.97265625,
            "text": "with p53",
            "probability": 0.0
        }
    ],
    "54e8c7220fc566b149000002_2": [
        {
            "start_logit": 5.3828125,
            "end_logit": 8.8671875,
            "text": "nucleus",
            "probability": 1.0
        },
        {
            "start_logit": -4.359375,
            "end_logit": 8.8671875,
            "text": "cell nucleus",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 5.3828125,
            "end_logit": -1.484375,
            "text": "nucleus.",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 8.8671875,
            "text": ", we show that the interaction takes place in the cell nucleus",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -6.32421875,
            "end_logit": 8.8671875,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -6.484375,
            "end_logit": 8.8671875,
            "text": "interaction takes place in the cell nucleus",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 8.8671875,
            "text": "using proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 8.8671875,
            "text": "we show that the interaction takes place in the cell nucleus",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -6.796875,
            "end_logit": 8.8671875,
            "text": "the interaction takes place in the cell nucleus",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 8.8671875,
            "text": "that the interaction takes place in the cell nucleus",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -6.96875,
            "end_logit": 8.8671875,
            "text": "in the cell nucleus",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 8.8671875,
            "text": "show that the interaction takes place in the cell nucleus",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 8.8671875,
            "text": "the cell nucleus",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.8671875,
            "text": "ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.8671875,
            "text": "place in the cell nucleus",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.8671875,
            "text": "takes place in the cell nucleus",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -4.359375,
            "end_logit": -1.484375,
            "text": "cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -5.73046875,
            "end_logit": -1.484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.26171875,
            "end_logit": -1.484375,
            "text": ", we show that the interaction takes place in the cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -6.32421875,
            "end_logit": -1.484375,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus.",
            "probability": 0.0
        }
    ],
    "58f0b0c070f9fc6f0f000006_1": [
        {
            "start_logit": 9.25,
            "end_logit": 9.078125,
            "text": "tardive dyskinesia",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.3720703125,
            "text": "tard",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": 9.078125,
            "text": "dyskinesia",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 9.078125,
            "text": "ive dyskinesia",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.99609375,
            "text": "tardive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.015625,
            "text": "tardive dyskinesia.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 9.078125,
            "text": "treating tardive dyskinesia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.078125,
            "text": "drug status for treating tardive dyskinesia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 9.078125,
            "text": "breakthrough drug status for treating tardive dyskinesia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 9.078125,
            "text": "Valbenazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5947265625,
            "end_logit": -7.015625,
            "text": "dyskinesia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -1.3720703125,
            "text": "treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -1.3720703125,
            "text": "drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.3720703125,
            "text": "breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.3720703125,
            "text": "Valbenazine granted breakthrough drug status for treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -4.78515625,
            "end_logit": -7.015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.0703125,
            "end_logit": -6.99609375,
            "text": "ive",
            "probability": 0.0
        },
        {
            "start_logit": -6.0703125,
            "end_logit": -7.015625,
            "text": "ive dyskinesia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -6.99609375,
            "text": "treating tardive",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -7.015625,
            "text": "treating tardive dyskinesia.",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_1": [
        {
            "start_logit": 9.046875,
            "end_logit": 4.7734375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9970703125
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.3125,
            "text": "Borderline",
            "probability": 0.002269744873046875
        },
        {
            "start_logit": 9.046875,
            "end_logit": -2.90234375,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.00046253204345703125
        },
        {
            "start_logit": 9.046875,
            "end_logit": -3.388671875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.00028395652770996094
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": 4.7734375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.00016045570373535156
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.59765625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.78125,
            "text": "Borderline oxacillin",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.8515625,
            "text": "Borderline oxacillin-",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.06640625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.18359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7464160919189453e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.3515625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -5.66015625,
            "end_logit": 4.7734375,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.6875,
            "end_logit": 4.7734375,
            "text": "aureus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -2.90234375,
            "text": "oxacillin-resistant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -3.388671875,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -5.59765625,
            "text": "oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -5.78125,
            "text": "oxacillin",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -5.8515625,
            "text": "oxacillin-",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -6.06640625,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -6.18359375,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_2": [
        {
            "start_logit": 7.7890625,
            "end_logit": 7.953125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 0.63525390625
        },
        {
            "start_logit": 7.23828125,
            "end_logit": 7.953125,
            "text": "MRSA",
            "probability": 0.36474609375
        },
        {
            "start_logit": 7.23828125,
            "end_logit": -1.2548828125,
            "text": "MRSA) in the clinical laboratory.",
            "probability": 3.6716461181640625e-05
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -3.19140625,
            "text": "Borderline",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -3.76171875,
            "text": "Borderline oxacillin-resistant",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -4.96484375,
            "end_logit": 7.953125,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -5.43359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -5.59375,
            "text": "Borderline oxacillin-",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -5.6015625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -5.7265625,
            "text": "Borderline oxacillin",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -5.82421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -5.90625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.09765625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.37890625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA) in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.40625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.23828125,
            "end_logit": -5.90625,
            "text": "MRSA)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.5078125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.6015625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.66796875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -6.69921875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 2.384185791015625e-07
        }
    ],
    "5aae6499fcf456587200000c_3": [
        {
            "start_logit": 7.7734375,
            "end_logit": 5.16796875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -3.33984375,
            "text": "borderline",
            "probability": 0.00020325183868408203
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -3.771484375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 0.00013124942779541016
        },
        {
            "start_logit": -2.52734375,
            "end_logit": 5.16796875,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 3.36766242980957e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -5.23828125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -5.375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 2.6464462280273438e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -5.5390625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -5.90234375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u2265",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.0234375,
            "text": "borderline oxacillin-resistant",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.16015625,
            "text": "borderline oxacillin",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.19140625,
            "text": "borderline oxacillin-",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.203125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.421875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.4765625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 7.7734375,
            "end_logit": -6.578125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 5.16796875,
            "text": "aureus",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 5.16796875,
            "text": "Staphylococcus aureus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.04296875,
            "end_logit": 5.16796875,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.078125,
            "end_logit": 5.16796875,
            "text": "Since it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 5.16796875,
            "text": "resistant Staphylococcus aureus",
            "probability": 4.172325134277344e-07
        }
    ],
    "5aae6499fcf456587200000c_4": [
        {
            "start_logit": 8.9296875,
            "end_logit": 3.67578125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance.",
            "probability": 0.630859375
        },
        {
            "start_logit": 8.9296875,
            "end_logit": 3.13671875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.364990234375
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -1.9189453125,
            "text": "Borderline",
            "probability": 0.002338409423828125
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -3.580078125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.00044465065002441406
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -4.05078125,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.0002770423889160156
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -4.86328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance",
            "probability": 0.00012254714965820312
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -4.94921875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents",
            "probability": 0.00011324882507324219
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.50390625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a",
            "probability": 6.455183029174805e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.60546875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.65625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype",
            "probability": 5.5670738220214844e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.85546875,
            "text": "Borderline oxacillin",
            "probability": 4.57763671875e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.9609375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -5.99609375,
            "text": "Borderline oxacillin-",
            "probability": 3.975629806518555e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.12890625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin",
            "probability": 3.457069396972656e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.13671875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequate",
            "probability": 3.457069396972656e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.1484375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of",
            "probability": 3.403425216674805e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.16015625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and",
            "probability": 3.349781036376953e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.2421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly",
            "probability": 3.0994415283203125e-05
        },
        {
            "start_logit": 8.9296875,
            "end_logit": -6.2890625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -2.54296875,
            "end_logit": 3.67578125,
            "text": ".",
            "probability": 6.556510925292969e-06
        }
    ],
    "5aae6499fcf456587200000c_5": [
        {
            "start_logit": 8.765625,
            "end_logit": -1.646484375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.464111328125
        },
        {
            "start_logit": 8.765625,
            "end_logit": -2.087890625,
            "text": "Borderline",
            "probability": 0.299560546875
        },
        {
            "start_logit": 8.765625,
            "end_logit": -3.044921875,
            "text": "Borderline oxacillin-resistant",
            "probability": 0.1146240234375
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.0234375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1",
            "probability": 0.0158843994140625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.078125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.015045166015625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.265625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit",
            "probability": 0.0124664306640625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.3515625,
            "text": "Borderline oxacillin-",
            "probability": 0.01143646240234375
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.36328125,
            "text": "Borderline oxacillin",
            "probability": 0.0113067626953125
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.43359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of",
            "probability": 0.01053619384765625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.59765625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values",
            "probability": 0.00894927978515625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.60546875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml",
            "probability": 0.00887298583984375
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.6328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 0.008636474609375
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.66015625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(",
            "probability": 0.00839996337890625
        },
        {
            "start_logit": 8.765625,
            "end_logit": -5.71484375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-",
            "probability": 0.00795745849609375
        },
        {
            "start_logit": -2.224609375,
            "end_logit": 3.283203125,
            "text": "mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 0.0010852813720703125
        },
        {
            "start_logit": -2.2578125,
            "end_logit": 3.283203125,
            "text": ".",
            "probability": 0.0010471343994140625
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 3.283203125,
            "text": "lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 1.9311904907226562e-05
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 3.283203125,
            "text": "but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 3.283203125,
            "text": ", but lack mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -2.224609375,
            "end_logit": -2.107421875,
            "text": "mecA",
            "probability": 4.947185516357422e-06
        }
    ],
    "5aae6499fcf456587200000c_6": [
        {
            "start_logit": 9.1015625,
            "end_logit": 5.6328125,
            "text": "borderline oxacillin resistant Staphylococcus aureus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.40234375,
            "text": "borderline",
            "probability": 0.0008792877197265625
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -2.9140625,
            "text": "borderline oxacillin resistant",
            "probability": 0.0001939535140991211
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -3.763671875,
            "text": "borderline oxacillin resistant Staphylococcus aureus (",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.83203125,
            "text": "borderline oxacillin",
            "probability": 1.043081283569336e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.953125,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BOR",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -2.6796875,
            "end_logit": 5.6328125,
            "text": "oxacillin resistant Staphylococcus aureus",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.15625,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA)",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.16796875,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.2734375,
            "text": "borderline oxacillin resistant Staphylococcus",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.171875,
            "text": "borderline oxacil",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.32421875,
            "end_logit": 5.6328125,
            "text": "aureus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 5.6328125,
            "text": "cillin resistant Staphylococcus aureus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 5.6328125,
            "text": "lin resistant Staphylococcus aureus",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.6796875,
            "end_logit": -2.9140625,
            "text": "oxacillin resistant",
            "probability": 0.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": -3.763671875,
            "text": "oxacillin resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": -5.83203125,
            "text": "oxacillin",
            "probability": 0.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": -5.953125,
            "text": "oxacillin resistant Staphylococcus aureus (BOR",
            "probability": 0.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": -6.15625,
            "text": "oxacillin resistant Staphylococcus aureus (BORSA)",
            "probability": 0.0
        },
        {
            "start_logit": -2.6796875,
            "end_logit": -6.16796875,
            "text": "oxacillin resistant Staphylococcus aureus (BORSA",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_7": [
        {
            "start_logit": 9.046875,
            "end_logit": 4.7734375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9970703125
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.3125,
            "text": "borderline",
            "probability": 0.002269744873046875
        },
        {
            "start_logit": 9.046875,
            "end_logit": -2.90234375,
            "text": "borderline oxacillin-resistant",
            "probability": 0.00046253204345703125
        },
        {
            "start_logit": 9.046875,
            "end_logit": -3.388671875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.00028395652770996094
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": 4.7734375,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.00016045570373535156
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.59765625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.78125,
            "text": "borderline oxacillin",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -5.8515625,
            "text": "borderline oxacillin-",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.06640625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.18359375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7464160919189453e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.3515625,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -5.66015625,
            "end_logit": 4.7734375,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.6875,
            "end_logit": 4.7734375,
            "text": "aureus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -2.90234375,
            "text": "oxacillin-resistant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -3.388671875,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -5.59765625,
            "text": "oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -5.78125,
            "text": "oxacillin",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -5.8515625,
            "text": "oxacillin-",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -6.06640625,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 0.0
        },
        {
            "start_logit": 0.3076171875,
            "end_logit": -6.18359375,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_8": [
        {
            "start_logit": 9.140625,
            "end_logit": 6.75,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9970703125
        },
        {
            "start_logit": 9.140625,
            "end_logit": 0.72119140625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0023956298828125
        },
        {
            "start_logit": 9.140625,
            "end_logit": -1.130859375,
            "text": "borderline",
            "probability": 0.00037598609924316406
        },
        {
            "start_logit": 9.140625,
            "end_logit": -2.9921875,
            "text": "borderline oxacillin-resistant",
            "probability": 5.8591365814208984e-05
        },
        {
            "start_logit": -1.095703125,
            "end_logit": 6.75,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.82421875,
            "text": "borderline oxacillin",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -5.8515625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BOR",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.22265625,
            "text": "borderline oxacillin-",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.2578125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 9.140625,
            "end_logit": -6.45703125,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -4.33203125,
            "end_logit": 6.75,
            "text": "aureus",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.890625,
            "end_logit": 6.75,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 6.75,
            "text": "Staphylococcus aureus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.095703125,
            "end_logit": 0.72119140625,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.33203125,
            "end_logit": 0.72119140625,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -2.9921875,
            "text": "oxacillin-resistant",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": 0.72119140625,
            "text": "(",
            "probability": 0.0
        },
        {
            "start_logit": -5.890625,
            "end_logit": 0.72119140625,
            "text": "cillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -6.828125,
            "end_logit": 0.72119140625,
            "text": "Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -1.095703125,
            "end_logit": -5.82421875,
            "text": "oxacillin",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_1": [
        {
            "start_logit": 8.578125,
            "end_logit": 8.921875,
            "text": "Parkinson's Disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": 8.921875,
            "text": "Disease",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -2.4921875,
            "text": "Parkinson",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 8.578125,
            "end_logit": -4.8515625,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.21875,
            "end_logit": 8.921875,
            "text": "'s Disease",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 8.921875,
            "text": "s Disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 8.921875,
            "text": "Unified Parkinson's Disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.62109375,
            "text": "Parkinson's Disease Rating",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.125,
            "end_logit": 8.921875,
            "text": "the Unified Parkinson's Disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 8.921875,
            "text": "During each study visit, the Fahn-Tolosa-Marin (FTM) scale, the Unified Parkinson's Disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -6.8125,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the treated limb",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 8.921875,
            "text": ", the Unified Parkinson's Disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.921875,
            "text": "FTM) scale, the Unified Parkinson's Disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.046875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.0859375,
            "text": "Parkinson's",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.1015625,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.578125,
            "end_logit": -7.12890625,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": -4.8515625,
            "text": "Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": -6.62109375,
            "text": "Disease Rating",
            "probability": 0.0
        },
        {
            "start_logit": -1.7958984375,
            "end_logit": -6.72265625,
            "text": "Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the treated limb.",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_2": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.8515625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -1.814453125,
            "end_logit": 8.8515625,
            "text": "Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -1.85546875,
            "end_logit": 8.8515625,
            "text": "tremor",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -2.80859375,
            "text": "essential",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 8.8515625,
            "text": "for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.3515625,
            "text": "essential tremor (ET",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.484375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.8515625,
            "text": "for essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.8515625,
            "text": "Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.8515625,
            "text": ": The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.80859375,
            "text": "essential tremor (ET), but",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.84765625,
            "text": "essential tremor (ET)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.87890625,
            "text": "essential tremor (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.99609375,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.0078125,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.046875,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.125,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.814453125,
            "end_logit": -1.2734375,
            "text": "Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -1.814453125,
            "end_logit": -2.80859375,
            "text": "Tremor (FTM) has been used in large trials for essential",
            "probability": 0.0
        },
        {
            "start_logit": -6.84375,
            "end_logit": -1.2734375,
            "text": "for Tremor",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_3": [
        {
            "start_logit": 7.15625,
            "end_logit": 5.5703125,
            "text": "Tremor",
            "probability": 0.99609375
        },
        {
            "start_logit": 1.70703125,
            "end_logit": 5.5703125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 0.004283905029296875
        },
        {
            "start_logit": 1.70703125,
            "end_logit": 1.2548828125,
            "text": "tremor",
            "probability": 5.716085433959961e-05
        },
        {
            "start_logit": 0.1400146484375,
            "end_logit": 0.953125,
            "text": "Essential Tremor",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 7.15625,
            "end_logit": -6.62890625,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 7.15625,
            "end_logit": -7.06640625,
            "text": "Tremor Rating",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 7.15625,
            "end_logit": -7.125,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor Rating",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 5.5703125,
            "text": "Five tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 1.70703125,
            "end_logit": -3.142578125,
            "text": "tremor severity",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 5.5703125,
            "text": "the Fahn-Tolosa-Marin Tremor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 1.70703125,
            "end_logit": -6.62890625,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0
        },
        {
            "start_logit": 1.70703125,
            "end_logit": -6.8984375,
            "text": "tremor severity scales",
            "probability": 0.0
        },
        {
            "start_logit": 1.70703125,
            "end_logit": -7.06640625,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": 1.70703125,
            "end_logit": -7.125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor Rating Scale, the Bain and Findley Clinical Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 0.953125,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 1.2548828125,
            "text": "Five tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 0.953125,
            "text": "of Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 0.953125,
            "text": ", the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 0.953125,
            "text": "Inwood Genetic Study of Essential Tremor",
            "probability": 0.0
        },
        {
            "start_logit": 0.1400146484375,
            "end_logit": -6.8515625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_4": [
        {
            "start_logit": 8.3671875,
            "end_logit": 8.5859375,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -1.544921875,
            "end_logit": 8.5859375,
            "text": "Tremor Rating Scale (TRS) in essential tremor",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": -2.177734375,
            "end_logit": 8.5859375,
            "text": "tremor",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -2.697265625,
            "text": "essential",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -5.3984375,
            "end_logit": 8.5859375,
            "text": "in essential tremor",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -5.7734375,
            "text": "essential tremor (ET)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -5.87890625,
            "text": "essential tremor (ET",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.53515625,
            "text": "essential tremor (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3671875,
            "end_logit": -6.60546875,
            "text": "essential tremor (ET).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 8.5859375,
            "text": "was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.5859375,
            "text": "study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.5859375,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.5859375,
            "text": "n Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.5859375,
            "text": "evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.544921875,
            "end_logit": -0.93701171875,
            "text": "Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -1.544921875,
            "end_logit": -2.697265625,
            "text": "Tremor Rating Scale (TRS) in essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.544921875,
            "end_logit": -5.7734375,
            "text": "Tremor Rating Scale (TRS) in essential tremor (ET)",
            "probability": 0.0
        },
        {
            "start_logit": -1.544921875,
            "end_logit": -5.87890625,
            "text": "Tremor Rating Scale (TRS) in essential tremor (ET",
            "probability": 0.0
        },
        {
            "start_logit": -6.796875,
            "end_logit": -0.93701171875,
            "text": "purpose of this study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor",
            "probability": 0.0
        },
        {
            "start_logit": -1.544921875,
            "end_logit": -6.296875,
            "text": "Tremor Rating",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_5": [
        {
            "start_logit": 6.42578125,
            "end_logit": 7.671875,
            "text": "Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -0.027557373046875,
            "text": "Tremor Rating Scale in essential tremor",
            "probability": 0.00045490264892578125
        },
        {
            "start_logit": 0.9765625,
            "end_logit": -0.027557373046875,
            "text": "essential tremor",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.671875,
            "text": "n Tremor",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.671875,
            "text": "the Fahn-Tolosa-Marin Tremor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 7.671875,
            "text": "Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 7.671875,
            "text": "of the Fahn-Tolosa-Marin Tremor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 7.671875,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -6.69921875,
            "text": "Tremor Rating",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -6.90625,
            "text": "Tremor Rating Scale in essential tremor.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.078125,
            "text": "Tremor Rating Scale",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 0.9765625,
            "end_logit": -6.90625,
            "text": "essential tremor.",
            "probability": 0.0
        },
        {
            "start_logit": -6.0859375,
            "end_logit": -0.027557373046875,
            "text": "in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -0.027557373046875,
            "text": "n Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -0.027557373046875,
            "text": "the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -0.027557373046875,
            "text": "Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -0.027557373046875,
            "text": "of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -0.027557373046875,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 0.0
        },
        {
            "start_logit": -4.25390625,
            "end_logit": -6.90625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.0859375,
            "end_logit": -6.90625,
            "text": "in essential tremor.",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_6": [
        {
            "start_logit": 9.125,
            "end_logit": 9.078125,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": 9.078125,
            "text": "Tremor",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.6005859375,
            "text": "Essential",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.24609375,
            "text": "Essential Tremor Rating",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.32421875,
            "text": "Essential Tremor Rating Assessment",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.125,
            "end_logit": -7.32421875,
            "text": "Essential Tremor Rating Assessment Scale",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.078125,
            "text": "the Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.078125,
            "text": "Clinical Rating Scale and the Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.078125,
            "text": "Rating Scale and the Essential Tremor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": -7.24609375,
            "text": "Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": -7.32421875,
            "text": "Tremor Rating Assessment",
            "probability": 0.0
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": -7.32421875,
            "text": "Tremor Rating Assessment Scale",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -1.6005859375,
            "text": "the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -1.6005859375,
            "text": "Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -1.6005859375,
            "text": "Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.24609375,
            "text": "the Essential Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.23828125,
            "text": "Clinical Rating Scale and",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.24609375,
            "text": "Clinical Rating Scale and the Essential Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.296875,
            "text": "the",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.32421875,
            "text": "the Essential Tremor Rating Assessment",
            "probability": 0.0
        }
    ],
    "58f4b1a170f9fc6f0f000010_1": [
        {
            "start_logit": -7.203125,
            "end_logit": -6.22265625,
            "text": "in Amanita phalloides",
            "probability": 0.087890625
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -6.22265625,
            "text": "Amanita phalloides",
            "probability": 0.081298828125
        },
        {
            "start_logit": -7.203125,
            "end_logit": -6.4296875,
            "text": "in Amanita phalloides poisoning",
            "probability": 0.07122802734375
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -6.4296875,
            "text": "Amanita phalloides poisoning",
            "probability": 0.06634521484375
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -6.22265625,
            "text": "-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.055450439453125
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.22265625,
            "text": "' short-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.055023193359375
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.22265625,
            "text": "patients' short-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.055023193359375
        },
        {
            "start_logit": -7.203125,
            "end_logit": -6.828125,
            "text": "in Amanita",
            "probability": 0.04779052734375
        },
        {
            "start_logit": -7.203125,
            "end_logit": -6.8359375,
            "text": "in Amanita phal",
            "probability": 0.04742431640625
        },
        {
            "start_logit": -7.203125,
            "end_logit": -6.859375,
            "text": "in Amanita phallo",
            "probability": 0.04632568359375
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -6.4296875,
            "text": "-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.044891357421875
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -6.828125,
            "text": "Amanita",
            "probability": 0.0445556640625
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.4296875,
            "text": "' short-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.0445556640625
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.4296875,
            "text": "patients' short-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 0.0445556640625
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -6.8359375,
            "text": "Amanita phal",
            "probability": 0.044219970703125
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -6.859375,
            "text": "Amanita phallo",
            "probability": 0.043182373046875
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -6.828125,
            "text": "-term post liver transplantation survival in Amanita",
            "probability": 0.0303955078125
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -6.8359375,
            "text": "-term post liver transplantation survival in Amanita phal",
            "probability": 0.0299224853515625
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.828125,
            "text": "' short-term post liver transplantation survival in Amanita",
            "probability": 0.0299224853515625
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.828125,
            "text": "patients' short-term post liver transplantation survival in Amanita",
            "probability": 0.0299224853515625
        }
    ],
    "58aa0c6f396a458e50000008_1": [
        {
            "start_logit": 7.734375,
            "end_logit": 7.64453125,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.1015625,
            "text": "oxytocin (OXT) and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.1171875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.1171875,
            "text": "oxytocin (OXT)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.13671875,
            "text": "oxytocin (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.13671875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.16015625,
            "text": "oxytocin (OXT",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.17578125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.1796875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.1796875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.19140625,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.20703125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.2109375,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.64453125,
            "text": "neurohypophysial hormone oxytocin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.72265625,
            "end_logit": -6.4375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -6.4375,
            "text": "pair bonding, parental behavior, and stress-related responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.04296875,
            "text": "neurohypophysial",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -7.1015625,
            "text": "neurohypophysial hormone oxytocin (OXT) and",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.1796875,
            "text": "pair bonding, parental behavior, and stress-related",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.19140625,
            "text": "pair bonding, parental behavior, and",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_2": [
        {
            "start_logit": 7.6875,
            "end_logit": 7.6953125,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 7.6875,
            "end_logit": -6.875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.0859375,
            "text": "oxytocin has roles",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.10546875,
            "text": "oxytocin has roles in social bonding,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.1171875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.125,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.125,
            "text": "oxytocin has roles in social bonding, energy metabolism, and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.140625,
            "text": "oxytocin has",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.14453125,
            "text": "oxytocin has roles in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.19140625,
            "text": "oxytocin has roles in social bonding",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.19921875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.24609375,
            "text": "oxytocin has roles in social bonding, energy metabolism",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.24609375,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.26953125,
            "text": "oxytocin has roles in social bonding, energy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.3046875,
            "text": "oxytocin has roles in social bonding, energy metabolism,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -7.3359375,
            "text": "oxytocin has roles in social",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.6953125,
            "text": "Neuropeptide hormone oxytocin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.68359375,
            "end_logit": -6.875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -6.875,
            "text": "social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -6.875,
            "text": "Neuropeptide hormone oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_3": [
        {
            "start_logit": 7.75,
            "end_logit": 7.625,
            "text": "Oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 7.75,
            "end_logit": -4.9765625,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.80859375,
            "text": "Oxytocin is known",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.8671875,
            "text": "Oxytocin is known as the 'love hormone",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.96875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -6.99609375,
            "text": "Oxytocin is known as",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.015625,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.01953125,
            "text": "Oxytocin is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.0234375,
            "text": "Oxytocin is known as the 'love hormone' due",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.03515625,
            "text": "Oxytocin is known as the 'love hormone' due its role in",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.046875,
            "text": "Oxytocin is known as the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.0546875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.0703125,
            "text": "Oxytocin is known as the 'love hormone' due its",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.0859375,
            "text": "Oxytocin is known as the 'love hormone' due its role",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.10546875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.12890625,
            "text": "Oxytocin is known as the 'love hormone'",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.15234375,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.15625,
            "text": "Oxytocin is known as the 'lov",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.11328125,
            "end_logit": -4.9765625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_4": [
        {
            "start_logit": 7.8125,
            "end_logit": 7.515625,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.3984375,
            "text": "oxytocin (OT",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.6015625,
            "text": "oxytocin (OT)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.65625,
            "text": "oxytocin (OT) hormone",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.734375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.89453125,
            "text": "oxytocin (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.9765625,
            "text": "oxytocin (OT) hormone pathway is",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -6.984375,
            "text": "oxytocin (OT) hormone pathway",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.0,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding behavior",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.01953125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.03515625,
            "text": "oxytocin (OT) hormone pathway is involved",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.0625,
            "text": "oxytocin (OT) hormone pathway is involved in numerous",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.08203125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.1171875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8125,
            "end_logit": -7.12890625,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.765625,
            "end_logit": -5.5390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -5.5390625,
            "text": "pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -5.5390625,
            "text": "in pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -6.3984375,
            "text": "(OT",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_5": [
        {
            "start_logit": 7.71875,
            "end_logit": 7.65234375,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.03125,
            "text": "oxytocin, a hormone involved in parent-offspring",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.08984375,
            "text": "oxytocin, a hormone involved in parent-offspring bonding",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.09375,
            "text": "oxytocin, a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.125,
            "text": "oxytocin, a hormone involved in parent",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.16796875,
            "text": "oxytocin,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.1796875,
            "text": "oxytocin, a hormone",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.20703125,
            "text": "oxytocin, a hormone involved in parent-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.24609375,
            "text": "oxytocin, a hormone involved in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.296875,
            "text": "oxytocin, a hormone involved",
            "probability": 2.980232238769531e-07
        }
    ],
    "58a5b1fe60087bc10a000024_1": [
        {
            "start_logit": 8.296875,
            "end_logit": 1.9892578125,
            "text": "SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.87744140625
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.11151123046875,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.1072998046875
        },
        {
            "start_logit": 8.296875,
            "end_logit": -2.197265625,
            "text": "SUMO",
            "probability": 0.0133209228515625
        },
        {
            "start_logit": 8.296875,
            "end_logit": -5.3671875,
            "text": "SUMO-conjugating",
            "probability": 0.0005583763122558594
        },
        {
            "start_logit": 8.296875,
            "end_logit": -5.38671875,
            "text": "SUMO-conjug",
            "probability": 0.0005478858947753906
        },
        {
            "start_logit": 8.296875,
            "end_logit": -5.9140625,
            "text": "SUMO-conjugating enzyme (Ubc9) is",
            "probability": 0.00032329559326171875
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": 1.9892578125,
            "text": ".",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": -1.630859375,
            "end_logit": 1.9892578125,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": -1.630859375,
            "end_logit": 1.9892578125,
            "text": ".",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -0.11151123046875,
            "text": ". SUMO-conjugating enzyme",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -5.73828125,
            "end_logit": 1.9892578125,
            "text": "in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -2.197265625,
            "text": ". SUMO",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.0625,
            "end_logit": 1.9892578125,
            "text": "(Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 1.9892578125,
            "text": "important conjunction enzyme in the SUMO pathway.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 1.9892578125,
            "text": "ubiquitin-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 1.9892578125,
            "text": "eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 1.9892578125,
            "text": "conjunction enzyme in the SUMO pathway.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 1.9892578125,
            "text": "an important conjunction enzyme in the SUMO pathway.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 1.9892578125,
            "text": "is an important conjunction enzyme in the SUMO pathway.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 1.9892578125,
            "text": "Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 2.384185791015625e-07
        }
    ],
    "58a5b1fe60087bc10a000024_2": [
        {
            "start_logit": 5.53515625,
            "end_logit": 3.34375,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.97998046875
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -1.3720703125,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.00881195068359375
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -1.390625,
            "text": "SUMO-conjugating enzyme UBC9 and",
            "probability": 0.00864410400390625
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -3.47265625,
            "text": "SUMO-conjugating",
            "probability": 0.0010776519775390625
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -4.32421875,
            "text": "SUMO-conjug",
            "probability": 0.00045990943908691406
        },
        {
            "start_logit": -2.34765625,
            "end_logit": 3.34375,
            "text": ".",
            "probability": 0.00037097930908203125
        },
        {
            "start_logit": -2.3671875,
            "end_logit": 3.34375,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.0003638267517089844
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -4.98046875,
            "text": "SUMO",
            "probability": 0.00023865699768066406
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -5.61328125,
            "text": "SUMO-conjugating enzyme UBC9 and is a",
            "probability": 0.00012671947479248047
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -5.73046875,
            "text": "SUMO-conjugating enzyme UBC9 and is",
            "probability": 0.00011271238327026367
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.05078125,
            "text": "SUMO-",
            "probability": 8.183717727661133e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.41796875,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation",
            "probability": 5.6684017181396484e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.4921875,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.64453125,
            "text": "SUMO-conjugating enzyme UBC9",
            "probability": 4.5180320739746094e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.69140625,
            "text": "SUMO-conjugating enzyme UBC",
            "probability": 4.309415817260742e-05
        },
        {
            "start_logit": -5.03515625,
            "end_logit": 3.34375,
            "text": "UBC9 and is a novel target for sumoylation.",
            "probability": 2.5331974029541016e-05
        },
        {
            "start_logit": -6.125,
            "end_logit": 3.34375,
            "text": "the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 3.34375,
            "text": "sumoylation.",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 3.34375,
            "text": "80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.703125,
            "end_logit": 3.34375,
            "text": "C9 and is a novel target for sumoylation.",
            "probability": 4.76837158203125e-06
        }
    ],
    "58a5b1fe60087bc10a000024_3": [
        {
            "start_logit": 0.97998046875,
            "end_logit": -0.9306640625,
            "text": "enhance",
            "probability": 0.470947265625
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -0.9306640625,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance",
            "probability": 0.38671875
        },
        {
            "start_logit": -1.8349609375,
            "end_logit": -0.9306640625,
            "text": "we further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance",
            "probability": 0.028228759765625
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -4.11328125,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.01605224609375
        },
        {
            "start_logit": -2.5078125,
            "end_logit": -0.9306640625,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance",
            "probability": 0.0144195556640625
        },
        {
            "start_logit": 0.97998046875,
            "end_logit": -4.64453125,
            "text": "enhance Ets-1 sumoylation,",
            "probability": 0.01149749755859375
        },
        {
            "start_logit": 0.97998046875,
            "end_logit": -4.73046875,
            "text": "enhance Ets-1 sumoylation",
            "probability": 0.01055145263671875
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -4.64453125,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation,",
            "probability": 0.00943756103515625
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -4.73046875,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation",
            "probability": 0.00865936279296875
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -4.984375,
            "text": "SUMO-conjugating",
            "probability": 0.00669097900390625
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -5.0859375,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can",
            "probability": 0.006046295166015625
        },
        {
            "start_logit": 0.97998046875,
            "end_logit": -5.46875,
            "text": "enhance Ets-1 sumoylation, while a SUMO protease",
            "probability": 0.005031585693359375
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -5.46875,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation, while a SUMO protease",
            "probability": 0.004123687744140625
        },
        {
            "start_logit": 0.97998046875,
            "end_logit": -5.67578125,
            "text": "enhance Ets-1 sumoylation, while",
            "probability": 0.00408935546875
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -5.5234375,
            "text": "SUMO-conjug",
            "probability": 0.003902435302734375
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -5.6015625,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase",
            "probability": 0.0036106109619140625
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -5.67578125,
            "text": "SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation, while",
            "probability": 0.003353118896484375
        },
        {
            "start_logit": 0.78271484375,
            "end_logit": -5.859375,
            "text": "SUMO-conjugating enzyme Ubc9 and",
            "probability": 0.0027904510498046875
        },
        {
            "start_logit": -1.8349609375,
            "end_logit": -3.3984375,
            "text": "we",
            "probability": 0.0023860931396484375
        },
        {
            "start_logit": -4.7890625,
            "end_logit": -0.9306640625,
            "text": "further demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance",
            "probability": 0.0014696121215820312
        }
    ],
    "58a5b1fe60087bc10a000024_4": [
        {
            "start_logit": 2.107421875,
            "end_logit": -0.302978515625,
            "text": "SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.78271484375
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -2.298828125,
            "text": "SUMO modification is required",
            "probability": 0.10638427734375
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -2.998046875,
            "text": "SUMO modification is required for",
            "probability": 0.0528564453125
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -4.62890625,
            "text": "SUMO modification is required for stimuli-induced p100 phosphorylation",
            "probability": 0.0103302001953125
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -4.8828125,
            "text": "SUMO modification is required for stimuli",
            "probability": 0.00804901123046875
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -4.92578125,
            "text": "SUMO modification is required for stimuli-induced",
            "probability": 0.0076751708984375
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -5.1875,
            "text": "SUMO modification is required for stimuli-induced p100 phosphorylation and that",
            "probability": 0.005931854248046875
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -5.3203125,
            "text": "SUMO modification is required for stimuli-",
            "probability": 0.005191802978515625
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -5.5078125,
            "text": "SUMO modification is required for stimuli-induced p100",
            "probability": 0.004306793212890625
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -5.58203125,
            "text": "SUMO modification is",
            "probability": 0.0039825439453125
        },
        {
            "start_logit": -3.28515625,
            "end_logit": -0.302978515625,
            "text": "The results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.0035686492919921875
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -5.9765625,
            "text": "SUMO modification is required for stimuli-induced p1",
            "probability": 0.00269317626953125
        },
        {
            "start_logit": 2.107421875,
            "end_logit": -6.07421875,
            "text": "SUMO modification is required for stimuli-induced p100 phosphorylation and that blocking",
            "probability": 0.00243377685546875
        },
        {
            "start_logit": -4.76953125,
            "end_logit": -0.302978515625,
            "text": "basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.0008053779602050781
        },
        {
            "start_logit": -4.91015625,
            "end_logit": -0.302978515625,
            "text": "results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.0006999969482421875
        },
        {
            "start_logit": -1.7578125,
            "end_logit": -3.56640625,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.0006275177001953125
        },
        {
            "start_logit": -3.28515625,
            "end_logit": -2.298828125,
            "text": "The results show that basal SUMO modification is required",
            "probability": 0.0004830360412597656
        },
        {
            "start_logit": -5.484375,
            "end_logit": -0.302978515625,
            "text": "modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.0003941059112548828
        },
        {
            "start_logit": -1.7578125,
            "end_logit": -4.265625,
            "text": "SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.00031185150146484375
        },
        {
            "start_logit": -3.28515625,
            "end_logit": -2.998046875,
            "text": "The results show that basal SUMO modification is required for",
            "probability": 0.0002409219741821289
        }
    ],
    "58a5b1fe60087bc10a000024_5": [
        {
            "start_logit": 6.8046875,
            "end_logit": 5.4296875,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -2.42578125,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.0003871917724609375
        },
        {
            "start_logit": -1.1552734375,
            "end_logit": 5.4296875,
            "text": ".",
            "probability": 0.0003485679626464844
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -3.97265625,
            "text": "SUMO",
            "probability": 8.213520050048828e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -4.40234375,
            "text": "SUMO-conjugating enzyme E2",
            "probability": 5.3882598876953125e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -4.85546875,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish",
            "probability": 3.421306610107422e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.1640625,
            "text": "SUMO-conjugating",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.3359375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.48046875,
            "text": "SUMO-conjug",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.515625,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.61328125,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.66796875,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in cr",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.81640625,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.859375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.9375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in cray",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -6.06640625,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -6.078125,
            "text": "SUMO-",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -6.13671875,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -6.1796875,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -5.265625,
            "end_logit": 5.4296875,
            "text": "viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 5.7220458984375e-06
        }
    ],
    "58a5b1fe60087bc10a000024_6": [
        {
            "start_logit": 3.89453125,
            "end_logit": 5.0625,
            "text": "E2 SUMO-conjugating enzyme",
            "probability": 0.423095703125
        },
        {
            "start_logit": 3.89453125,
            "end_logit": 4.96875,
            "text": "E2 SUMO-conjugating enzyme.",
            "probability": 0.38525390625
        },
        {
            "start_logit": 1.919921875,
            "end_logit": 5.0625,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.05908203125
        },
        {
            "start_logit": 1.919921875,
            "end_logit": 4.96875,
            "text": "SUMO-conjugating enzyme.",
            "probability": 0.05377197265625
        },
        {
            "start_logit": 1.48046875,
            "end_logit": 5.0625,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 0.037994384765625
        },
        {
            "start_logit": 1.48046875,
            "end_logit": 4.96875,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.03460693359375
        },
        {
            "start_logit": -1.7001953125,
            "end_logit": 4.96875,
            "text": ".",
            "probability": 0.0014390945434570312
        },
        {
            "start_logit": -2.19140625,
            "end_logit": 5.0625,
            "text": "we revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 0.0009660720825195312
        },
        {
            "start_logit": -2.19140625,
            "end_logit": 4.96875,
            "text": "we revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0008797645568847656
        },
        {
            "start_logit": -2.37890625,
            "end_logit": 5.0625,
            "text": "revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 0.00080108642578125
        },
        {
            "start_logit": -2.37890625,
            "end_logit": 4.96875,
            "text": "revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0007290840148925781
        },
        {
            "start_logit": -3.1640625,
            "end_logit": 5.0625,
            "text": "SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 0.0003654956817626953
        },
        {
            "start_logit": -3.1640625,
            "end_logit": 4.96875,
            "text": "SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00033283233642578125
        },
        {
            "start_logit": -4.13671875,
            "end_logit": 5.0625,
            "text": ", we revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 0.00013756752014160156
        },
        {
            "start_logit": -4.34375,
            "end_logit": 5.0625,
            "text": "unique E2 SUMO-conjugating enzyme",
            "probability": 0.00011229515075683594
        },
        {
            "start_logit": -4.34375,
            "end_logit": 4.96875,
            "text": "unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00010222196578979492
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 5.0625,
            "text": "the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 6.347894668579102e-05
        },
        {
            "start_logit": -4.9140625,
            "end_logit": 4.96875,
            "text": "the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 5.7816505432128906e-05
        },
        {
            "start_logit": -5.2578125,
            "end_logit": 5.0625,
            "text": "Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 4.500150680541992e-05
        },
        {
            "start_logit": -5.296875,
            "end_logit": 5.0625,
            "text": "ited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 4.3272972106933594e-05
        }
    ],
    "5c011057133db5eb78000025_1": [
        {
            "start_logit": 9.4375,
            "end_logit": 9.171875,
            "text": "phase II",
            "probability": 1.0
        },
        {
            "start_logit": 9.4375,
            "end_logit": -0.423583984375,
            "text": "phase",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -0.97021484375,
            "end_logit": 9.171875,
            "text": "II",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.11328125,
            "text": "phase II clinical trials.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.11328125,
            "text": "phase II clinical trials",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.4375,
            "end_logit": -7.1640625,
            "text": "phase II clinical",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.015625,
            "end_logit": 9.171875,
            "text": "in phase II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.171875,
            "text": "109 and sutezolid) have been evaluated in phase II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 9.171875,
            "text": "and sutezolid) have been evaluated in phase II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 9.171875,
            "text": "sutezolid) have been evaluated in phase II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.171875,
            "text": "been evaluated in phase II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 9.171875,
            "text": "(AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.015625,
            "end_logit": -0.423583984375,
            "text": "in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.423583984375,
            "text": "109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.423583984375,
            "text": "and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -0.423583984375,
            "text": "sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -0.423583984375,
            "text": "been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -0.423583984375,
            "text": "(AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -0.97021484375,
            "end_logit": -7.11328125,
            "text": "II clinical trials.",
            "probability": 0.0
        },
        {
            "start_logit": -0.97021484375,
            "end_logit": -7.11328125,
            "text": "II clinical trials",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_1": [
        {
            "start_logit": 8.9609375,
            "end_logit": 9.0546875,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -1.08984375,
            "text": "primary microcephaly and define a novel laminopathy.",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": -1.5380859375,
            "end_logit": 9.0546875,
            "text": "y",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -1.9267578125,
            "text": "primary",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -2.234375,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -3.859375,
            "text": "primary microcephaly and",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.2265625,
            "text": "primary microcephaly and define",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 9.0546875,
            "text": "microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.54296875,
            "text": "primary microcephaly and define a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.6015625,
            "text": "primary microcephal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 9.0546875,
            "text": "ephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.7734375,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.84375,
            "text": "primary microc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 9.0546875,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.11328125,
            "text": "primary microcephaly and define a novel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5380859375,
            "end_logit": -1.08984375,
            "text": "y and define a novel laminopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.5380859375,
            "end_logit": -2.234375,
            "text": "y and define a novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -1.5380859375,
            "end_logit": -3.859375,
            "text": "y and",
            "probability": 0.0
        },
        {
            "start_logit": -4.6953125,
            "end_logit": -1.08984375,
            "text": "laminopathy.",
            "probability": 0.0
        },
        {
            "start_logit": -5.5546875,
            "end_logit": -1.08984375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_2": [
        {
            "start_logit": 6.828125,
            "end_logit": 6.28125,
            "text": "laminopathy",
            "probability": 0.91748046875
        },
        {
            "start_logit": 4.41015625,
            "end_logit": 6.28125,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.0814208984375
        },
        {
            "start_logit": 4.41015625,
            "end_logit": 0.81982421875,
            "text": "primary microcephaly",
            "probability": 0.00034737586975097656
        },
        {
            "start_logit": 1.087890625,
            "end_logit": 4.0390625,
            "text": "lamin \u0251-helical rod domain",
            "probability": 0.00031256675720214844
        },
        {
            "start_logit": 6.828125,
            "end_logit": -3.5859375,
            "text": "lamin",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": -0.2183837890625,
            "end_logit": 3.1796875,
            "text": "microcephaly",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": 6.828125,
            "end_logit": -4.73828125,
            "text": "laminopathy. The distinct nature of this lamin B",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -4.28515625,
            "end_logit": 6.28125,
            "text": "opathy",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 4.0390625,
            "text": "\u0251-helical rod domain",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": 6.828125,
            "end_logit": -5.3359375,
            "text": "laminopathy.",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 6.28125,
            "text": "of laminopathy",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 4.0390625,
            "text": ". Recurrent variants were established to be de novo in nine cases and shown to affect highly conserved residues within the lamin \u0251-helical rod domain",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 4.41015625,
            "end_logit": -3.5859375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 3.1796875,
            "text": ".METHODS: We investigated exome and genome sequencing from the Deciphering Developmental Disorders Study and the 100,000 Genomes Project to identify novel microcephaly",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 4.41015625,
            "end_logit": -5.3359375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.08984375,
            "end_logit": 4.0390625,
            "text": "helical rod domain",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 4.41015625,
            "end_logit": -5.80078125,
            "text": "primary",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.9375,
            "end_logit": 3.1796875,
            "text": "METHODS: We investigated exome and genome sequencing from the Deciphering Developmental Disorders Study and the 100,000 Genomes Project to identify novel microcephaly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 0.81982421875,
            "text": ".CONCLUSION: We identify dominant pathogenic variants in LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.087890625,
            "end_logit": -5.24609375,
            "text": "lamin",
            "probability": 5.960464477539063e-08
        }
    ],
    "601bfa531cb411341a000008_3": [
        {
            "start_logit": 8.5390625,
            "end_logit": 8.8203125,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -0.67919921875,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -2.048828125,
            "end_logit": 8.8203125,
            "text": "y",
            "probability": 2.5272369384765625e-05
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -2.67578125,
            "text": "primary",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -4.640625,
            "text": "primary microcephaly and",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 8.8203125,
            "text": "microcephaly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.44921875,
            "text": "primary microcephaly and define",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.8203125,
            "text": "ephaly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.5390625,
            "text": "primary microcephaly and define a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.765625,
            "text": "primary microcephal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.78125,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.91796875,
            "text": "primary microcephaly and define a novel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.8203125,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.048828125,
            "end_logit": -0.67919921875,
            "text": "y and define a novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -4.9765625,
            "end_logit": -0.67919921875,
            "text": "laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -2.048828125,
            "end_logit": -4.640625,
            "text": "y and",
            "probability": 0.0
        },
        {
            "start_logit": -6.37890625,
            "end_logit": -0.67919921875,
            "text": "microcephaly and define a novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -0.67919921875,
            "text": "ephaly and define a novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -0.67919921875,
            "text": "novel laminopathy",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -0.67919921875,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly and define a novel laminopathy",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_4": [
        {
            "start_logit": 6.8046875,
            "end_logit": 8.671875,
            "text": "primary microcephaly",
            "probability": 0.5107421875
        },
        {
            "start_logit": 6.8046875,
            "end_logit": 8.1796875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 0.312255859375
        },
        {
            "start_logit": 6.234375,
            "end_logit": 8.1796875,
            "text": "laminopathy",
            "probability": 0.1766357421875
        },
        {
            "start_logit": -2.2734375,
            "end_logit": 8.671875,
            "text": "y",
            "probability": 5.835294723510742e-05
        },
        {
            "start_logit": -2.2734375,
            "end_logit": 8.1796875,
            "text": "y, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": -3.150390625,
            "end_logit": 8.1796875,
            "text": "opathy",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.1796875,
            "text": "a new form of laminopathy",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 8.671875,
            "text": "microcephaly",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -4.33984375,
            "text": "primary",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -4.65234375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of lamin",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 8.1796875,
            "text": "microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 8.671875,
            "text": "ephaly",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 8.1796875,
            "text": "new form of laminopathy",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.234375,
            "end_logit": -4.65234375,
            "text": "lamin",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.23828125,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.671875,
            "text": "of primary microcephaly",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 8.1796875,
            "text": "ephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.671875,
            "text": "in LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 8.1796875,
            "text": "of laminopathy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 8.1796875,
            "text": "form of laminopathy",
            "probability": 2.980232238769531e-07
        }
    ],
    "61f7d745882a024a10000038_1": [
        {
            "start_logit": 7.69140625,
            "end_logit": 7.625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -6.8515625,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the vaccine).",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.2109375,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the vaccine)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.24609375,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the vaccine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.26953125,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.39453125,
            "text": "malaria infection (CHMI) using",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.39453125,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.39453125,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.40234375,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.40625,
            "text": "malaria infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.625,
            "text": "100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.625,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.625,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.625,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.625,
            "text": "against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.625,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.625,
            "text": "PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.625,
            "text": "attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.625,
            "text": "PZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.625,
            "text": "(PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_2": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.1875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": 7.1875,
            "text": "100% against homologous controlled human malaria",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -6.65234375,
            "text": "malaria infection (CHMI) in nonimmune adults.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 7.1875,
            "text": "of 100% against homologous controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 7.1875,
            "text": "human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.1875,
            "text": "vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.1875,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.1875,
            "text": "VEs) of 100% against homologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.1875,
            "text": "(VEs) of 100% against homologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.1875,
            "text": "shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.5703125,
            "end_logit": -6.65234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -5.3828125,
            "text": "100%",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -6.65234375,
            "text": "100% against homologous controlled human malaria infection (CHMI) in nonimmune adults.",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -6.875,
            "text": "100",
            "probability": 0.0
        },
        {
            "start_logit": -6.94140625,
            "end_logit": -5.3828125,
            "text": "of 100%",
            "probability": 0.0
        },
        {
            "start_logit": -5.15234375,
            "end_logit": -7.203125,
            "text": "100% against",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -5.3828125,
            "text": "vaccine efficacies (VEs) of 100%",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -5.3828125,
            "text": "VEs) of 100%",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -5.3828125,
            "text": "(VEs) of 100%",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -5.3828125,
            "text": "shown vaccine efficacies (VEs) of 100%",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_3": [
        {
            "start_logit": 7.66015625,
            "end_logit": 7.671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.671875,
            "text": ") malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.328125,
            "text": "malaria vaccine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.34375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.671875,
            "text": "BACKGROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.37890625,
            "text": "malaria vaccine,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.671875,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.4140625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.671875,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.671875,
            "text": "sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.671875,
            "text": "(SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.671875,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.47265625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.48046875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.48828125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.4921875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.51171875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.2421875,
            "end_logit": -7.1015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.328125,
            "text": ") malaria vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.34375,
            "text": ") malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_4": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.51171875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 7.51171875,
            "text": "In this limited review, we focus on four approaches to malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.51171875,
            "text": "this limited review, we focus on four approaches to malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.51171875,
            "text": "limited review, we focus on four approaches to malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.484375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.51171875,
            "text": ", we focus on four approaches to malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.51171875,
            "text": "review, we focus on four approaches to malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.51171875,
            "text": "approaches to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.51171875,
            "text": "four approaches to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -7.03125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.44921875,
            "end_logit": -7.484375,
            "text": "In this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.484375,
            "text": "this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -7.484375,
            "text": "limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -7.484375,
            "text": ", we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.4375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.484375,
            "text": "review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.46484375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.4765625,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -7.43359375,
            "text": ") prime boost vaccines that include recombinant DNA, viruses and bacteria, and protein with adjuvant aimed primarily at Pf",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_5": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.51171875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 7.51171875,
            "text": "In this limited review, we focus on four approaches to malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.51171875,
            "text": "this limited review, we focus on four approaches to malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 7.51171875,
            "text": "limited review, we focus on four approaches to malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.484375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.51171875,
            "text": ", we focus on four approaches to malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.51171875,
            "text": "review, we focus on four approaches to malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.51171875,
            "text": "approaches to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.51171875,
            "text": "four approaches to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.0390625,
            "end_logit": -7.03125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.44921875,
            "end_logit": -7.484375,
            "text": "In this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.484375,
            "text": "this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -7.484375,
            "text": "limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -7.484375,
            "text": ", we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.4375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.484375,
            "text": "review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.46484375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.4765625,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -7.43359375,
            "text": ") prime boost vaccines that include recombinant DNA, viruses and bacteria, and protein with adjuvant aimed primarily at Pf",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_6": [
        {
            "start_logit": 7.84375,
            "end_logit": 7.47265625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.046875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.23046875,
            "text": "malaria vaccine",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.265625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.84375,
            "end_logit": -7.27734375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.47265625,
            "text": "A live-attenuated malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.47265625,
            "text": "attenuated malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.47265625,
            "text": "live-attenuated malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -6.21875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -6.54296875,
            "text": ". No injectable malaria vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -6.6796875,
            "text": ". No injectable malaria vaccine has",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -6.75390625,
            "text": ". No injectable malaria",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -6.83984375,
            "text": ". No injectable malaria vaccine has demonstrated",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -6.98828125,
            "text": ". No",
            "probability": 0.0
        },
        {
            "start_logit": -4.44921875,
            "end_logit": -7.22265625,
            "text": ". No injectable",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -6.21875,
            "text": "14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -6.21875,
            "text": "human malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -6.21875,
            "text": "to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -6.21875,
            "text": "up to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -6.21875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_7": [
        {
            "start_logit": 7.80078125,
            "end_logit": 7.5234375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -6.12890625,
            "text": "malaria, but the features of the antibody response induced by this treatment remain unclear.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.02734375,
            "text": "malaria,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.08984375,
            "text": "malaria, but the features of the antibody response induced",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.26171875,
            "text": "malaria, but the features of the antibody response",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.32421875,
            "text": "malaria, but",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.33203125,
            "text": "malaria, but the features of the antibody response induced by this treatment remain",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.80078125,
            "end_logit": -7.33984375,
            "text": "malaria, but the features of the antibody response induced by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.5234375,
            "text": "against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.5234375,
            "text": "shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.5234375,
            "text": "Immunization with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.5234375,
            "text": "Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.5234375,
            "text": "been shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.5234375,
            "text": "attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.5234375,
            "text": "with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.5234375,
            "text": "protective against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.5234375,
            "text": "has been shown to be protective against malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.5234375,
            "text": "(PfSPZs) has been shown to be protective against malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.44140625,
            "end_logit": -6.12890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -6.12890625,
            "text": "but the features of the antibody response induced by this treatment remain unclear.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_8": [
        {
            "start_logit": 7.61328125,
            "end_logit": 7.734375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.734375,
            "text": "human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.734375,
            "text": "of the candidate human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.15625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.234375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.24609375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.2890625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.734375,
            "text": "the candidate human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.359375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.734375,
            "text": "candidate human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.3984375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.4453125,
            "text": "malaria vaccines,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.44921875,
            "text": "malaria vaccines, which",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.453125,
            "text": "malaria vaccines, which is based on human malaria sporozoites",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.4609375,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.61328125,
            "end_logit": -7.47265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -6.62890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -6.62890625,
            "text": ", has been shown to protect a significant proportion of vaccine recipients from getting malaria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -6.62890625,
            "text": "human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -6.62890625,
            "text": "on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_9": [
        {
            "start_logit": 7.60546875,
            "end_logit": 7.63671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.63671875,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -7.3828125,
            "text": "malaria infection (CHMI) using",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -7.4140625,
            "text": "malaria infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -7.41796875,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -7.44921875,
            "text": "malaria infection (CHMI) using homologous",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.63671875,
            "text": "100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.60546875,
            "end_logit": -7.4609375,
            "text": "malaria infection (CHMI)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.63671875,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.63671875,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.63671875,
            "text": "PZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.63671875,
            "text": "PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.63671875,
            "text": "Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.63671875,
            "text": "Z Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.02734375,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.02734375,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.02734375,
            "text": ": A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.02734375,
            "text": "PZ Vaccine) has shown up",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -7.02734375,
            "text": "BACKGROUND: A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.02734375,
            "text": "PfSPZ Vaccine) has shown up",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_10": [
        {
            "start_logit": 7.72265625,
            "end_logit": 7.5859375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -6.87109375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.03515625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.21484375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.5859375,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.37890625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.38671875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.41796875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.72265625,
            "end_logit": -7.4375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.5859375,
            "text": ", is highly protective against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.5859375,
            "text": "against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.5859375,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.5859375,
            "text": "highly protective against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.02734375,
            "end_logit": -6.87109375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -6.87109375,
            "text": ", but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -6.87109375,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -6.87109375,
            "text": "but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -6.87109375,
            "text": "the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -6.87109375,
            "text": ", is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -7.03515625,
            "text": ", but the durability of protection is unknown",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_11": [
        {
            "start_logit": 7.09765625,
            "end_logit": 6.4453125,
            "text": "malaria",
            "probability": 0.97412109375
        },
        {
            "start_logit": 3.38671875,
            "end_logit": 6.4453125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.0236358642578125
        },
        {
            "start_logit": 4.3125,
            "end_logit": 2.849609375,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 0.0016460418701171875
        },
        {
            "start_logit": 3.38671875,
            "end_logit": 2.849609375,
            "text": "malaria",
            "probability": 0.0006499290466308594
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -5.328125,
            "text": "malaria infection in malaria",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -5.6015625,
            "text": "malaria infection in malaria-naive ind",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -5.75390625,
            "text": "malaria infection",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -5.78515625,
            "text": "malaria infection in malaria-naive",
            "probability": 4.76837158203125e-06
        },
        {
            "start_logit": -5.4296875,
            "end_logit": 6.4453125,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -6.1171875,
            "text": "malaria infection in",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -6.1953125,
            "text": "malaria infection in malaria-",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 4.3125,
            "end_logit": -3.8515625,
            "text": "Plasmodium falciparum",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -6.38671875,
            "end_logit": 6.4453125,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 6.4453125,
            "text": "human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 6.4453125,
            "text": ", non-replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 4.3125,
            "end_logit": -5.21484375,
            "text": "Plasmodium falciparum sporozite",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.3125,
            "end_logit": -5.22265625,
            "text": "Plasmodium falciparum spor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.4453125,
            "text": "safe and protective against P falciparum controlled human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 4.3125,
            "end_logit": -5.4140625,
            "text": "Plasmodium falciparum sporoz",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.3125,
            "end_logit": -5.42578125,
            "text": "Plasmodium falciparum sporozite (",
            "probability": 4.172325134277344e-07
        }
    ],
    "61f7d745882a024a10000038_12": [
        {
            "start_logit": 7.43359375,
            "end_logit": 7.8828125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -6.921875,
            "text": "malaria by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.8828125,
            "text": "Sterile protection against human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.8828125,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.8828125,
            "text": "against human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.23828125,
            "text": "malaria by chemoatten",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.265625,
            "text": "malaria by chemoattenuated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.296875,
            "text": "malaria by chemoat",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -6.921875,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -6.921875,
            "text": "human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -6.921875,
            "text": "against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.23828125,
            "text": "Sterile protection against human malaria by chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.265625,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.296875,
            "text": "Sterile protection against human malaria by chemoat",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.23828125,
            "text": "human malaria by chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.38671875,
            "text": "Sterile protection",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.23828125,
            "text": "against human malaria by chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.265625,
            "text": "human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.41796875,
            "text": "Sterile protection against human",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.265625,
            "text": "against human malaria by chemoattenuated",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_13": [
        {
            "start_logit": 7.7421875,
            "end_logit": 7.5703125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.7421875,
            "end_logit": -7.0625,
            "text": "malaria.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.7421875,
            "end_logit": -7.375,
            "text": "malaria. A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.5703125,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.5703125,
            "text": ", cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.5703125,
            "text": ", is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.5703125,
            "text": ", purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.5703125,
            "text": "aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.5703125,
            "text": ", aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.5703125,
            "text": "cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.5703125,
            "text": "against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.5703125,
            "text": "of radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.5703125,
            "text": "purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.5703125,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -7.0625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -7.375,
            "text": ". A",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.0625,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -7.0625,
            "text": ", cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria.",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.1015625,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -7.0625,
            "text": ", is administered by direct venous inoculation (DVI) for maximal efficacy against malaria.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_14": [
        {
            "start_logit": 7.828125,
            "end_logit": 7.51953125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 7.51953125,
            "text": ". The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.2421875,
            "text": "malaria vaccines because of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.28125,
            "text": "malaria vaccines because",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.29296875,
            "text": "malaria vaccines because of its",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.828125,
            "end_logit": -7.35546875,
            "text": "malaria vaccines",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.51953125,
            "text": "(PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.51953125,
            "text": "The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.51953125,
            "text": "has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.51953125,
            "text": "been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.51953125,
            "text": "sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.51953125,
            "text": "radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.51953125,
            "text": "considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.51953125,
            "text": "nfections. The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.51953125,
            "text": "PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.51953125,
            "text": "ozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.51953125,
            "text": "PZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.51953125,
            "text": "attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.51953125,
            "text": "Z) vaccine has been considered the gold standard for malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.51953125,
            "text": "for malaria",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_15": [
        {
            "start_logit": 7.73046875,
            "end_logit": 7.58984375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.58984375,
            "text": ") malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.421875,
            "text": "malaria vaccine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.453125,
            "text": "malaria vaccine,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.48828125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.51171875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.5234375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.58984375,
            "text": ": A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.53125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73046875,
            "end_logit": -7.53515625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.58984375,
            "text": "sporozoite (SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.09375,
            "text": "human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.09375,
            "text": ", protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.2109375,
            "text": "after 5 doses",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -7.2109375,
            "text": "5 doses",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.09375,
            "text": "(same strain as in the vaccine) controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.09375,
            "text": "PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.2109375,
            "text": "human malaria infection (CHMI) 3 weeks after 5 doses",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.09375,
            "text": "PZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -7.09375,
            "text": "against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_16": [
        {
            "start_logit": 7.89453125,
            "end_logit": 7.421875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 7.421875,
            "text": "on malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.0859375,
            "text": "malaria chemoprophylaxis.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.24609375,
            "text": "malaria chemoprophylaxis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.26953125,
            "text": "malaria chemo",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.29296875,
            "text": "malaria chemoprop",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.33203125,
            "text": "malaria chemoprophy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.3359375,
            "text": "malaria chemoprophylax",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.89453125,
            "end_logit": -7.3828125,
            "text": "malaria chemoprophyla",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.421875,
            "text": "while on malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.421875,
            "text": "(IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.421875,
            "text": "those who were exposed to live PfSPZ while on malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.421875,
            "text": "who were exposed to live PfSPZ while on malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.421875,
            "text": "intravenous (IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.421875,
            "text": "in those who were exposed to live PfSPZ while on malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.421875,
            "text": ") inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.421875,
            "text": "exposed to live PfSPZ while on malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.19140625,
            "end_logit": -7.0859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.5703125,
            "end_logit": -7.0859375,
            "text": "on malaria chemoprophylaxis.",
            "probability": 0.0
        },
        {
            "start_logit": -6.5703125,
            "end_logit": -7.24609375,
            "text": "on malaria chemoprophylaxis",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_17": [
        {
            "start_logit": 8.0625,
            "end_logit": 7.23046875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.23046875,
            "text": "to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.23046875,
            "text": "CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.23046875,
            "text": "43 and MGG4); or individuals exposed to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.23046875,
            "text": "); or individuals exposed to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.23046875,
            "text": "317 and 311); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.23046875,
            "text": "); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.23046875,
            "text": "; or individuals exposed to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.49609375,
            "text": "pared in vitro and",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.58203125,
            "text": "pared in vitro and in vivo activities of six",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.59765625,
            "text": "pared in vitro",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.6015625,
            "text": "pared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.61328125,
            "text": "pared in vitro and in vivo activities of",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.6328125,
            "text": "pared in vitro and in vivo activities of six CSP-specific mAbs derived",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.640625,
            "text": "pared in vitro and in vivo",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_18": [
        {
            "start_logit": 7.6640625,
            "end_logit": 7.6796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.8046875,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.9140625,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.0078125,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.09765625,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.1171875,
            "text": "malaria by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.1328125,
            "text": "malaria by a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.19921875,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.234375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.234375,
            "text": "malaria by a simple chemoattenuated",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.25390625,
            "text": "malaria by a simple chemoattenuated PfS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.25390625,
            "text": "malaria by a simple chemoatten",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.26171875,
            "text": "malaria by a simple chemoat",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.265625,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.296875,
            "text": "malaria by a simple chemoattenuated PfSPZ",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.3046875,
            "text": "malaria by a simple chemoattenuated PfSP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.328125,
            "text": "malaria by a simple",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.6796875,
            "text": "Heterologous protection against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.6796875,
            "text": "against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -6.8046875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_19": [
        {
            "start_logit": 7.75,
            "end_logit": 7.609375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.0546875,
            "text": "malaria at",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.11328125,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.125,
            "text": "malaria at 1 year and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.2265625,
            "text": "malaria at 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.265625,
            "text": "malaria at 1 year",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.3046875,
            "text": "malaria at 1 year and immune correlates following",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.3125,
            "text": "malaria at 1 year and immune correlates following PfSPZ",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.31640625,
            "text": "malaria at 1 year and immune correlates",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.3203125,
            "text": "malaria at 1 year and immune correlates following PfS",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.3359375,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.75,
            "end_logit": -7.33984375,
            "text": "malaria at 1 year and immune correlates following PfSP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.609375,
            "text": "against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.609375,
            "text": "Protection against malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.625,
            "end_logit": -7.11328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.0546875,
            "text": "against malaria at",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.11328125,
            "text": "against malaria at 1 year and immune correlates following PfSPZ vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.125,
            "text": "against malaria at 1 year and",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -7.0546875,
            "text": "Protection against malaria at",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.11328125,
            "text": "immune correlates following PfSPZ vaccination.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_20": [
        {
            "start_logit": 7.6640625,
            "end_logit": 7.6796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.91796875,
            "text": "malaria infection.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -7.140625,
            "text": "malaria infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.6796875,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.6796875,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.6796875,
            "text": "T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.6796875,
            "text": "against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.6796875,
            "text": "cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.6796875,
            "text": "Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.6796875,
            "text": "heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.6796875,
            "text": "strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.6796875,
            "text": "protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.6796875,
            "text": "ending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.6796875,
            "text": "-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.6796875,
            "text": "transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.6796875,
            "text": "induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.6796875,
            "text": "PZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.63671875,
            "end_logit": -6.91796875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -6.91796875,
            "text": "human malaria infection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.91796875,
            "text": "controlled human malaria infection.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_21": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.453125,
            "text": "Plasmodium falciparum malaria",
            "probability": 1.0
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": 9.453125,
            "text": "malaria",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.673828125,
            "text": "Plasmodium",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": -5.5703125,
            "end_logit": 9.453125,
            "text": "falciparum malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.70703125,
            "text": "Plasmodium falciparum malaria by PfSPZ Vaccine.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.453125,
            "text": "Protection against Plasmodium falciparum malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.9296875,
            "text": "Plasmodium falciparum malaria by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.453125,
            "text": "against Plasmodium falciparum malaria",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.20703125,
            "text": "Plasmodium falciparum malaria by PfSP",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.25390625,
            "text": "Plasmodium falciparum malaria by PfSPZ",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26171875,
            "text": "Plasmodium falciparum",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.26953125,
            "text": "Plasmodium falciparum malaria by PfS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.28515625,
            "text": "Plasmodium falciparum malaria by PfSPZ Vaccine",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": -6.70703125,
            "text": "malaria by PfSPZ Vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": -6.9296875,
            "text": "malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": -7.20703125,
            "text": "malaria by PfSP",
            "probability": 0.0
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": -7.25390625,
            "text": "malaria by PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": -7.26953125,
            "text": "malaria by PfS",
            "probability": 0.0
        },
        {
            "start_logit": -0.270263671875,
            "end_logit": -7.28515625,
            "text": "malaria by PfSPZ Vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -1.673828125,
            "text": "Protection against Plasmodium",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_22": [
        {
            "start_logit": 7.53515625,
            "end_logit": 7.8125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -6.84765625,
            "text": "malaria by",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.04296875,
            "text": "malaria by chemoattenuated PfSPZ vaccine.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.8125,
            "text": "Sterile protection against human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.171875,
            "text": "malaria by chemoatten",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.1875,
            "text": "malaria by chemoattenuated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.8125,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.29296875,
            "text": "malaria by chemoat",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.3359375,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.33984375,
            "text": "malaria by chemoattenuated PfS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.3515625,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 7.8125,
            "text": "protection against human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.3671875,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.8125,
            "text": "against human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": -7.04296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -6.84765625,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -6.84765625,
            "text": "human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -7.04296875,
            "text": "Sterile protection against human malaria by chemoattenuated PfSPZ vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -6.84765625,
            "text": "protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -6.84765625,
            "text": "against human malaria by",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_23": [
        {
            "start_logit": 7.76953125,
            "end_logit": 7.5703125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.18359375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.26953125,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.2734375,
            "text": "malaria in infants in western Kenya: a double-blind",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.28125,
            "text": "malaria in infants in western Kenya: a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.2890625,
            "text": "malaria in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.3046875,
            "text": "malaria in infants in western Kenya:",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.3203125,
            "text": "malaria in infants in western Kenya: a double",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.3203125,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.3359375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.3359375,
            "text": "malaria in infants in western Kenya",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.33984375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.34375,
            "text": "malaria in infants in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.37109375,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.76953125,
            "end_logit": -7.37890625,
            "text": "malaria in infants in western",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.5703125,
            "text": "against malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.5703125,
            "text": "Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.5703125,
            "text": "PfSPZ Vaccine against malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.5703125,
            "text": "Vaccine against malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.5703125,
            "text": "of PfSPZ Vaccine against malaria",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_24": [
        {
            "start_logit": 7.67578125,
            "end_logit": 7.68359375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.68359375,
            "text": "human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.45703125,
            "text": "malaria infection (CHMI) by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.5234375,
            "text": "malaria infection (CHMI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.52734375,
            "text": "malaria infection (CH",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.5390625,
            "text": "malaria infection (CHMI) by direct",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.5390625,
            "text": "malaria infection (CHMI) by direct venous inoculation (DV",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.546875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.546875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.55078125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.67578125,
            "end_logit": -7.55859375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.48828125,
            "text": ", infectious Plasmodium falciparum (Pf) sporozoites (SPZ) (PfSPZ Challenge) to",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.45703125,
            "text": "human malaria infection (CHMI) by",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.546875,
            "text": ", infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.546875,
            "text": ", infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.55078125,
            "text": ", infectious Plasmodium falciparum (Pf",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.55859375,
            "text": ", infectious Plasmodium falciparum (Pf) sporozoites (SPZ) (PfSPZ Challenge) to try to",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.5234375,
            "text": "human malaria infection (CHMI",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.52734375,
            "text": "human malaria infection (CH",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -7.5390625,
            "text": "human malaria infection (CHMI) by direct",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_25": [
        {
            "start_logit": 7.74609375,
            "end_logit": 7.578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -6.703125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.09765625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.203125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.578125,
            "text": "human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.3671875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.74609375,
            "end_logit": -7.40625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.578125,
            "text": ", is highly protective against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.578125,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.578125,
            "text": "against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.578125,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.109375,
            "end_logit": -6.703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -6.703125,
            "text": "human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -6.703125,
            "text": ", but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -6.703125,
            "text": "but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.30078125,
            "end_logit": -6.703125,
            "text": "the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -6.703125,
            "text": ", is highly protective against controlled human malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -6.703125,
            "text": "after immunization, but the durability of protection is unknown.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_26": [
        {
            "start_logit": 7.73828125,
            "end_logit": 7.58203125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -6.69921875,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.078125,
            "text": "malaria through long-lived tissue-resident T cells and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.12890625,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.15234375,
            "text": "malaria through",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.34375,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.37109375,
            "text": "malaria through long-lived tissue-resident T cells and that",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.38671875,
            "text": "malaria through long-lived tissue-resident T cells and that administration of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.39453125,
            "text": "malaria through long-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.3984375,
            "text": "malaria through long",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.40234375,
            "text": "malaria through long-lived",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.4140625,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.42578125,
            "text": "malaria through long-lived tissue-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.4296875,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.73828125,
            "end_logit": -7.4375,
            "text": "malaria through long-lived tissue",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.58203125,
            "text": "Our findings suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.58203125,
            "text": "findings suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.58203125,
            "text": "that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.58203125,
            "text": "durable protection to malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.58203125,
            "text": "PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_27": [
        {
            "start_logit": 7.8203125,
            "end_logit": 7.51953125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -6.98828125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.18359375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.28125,
            "text": "malaria vaccine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.296875,
            "text": "malaria vaccine, Plasmodium falciparum spor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.30078125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.30078125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.31640625,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.32421875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CH",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.328125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 7.51953125,
            "text": "A live-attenuated malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.51953125,
            "text": "attenuated malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.51953125,
            "text": "live-attenuated malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.6796875,
            "end_logit": -6.35546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -6.35546875,
            "text": "to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -6.35546875,
            "text": "human malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -6.35546875,
            "text": "14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -6.35546875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -6.35546875,
            "text": "the vaccine strain up to 14 mo after final vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -6.35546875,
            "text": "controlled human malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_28": [
        {
            "start_logit": 8.0234375,
            "end_logit": 7.265625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -4.96875,
            "end_logit": 7.265625,
            "text": ". PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.78515625,
            "text": "malaria season.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.0859375,
            "text": "malaria season.FUNDING: US National",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.15234375,
            "text": "malaria season",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.24609375,
            "text": "malaria season.FUNDING:",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.28515625,
            "text": "malaria season.FUNDING: US National In",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.29296875,
            "text": "malaria season.FUNDING: US",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.3046875,
            "text": "malaria season.FUNDING",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.265625,
            "text": "P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.265625,
            "text": "ON: PfSPZ Vaccine was well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.265625,
            "text": "against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.265625,
            "text": "in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.265625,
            "text": "African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.265625,
            "text": "significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.265625,
            "text": "protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.265625,
            "text": "adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.265625,
            "text": "PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.265625,
            "text": "well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.265625,
            "text": "falciparum infection throughout an entire malaria",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_29": [
        {
            "start_logit": 7.69140625,
            "end_logit": 7.640625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 7.640625,
            "text": ") malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.20703125,
            "text": "malaria vaccine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.2890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.33984375,
            "text": "malaria vaccine,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.37890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.4140625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.421875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.640625,
            "text": "BACKGROUND: A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.640625,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.640625,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.640625,
            "text": "sporozoite (SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.640625,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.640625,
            "text": "(SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.640625,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -7.02734375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -7.20703125,
            "text": ") malaria vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -7.2890625,
            "text": ") malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -7.33984375,
            "text": ") malaria vaccine,",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_30": [
        {
            "start_logit": 6.5703125,
            "end_logit": 6.21484375,
            "text": "malaria",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.170654296875,
            "end_logit": 6.21484375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.0011835098266601562
        },
        {
            "start_logit": 3.603515625,
            "end_logit": 0.005096435546875,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 0.00010383129119873047
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.38671875,
            "text": "malaria infection in malaria",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.0234375,
            "text": "malaria infection in malaria-naive",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.0703125,
            "text": "malaria infection",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.37109375,
            "text": "malaria infection in",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 6.21484375,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -3.501953125,
            "text": "Plasmodium falciparum",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.50390625,
            "text": "malaria infection in malaria-",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -0.170654296875,
            "end_logit": 0.005096435546875,
            "text": "malaria",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 6.21484375,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 6.21484375,
            "text": "human malaria",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.21484375,
            "text": ", non-replicating, whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -5.42578125,
            "text": "Plasmodium falciparum spor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -5.68359375,
            "text": "Plasmodium falciparum sporozite",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -5.7265625,
            "text": "Plasmodium falciparum sporoz",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -5.74609375,
            "text": "Plasmodium falciparum sporozite (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -6.390625,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria sporozoite vaccine that has been reported to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.603515625,
            "end_logit": -6.48046875,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria spor",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_31": [
        {
            "start_logit": 7.6953125,
            "end_logit": 7.64453125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.15234375,
            "text": "malaria infection ten weeks after the last dose (group III).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 7.64453125,
            "text": "human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.64453125,
            "text": "controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.375,
            "text": "malaria infection ten weeks after the last dose (group III",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.64453125,
            "text": "9 (100%) volunteers who underwent controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.37890625,
            "text": "malaria infection ten weeks after the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.39453125,
            "text": "malaria infection ten weeks after",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.64453125,
            "text": "(100%) volunteers who underwent controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.64453125,
            "text": "in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.4296875,
            "text": "malaria infection ten",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.64453125,
            "text": "volunteers who underwent controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.64453125,
            "text": ") volunteers who underwent controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6953125,
            "end_logit": -7.484375,
            "text": "malaria infection ten weeks after the last",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.64453125,
            "text": "9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.64453125,
            "text": "underwent controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.64453125,
            "text": "safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.64453125,
            "text": "out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.0625,
            "end_logit": -7.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.13671875,
            "end_logit": -7.15234375,
            "text": "human malaria infection ten weeks after the last dose (group III).",
            "probability": 0.0
        }
    ],
    "622d1ed13a8413c6530000a3_1": [
        {
            "start_logit": 8.9921875,
            "end_logit": -1.5546875,
            "text": "The",
            "probability": 0.406005859375
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -2.318359375,
            "text": "The daughterless (da) gene in Drosophila",
            "probability": 0.1888427734375
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -2.431640625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator",
            "probability": 0.169189453125
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -4.19921875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose",
            "probability": 0.028839111328125
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -4.21484375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly",
            "probability": 0.0283966064453125
        },
        {
            "start_logit": -0.513671875,
            "end_logit": 5.203125,
            "text": "daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have been extensively examined.",
            "probability": 0.02593994140625
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -4.43359375,
            "text": "The daughterless (da) gene in Drosophila encodes",
            "probability": 0.0228118896484375
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -4.84375,
            "text": "The daughterless (da) gene in Drosophila encodes a",
            "probability": 0.01514434814453125
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.00390625,
            "text": "The daughterless (da) gene in",
            "probability": 0.01290130615234375
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.0078125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed",
            "probability": 0.012847900390625
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.02734375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination",
            "probability": 0.012603759765625
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.12109375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional",
            "probability": 0.011474609375
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.1953125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and",
            "probability": 0.010650634765625
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.25,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of",
            "probability": 0.0100860595703125
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.359375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have",
            "probability": 0.00904083251953125
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.5,
            "text": "The daughterless (da)",
            "probability": 0.0078582763671875
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.5390625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the",
            "probability": 0.0075531005859375
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.5625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control",
            "probability": 0.00737762451171875
        },
        {
            "start_logit": 8.9921875,
            "end_logit": -5.625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex",
            "probability": 0.006931304931640625
        },
        {
            "start_logit": -2.0703125,
            "end_logit": 5.203125,
            "text": ".",
            "probability": 0.005481719970703125
        }
    ],
    "56bc9268ac7ad1001900001b_1": [
        {
            "start_logit": 9.0078125,
            "end_logit": 7.3125,
            "text": "interleukin-17 receptor",
            "probability": 0.91015625
        },
        {
            "start_logit": 9.0078125,
            "end_logit": 4.99609375,
            "text": "interleukin-17",
            "probability": 0.090087890625
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.9326171875,
            "text": "interleukin",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -4.890625,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -3.763671875,
            "end_logit": 7.3125,
            "text": "receptor",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.50390625,
            "text": "interleukin-17 receptor A",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 7.3125,
            "text": "17 receptor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.85546875,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.04296875,
            "text": "interleukin-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.15234375,
            "text": "interleukin-17 receptor A monoclonal",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.25390625,
            "text": "interleukin-17 receptor A monoclonal antibody bro",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.28515625,
            "text": "interleukin-17 receptor A monoclonal antibody broda",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.32421875,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.34375,
            "text": "interleukin-17 receptor A monoclonal antibody brodaluma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -7.36328125,
            "text": "interleukin-17 receptor A monoclonal antibody",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 7.3125,
            "text": "-17 receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 4.99609375,
            "text": "17",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.3125,
            "text": "-interleukin-17 receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.3125,
            "text": ": Early clinical studies suggested that the anti-interleukin-17 receptor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.3125,
            "text": "BACKGROUND: Early clinical studies suggested that the anti-interleukin-17 receptor",
            "probability": 5.960464477539063e-08
        }
    ],
    "56bc9268ac7ad1001900001b_2": [
        {
            "start_logit": 9.1484375,
            "end_logit": 9.0,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.564453125,
            "text": "interleukin",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": -1.650390625,
            "end_logit": 9.0,
            "text": "17",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -3.07421875,
            "text": "interleukin-17-receptor antibody for psoriasis",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.37890625,
            "text": "interleukin-17-receptor antibody for psoriasis.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -6.53515625,
            "text": "interleukin-17-receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 9.0,
            "text": "-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.0234375,
            "text": "interleukin-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.09375,
            "text": "interleukin-17-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -7.21875,
            "text": "interleukin-17-receptor antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.0,
            "text": "-interleukin-17",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.0,
            "text": "anti-interleukin-17",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 9.0,
            "text": ", an anti-interleukin-17",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.0,
            "text": "an anti-interleukin-17",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.650390625,
            "end_logit": -3.07421875,
            "text": "17-receptor antibody for psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.24609375,
            "end_logit": -3.07421875,
            "text": "psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -1.650390625,
            "end_logit": -6.37890625,
            "text": "17-receptor antibody for psoriasis.",
            "probability": 0.0
        },
        {
            "start_logit": -1.650390625,
            "end_logit": -6.53515625,
            "text": "17-receptor",
            "probability": 0.0
        },
        {
            "start_logit": -1.650390625,
            "end_logit": -7.09375,
            "text": "17-",
            "probability": 0.0
        },
        {
            "start_logit": -1.650390625,
            "end_logit": -7.21875,
            "text": "17-receptor antibody",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_1": [
        {
            "start_logit": 1.1123046875,
            "end_logit": 9.1171875,
            "text": "hypertension",
            "probability": 0.80517578125
        },
        {
            "start_logit": -0.3125,
            "end_logit": 9.1171875,
            "text": "essential hypertension",
            "probability": 0.1942138671875
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.1171875,
            "text": "with essential hypertension",
            "probability": 0.0002713203430175781
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 9.1171875,
            "text": "patients with essential hypertension",
            "probability": 0.00023448467254638672
        },
        {
            "start_logit": 1.1123046875,
            "end_logit": -6.99609375,
            "text": "hypertension (WHO classification I or II).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.1123046875,
            "end_logit": -7.265625,
            "text": "hypertension (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.3125,
            "end_logit": -6.99609375,
            "text": "essential hypertension (WHO classification I or II).",
            "probability": 0.0
        },
        {
            "start_logit": -0.3125,
            "end_logit": -7.265625,
            "text": "essential hypertension (",
            "probability": 0.0
        },
        {
            "start_logit": -3.330078125,
            "end_logit": -6.99609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.18359375,
            "text": "antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.26953125,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.37109375,
            "text": "antihypertensive treatment with",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.40234375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.421875,
            "text": "antihypertensive treatment with isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -6.99609375,
            "text": "with essential hypertension (WHO classification I or II).",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -6.99609375,
            "text": "patients with essential hypertension (WHO classification I or II).",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.265625,
            "text": "with essential hypertension (",
            "probability": 0.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -7.18359375,
            "text": "preliminary data of an open multicenter trial of antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -7.18359375,
            "text": "data of an open multicenter trial of antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -7.26953125,
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_2": [
        {
            "start_logit": 1.0048828125,
            "end_logit": 9.5234375,
            "text": "hypertension",
            "probability": 0.9912109375
        },
        {
            "start_logit": -4.05859375,
            "end_logit": 9.5234375,
            "text": "essential hypertension",
            "probability": 0.006252288818359375
        },
        {
            "start_logit": -6.59375,
            "end_logit": 9.5234375,
            "text": "antihypertensive drug in blacks with essential hypertension",
            "probability": 0.0004954338073730469
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.5234375,
            "text": "Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 0.0002734661102294922
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.5234375,
            "text": "with essential hypertension",
            "probability": 0.00023221969604492188
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.5234375,
            "text": "blacks with essential hypertension",
            "probability": 0.00021982192993164062
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.5234375,
            "text": "effective antihypertensive drug in blacks with essential hypertension",
            "probability": 0.00019848346710205078
        },
        {
            "start_logit": -7.515625,
            "end_logit": 9.5234375,
            "text": "drug in blacks with essential hypertension",
            "probability": 0.00019693374633789062
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 9.5234375,
            "text": "dipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 0.00019252300262451172
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.5234375,
            "text": "in blacks with essential hypertension",
            "probability": 0.00019252300262451172
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 9.5234375,
            "text": "pine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 0.00019252300262451172
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.046875,
            "text": "hypertension, resulting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.0703125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.17578125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.1875,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.19921875,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.25390625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.27734375,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.28515625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.0048828125,
            "end_logit": -7.29296875,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c3184050c68dd416000003_3": [
        {
            "start_logit": 1.1123046875,
            "end_logit": 9.1171875,
            "text": "hypertension",
            "probability": 0.80517578125
        },
        {
            "start_logit": -0.3125,
            "end_logit": 9.1171875,
            "text": "essential hypertension",
            "probability": 0.1942138671875
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.1171875,
            "text": "with essential hypertension",
            "probability": 0.0002713203430175781
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 9.1171875,
            "text": "patients with essential hypertension",
            "probability": 0.00023448467254638672
        },
        {
            "start_logit": 1.1123046875,
            "end_logit": -6.99609375,
            "text": "hypertension (WHO classification I or II).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 1.1123046875,
            "end_logit": -7.265625,
            "text": "hypertension (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.3125,
            "end_logit": -6.99609375,
            "text": "essential hypertension (WHO classification I or II).",
            "probability": 0.0
        },
        {
            "start_logit": -0.3125,
            "end_logit": -7.265625,
            "text": "essential hypertension (",
            "probability": 0.0
        },
        {
            "start_logit": -3.330078125,
            "end_logit": -6.99609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.18359375,
            "text": "antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.26953125,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.37109375,
            "text": "antihypertensive treatment with",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.40234375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/",
            "probability": 0.0
        },
        {
            "start_logit": -6.41015625,
            "end_logit": -7.421875,
            "text": "antihypertensive treatment with isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -6.99609375,
            "text": "with essential hypertension (WHO classification I or II).",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -6.99609375,
            "text": "patients with essential hypertension (WHO classification I or II).",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -7.265625,
            "text": "with essential hypertension (",
            "probability": 0.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -7.18359375,
            "text": "preliminary data of an open multicenter trial of antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -7.03515625,
            "end_logit": -7.18359375,
            "text": "data of an open multicenter trial of antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.97265625,
            "end_logit": -7.26953125,
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_4": [
        {
            "start_logit": 6.8515625,
            "end_logit": 8.1875,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 8.1875,
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.1875,
            "text": "mild-to-moderate hypertension",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.1328125,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.87890625,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.921875,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.06640625,
            "text": "hypertension (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.12109375,
            "text": "hypertension (mean age 59",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.125,
            "text": "hypertension (mean age 59 years) using",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.15234375,
            "text": "hypertension (mean age 59 years)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.15234375,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.16796875,
            "text": "hypertension (mean age 59 years) using casual and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.19921875,
            "text": "hypertension (mean",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.94921875,
            "end_logit": -6.1328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -6.1328125,
            "text": "blood pressure measurement.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -6.1328125,
            "text": "mild-to-moderate hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement.",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -6.96875,
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.03125,
            "text": "antihypertensive effect",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.06640625,
            "text": "antihypertensive effect of isradipine was",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -7.06640625,
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension (",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_5": [
        {
            "start_logit": 1.2822265625,
            "end_logit": 7.85546875,
            "text": "coronary flow reserve in patients with arterial hypertension",
            "probability": 0.9580078125
        },
        {
            "start_logit": -1.9931640625,
            "end_logit": 7.85546875,
            "text": "hypertension",
            "probability": 0.0361328125
        },
        {
            "start_logit": -4.50390625,
            "end_logit": 7.85546875,
            "text": "arterial hypertension",
            "probability": 0.0029315948486328125
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 7.85546875,
            "text": "[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0017995834350585938
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.85546875,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0002970695495605469
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 7.85546875,
            "text": "with arterial hypertension",
            "probability": 0.0002663135528564453
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.85546875,
            "text": "Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.00020110607147216797
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.85546875,
            "text": "in patients with arterial hypertension",
            "probability": 0.0001615285873413086
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -3.50390625,
            "text": "coronary flow reserve in patients with arterial hypertension and microvascular angina].",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -4.2734375,
            "text": "coronary flow reserve in patients with arterial hypertension and microvascular angina]",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -5.55859375,
            "text": "coronary flow reserve",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -5.8984375,
            "text": "coronary flow reserve in patients with arterial hypertension and microvascular angina",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -6.00390625,
            "text": "coronary flow reserve in",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -6.21484375,
            "text": "coronary",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -6.2734375,
            "text": "coronary flow reserve in patients with arterial hypertension and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -6.3359375,
            "text": "coronary flow reserve in patients",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -6.49609375,
            "text": "coronary flow",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.9931640625,
            "end_logit": -3.50390625,
            "text": "hypertension and microvascular angina].",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 1.2822265625,
            "end_logit": -6.8515625,
            "text": "coronary flow reserve in patients with arterial hypertension and microvascular",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.9931640625,
            "end_logit": -4.2734375,
            "text": "hypertension and microvascular angina]",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56c3184050c68dd416000003_6": [
        {
            "start_logit": 7.30859375,
            "end_logit": 8.6875,
            "text": "arterial hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -2.09765625,
            "end_logit": 8.6875,
            "text": "hypertension",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -3.630859375,
            "text": "arterial",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -5.125,
            "end_logit": 8.6875,
            "text": "[Isradipine in arterial hypertension",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -4.88671875,
            "text": "arterial hypertension in motor vehicle drivers]",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.6875,
            "text": "Isradipine in arterial hypertension",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -6.48046875,
            "text": "arterial hypertension in motor vehicle drivers",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -6.52734375,
            "text": "arterial hypertension in motor vehicle",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -6.5546875,
            "text": "arterial hypertension in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -6.57421875,
            "text": "arterial hypertension in motor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -6.6875,
            "text": "arterial hypertension in motor vehicle drivers].",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.09765625,
            "end_logit": -4.88671875,
            "text": "hypertension in motor vehicle drivers]",
            "probability": 0.0
        },
        {
            "start_logit": -2.09765625,
            "end_logit": -6.48046875,
            "text": "hypertension in motor vehicle drivers",
            "probability": 0.0
        },
        {
            "start_logit": -2.09765625,
            "end_logit": -6.52734375,
            "text": "hypertension in motor vehicle",
            "probability": 0.0
        },
        {
            "start_logit": -2.09765625,
            "end_logit": -6.5546875,
            "text": "hypertension in",
            "probability": 0.0
        },
        {
            "start_logit": -2.09765625,
            "end_logit": -6.57421875,
            "text": "hypertension in motor",
            "probability": 0.0
        },
        {
            "start_logit": -5.125,
            "end_logit": -3.630859375,
            "text": "[Isradipine in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -2.09765625,
            "end_logit": -6.6875,
            "text": "hypertension in motor vehicle drivers].",
            "probability": 0.0
        },
        {
            "start_logit": -5.125,
            "end_logit": -4.88671875,
            "text": "[Isradipine in arterial hypertension in motor vehicle drivers]",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -3.630859375,
            "text": "Isradipine in arterial",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_7": [
        {
            "start_logit": -0.35986328125,
            "end_logit": 9.3359375,
            "text": "hypertension",
            "probability": 0.74853515625
        },
        {
            "start_logit": -1.462890625,
            "end_logit": 9.3359375,
            "text": "essential hypertension",
            "probability": 0.248779296875
        },
        {
            "start_logit": -7.21875,
            "end_logit": 9.3359375,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension",
            "probability": 0.00078582763671875
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.3359375,
            "text": "patients with essential hypertension",
            "probability": 0.0006237030029296875
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 9.3359375,
            "text": "elderly patients with essential hypertension",
            "probability": 0.0005793571472167969
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.3359375,
            "text": "isradipine in elderly patients with essential hypertension",
            "probability": 0.0005769729614257812
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 9.3359375,
            "text": "safety and efficacy of isradipine in elderly patients with essential hypertension",
            "probability": 0.000537872314453125
        },
        {
            "start_logit": -0.35986328125,
            "end_logit": -6.64453125,
            "text": "hypertension.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -6.64453125,
            "text": "essential hypertension.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.26953125,
            "end_logit": -6.64453125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -6.64453125,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -6.64453125,
            "text": "patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -6.953125,
            "text": "Evaluation of the safety and efficacy of isradipine in",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -6.64453125,
            "text": "elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -6.64453125,
            "text": "isradipine in elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.64453125,
            "text": "safety and efficacy of isradipine in elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.09765625,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.19140625,
            "text": "Evaluation of the safety and",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.1953125,
            "text": "Evaluation of",
            "probability": 0.0
        },
        {
            "start_logit": -7.21875,
            "end_logit": -7.1953125,
            "text": "Evaluation of the safety and efficacy",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_8": [
        {
            "start_logit": 6.765625,
            "end_logit": 8.34375,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.34375,
            "text": "treatment of hypertension",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.34375,
            "text": "of hypertension",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.34375,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.765625,
            "end_logit": -6.609375,
            "text": "hypertension.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.48046875,
            "end_logit": -6.609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.609375,
            "text": "treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -6.609375,
            "text": "of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.609375,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.8203125,
            "text": "A",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.96875,
            "text": "A multicenter evaluation",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.98828125,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -7.16015625,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -7.203125,
            "text": "treatment",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.0859375,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.09375,
            "text": "A multicenter",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.12109375,
            "text": "A multicenter evaluation of",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.16015625,
            "text": "of",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.1484375,
            "text": "A multicenter evaluation of the safety and",
            "probability": 0.0
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -7.15625,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_9": [
        {
            "start_logit": 7.1953125,
            "end_logit": 8.046875,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.046875,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.046875,
            "text": "in the use of isradipine as a therapy for hypertension",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.046875,
            "text": "isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.046875,
            "text": "is advisable to be very careful in the use of isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.046875,
            "text": "for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.046875,
            "text": "use of isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.046875,
            "text": "careful in the use of isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.046875,
            "text": "very careful in the use of isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.046875,
            "text": "of isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.046875,
            "text": "the use of isradipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.046875,
            "text": "pine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.046875,
            "text": "dipine as a therapy for hypertension",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -6.72265625,
            "text": "hypertension and other indications.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.0625,
            "text": "hypertension and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -7.37890625,
            "text": "hypertension and other indications",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.140625,
            "end_logit": -6.72265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -6.72265625,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension and other indications.",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -6.72265625,
            "text": "in the use of isradipine as a therapy for hypertension and other indications.",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -6.72265625,
            "text": "other indications.",
            "probability": 0.0
        }
    ],
    "56ffd08bcf1c325851000009_1": [
        {
            "start_logit": 8.390625,
            "end_logit": 7.9453125,
            "text": "the 7SL RNA gene",
            "probability": 0.984375
        },
        {
            "start_logit": 8.390625,
            "end_logit": 3.787109375,
            "text": "the 7SL RNA gene.",
            "probability": 0.0153045654296875
        },
        {
            "start_logit": -2.228515625,
            "end_logit": 7.9453125,
            "text": "7SL RNA gene",
            "probability": 2.396106719970703e-05
        },
        {
            "start_logit": 8.390625,
            "end_logit": -2.8046875,
            "text": "the",
            "probability": 2.09808349609375e-05
        },
        {
            "start_logit": -2.935546875,
            "end_logit": 7.9453125,
            "text": "from the 7SL RNA gene",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": -3.001953125,
            "end_logit": 7.9453125,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -3.2734375,
            "end_logit": 7.9453125,
            "text": "gene",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -6.0078125,
            "end_logit": 7.9453125,
            "text": "300 bp, and originate from the 7SL RNA gene",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 7.9453125,
            "text": "SL RNA gene",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 7.9453125,
            "text": "L RNA gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.228515625,
            "end_logit": 3.787109375,
            "text": "7SL RNA gene.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.41015625,
            "end_logit": 7.9453125,
            "text": "about 300 bp, and originate from the 7SL RNA gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 7.9453125,
            "text": "RNA gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.9453125,
            "text": "size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 7.9453125,
            "text": "elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.9453125,
            "text": ", but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 7.9453125,
            "text": ", fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.935546875,
            "end_logit": 3.787109375,
            "text": "from the 7SL RNA gene.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.994140625,
            "end_logit": 3.787109375,
            "text": ".",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 7.9453125,
            "text": "of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58cf5c5a8acda34529000003_1": [
        {
            "start_logit": -0.44140625,
            "end_logit": 2.98828125,
            "text": "in telomeric repeats",
            "probability": 0.6064453125
        },
        {
            "start_logit": -1.7265625,
            "end_logit": 2.98828125,
            "text": "telomeric repeats",
            "probability": 0.167724609375
        },
        {
            "start_logit": -2.8984375,
            "end_logit": 2.98828125,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.05194091796875
        },
        {
            "start_logit": -2.2578125,
            "end_logit": 1.90625,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.033416748046875
        },
        {
            "start_logit": -0.44140625,
            "end_logit": 0.06658935546875,
            "text": "in telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.032623291015625
        },
        {
            "start_logit": -3.484375,
            "end_logit": 2.98828125,
            "text": "T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.0289154052734375
        },
        {
            "start_logit": -2.8984375,
            "end_logit": 1.90625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.017608642578125
        },
        {
            "start_logit": -1.7265625,
            "end_logit": 0.06658935546875,
            "text": "telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.00902557373046875
        },
        {
            "start_logit": -4.69140625,
            "end_logit": 2.98828125,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.0086517333984375
        },
        {
            "start_logit": -4.94921875,
            "end_logit": 2.98828125,
            "text": "repeats",
            "probability": 0.006683349609375
        },
        {
            "start_logit": -5.015625,
            "end_logit": 2.98828125,
            "text": "-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.006252288818359375
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 2.98828125,
            "text": "uracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.004665374755859375
        },
        {
            "start_logit": -5.31640625,
            "end_logit": 2.98828125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.004627227783203125
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 2.98828125,
            "text": "glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.004611968994140625
        },
        {
            "start_logit": -5.63671875,
            "end_logit": 2.98828125,
            "text": "D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.003360748291015625
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 2.98828125,
            "text": "-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.003231048583984375
        },
        {
            "start_logit": -5.71484375,
            "end_logit": 2.98828125,
            "text": "osyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.003108978271484375
        },
        {
            "start_logit": -4.69140625,
            "end_logit": 1.90625,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0029296875
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 2.98828125,
            "text": "hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.0021533966064453125
        },
        {
            "start_logit": -5.015625,
            "end_logit": 1.90625,
            "text": "-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0021190643310546875
        }
    ],
    "58cf5c5a8acda34529000003_2": [
        {
            "start_logit": -1.31640625,
            "end_logit": 3.19140625,
            "text": "in telomeric repeats",
            "probability": 0.462890625
        },
        {
            "start_logit": -1.8740234375,
            "end_logit": 3.19140625,
            "text": "telomeric repeats",
            "probability": 0.26513671875
        },
        {
            "start_logit": -2.83203125,
            "end_logit": 3.19140625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.10174560546875
        },
        {
            "start_logit": -3.80078125,
            "end_logit": 3.19140625,
            "text": "T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.038604736328125
        },
        {
            "start_logit": -2.83203125,
            "end_logit": 1.8896484375,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0276947021484375
        },
        {
            "start_logit": -4.890625,
            "end_logit": 3.19140625,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.01297760009765625
        },
        {
            "start_logit": -4.9375,
            "end_logit": 3.19140625,
            "text": "-D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.01238250732421875
        },
        {
            "start_logit": -5.203125,
            "end_logit": 3.19140625,
            "text": "uracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.009490966796875
        },
        {
            "start_logit": -5.234375,
            "end_logit": 3.19140625,
            "text": "repeats",
            "probability": 0.0092010498046875
        },
        {
            "start_logit": -5.3125,
            "end_logit": 3.19140625,
            "text": "glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.008514404296875
        },
        {
            "start_logit": -4.0625,
            "end_logit": 1.8896484375,
            "text": "Base J (\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.008087158203125
        },
        {
            "start_logit": -5.51171875,
            "end_logit": 3.19140625,
            "text": "D-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.006977081298828125
        },
        {
            "start_logit": -5.5625,
            "end_logit": 3.19140625,
            "text": "osyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.00662994384765625
        },
        {
            "start_logit": -5.62890625,
            "end_logit": 3.19140625,
            "text": "-glucosyl-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.00620269775390625
        },
        {
            "start_logit": -5.734375,
            "end_logit": 3.19140625,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.005584716796875
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 3.19140625,
            "text": "hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.004718780517578125
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 3.19140625,
            "text": "-hydroxymethyluracil) replaces 1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.0035610198974609375
        },
        {
            "start_logit": -4.890625,
            "end_logit": 1.8896484375,
            "text": "(\u03b2-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0035343170166015625
        },
        {
            "start_logit": -4.9375,
            "end_logit": 1.8896484375,
            "text": "-D-glucosyl-hydroxymethyluracil",
            "probability": 0.0033721923828125
        },
        {
            "start_logit": -5.203125,
            "end_logit": 1.8896484375,
            "text": "uracil",
            "probability": 0.0025844573974609375
        }
    ],
    "61f86c03882a024a10000044_1": [
        {
            "start_logit": 5.16796875,
            "end_logit": 8.875,
            "text": "recessive hereditary motor neuropathy",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.5205078125,
            "end_logit": 8.875,
            "text": "hereditary motor neuropathy",
            "probability": 0.0012388229370117188
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": 8.875,
            "text": "neuropathy",
            "probability": 0.0008287429809570312
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 8.875,
            "text": "motor neuropathy",
            "probability": 1.5854835510253906e-05
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 8.875,
            "text": "An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -6.4375,
            "end_logit": 8.875,
            "text": "ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 5.16796875,
            "end_logit": -3.029296875,
            "text": "recessive hereditary motor neuropathy.",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 8.875,
            "text": "in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 8.875,
            "text": "VWA1 causes recessive hereditary motor neuropathy",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 8.875,
            "text": "10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -7.25,
            "end_logit": 8.875,
            "text": "causes recessive hereditary motor neuropathy",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.875,
            "text": "A1 causes recessive hereditary motor neuropathy",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.875,
            "text": "bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.875,
            "text": "repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.875,
            "text": "expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 5.16796875,
            "end_logit": -5.796875,
            "text": "recessive",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.16796875,
            "end_logit": -7.01953125,
            "text": "recessive hereditary motor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5205078125,
            "end_logit": -3.029296875,
            "text": "hereditary motor neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.9208984375,
            "end_logit": -3.029296875,
            "text": "neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.5205078125,
            "end_logit": -7.01953125,
            "text": "hereditary motor",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_1": [
        {
            "start_logit": 8.765625,
            "end_logit": 8.9296875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.8017578125,
            "end_logit": 8.9296875,
            "text": "fibrosis",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -2.376953125,
            "text": "cystic",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.921875,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.92578125,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.9765625,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.109375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.9296875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.23046875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.9296875,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.28125,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.9296875,
            "text": "of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.9296875,
            "text": "BACKGROUND: Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.9296875,
            "text": ": Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.36328125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.9296875,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.9296875,
            "text": "chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.9296875,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_2": [
        {
            "start_logit": 7.25390625,
            "end_logit": 8.078125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -3.02734375,
            "end_logit": 8.078125,
            "text": "fibrosis",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -4.265625,
            "text": "cystic",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -5.703125,
            "end_logit": 8.078125,
            "text": "(cystic fibrosis",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 8.078125,
            "text": "Objective: To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 8.078125,
            "text": "To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -6.39453125,
            "text": "cystic fibrosis transmembrane",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.078125,
            "text": "descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.078125,
            "text": "CFTR (cystic fibrosis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 8.078125,
            "text": "associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.078125,
            "text": "epidemiological data, CFTR (cystic fibrosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.078125,
            "text": ", CFTR (cystic fibrosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.078125,
            "text": "the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.078125,
            "text": "with epidemiological data, CFTR (cystic fibrosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -6.625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -6.6796875,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -6.74609375,
            "text": "cystic fibrosis transmembrane conductance regulator",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -6.9921875,
            "text": "cystic fibrosis transmembrane conductance regulator)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -7.03515625,
            "text": "cystic fibrosis transmembrane conductance",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.25390625,
            "end_logit": -7.06640625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST",
            "probability": 2.384185791015625e-07
        }
    ],
    "5c6e16eb7c78d6947100004e_3": [
        {
            "start_logit": 8.6796875,
            "end_logit": 9.0390625,
            "text": "Cystic Fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": 9.0390625,
            "text": "Fibrosis",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -2.376953125,
            "text": "Cystic",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.7109375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.78515625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.9453125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.98046875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -6.99609375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in support",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.0,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.0390625,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.04296875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.046875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.08203125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.0859375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6796875,
            "end_logit": -7.10546875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 9.0390625,
            "text": "Sweat Metabolome of Screen-Positive Cystic Fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 9.0390625,
            "text": "The Sweat Metabolome of Screen-Positive Cystic Fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -6.7109375,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -6.78515625,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4580078125,
            "end_logit": -6.9453125,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_4": [
        {
            "start_logit": 8.7109375,
            "end_logit": 8.921875,
            "text": "Cystic Fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.8525390625,
            "end_logit": 8.921875,
            "text": "Fibrosis",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -2.486328125,
            "text": "Cystic",
            "probability": 1.1205673217773438e-05
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.98046875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of diagnosis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.98046875,
            "text": "Cystic Fibrosis Patients.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.921875,
            "text": "Assessment of Correlation between Sweat Chloride Levels and Clinical Features of Cystic Fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.1953125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -7.21875,
            "text": "Cystic Fibrosis Patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.921875,
            "text": "of Cystic Fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.921875,
            "text": "Clinical Features of Cystic Fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.921875,
            "text": "between Sweat Chloride Levels and Clinical Features of Cystic Fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8525390625,
            "end_logit": -6.98046875,
            "text": "Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of diagnosis.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8525390625,
            "end_logit": -6.98046875,
            "text": "Fibrosis Patients.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8525390625,
            "end_logit": -7.1953125,
            "text": "Fibrosis Patients.The diagnosis is often delayed and",
            "probability": 0.0
        },
        {
            "start_logit": -1.8525390625,
            "end_logit": -7.21875,
            "text": "Fibrosis Patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -2.486328125,
            "text": "Assessment of Correlation between Sweat Chloride Levels and Clinical Features of Cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -2.486328125,
            "text": "of Cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -2.486328125,
            "text": "Clinical Features of Cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -2.486328125,
            "text": "between Sweat Chloride Levels and Clinical Features of Cystic",
            "probability": 0.0
        },
        {
            "start_logit": -4.58984375,
            "end_logit": -6.98046875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_5": [
        {
            "start_logit": 7.92578125,
            "end_logit": 8.78125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.98828125,
            "end_logit": 8.78125,
            "text": "fibrosis",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -3.58203125,
            "end_logit": 8.78125,
            "text": "In cystic fibrosis",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -3.54296875,
            "text": "cystic",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -5.94140625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.484375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.5078125,
            "text": "cystic fibrosis (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.5234375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.5390625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.56640625,
            "text": "cystic fibrosis (CF)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.6171875,
            "text": "cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.64453125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.70703125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.73046875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.81640625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.8203125,
            "text": "cystic fibrosis (CF), sweat chloride concentration",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.84765625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.859375,
            "text": "cystic fibrosis (CF), sweat chloride",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.92578125,
            "end_logit": -6.8671875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.58203125,
            "end_logit": -3.54296875,
            "text": "In cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_6": [
        {
            "start_logit": 8.71875,
            "end_logit": 8.8828125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.9091796875,
            "end_logit": 8.8828125,
            "text": "fibrosis",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 8.71875,
            "end_logit": -2.474609375,
            "text": "cystic",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.8359375,
            "text": "cystic fibrosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.94921875,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.1171875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.12109375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.1953125,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.8828125,
            "text": "of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.234375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.8828125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.3203125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.3359375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.33984375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.3515625,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.8828125,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.36328125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.8828125,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.8828125,
            "text": "BACKGROUND Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.8828125,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_7": [
        {
            "start_logit": 8.828125,
            "end_logit": 8.953125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": 8.953125,
            "text": "fibrosis",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 8.828125,
            "end_logit": -2.2890625,
            "text": "cystic",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.90625,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.94921875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.0234375,
            "text": "cystic fibrosis (CF).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.03125,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.953125,
            "text": "of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.953125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.953125,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.953125,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.953125,
            "text": "is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.953125,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.953125,
            "text": "chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.953125,
            "text": "testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.953125,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.953125,
            "text": "the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -6.90625,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -6.94921875,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.0234375,
            "text": "fibrosis (CF).",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_8": [
        {
            "start_logit": 8.8125,
            "end_logit": 8.953125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.8037109375,
            "end_logit": 8.953125,
            "text": "fibrosis",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -2.34765625,
            "text": "cystic",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.76171875,
            "text": "cystic fibrosis (CF) in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.7890625,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 8.953125,
            "text": "The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.88671875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.92578125,
            "text": "cystic fibrosis (CF) in support",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.94140625,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.95703125,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -6.9765625,
            "text": "cystic fibrosis (CF) in support of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8125,
            "end_logit": -7.125,
            "text": "cystic fibrosis (CF) in support of universal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.953125,
            "text": "sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.953125,
            "text": "of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.953125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.953125,
            "text": "remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.953125,
            "text": "for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.953125,
            "text": "chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.953125,
            "text": "gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8037109375,
            "end_logit": -6.76171875,
            "text": "fibrosis (CF) in",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_9": [
        {
            "start_logit": 8.6171875,
            "end_logit": 8.8046875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": 8.8046875,
            "text": "fibrosis",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -2.6328125,
            "text": "cystic",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.94140625,
            "text": "cystic fibrosis,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -6.953125,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.8046875,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.6171875,
            "end_logit": -7.265625,
            "text": "cystic fibrosis, electrolyte metabolism disorders",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.8046875,
            "text": "for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.8046875,
            "text": "biomarker for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.8046875,
            "text": "chloride is of interest as a biomarker for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -6.94140625,
            "text": "fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -6.953125,
            "text": "fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 0.0
        },
        {
            "start_logit": -2.064453125,
            "end_logit": -7.265625,
            "text": "fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -2.6328125,
            "text": "Sweat chloride is of interest as a biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -2.6328125,
            "text": "for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -2.6328125,
            "text": "biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -2.6328125,
            "text": "chloride is of interest as a biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -4.11328125,
            "end_logit": -6.953125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.94140625,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.953125,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_10": [
        {
            "start_logit": 8.828125,
            "end_logit": 8.953125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": 8.953125,
            "text": "fibrosis",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 8.828125,
            "end_logit": -2.2890625,
            "text": "cystic",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.90625,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -6.94921875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.0234375,
            "text": "cystic fibrosis (CF).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.03125,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.953125,
            "text": "of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.953125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.953125,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.953125,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.953125,
            "text": "is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.953125,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.953125,
            "text": "chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.953125,
            "text": "testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.953125,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.953125,
            "text": "the gold standard for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -6.90625,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -6.94921875,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.7763671875,
            "end_logit": -7.0234375,
            "text": "fibrosis (CF).",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_11": [
        {
            "start_logit": 8.71875,
            "end_logit": 8.8828125,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.9091796875,
            "end_logit": 8.8828125,
            "text": "fibrosis",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 8.71875,
            "end_logit": -2.474609375,
            "text": "cystic",
            "probability": 1.1742115020751953e-05
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.8359375,
            "text": "cystic fibrosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -6.94921875,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.1171875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.12109375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.1953125,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.8828125,
            "text": "of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.234375,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.8828125,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.3203125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.3359375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.33984375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.3515625,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.8828125,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.71875,
            "end_logit": -7.36328125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.8828125,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.8828125,
            "text": "BACKGROUND Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.8828125,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_12": [
        {
            "start_logit": 8.9140625,
            "end_logit": 9.0,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.67578125,
            "end_logit": 9.0,
            "text": "fibrosis",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -2.123046875,
            "text": "cystic",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.0,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.05078125,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.12890625,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.171875,
            "text": "cystic fibrosis (CF) diagnosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9140625,
            "end_logit": -7.234375,
            "text": "cystic fibrosis (CF) diagnosis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 9.0,
            "text": "for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 9.0,
            "text": "BACKGROUND Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 9.0,
            "text": "Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.71875,
            "end_logit": 9.0,
            "text": "is the gold standard test for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 9.0,
            "text": "test for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 9.0,
            "text": "chloride test is the gold standard test for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 9.0,
            "text": "gold standard test for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.67578125,
            "end_logit": -7.0,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.67578125,
            "end_logit": -7.05078125,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.67578125,
            "end_logit": -7.12890625,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.67578125,
            "end_logit": -7.171875,
            "text": "fibrosis (CF) diagnosis",
            "probability": 0.0
        },
        {
            "start_logit": -1.67578125,
            "end_logit": -7.234375,
            "text": "fibrosis (CF) diagnosis.",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_13": [
        {
            "start_logit": 8.3984375,
            "end_logit": 8.7734375,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -2.16015625,
            "end_logit": 8.7734375,
            "text": "fibrosis",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -3.025390625,
            "text": "cystic",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -5.859375,
            "text": "cystic fibrosis due",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 8.7734375,
            "text": "Sweat chloride test is known to be a screening test for the cystic fibrosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -6.51953125,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -6.65625,
            "text": "cystic fibrosis due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -6.9609375,
            "text": "cystic fibrosis due to the fact",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.7734375,
            "text": "chloride test is known to be a screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.7734375,
            "text": "the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3984375,
            "end_logit": -7.0078125,
            "text": "cystic fibrosis due to the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.7734375,
            "text": "for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.7734375,
            "text": "test is known to be a screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.7734375,
            "text": "screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.7734375,
            "text": "known to be a screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.7734375,
            "text": "test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -5.859375,
            "text": "fibrosis due",
            "probability": 0.0
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.51953125,
            "text": "fibrosis due to the fact that electrolyte levels in sweat are elevated in patients.",
            "probability": 0.0
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.65625,
            "text": "fibrosis due to",
            "probability": 0.0
        },
        {
            "start_logit": -2.16015625,
            "end_logit": -6.9609375,
            "text": "fibrosis due to the fact",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_14": [
        {
            "start_logit": 8.84375,
            "end_logit": 8.9765625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.7119140625,
            "end_logit": 8.9765625,
            "text": "fibrosis",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": 8.84375,
            "end_logit": -2.251953125,
            "text": "cystic",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.89453125,
            "text": "cystic fibrosis (CF).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.921875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -6.92578125,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.84375,
            "end_logit": -7.05078125,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.9765625,
            "text": "OBJECTIVE Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.9765625,
            "text": "for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.9765625,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.9765625,
            "text": "diagnostic tool for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.9765625,
            "text": "standard diagnostic tool for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.9765625,
            "text": "tool for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.9765625,
            "text": "considered a standard diagnostic tool for cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7119140625,
            "end_logit": -6.89453125,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -1.7119140625,
            "end_logit": -6.921875,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.7119140625,
            "end_logit": -6.92578125,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.7119140625,
            "end_logit": -7.05078125,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -2.251953125,
            "text": "OBJECTIVE Sweat chloride measurement is considered a standard diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -2.251953125,
            "text": "for cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_15": [
        {
            "start_logit": 8.765625,
            "end_logit": 8.9140625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.859375,
            "end_logit": 8.9140625,
            "text": "fibrosis",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -2.400390625,
            "text": "cystic",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.9140625,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -6.96484375,
            "text": "cystic fibrosis (CF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.0859375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.1171875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.9140625,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.9140625,
            "text": "of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.9140625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.26171875,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.3046875,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.34375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.9140625,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.35546875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.765625,
            "end_logit": -7.375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.9140625,
            "text": "chloride testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.9140625,
            "text": "testing for diagnosis of cystic fibrosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.859375,
            "end_logit": -6.9140625,
            "text": "fibrosis (",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_1": [
        {
            "start_logit": 5.09375,
            "end_logit": 9.5234375,
            "text": "bladder cancer",
            "probability": 0.986328125
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": 9.5234375,
            "text": "cancer",
            "probability": 0.0130157470703125
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 9.5234375,
            "text": "Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.5234375,
            "text": "Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.5234375,
            "text": "for bladder cancer",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 5.09375,
            "end_logit": -6.10546875,
            "text": "bladder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 5.09375,
            "end_logit": -6.90625,
            "text": "bladder cancer: a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.09375,
            "end_logit": -7.125,
            "text": "bladder cancer:",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.09375,
            "end_logit": -7.1875,
            "text": "bladder cancer: a review",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.09375,
            "end_logit": -7.3046875,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and BCG infections.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.09375,
            "end_logit": -7.3984375,
            "text": "bladder cancer: a review of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.09375,
            "end_logit": -7.40625,
            "text": "bladder cancer: a review of immunological aspects,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.09375,
            "end_logit": -7.41015625,
            "text": "bladder cancer: a review of immunological aspects",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -6.90625,
            "text": "cancer: a",
            "probability": 0.0
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -7.125,
            "text": "cancer:",
            "probability": 0.0
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -7.1875,
            "text": "cancer: a review",
            "probability": 0.0
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -7.3046875,
            "text": "cancer: a review of immunological aspects, clinical effects and BCG infections.",
            "probability": 0.0
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -7.3984375,
            "text": "cancer: a review of",
            "probability": 0.0
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -7.40625,
            "text": "cancer: a review of immunological aspects,",
            "probability": 0.0
        },
        {
            "start_logit": 0.7685546875,
            "end_logit": -7.41015625,
            "text": "cancer: a review of immunological aspects",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_2": [
        {
            "start_logit": 7.43359375,
            "end_logit": 7.90234375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 7.90234375,
            "text": "bladder cancer",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.90234375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -6.88671875,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.90234375,
            "text": "for bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.90234375,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.21484375,
            "text": "cancer has been used since",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.33203125,
            "text": "cancer has been used since 1976",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.3359375,
            "text": "cancer has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.3828125,
            "text": "cancer has been",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.38671875,
            "text": "cancer has been used",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.4609375,
            "text": "cancer has been used since 1976 when the first evidence",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.46484375,
            "text": "cancer has been used since 1976 when the first evidence of its ability to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.46875,
            "text": "cancer has been used since 1976 when",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.46875,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.46875,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.43359375,
            "end_logit": -7.47265625,
            "text": "cancer has been used since 1976 when the first evidence of its ability",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4375,
            "end_logit": -6.88671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -6.88671875,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published.",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -7.21484375,
            "text": "bladder cancer has been used since",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_3": [
        {
            "start_logit": 7.3125,
            "end_logit": 8.0078125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 8.0078125,
            "text": "bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 8.0078125,
            "text": "non-muscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.0078125,
            "text": "BCG immunotherapy is the choice of care for high-grade non-muscle invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.0078125,
            "text": "-muscle invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.0078125,
            "text": "invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.0078125,
            "text": "for high-grade non-muscle invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.0078125,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.0078125,
            "text": "choice of care for high-grade non-muscle invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.0078125,
            "text": "immunotherapy is the choice of care for high-grade non-muscle invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.0078125,
            "text": "is the choice of care for high-grade non-muscle invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0078125,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0078125,
            "text": "muscle invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.109375,
            "text": "cancer (NMIBC) after transurethral resection.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.21484375,
            "text": "cancer (NMIBC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.359375,
            "text": "cancer (NMIBC) after",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.39453125,
            "text": "cancer (NMIB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.3984375,
            "text": "cancer (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.40234375,
            "text": "cancer (NMIBC) after transurethral resection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.421875,
            "text": "cancer (NMIBC)",
            "probability": 1.7881393432617188e-07
        }
    ],
    "60292d191cb411341a00010e_4": [
        {
            "start_logit": 7.29296875,
            "end_logit": 7.984375,
            "text": "Cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.283203125,
            "end_logit": 7.984375,
            "text": "Bladder Cancer",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.984375,
            "text": "Treatment of Bladder Cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.984375,
            "text": "of Bladder Cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.984375,
            "text": "the Treatment of Bladder Cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.984375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.984375,
            "text": "Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.984375,
            "text": "for the Treatment of Bladder Cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.984375,
            "text": "Renal Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.84765625,
            "text": "Cancer.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.984375,
            "text": "Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.283203125,
            "end_logit": -6.84765625,
            "text": "Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.50390625,
            "end_logit": -6.84765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.84765625,
            "text": "Treatment of Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -6.84765625,
            "text": "of Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -6.84765625,
            "text": "the Treatment of Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -6.84765625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -6.84765625,
            "text": "Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -6.84765625,
            "text": "for the Treatment of Bladder Cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -6.84765625,
            "text": "Renal Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_5": [
        {
            "start_logit": 7.04296875,
            "end_logit": 8.2109375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -2.138671875,
            "end_logit": 8.2109375,
            "text": "bladder cancer",
            "probability": 0.00010311603546142578
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.2109375,
            "text": "superficial bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.2109375,
            "text": "It is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 8.2109375,
            "text": "is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.2109375,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 8.2109375,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 8.2109375,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.2109375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.2109375,
            "text": "treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.2109375,
            "text": "an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.2109375,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.2109375,
            "text": "(BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.2109375,
            "text": "as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.2109375,
            "text": "immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.2109375,
            "text": "since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.609375,
            "text": "cancer.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.138671875,
            "end_logit": -6.609375,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.46875,
            "end_logit": -6.609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -6.609375,
            "text": "superficial bladder cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_6": [
        {
            "start_logit": 7.56640625,
            "end_logit": 7.80078125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.80078125,
            "text": "bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.80078125,
            "text": "with bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.80078125,
            "text": "involvement with bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.80078125,
            "text": "Prostatic urethral mucosal involvement with bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.328125,
            "text": "cancer can",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.359375,
            "text": "cancer can be",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.36328125,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.43359375,
            "text": "cancer can be effectively",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.4609375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.39453125,
            "end_logit": -7.09765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.55078125,
            "end_logit": -7.328125,
            "text": "bladder cancer can",
            "probability": 0.0
        },
        {
            "start_logit": -6.55078125,
            "end_logit": -7.359375,
            "text": "bladder cancer can be",
            "probability": 0.0
        },
        {
            "start_logit": -6.55078125,
            "end_logit": -7.36328125,
            "text": "bladder cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but",
            "probability": 0.0
        },
        {
            "start_logit": -6.55078125,
            "end_logit": -7.43359375,
            "text": "bladder cancer can be effectively",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -7.09765625,
            "text": "in tumor recurrence rates, but has had no positive impact on disease progression or prolongation of survival.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.09765625,
            "text": "tumor recurrence rates, but has had no positive impact on disease progression or prolongation of survival.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.09765625,
            "text": "intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression or prolongation of survival.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.09765625,
            "text": "-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression or prolongation of survival.",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.09765625,
            "text": ", but has had no positive impact on disease progression or prolongation of survival.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_7": [
        {
            "start_logit": 7.1171875,
            "end_logit": 8.1484375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.82421875,
            "end_logit": 8.1484375,
            "text": "bladder cancer",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 8.1484375,
            "text": "in nonmuscle invasive bladder cancer",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 8.1484375,
            "text": "nonmuscle invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.1484375,
            "text": "uscle invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.1484375,
            "text": "invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.1171875,
            "end_logit": -7.09375,
            "text": "cancer.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.3046875,
            "end_logit": -7.09375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.82421875,
            "end_logit": -7.09375,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.48828125,
            "end_logit": -7.09375,
            "text": "in nonmuscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.62890625,
            "end_logit": -7.09375,
            "text": "nonmuscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -7.09375,
            "text": "uscle invasive bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -7.09375,
            "text": "invasive bladder cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_8": [
        {
            "start_logit": 7.50390625,
            "end_logit": 7.83203125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 7.83203125,
            "text": "bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.83203125,
            "text": "superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.83203125,
            "text": "in superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.83203125,
            "text": "The advantage of BCG immunotherapy over intravesical chemotherapy in superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.83203125,
            "text": "advantage of BCG immunotherapy over intravesical chemotherapy in superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.41015625,
            "text": "cancer has been most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.421875,
            "text": "cancer has been most apparent",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.515625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.51953125,
            "text": "cancer has been most apparent in patients with carcinoma in situ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.53515625,
            "text": "cancer has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.546875,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.5625,
            "text": "cancer has been most apparent in patients with carcinoma in situ (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.57421875,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.50390625,
            "end_logit": -7.58984375,
            "text": "cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.01171875,
            "end_logit": -7.02734375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -7.41015625,
            "text": "bladder cancer has been most",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -7.421875,
            "text": "bladder cancer has been most apparent",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -7.515625,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS",
            "probability": 0.0
        },
        {
            "start_logit": -6.5234375,
            "end_logit": -7.51953125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_9": [
        {
            "start_logit": 7.6796875,
            "end_logit": 7.65625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 7.65625,
            "text": "bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.296875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.296875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.30859375,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.65625,
            "text": "dministration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 7.65625,
            "text": "for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.65625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.65625,
            "text": "-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.65625,
            "text": "of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.65625,
            "text": "tration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.65625,
            "text": "standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.65625,
            "text": "invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.65625,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.484375,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.515625,
            "text": "cancer (NMIBC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.62890625,
            "end_logit": -7.296875,
            "text": ". While",
            "probability": 0.0
        },
        {
            "start_logit": -4.62890625,
            "end_logit": -7.296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.62890625,
            "end_logit": -7.30859375,
            "text": ". While most a",
            "probability": 0.0
        },
        {
            "start_logit": -4.62890625,
            "end_logit": -7.484375,
            "text": ". While most",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_10": [
        {
            "start_logit": 7.54296875,
            "end_logit": 7.73828125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 7.73828125,
            "text": "bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 7.73828125,
            "text": ") bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.73828125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.73828125,
            "text": "stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.73828125,
            "text": "(T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.73828125,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.73828125,
            "text": "immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.73828125,
            "text": "treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.73828125,
            "text": "for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.73828125,
            "text": "BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.73828125,
            "text": "current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.40234375,
            "text": "cancer (BC), though its efficacy is limited",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.44921875,
            "text": "cancer (BC), though its efficacy is limited by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.46484375,
            "text": "cancer (BC), though its efficacy is limited by high recurrence",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.46484375,
            "text": "cancer (BC), though",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.48046875,
            "text": "cancer (BC), though its efficacy is limited by high",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.50390625,
            "text": "cancer (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.51171875,
            "text": "cancer (BC), though its efficacy is limited by high recurrence and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.54296875,
            "end_logit": -7.53125,
            "text": "cancer (BC",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_11": [
        {
            "start_logit": 7.625,
            "end_logit": 7.73046875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.73046875,
            "text": "with non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.73046875,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.73046875,
            "text": "patients with non-muscle-invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.73046875,
            "text": "-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.73046875,
            "text": "bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.73046875,
            "text": "The standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.73046875,
            "text": "standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.73046875,
            "text": "most patients with non-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.73046875,
            "text": "invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.73046875,
            "text": "for most patients with non-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.421875,
            "text": "cancer (NMIBC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.46484375,
            "text": "cancer (NMIB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.46875,
            "text": "cancer (NM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.625,
            "end_logit": -7.4765625,
            "text": "cancer (NMIBC)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.13671875,
            "end_logit": -7.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.421875,
            "text": "with non-muscle-invasive bladder cancer (NMIBC",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.43359375,
            "text": "with non-muscle-invasive bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.46484375,
            "text": "with non-muscle-invasive bladder cancer (NMIB",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.46875,
            "text": "with non-muscle-invasive bladder cancer (NM",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_12": [
        {
            "start_logit": 7.29296875,
            "end_logit": 8.015625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.412109375,
            "end_logit": 8.015625,
            "text": "bladder cancer",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 8.015625,
            "text": "superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 8.015625,
            "text": "It is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 8.015625,
            "text": "is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 8.015625,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 8.015625,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.015625,
            "text": "years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.015625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.29296875,
            "end_logit": -6.69140625,
            "text": "cancer.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.015625,
            "text": "treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.015625,
            "text": "(BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.015625,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.015625,
            "text": "an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.015625,
            "text": "as an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.015625,
            "text": "immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.015625,
            "text": "since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -3.412109375,
            "end_logit": -6.69140625,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.4296875,
            "end_logit": -6.69140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -6.69140625,
            "text": "superficial bladder cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_13": [
        {
            "start_logit": 7.71875,
            "end_logit": 7.61328125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 7.71875,
            "end_logit": -6.91015625,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC. However",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.0703125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 7.61328125,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.41796875,
            "text": "cancer (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.71875,
            "end_logit": -7.44140625,
            "text": "cancer (NMIBC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.61328125,
            "text": "-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.61328125,
            "text": "Intravesical immunotherapy with bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.61328125,
            "text": "with bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.61328125,
            "text": "immunotherapy with bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.61328125,
            "text": "bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.61328125,
            "text": "bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 7.61328125,
            "text": "ille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.61328125,
            "text": "invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.61328125,
            "text": "Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.61328125,
            "text": "-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.90625,
            "end_logit": -6.91015625,
            "text": ". However",
            "probability": 0.0
        },
        {
            "start_logit": -4.90625,
            "end_logit": -7.0703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -6.91015625,
            "text": "non-muscle-invasive bladder cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC. However",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -7.0703125,
            "text": "non-muscle-invasive bladder cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_14": [
        {
            "start_logit": 6.22265625,
            "end_logit": 8.6171875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.533203125,
            "end_logit": 8.6171875,
            "text": "bladder cancer",
            "probability": 5.7816505432128906e-05
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.6171875,
            "text": "for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.6171875,
            "text": "risk non-muscle invasive bladder cancer",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.6171875,
            "text": "non-muscle invasive bladder cancer",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.6171875,
            "text": "first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 8.6171875,
            "text": "invasive bladder cancer",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.6171875,
            "text": "intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.6171875,
            "text": "a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.375,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.37890625,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.390625,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30-40",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.3984375,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.3984375,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.43359375,
            "text": "cancer, its long-term efficacy is still arguable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.44140625,
            "text": "cancer, its long-term efficacy is still arguable as a proportion of up to 30-40%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.22265625,
            "end_logit": -7.46875,
            "text": "cancer, its long-term efficacy is still arguable as",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.533203125,
            "end_logit": -7.375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to",
            "probability": 0.0
        },
        {
            "start_logit": -3.533203125,
            "end_logit": -7.37890625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30",
            "probability": 0.0
        },
        {
            "start_logit": -3.533203125,
            "end_logit": -7.390625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_15": [
        {
            "start_logit": 7.87890625,
            "end_logit": 7.33203125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.3515625,
            "text": "cancer and urothelial CIS and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.3828125,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.390625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.4140625,
            "text": "cancer and urothelial CIS and platin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.4296875,
            "text": "cancer and urothelial CIS and platin-based",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.44921875,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy-related atypia seen",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.33203125,
            "text": "bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.33203125,
            "text": "treat high-risk non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.33203125,
            "text": "risk non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.33203125,
            "text": "of bladder tumour to reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.33203125,
            "text": "intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.33203125,
            "text": "bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.33203125,
            "text": "-muscle-invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.21875,
            "end_logit": -7.26171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -7.3515625,
            "text": "bladder cancer and urothelial CIS and",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -7.3515625,
            "text": "treat high-risk non-muscle-invasive bladder cancer and urothelial CIS and",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -7.3828125,
            "text": "bladder cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -7.390625,
            "text": "bladder cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -7.4140625,
            "text": "bladder cancer and urothelial CIS and platin",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_16": [
        {
            "start_logit": 7.7109375,
            "end_logit": 7.59375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 7.59375,
            "text": "bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 7.59375,
            "text": "risk non-muscle invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 7.59375,
            "text": "treat high risk non-muscle invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.59375,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.59375,
            "text": "high risk non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.59375,
            "text": "-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.59375,
            "text": "intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -7.4765625,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.59375,
            "text": "of bladder tumor to reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -7.49609375,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy related",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.7109375,
            "end_logit": -7.49609375,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.59375,
            "text": "invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.59375,
            "text": "muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.59375,
            "text": "BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.59375,
            "text": "reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.59375,
            "text": "to treat high risk non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.8359375,
            "end_logit": -7.26953125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -7.4765625,
            "text": "bladder cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to",
            "probability": 0.0
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -7.49609375,
            "text": "bladder cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy related",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_17": [
        {
            "start_logit": 7.57421875,
            "end_logit": 7.75,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 7.75,
            "text": "bladder cancer",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 7.75,
            "text": "review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 7.75,
            "text": "This comprehensive review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 7.75,
            "text": "comprehensive review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.75,
            "text": "in intravesical therapy of bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.75,
            "text": "highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.75,
            "text": "of bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.75,
            "text": "intravesical therapy of bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.2265625,
            "text": "cancer and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.75,
            "text": "developments in intravesical therapy of bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.75,
            "text": "therapy of bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.75,
            "text": "recent developments in intravesical therapy of bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.3125,
            "text": "cancer and summarizes the mechanisms of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.34765625,
            "text": "cancer and summarizes the mechanisms of action",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.41015625,
            "text": "cancer and summarizes the mechanisms",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.4140625,
            "text": "cancer and summarizes the mechanisms of action of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.453125,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.484375,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.57421875,
            "end_logit": -7.48828125,
            "text": "cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and prophylaxis of",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_18": [
        {
            "start_logit": 7.6484375,
            "end_logit": 7.7109375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.7109375,
            "text": "review summarises the history and development of BCG as a modern cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 7.7109375,
            "text": "This review summarises the history and development of BCG as a modern cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 7.7109375,
            "text": "summarises the history and development of BCG as a modern cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.7109375,
            "text": "ises the history and development of BCG as a modern cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.29296875,
            "text": "cancer treatment,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.7109375,
            "text": "history and development of BCG as a modern cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.7109375,
            "text": "the history and development of BCG as a modern cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.375,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses promising new therapies closely related to BCG, and briefly explores the possibility",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.37890625,
            "text": "cancer treatment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.7109375,
            "text": "modern cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.39453125,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer, discusses promising new therapies closely related to BCG, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.453125,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.78125,
            "end_logit": -6.9921875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -7.0546875,
            "text": "review",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -7.29296875,
            "text": "review summarises the history and development of BCG as a modern cancer treatment,",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -7.37890625,
            "text": "review summarises the history and development of BCG as a modern cancer treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -7.44921875,
            "text": "review summarises the history and development of BCG as",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -7.453125,
            "text": "review summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer,",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -7.4609375,
            "text": "review summarises the history and development of BCG as a",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_19": [
        {
            "start_logit": 7.2578125,
            "end_logit": 8.046875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.5390625,
            "end_logit": 8.046875,
            "text": "bladder cancer",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.046875,
            "text": "prevent the recurrence of superficial bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.046875,
            "text": "and prevent the recurrence of superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.046875,
            "text": "treat and prevent the recurrence of superficial bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.046875,
            "text": "of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.046875,
            "text": "Immunotherapy by intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.046875,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.046875,
            "text": "superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.046875,
            "text": "the recurrence of superficial bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.046875,
            "text": "intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.046875,
            "text": "Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.046875,
            "text": "(BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.046875,
            "text": "delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.046875,
            "text": "by intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.046875,
            "text": "recurrence of superficial bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.2578125,
            "end_logit": -7.00390625,
            "text": "cancer.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.5390625,
            "end_logit": -7.00390625,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": -7.00390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.00390625,
            "text": "prevent the recurrence of superficial bladder cancer.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_20": [
        {
            "start_logit": 7.6171875,
            "end_logit": 7.75390625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.75390625,
            "text": "bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.03125,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of cancer.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.18359375,
            "text": "cancer and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.75390625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.26171875,
            "text": "cancer and one",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 7.75390625,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.2734375,
            "text": "cancer and one of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.27734375,
            "text": "cancer and one of the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.75390625,
            "text": "-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.75390625,
            "text": "of non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.75390625,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.75390625,
            "text": "invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.75390625,
            "text": "treatment of non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.37109375,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.37890625,
            "text": "cancer and one of the most",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.75390625,
            "text": "effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.39453125,
            "text": "cancer and one of the most successful applications of immunotherapy to the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.75390625,
            "text": "muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.75390625,
            "text": "(BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_21": [
        {
            "start_logit": 7.6796875,
            "end_logit": 7.6484375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.1484375,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.6484375,
            "text": "bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 7.6484375,
            "text": "The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.6484375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.6484375,
            "text": "for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.6484375,
            "text": "administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.6484375,
            "text": "-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.6484375,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.6484375,
            "text": "invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.6484375,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.6484375,
            "text": "standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.48828125,
            "text": "cancer (NMIBC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.6484375,
            "text": "has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.6484375,
            "text": ": The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.5078125,
            "text": "cancer (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.5078125,
            "text": "cancer (NMIBC) and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.53125,
            "text": "cancer (NM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.79296875,
            "end_logit": -7.1484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -7.1484375,
            "text": "bladder cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_22": [
        {
            "start_logit": 7.63671875,
            "end_logit": 7.71484375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.71484375,
            "text": "When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.71484375,
            "text": "bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.71484375,
            "text": ": When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.71484375,
            "text": "SUMMARY: When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.2734375,
            "text": "cancer is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.71484375,
            "text": "-muscle-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.71484375,
            "text": "-invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.37890625,
            "text": "cancer is persistent",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.42578125,
            "text": "cancer is persistent or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.47265625,
            "text": "cancer is persistent or recurs",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.63671875,
            "end_logit": -7.5,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.99609375,
            "end_logit": -7.04296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -7.04296875,
            "text": "of a \"BCG unresponsive\" disease.",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.04296875,
            "text": "this meets the new definition of a \"BCG unresponsive\" disease.",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -7.04296875,
            "text": "the new definition of a \"BCG unresponsive\" disease.",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.04296875,
            "text": "s the new definition of a \"BCG unresponsive\" disease.",
            "probability": 0.0
        },
        {
            "start_logit": -7.15625,
            "end_logit": -7.2734375,
            "text": "When T1 high-grade non-muscle-invasive bladder cancer is",
            "probability": 0.0
        },
        {
            "start_logit": -7.390625,
            "end_logit": -7.04296875,
            "text": "; this meets the new definition of a \"BCG unresponsive\" disease.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.04296875,
            "text": "meets the new definition of a \"BCG unresponsive\" disease.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_23": [
        {
            "start_logit": 7.19140625,
            "end_logit": 8.109375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 8.109375,
            "text": "bladder cancer",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.109375,
            "text": "-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.109375,
            "text": "patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.109375,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.109375,
            "text": "Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.109375,
            "text": "treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.109375,
            "text": "primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.109375,
            "text": "with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.109375,
            "text": "in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.109375,
            "text": "grade non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.109375,
            "text": "invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.109375,
            "text": "of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.109375,
            "text": "-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.109375,
            "text": "PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.19140625,
            "end_logit": -6.98828125,
            "text": "cancer treated with BCG immunotherapy.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.19140625,
            "end_logit": -7.2578125,
            "text": "cancer treated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.19140625,
            "end_logit": -7.44921875,
            "text": "cancer treated with BCG",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.19140625,
            "end_logit": -7.4765625,
            "text": "cancer treated with BCG immunotherapy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": -6.98828125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_24": [
        {
            "start_logit": 7.36328125,
            "end_logit": 7.96875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -4.55078125,
            "end_logit": 7.96875,
            "text": "bladder cancer",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.96875,
            "text": "In the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.96875,
            "text": "treating bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 7.96875,
            "text": ", intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.96875,
            "text": "past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.96875,
            "text": "intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.96875,
            "text": "(BCG) has been used for treating bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.96875,
            "text": "the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.96875,
            "text": "three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.96875,
            "text": "for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.96875,
            "text": "Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.96875,
            "text": "instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.96875,
            "text": "been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.96875,
            "text": "ille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -6.98046875,
            "text": "cancer and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.36328125,
            "end_logit": -7.171875,
            "text": "cancer and it still remains at the forefront of immunotherapy for cancer patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.55078125,
            "end_logit": -6.98046875,
            "text": "bladder cancer and",
            "probability": 0.0
        },
        {
            "start_logit": -4.55078125,
            "end_logit": -7.171875,
            "text": "bladder cancer and it still remains at the forefront of immunotherapy for cancer patients.",
            "probability": 0.0
        },
        {
            "start_logit": -5.1484375,
            "end_logit": -7.171875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_25": [
        {
            "start_logit": 6.7421875,
            "end_logit": 8.4140625,
            "text": "cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.56298828125,
            "end_logit": 8.4140625,
            "text": "bladder cancer",
            "probability": 0.0006718635559082031
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.4140625,
            "text": "of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.4140625,
            "text": "intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.4140625,
            "text": "for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.4140625,
            "text": "Although BCG-based therapy is the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.4140625,
            "text": "invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.4140625,
            "text": "tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.4140625,
            "text": "into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.4140625,
            "text": "effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.4140625,
            "text": "most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.4140625,
            "text": "BCG-based therapy is the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.4140625,
            "text": "this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.4140625,
            "text": "therapy is the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -7.0546875,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to 50 % of patients.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -7.42578125,
            "text": "cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -7.47265625,
            "text": "cancer, BCG is ineffective in approximately 30-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.7421875,
            "end_logit": -7.4921875,
            "text": "cancer, BCG is ineffective in approximately",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.56298828125,
            "end_logit": -7.0546875,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to 50 % of patients.",
            "probability": 0.0
        },
        {
            "start_logit": -0.56298828125,
            "end_logit": -7.42578125,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_26": [
        {
            "start_logit": 7.09765625,
            "end_logit": 8.171875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.171875,
            "text": "bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.171875,
            "text": "search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.171875,
            "text": "the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.171875,
            "text": "in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.171875,
            "text": "less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.171875,
            "text": "for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.171875,
            "text": "genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.171875,
            "text": "the genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.171875,
            "text": "toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.171875,
            "text": "has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.171875,
            "text": ", the genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.171875,
            "text": "for bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.09765625,
            "end_logit": -7.1171875,
            "text": "cancer immunotherapy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.20703125,
            "end_logit": -7.1171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.90625,
            "end_logit": -7.1171875,
            "text": "bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.1171875,
            "text": "search for less toxic and more potent therapeutic agents for bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -7.1171875,
            "text": "the search for less toxic and more potent therapeutic agents for bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.1171875,
            "text": "in the search for less toxic and more potent therapeutic agents for bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48046875,
            "end_logit": -7.1171875,
            "text": "less toxic and more potent therapeutic agents for bladder cancer immunotherapy.",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_27": [
        {
            "start_logit": 6.51171875,
            "end_logit": 8.546875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -2.01171875,
            "end_logit": 8.546875,
            "text": "bladder cancer",
            "probability": 0.0001971721649169922
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.546875,
            "text": "of bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.546875,
            "text": "BCG immunotherapy of bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.51171875,
            "end_logit": -7.1328125,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.01171875,
            "end_logit": -7.1328125,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -5.36328125,
            "end_logit": -7.1328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -7.1328125,
            "text": "immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -7.1328125,
            "text": "tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.1328125,
            "text": "of tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.1328125,
            "text": "of bladder cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.1328125,
            "text": "inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.1328125,
            "text": "associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.1328125,
            "text": "BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        }
    ],
    "5e776db8835f4e4777000011_1": [
        {
            "start_logit": 8.6875,
            "end_logit": 8.3359375,
            "text": "MannKind Corporation",
            "probability": 0.9990234375
        },
        {
            "start_logit": 5.453125,
            "end_logit": 4.734375,
            "text": "Sanofi",
            "probability": 0.0010652542114257812
        },
        {
            "start_logit": 8.6875,
            "end_logit": -2.49609375,
            "text": "Mann",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -2.744140625,
            "end_logit": 8.3359375,
            "text": "tion",
            "probability": 1.0788440704345703e-05
        },
        {
            "start_logit": 8.6875,
            "end_logit": -4.90234375,
            "text": "MannKind",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.6875,
            "end_logit": -5.58984375,
            "text": "MannKind Corporation started",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.6875,
            "end_logit": -6.0078125,
            "text": "MannKind Corpora",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.921875,
            "end_logit": 8.3359375,
            "text": "Kind Corporation",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.453125,
            "end_logit": -3.43359375,
            "text": "Sanofi after",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 8.3359375,
            "text": "Corporation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 8.3359375,
            "text": "d Corporation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 8.3359375,
            "text": ", MannKind Corporation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.3359375,
            "text": "contrary, MannKind Corporation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.3359375,
            "text": "In contrary, MannKind Corporation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.9765625,
            "end_logit": 4.734375,
            "text": ". Afrezza has been marketed since February, 2015 by Sanofi",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.453125,
            "end_logit": -5.41796875,
            "text": "San",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.21875,
            "end_logit": 4.734375,
            "text": "by Sanofi",
            "probability": 0.0
        },
        {
            "start_logit": 5.453125,
            "end_logit": -6.33203125,
            "text": "Sanofi after getting FDA",
            "probability": 0.0
        },
        {
            "start_logit": 5.453125,
            "end_logit": -6.48828125,
            "text": "Sanofi after getting",
            "probability": 0.0
        },
        {
            "start_logit": 5.453125,
            "end_logit": -6.83203125,
            "text": "Sanofi after getting FDA approval in June 2014.",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_1": [
        {
            "start_logit": 9.0078125,
            "end_logit": 6.60546875,
            "text": "Nox1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -0.1112060546875,
            "text": "Nox1 oxidase",
            "probability": 0.001216888427734375
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.8603515625,
            "text": "Nox",
            "probability": 0.00021135807037353516
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -4.953125,
            "text": "Nox1 oxidase,",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.36328125,
            "text": "Nox1 oxidase, functions",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.48046875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox)",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.57421875,
            "text": "Nox1 oxidase, functions as either a",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.578125,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1)",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.5859375,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox), respectively",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.65234375,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.65625,
            "text": "Nox1 oxidase, functions as either",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.68359375,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -4.30859375,
            "end_logit": 6.60546875,
            "text": "1",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.7265625,
            "text": "Nox1 oxidase, functions as either a canonical or",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.77734375,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 6.60546875,
            "text": ", Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 6.60546875,
            "text": "family, Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.60546875,
            "text": "of this family, Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 6.60546875,
            "text": "A unique member of this family, Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 6.60546875,
            "text": "this family, Nox1",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5a51060087bc10a000021_2": [
        {
            "start_logit": 9.2109375,
            "end_logit": 8.8671875,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -0.986328125,
            "text": "Nox1.",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": 9.2109375,
            "end_logit": -1.2470703125,
            "text": "Nox",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": 8.8671875,
            "text": "1",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -5.375,
            "end_logit": 8.8671875,
            "text": "superoxide-producing activity of Nox1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.94140625,
            "end_logit": 8.8671875,
            "text": "Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.99609375,
            "end_logit": 8.8671875,
            "text": "of Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": 8.8671875,
            "text": "Phosphorylation of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 8.8671875,
            "text": "the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 8.8671875,
            "text": "interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.8671875,
            "text": "with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.8671875,
            "text": "Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.8671875,
            "text": "its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25,
            "end_logit": 8.8671875,
            "text": "at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.8671875,
            "text": "of Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.8671875,
            "text": "o1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.8671875,
            "text": "threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7685546875,
            "end_logit": -0.986328125,
            "text": "1.",
            "probability": 0.0
        },
        {
            "start_logit": -4.09765625,
            "end_logit": -0.986328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -0.986328125,
            "text": "superoxide-producing activity of Nox1.",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_3": [
        {
            "start_logit": 8.9375,
            "end_logit": 9.03125,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": 9.03125,
            "text": "1",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -1.7509765625,
            "text": "Nox",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -5.8125,
            "end_logit": 9.03125,
            "text": "Superoxide production by Nox1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -5.953125,
            "text": "Nox1,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 9.03125,
            "text": "by Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.48828125,
            "text": "Nox1, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.53125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.55859375,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.63671875,
            "text": "Nox1, a member of the Nox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.65625,
            "text": "Nox1, a member of the Nox family",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.703125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.70703125,
            "text": "Nox1, a member",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.7109375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.8125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.8984375,
            "text": "Nox1, a member of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -5.953125,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -1.7509765625,
            "text": "Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -6.48828125,
            "text": "1, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -6.53125,
            "text": "1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_4": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.046875,
            "text": "Noxa1",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.287109375,
            "text": "Nox",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -1.2880859375,
            "end_logit": 9.046875,
            "text": "a1",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.27734375,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.38671875,
            "text": "Noxa1, an interaction that participates in Nox1 activation.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.53515625,
            "end_logit": 9.046875,
            "text": "Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Noxa1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.90234375,
            "text": "Noxa1, an interaction that participates in Nox1 activation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.15625,
            "text": "Noxa1,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.15625,
            "end_logit": 9.046875,
            "text": "with Noxa1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.33984375,
            "text": "Noxa1, an interaction that participates in Nox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 9.046875,
            "text": "interact with Noxa1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 9.046875,
            "text": "sufficiently interact with Noxa1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.625,
            "text": "Noxa1, an interaction that participates in Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.2880859375,
            "end_logit": -5.27734375,
            "text": "a1, an interaction that participates in Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -1.2880859375,
            "end_logit": -5.38671875,
            "text": "a1, an interaction that participates in Nox1 activation.",
            "probability": 0.0
        },
        {
            "start_logit": -5.53515625,
            "end_logit": -1.287109375,
            "text": "Phosphorylation of Thr341 allows Noxo1 to sufficiently interact with Nox",
            "probability": 0.0
        },
        {
            "start_logit": -1.2880859375,
            "end_logit": -5.90234375,
            "text": "a1, an interaction that participates in Nox1 activation",
            "probability": 0.0
        },
        {
            "start_logit": -1.2880859375,
            "end_logit": -6.15625,
            "text": "a1,",
            "probability": 0.0
        },
        {
            "start_logit": -6.15625,
            "end_logit": -1.287109375,
            "text": "with Nox",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -1.287109375,
            "text": "interact with Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_5": [
        {
            "start_logit": 9.234375,
            "end_logit": 8.890625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.275390625,
            "text": "Nox",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": -1.73046875,
            "end_logit": 8.890625,
            "text": "1",
            "probability": 1.722574234008789e-05
        },
        {
            "start_logit": 9.234375,
            "end_logit": -5.234375,
            "text": "Nox1 activity in different manners.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.21875,
            "text": "Nox1 activity",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.42578125,
            "text": "Nox1 activity in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.5703125,
            "text": "Nox1 activity in different",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.88671875,
            "text": "Nox1 activity in different manner",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 8.890625,
            "text": "Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.890625,
            "text": "phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.890625,
            "text": "appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.890625,
            "text": "regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.890625,
            "text": "of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.890625,
            "text": "to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.890625,
            "text": "at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.890625,
            "text": "and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.890625,
            "text": "Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.890625,
            "text": "341 and at Ser154 appears to regulate Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.73046875,
            "end_logit": -5.234375,
            "text": "1 activity in different manners.",
            "probability": 0.0
        },
        {
            "start_logit": -1.73046875,
            "end_logit": -6.21875,
            "text": "1 activity",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_6": [
        {
            "start_logit": 7.4296875,
            "end_logit": 3.8828125,
            "text": "Nox1",
            "probability": 0.9970703125
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -2.912109375,
            "text": "Nox",
            "probability": 0.0011148452758789062
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -3.490234375,
            "text": "Nox1 is known",
            "probability": 0.0006246566772460938
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -3.765625,
            "text": "Nox1 is known to",
            "probability": 0.0004754066467285156
        },
        {
            "start_logit": -0.391357421875,
            "end_logit": 3.8828125,
            "text": "gp91(phox)/Nox2 and Nox1",
            "probability": 0.00040030479431152344
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -4.05078125,
            "text": "Nox1 is known to absolutely require both",
            "probability": 0.00035762786865234375
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -5.4609375,
            "text": "Nox1 is known to absolutely",
            "probability": 8.726119995117188e-05
        },
        {
            "start_logit": 7.4296875,
            "end_logit": -5.63671875,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 7.343292236328125e-05
        },
        {
            "start_logit": -4.234375,
            "end_logit": 3.8828125,
            "text": "and Nox1",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -0.391357421875,
            "end_logit": -0.92333984375,
            "text": "gp91(phox)",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -5.734375,
            "end_logit": 3.8828125,
            "text": "The activity of other Nox enzymes such as gp91(phox)/Nox2 and Nox1",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.09765625,
            "end_logit": 3.8828125,
            "text": "1",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.23828125,
            "end_logit": 3.8828125,
            "text": "Nox enzymes such as gp91(phox)/Nox2 and Nox1",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 3.8828125,
            "text": "91(phox)/Nox2 and Nox1",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.453125,
            "end_logit": 3.8828125,
            "text": "as gp91(phox)/Nox2 and Nox1",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 3.8828125,
            "text": "(phox)/Nox2 and Nox1",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -0.391357421875,
            "end_logit": -2.912109375,
            "text": "gp91(phox)/Nox2 and Nox",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.391357421875,
            "end_logit": -3.490234375,
            "text": "gp91(phox)/Nox2 and Nox1 is known",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.391357421875,
            "end_logit": -3.765625,
            "text": "gp91(phox)/Nox2 and Nox1 is known to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.391357421875,
            "end_logit": -4.05078125,
            "text": "gp91(phox)/Nox2 and Nox1 is known to absolutely require both",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5a51060087bc10a000021_7": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.046875,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2578125,
            "text": "NOX",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -1.470703125,
            "end_logit": 9.046875,
            "text": "1",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.72265625,
            "text": "NOX1 was",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.72265625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.73828125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.97265625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.9765625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.9921875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.046875,
            "text": "of NOX1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.046875,
            "text": "Studies of cytosolic co-factors showed that the C-terminal cytoplasmic domain of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.046875,
            "text": "the C-terminal cytoplasmic domain of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.046875,
            "text": "that the C-terminal cytoplasmic domain of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -5.72265625,
            "text": "1 was",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -1.2578125,
            "text": "of NOX",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.72265625,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.73828125,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.875,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.97265625,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_8": [
        {
            "start_logit": 9.03125,
            "end_logit": 8.7734375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.03125,
            "end_logit": -1.1767578125,
            "text": "Nox1.",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 9.03125,
            "end_logit": -1.552734375,
            "text": "Nox",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": -1.88671875,
            "end_logit": 8.7734375,
            "text": "1",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": -2.712890625,
            "end_logit": 8.7734375,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -5.8125,
            "end_logit": 8.7734375,
            "text": ", NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 8.7734375,
            "text": "(NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 8.7734375,
            "text": "of Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 8.7734375,
            "text": "shown to interact with the NADPH-binding region of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 8.7734375,
            "text": "NADPH-binding region of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.7734375,
            "text": "with the NADPH-binding region of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.7734375,
            "text": "Additionally, NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.7734375,
            "text": "the NADPH-binding region of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.7734375,
            "text": "interact with the NADPH-binding region of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.7734375,
            "text": "region of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.7734375,
            "text": "to interact with the NADPH-binding region of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.7734375,
            "text": "NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.88671875,
            "end_logit": -1.1767578125,
            "text": "1.",
            "probability": 0.0
        },
        {
            "start_logit": -2.712890625,
            "end_logit": -1.1767578125,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1.",
            "probability": 0.0
        },
        {
            "start_logit": -2.712890625,
            "end_logit": -1.552734375,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_9": [
        {
            "start_logit": 8.9375,
            "end_logit": 9.0234375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.4697265625,
            "end_logit": 9.0234375,
            "text": "1",
            "probability": 2.9981136322021484e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -1.8466796875,
            "text": "Nox",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -2.646484375,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1.",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 8.9375,
            "end_logit": -3.12109375,
            "text": "Nox1,",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 8.9375,
            "end_logit": -5.91796875,
            "text": "Nox1, complexed with p22(phox) at",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.19140625,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 9.0234375,
            "text": "Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.31640625,
            "text": "Nox1, complexed with p22(phox) at the membrane,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 9.0234375,
            "text": "NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.37109375,
            "text": "Nox1, complexed with p22(phox) at the membrane",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.48828125,
            "text": "Nox1, complexed with p22(phox) at the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.609375,
            "text": "Nox1, complexed with p22(phox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 9.0234375,
            "text": "producing NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 9.0234375,
            "text": "oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 9.0234375,
            "text": "of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.0234375,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 9.0234375,
            "text": "phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.4697265625,
            "end_logit": -2.646484375,
            "text": "1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4697265625,
            "end_logit": -3.12109375,
            "text": "1,",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_10": [
        {
            "start_logit": 7.8359375,
            "end_logit": 6.31640625,
            "text": "NADPH oxidase 1",
            "probability": 0.9921875
        },
        {
            "start_logit": 7.8359375,
            "end_logit": 1.412109375,
            "text": "NADPH oxidase 1 assembly and activation.",
            "probability": 0.007343292236328125
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -3.001953125,
            "text": "NADPH oxidase 1 assembly and",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -3.015625,
            "text": "NADPH oxidase 1 assembly",
            "probability": 8.755922317504883e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -3.2890625,
            "text": "NADPH oxidase 1 assembly and activation",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -3.37890625,
            "text": "NADPH",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": -2.20703125,
            "end_logit": 6.31640625,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 4.297494888305664e-05
        },
        {
            "start_logit": 7.8359375,
            "end_logit": -4.74609375,
            "text": "NADPH oxidase",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": -4.78515625,
            "end_logit": 6.31640625,
            "text": "1",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 6.31640625,
            "text": "optimal NADPH oxidase 1",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 6.31640625,
            "text": "phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 6.31640625,
            "text": "on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.20703125,
            "end_logit": 1.412109375,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.31640625,
            "text": "O1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.31640625,
            "text": "oxidase 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.31640625,
            "text": "for optimal NADPH oxidase 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 6.31640625,
            "text": "serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.31640625,
            "text": "critical for optimal NADPH oxidase 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.587890625,
            "end_logit": 1.412109375,
            "text": ".",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.78515625,
            "end_logit": 1.412109375,
            "text": "1 assembly and activation.",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_11": [
        {
            "start_logit": 9.015625,
            "end_logit": 9.015625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.6142578125,
            "end_logit": 9.015625,
            "text": "1",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.015625,
            "end_logit": -1.83203125,
            "text": "Nox",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 9.015625,
            "end_logit": -3.94921875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 9.015625,
            "end_logit": -5.9921875,
            "text": "Nox1 requires",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.46875,
            "text": "Nox1 requires both",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.78125,
            "text": "Nox1 requires both the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8125,
            "end_logit": 9.015625,
            "text": "NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.81640625,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.890625,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.89453125,
            "text": "Nox1 requires both the organizer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -6.92578125,
            "text": "Nox1 requires both the organizer protein Noxo1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.015625,
            "end_logit": -7.0,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 9.015625,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.015625,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.359375,
            "end_logit": 9.015625,
            "text": "producing NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.015625,
            "text": "oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.015625,
            "text": "of the superoxide-producing NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.015625,
            "text": "the superoxide-producing NADPH oxidase Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6142578125,
            "end_logit": -3.94921875,
            "text": "1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_12": [
        {
            "start_logit": 9.109375,
            "end_logit": 8.9140625,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.4833984375,
            "text": "NOX",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": 8.9140625,
            "text": "1",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.046875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.06640625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.15625,
            "text": "NOX1,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.16796875,
            "text": "NOX1, an NADPH oxidase homologue that",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.34765625,
            "text": "NOX1, an NADPH oxidase homologue",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.4921875,
            "text": "NOX1, an NADPH oxidase homologue that is most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.515625,
            "text": "NOX1, an NADPH oxidase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.58984375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.640625,
            "text": "NOX1, an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.66796875,
            "text": "NOX1, an NADPH oxidase homologue that is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.703125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.7265625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.76953125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": -6.046875,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells,",
            "probability": 0.0
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": -6.06640625,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 0.0
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": -6.15625,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -1.8173828125,
            "end_logit": -6.16796875,
            "text": "1, an NADPH oxidase homologue that",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_13": [
        {
            "start_logit": 6.5703125,
            "end_logit": 7.328125,
            "text": "Nox1",
            "probability": 0.7646484375
        },
        {
            "start_logit": 6.9921875,
            "end_logit": 5.72265625,
            "text": "Noxa1",
            "probability": 0.235107421875
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -2.03515625,
            "text": "Noxa1, respectively.",
            "probability": 0.0001004934310913086
        },
        {
            "start_logit": -3.806640625,
            "end_logit": 7.328125,
            "text": "1",
            "probability": 2.384185791015625e-05
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -4.03515625,
            "text": "Nox",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -4.0859375,
            "text": "Nox",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -4.6171875,
            "text": "Nox1,",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 7.328125,
            "text": "Activation of Nox1",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.02734375,
            "text": "Nox1, an oxidase that",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.0390625,
            "text": "Nox1, an oxidase",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.19140625,
            "text": "Nox1, an",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.43359375,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon,",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.65234375,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67phox",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.9921875,
            "end_logit": -6.17578125,
            "text": "Noxa1, respectively",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.53125,
            "end_logit": 7.328125,
            "text": "of Nox1",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -5.921875,
            "text": "Nox1, an oxidase that is likely involved in host defence",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.1328125,
            "text": "Nox1, an oxidase that is",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.30859375,
            "text": "Nox1, an oxidase that is likely involved in host defence at",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.3203125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.5703125,
            "end_logit": -6.3203125,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon",
            "probability": 8.940696716308594e-07
        }
    ],
    "58a5a51060087bc10a000021_14": [
        {
            "start_logit": 6.4453125,
            "end_logit": -0.67919921875,
            "text": "NADPH oxidase 1 with betaPix",
            "probability": 0.62646484375
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -1.94140625,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.1773681640625
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -2.22265625,
            "text": "NADPH oxidase 1",
            "probability": 0.1339111328125
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -4.39453125,
            "text": "NADPH",
            "probability": 0.01525115966796875
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -4.55078125,
            "text": "NADPH oxidase 1 with betaPix and",
            "probability": 0.0130462646484375
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -4.875,
            "text": "NADPH oxidase 1 with beta",
            "probability": 0.00943756103515625
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -5.1953125,
            "text": "NADPH oxidase",
            "probability": 0.0068511962890625
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -5.73828125,
            "text": "NADPH oxidase 1 with",
            "probability": 0.003978729248046875
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -5.890625,
            "text": "NADPH oxidase 1 with betaPi",
            "probability": 0.0034160614013671875
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -5.97265625,
            "text": "NADPH oxidase 1 with betaPix and Nox",
            "probability": 0.0031490325927734375
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -6.10546875,
            "text": "NADPH oxidase 1 with betaPix and Nox Organize",
            "probability": 0.0027561187744140625
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -6.1796875,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer",
            "probability": 0.002559661865234375
        },
        {
            "start_logit": 6.4453125,
            "end_logit": -6.35546875,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1",
            "probability": 0.0021457672119140625
        },
        {
            "start_logit": -3.595703125,
            "end_logit": -1.94140625,
            "text": ".",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -0.67919921875,
            "text": "Molecular interaction of NADPH oxidase 1 with betaPix",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -0.67919921875,
            "text": "of NADPH oxidase 1 with betaPix",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -0.67919921875,
            "text": "oxidase 1 with betaPix",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": -0.67919921875,
            "text": "with betaPix",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": -0.67919921875,
            "text": "betaPix",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.67919921875,
            "text": "Pix",
            "probability": 5.364418029785156e-07
        }
    ],
    "58a5a51060087bc10a000021_15": [
        {
            "start_logit": 6.3203125,
            "end_logit": 4.58203125,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.79931640625
        },
        {
            "start_logit": 6.3203125,
            "end_logit": 2.244140625,
            "text": "NADPH oxidase 1 (NOX1)",
            "probability": 0.07672119140625
        },
        {
            "start_logit": 6.3203125,
            "end_logit": 2.037109375,
            "text": "NADPH oxidase 1",
            "probability": 0.0626220703125
        },
        {
            "start_logit": 3.396484375,
            "end_logit": 4.58203125,
            "text": "NOX1",
            "probability": 0.042694091796875
        },
        {
            "start_logit": 6.3203125,
            "end_logit": 0.2471923828125,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0104217529296875
        },
        {
            "start_logit": 3.396484375,
            "end_logit": 2.244140625,
            "text": "NOX1)",
            "probability": 0.00412750244140625
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -1.2265625,
            "text": "NADPH oxidase 1 (NOX1),",
            "probability": 0.0023899078369140625
        },
        {
            "start_logit": 3.396484375,
            "end_logit": 0.2471923828125,
            "text": "NOX",
            "probability": 0.0005612373352050781
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -3.6328125,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 0.0002155303955078125
        },
        {
            "start_logit": -2.35546875,
            "end_logit": 4.58203125,
            "text": "(NOX1",
            "probability": 0.00013589859008789062
        },
        {
            "start_logit": 3.396484375,
            "end_logit": -1.2265625,
            "text": "NOX1),",
            "probability": 0.00012862682342529297
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -4.4453125,
            "text": "NADPH",
            "probability": 9.560585021972656e-05
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -4.68359375,
            "text": "NADPH oxidase",
            "probability": 7.56382942199707e-05
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -4.9765625,
            "text": "NADPH oxidase 1 (NOX1), which",
            "probability": 5.620718002319336e-05
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -5.16796875,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22",
            "probability": 4.661083221435547e-05
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -5.30078125,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX",
            "probability": 4.0471553802490234e-05
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -5.93359375,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX) and",
            "probability": 2.1696090698242188e-05
        },
        {
            "start_logit": -4.4296875,
            "end_logit": 4.58203125,
            "text": "by NADPH oxidase 1 (NOX1",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": -2.35546875,
            "end_logit": 2.244140625,
            "text": "(NOX1)",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": 3.396484375,
            "end_logit": -3.6328125,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 1.1563301086425781e-05
        }
    ],
    "58a5a51060087bc10a000021_16": [
        {
            "start_logit": 9.0859375,
            "end_logit": 8.9453125,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.5517578125,
            "text": "NOX",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -1.7666015625,
            "end_logit": 8.9453125,
            "text": "1",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.28515625,
            "text": "NOX1,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.453125,
            "text": "NOX1, an NADPH oxidase homologue that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.5,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.51953125,
            "text": "NOX1, an NADPH oxidase homologue",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.609375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.6875,
            "text": "NOX1, an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.6875,
            "text": "NOX1, an NADPH oxidase homologue that is most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.69140625,
            "text": "NOX1, an NADPH oxidase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.703125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.83984375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.8515625,
            "text": "NOX1, an NADPH oxidase homologue that is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.87109375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.87109375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.9453125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7666015625,
            "end_logit": -6.28515625,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -1.7666015625,
            "end_logit": -6.453125,
            "text": "1, an NADPH oxidase homologue that",
            "probability": 0.0
        },
        {
            "start_logit": -1.7666015625,
            "end_logit": -6.5,
            "text": "1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_17": [
        {
            "start_logit": 8.421875,
            "end_logit": 8.9609375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": 8.9609375,
            "text": "1",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 8.421875,
            "end_logit": -2.75390625,
            "text": "Nox",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": 8.421875,
            "end_logit": -5.8359375,
            "text": "Nox1 requires",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.9609375,
            "text": "NADPH oxidase Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.39453125,
            "text": "Nox1 requires both",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.9609375,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.9609375,
            "text": "of the superoxide-producing NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.9609375,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.9609375,
            "text": "producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.9609375,
            "text": "oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.9609375,
            "text": "Nox1 requires both the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.96875,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.9609375,
            "text": "the superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.98828125,
            "text": "Nox1 requires both the organizer protein Noxo1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.05078125,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.0546875,
            "text": "Nox1 requires both the organizer protein Nox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.0546875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.1171875,
            "text": "Nox1 requires both the organizer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7333984375,
            "end_logit": -5.8359375,
            "text": "1 requires",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_18": [
        {
            "start_logit": 8.6953125,
            "end_logit": 9.03125,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.3798828125,
            "end_logit": 9.03125,
            "text": "1",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -2.1640625,
            "text": "Nox",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -3.130859375,
            "text": "Nox1,",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -5.88671875,
            "text": "Nox1, complexed with p22(phox) at",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.0234375,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 9.03125,
            "text": "Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.546875,
            "end_logit": 9.03125,
            "text": "NADPH oxidase Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 9.03125,
            "text": "oxidase Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.390625,
            "text": "Nox1, complexed with p22(phox) at the membrane",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 9.03125,
            "text": "producing NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.5,
            "text": "Nox1, complexed with p22(phox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.5,
            "text": "Nox1, complexed with p22(phox) at the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.54296875,
            "text": "Nox1, complexed with p22(phox) at the membrane,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6953125,
            "end_logit": -6.7265625,
            "text": "Nox1, complexed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.03125,
            "text": "of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 9.03125,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.03125,
            "text": "phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.3798828125,
            "end_logit": -3.130859375,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -1.3798828125,
            "end_logit": -5.88671875,
            "text": "1, complexed with p22(phox) at",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_19": [
        {
            "start_logit": 6.6171875,
            "end_logit": 7.16015625,
            "text": "NADPH oxidase 1 (Nox1",
            "probability": 0.794921875
        },
        {
            "start_logit": 5.23046875,
            "end_logit": 7.16015625,
            "text": "Nox1",
            "probability": 0.1978759765625
        },
        {
            "start_logit": 6.6171875,
            "end_logit": 1.4111328125,
            "text": "NADPH oxidase 1 (Nox1) is",
            "probability": 0.0025310516357421875
        },
        {
            "start_logit": 0.77294921875,
            "end_logit": 7.16015625,
            "text": "(Nox1",
            "probability": 0.0022945404052734375
        },
        {
            "start_logit": 6.6171875,
            "end_logit": 0.458740234375,
            "text": "NADPH oxidase 1 (Nox1)",
            "probability": 0.0009717941284179688
        },
        {
            "start_logit": 5.23046875,
            "end_logit": 1.4111328125,
            "text": "Nox1) is",
            "probability": 0.0006299018859863281
        },
        {
            "start_logit": 5.23046875,
            "end_logit": 0.458740234375,
            "text": "Nox1)",
            "probability": 0.0002428293228149414
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -2.173828125,
            "text": "NADPH oxidase 1 (Nox1) is a",
            "probability": 7.015466690063477e-05
        },
        {
            "start_logit": -3.662109375,
            "end_logit": 7.16015625,
            "text": "1",
            "probability": 2.7239322662353516e-05
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -3.19140625,
            "text": "NADPH oxidase 1",
            "probability": 2.5212764739990234e-05
        },
        {
            "start_logit": 5.23046875,
            "end_logit": -2.173828125,
            "text": "Nox1) is a",
            "probability": 1.7464160919189453e-05
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -3.83984375,
            "text": "NADPH oxidase 1 (Nox",
            "probability": 1.329183578491211e-05
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -4.06640625,
            "text": "NADPH",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": 0.77294921875,
            "end_logit": 1.4111328125,
            "text": "(Nox1) is",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -4.52734375,
            "text": "NADPH oxidase 1 (",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 5.23046875,
            "end_logit": -3.83984375,
            "text": "Nox",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 0.77294921875,
            "end_logit": 0.458740234375,
            "text": "(Nox1)",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -5.50390625,
            "text": "NADPH oxidase",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -5.546875,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox)",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -5.6875,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme",
            "probability": 2.086162567138672e-06
        }
    ],
    "58a5a51060087bc10a000021_20": [
        {
            "start_logit": 8.9453125,
            "end_logit": 9.0546875,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.48828125,
            "end_logit": 9.0546875,
            "text": "1",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -1.7666015625,
            "text": "Nox",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": -4.07421875,
            "end_logit": 9.0546875,
            "text": "Superoxide production by Nox1",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 9.0546875,
            "text": "by Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.453125,
            "text": "Nox1,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.55078125,
            "text": "Nox1, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.59375,
            "text": "Nox1, a member of the Nox family",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.6015625,
            "text": "Nox1, a member",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.62109375,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.73046875,
            "text": "Nox1, a member of the Nox",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.77734375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.81640625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.8203125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.953125,
            "text": "Nox1, a member of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9453125,
            "end_logit": -6.98046875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.0546875,
            "text": "UNLABELLED: Superoxide production by Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -1.7666015625,
            "text": "Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -1.7666015625,
            "text": "by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -1.48828125,
            "end_logit": -6.453125,
            "text": "1,",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_21": [
        {
            "start_logit": 5.53515625,
            "end_logit": 4.39453125,
            "text": "NOX",
            "probability": 0.4658203125
        },
        {
            "start_logit": 4.82421875,
            "end_logit": 4.39453125,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.2288818359375
        },
        {
            "start_logit": 5.53515625,
            "end_logit": 3.521484375,
            "text": "NOX1",
            "probability": 0.1942138671875
        },
        {
            "start_logit": 4.82421875,
            "end_logit": 3.521484375,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.09539794921875
        },
        {
            "start_logit": 4.82421875,
            "end_logit": 0.95166015625,
            "text": "NADPH oxidase 1",
            "probability": 0.007328033447265625
        },
        {
            "start_logit": 4.82421875,
            "end_logit": 0.81982421875,
            "text": "NADPH oxidase 1 (",
            "probability": 0.00641632080078125
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -1.7744140625,
            "text": "NOX1)",
            "probability": 0.0009765625
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -1.7744140625,
            "text": "NADPH oxidase 1 (NOX1)",
            "probability": 0.0004794597625732422
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -3.083984375,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.",
            "probability": 0.0002636909484863281
        },
        {
            "start_logit": -2.16796875,
            "end_logit": 4.39453125,
            "text": "(NOX",
            "probability": 0.00021028518676757812
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -3.083984375,
            "text": "NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.",
            "probability": 0.00012946128845214844
        },
        {
            "start_logit": -2.16796875,
            "end_logit": 3.521484375,
            "text": "(NOX1",
            "probability": 8.767843246459961e-05
        },
        {
            "start_logit": -3.287109375,
            "end_logit": 4.39453125,
            "text": "p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX",
            "probability": 6.878376007080078e-05
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -4.0546875,
            "text": "NADPH oxidase",
            "probability": 4.9173831939697266e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -4.9140625,
            "text": "NOX1) mediates",
            "probability": 4.208087921142578e-05
        },
        {
            "start_logit": -4.15234375,
            "end_logit": 4.39453125,
            "text": "of NADPH oxidase 1 (NOX",
            "probability": 2.8908252716064453e-05
        },
        {
            "start_logit": -3.287109375,
            "end_logit": 3.521484375,
            "text": "p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -5.390625,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a",
            "probability": 2.6345252990722656e-05
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -4.78515625,
            "text": "NADPH",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 4.82421875,
            "end_logit": -4.9140625,
            "text": "NADPH oxidase 1 (NOX1) mediates",
            "probability": 2.0802021026611328e-05
        }
    ],
    "58a5a51060087bc10a000021_22": [
        {
            "start_logit": 9.2578125,
            "end_logit": 9.046875,
            "text": "NOX1",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.2578125,
            "text": "NOX",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -1.470703125,
            "end_logit": 9.046875,
            "text": "1",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -5.72265625,
            "text": "NOX1 was",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.72265625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.73828125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.97265625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.9765625,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -6.9921875,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 9.046875,
            "text": "of NOX1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 9.046875,
            "text": "Studies of cytosolic co-factors showed that the C-terminal cytoplasmic domain of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.046875,
            "text": "the C-terminal cytoplasmic domain of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 9.046875,
            "text": "that the C-terminal cytoplasmic domain of NOX1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -5.72265625,
            "text": "1 was",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -1.2578125,
            "text": "of NOX",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.72265625,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.73828125,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.875,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region",
            "probability": 0.0
        },
        {
            "start_logit": -1.470703125,
            "end_logit": -6.97265625,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_23": [
        {
            "start_logit": 8.375,
            "end_logit": 6.8203125,
            "text": "p67(phox)",
            "probability": 1.0
        },
        {
            "start_logit": 8.375,
            "end_logit": -2.966796875,
            "text": "p",
            "probability": 5.608797073364258e-05
        },
        {
            "start_logit": 8.375,
            "end_logit": -4.1171875,
            "text": "p67(phox) that",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -4.37109375,
            "end_logit": 6.8203125,
            "text": ")",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -5.96484375,
            "text": "p67(phox",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.4453125,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.48046875,
            "text": "p67",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.62109375,
            "text": "p67(",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.6875,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.140625,
            "end_logit": 6.8203125,
            "text": "of p67(phox)",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.734375,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.375,
            "end_logit": -6.80078125,
            "text": "p67(phox) that acts in conjunction with Nox organizer 1 (NoxO1) to",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 6.8203125,
            "text": "67(phox)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 6.8203125,
            "text": "(phox)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 6.8203125,
            "text": "phox)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 6.8203125,
            "text": "homologue of p67(phox)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.8271484375,
            "end_logit": 0.04046630859375,
            "text": "Nox1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.37109375,
            "end_logit": 0.04046630859375,
            "text": ") that acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 0.0
        },
        {
            "start_logit": -1.8271484375,
            "end_logit": -3.310546875,
            "text": "Nox1.",
            "probability": 0.0
        },
        {
            "start_logit": -1.8271484375,
            "end_logit": -4.0546875,
            "text": "Nox",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_24": [
        {
            "start_logit": 8.984375,
            "end_logit": 8.734375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.8076171875,
            "text": "Nox",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -2.1796875,
            "end_logit": 8.734375,
            "text": "1",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -5.9140625,
            "text": "Nox1 is highly expressed in the colon, and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.03515625,
            "text": "Nox1 is highly expressed in the colon,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.1328125,
            "text": "Nox1 is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.26953125,
            "text": "Nox1 is highly",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.27734375,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.71875,
            "text": "Nox1 is highly expressed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.75390625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit Nox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.7890625,
            "text": "Nox1 is highly expressed in the colon, and requires two",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.86328125,
            "text": "Nox1 is highly expressed in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.8671875,
            "text": "Nox1 is highly expressed in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.88671875,
            "text": "Nox1 is highly expressed in the colon",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -5.9140625,
            "text": "1 is highly expressed in the colon, and",
            "probability": 0.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -6.03515625,
            "text": "1 is highly expressed in the colon,",
            "probability": 0.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -6.1328125,
            "text": "1 is",
            "probability": 0.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -6.26953125,
            "text": "1 is highly",
            "probability": 0.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -6.27734375,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 0.0
        },
        {
            "start_logit": -2.1796875,
            "end_logit": -6.71875,
            "text": "1 is highly expressed",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_25": [
        {
            "start_logit": 9.0625,
            "end_logit": 8.78125,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.625,
            "text": "Nox",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 8.78125,
            "text": "1",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -5.70703125,
            "text": "Nox1 is highly expressed in the colon,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -5.79296875,
            "text": "Nox1 is",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.0859375,
            "text": "Nox1 is highly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.36328125,
            "text": "Nox1 is highly expressed in the colon, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5546875,
            "text": "Nox1 is highly expressed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5625,
            "text": "Nox1 is highly expressed in the colon, and it requires two",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.66015625,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.6796875,
            "text": "Nox1 is highly expressed in the colon, and it",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.703125,
            "text": "Nox1 is highly expressed in the colon",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.734375,
            "text": "Nox1 is highly expressed in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.74609375,
            "text": "Nox1 is highly expressed in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.76953125,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.7890625,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and Nox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.859375,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.068359375,
            "end_logit": -5.70703125,
            "text": "1 is highly expressed in the colon,",
            "probability": 0.0
        },
        {
            "start_logit": -2.068359375,
            "end_logit": -5.79296875,
            "text": "1 is",
            "probability": 0.0
        },
        {
            "start_logit": -2.068359375,
            "end_logit": -6.0859375,
            "text": "1 is highly",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_26": [
        {
            "start_logit": 6.06640625,
            "end_logit": 4.48828125,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.79833984375
        },
        {
            "start_logit": 6.06640625,
            "end_logit": 2.291015625,
            "text": "NADPH oxidase 1 (NOX1)",
            "probability": 0.0888671875
        },
        {
            "start_logit": 3.54296875,
            "end_logit": 4.48828125,
            "text": "NOX1",
            "probability": 0.06402587890625
        },
        {
            "start_logit": 6.06640625,
            "end_logit": 1.0947265625,
            "text": "NADPH oxidase 1",
            "probability": 0.02679443359375
        },
        {
            "start_logit": 6.06640625,
            "end_logit": 0.153564453125,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 0.0104522705078125
        },
        {
            "start_logit": 3.54296875,
            "end_logit": 2.291015625,
            "text": "NOX1)",
            "probability": 0.0071258544921875
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -1.2861328125,
            "text": "NADPH oxidase 1 (NOX1),",
            "probability": 0.0024814605712890625
        },
        {
            "start_logit": 3.54296875,
            "end_logit": 0.153564453125,
            "text": "NOX",
            "probability": 0.0008378028869628906
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -3.556640625,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 0.000255584716796875
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 4.48828125,
            "text": "(NOX1",
            "probability": 0.00023448467254638672
        },
        {
            "start_logit": 3.54296875,
            "end_logit": -1.2861328125,
            "text": "NOX1),",
            "probability": 0.0001990795135498047
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -4.60546875,
            "text": "NADPH",
            "probability": 8.96453857421875e-05
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -4.640625,
            "text": "NADPH oxidase",
            "probability": 8.690357208251953e-05
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -4.89453125,
            "text": "NADPH oxidase 1 (NOX1), which",
            "probability": 6.717443466186523e-05
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -5.265625,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22",
            "probability": 4.655122756958008e-05
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -5.28125,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX",
            "probability": 4.583597183227539e-05
        },
        {
            "start_logit": -3.88671875,
            "end_logit": 4.48828125,
            "text": "by NADPH oxidase 1 (NOX1",
            "probability": 3.796815872192383e-05
        },
        {
            "start_logit": 6.06640625,
            "end_logit": -5.53125,
            "text": "NADPH oxidase 1 (NOX1), which is mainly expressed in colon epithelial cells,",
            "probability": 3.5703182220458984e-05
        },
        {
            "start_logit": -2.068359375,
            "end_logit": 2.291015625,
            "text": "(NOX1)",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": 3.54296875,
            "end_logit": -3.556640625,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 2.0503997802734375e-05
        }
    ],
    "58a5a51060087bc10a000021_27": [
        {
            "start_logit": 8.9375,
            "end_logit": 9.03125,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": 9.03125,
            "text": "1",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 8.9375,
            "end_logit": -1.7509765625,
            "text": "Nox",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -5.8125,
            "end_logit": 9.03125,
            "text": "Superoxide production by Nox1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -5.953125,
            "text": "Nox1,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 9.03125,
            "text": "by Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.48828125,
            "text": "Nox1, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.53125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.55859375,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.63671875,
            "text": "Nox1, a member of the Nox",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.65625,
            "text": "Nox1, a member of the Nox family",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.703125,
            "text": "Nox1, a member of the Nox family NAP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.70703125,
            "text": "Nox1, a member",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.7109375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.8125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.9375,
            "end_logit": -6.8984375,
            "text": "Nox1, a member of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -5.953125,
            "text": "1,",
            "probability": 0.0
        },
        {
            "start_logit": -5.8125,
            "end_logit": -1.7509765625,
            "text": "Superoxide production by Nox",
            "probability": 0.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -6.48828125,
            "text": "1, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.4853515625,
            "end_logit": -6.53125,
            "text": "1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_1": [
        {
            "start_logit": 9.375,
            "end_logit": 9.046875,
            "text": "IFN signature",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.82568359375,
            "text": "IFN",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": -1.4970703125,
            "end_logit": 9.046875,
            "text": "signature",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.73046875,
            "text": "IFN signature was",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 9.046875,
            "text": "I IFN signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.05078125,
            "text": "IFN signature was assessed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 9.046875,
            "text": "type I IFN signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.3203125,
            "text": "IFN signature was assessed in these subjects to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.3828125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.3828125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.3984375,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease-",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.40625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.41015625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.4140625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.41796875,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.421875,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.046875,
            "text": "A five gene type I IFN signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 9.046875,
            "text": "five gene type I IFN signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.046875,
            "text": "gene type I IFN signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -0.82568359375,
            "text": "I IFN",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_2": [
        {
            "start_logit": 9.296875,
            "end_logit": 8.90625,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.072265625,
            "text": "interferon",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": -1.8154296875,
            "end_logit": 8.90625,
            "text": "signature",
            "probability": 1.4960765838623047e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.44921875,
            "text": "interferon signature similar to but less intense than that seen in patients with lupus.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -6.9296875,
            "text": "interferon signature similar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.1875,
            "text": "interferon signature similar to but",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.23828125,
            "text": "interferon signature similar to but less intense than that seen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.25,
            "text": "interferon signature similar to but less",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.28125,
            "text": "interferon signature similar to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.32421875,
            "text": "interferon signature similar to but less intense",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.90625,
            "text": "Gene expression analysis of peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.90625,
            "text": "an interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.90625,
            "text": "cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8154296875,
            "end_logit": -6.44921875,
            "text": "signature similar to but less intense than that seen in patients with lupus.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -1.072265625,
            "text": "Gene expression analysis of peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -1.072265625,
            "text": "an interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -1.072265625,
            "text": "cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.8154296875,
            "end_logit": -6.9296875,
            "text": "signature similar",
            "probability": 0.0
        },
        {
            "start_logit": -1.8154296875,
            "end_logit": -7.1875,
            "text": "signature similar to but",
            "probability": 0.0
        },
        {
            "start_logit": -1.8154296875,
            "end_logit": -7.23828125,
            "text": "signature similar to but less intense than that seen",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_3": [
        {
            "start_logit": 9.171875,
            "end_logit": 8.984375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 9.171875,
            "end_logit": -1.4345703125,
            "text": "interferon",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.728515625,
            "end_logit": 8.984375,
            "text": "signature",
            "probability": 1.8477439880371094e-05
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 8.984375,
            "text": "the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.171875,
            "end_logit": -6.9140625,
            "text": "interferon signature.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.984375,
            "text": "termed the interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.984375,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.984375,
            "text": "expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -1.4345703125,
            "text": "the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.728515625,
            "end_logit": -6.9140625,
            "text": "signature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -1.4345703125,
            "text": "termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -1.4345703125,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.4345703125,
            "text": "expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -4.81640625,
            "end_logit": -6.9140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -6.9140625,
            "text": "the interferon signature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -6.9140625,
            "text": "termed the interferon signature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -7.1796875,
            "text": "termed",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -6.9140625,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -6.9140625,
            "text": "expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.0703125,
            "text": ", and a",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_4": [
        {
            "start_logit": 9.1640625,
            "end_logit": 8.96875,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.48046875,
            "text": "interferon",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -1.7099609375,
            "end_logit": 8.96875,
            "text": "signature",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.65625,
            "text": "interferon signature in lupus).",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.94921875,
            "text": "interferon signature in lupus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.98046875,
            "text": "interferon signature in lupus)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.09375,
            "text": "interferon signature in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.96875,
            "text": ". interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 8.96875,
            "text": ", have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.96875,
            "text": ".g. interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.96875,
            "text": "led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.96875,
            "text": "autoimmune disorders, have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.96875,
            "text": "in these diseases (e.g. interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7099609375,
            "end_logit": -5.65625,
            "text": "signature in lupus).",
            "probability": 0.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -1.48046875,
            "text": ". interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -1.48046875,
            "text": ", have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.7099609375,
            "end_logit": -6.94921875,
            "text": "signature in lupus",
            "probability": 0.0
        },
        {
            "start_logit": -1.7099609375,
            "end_logit": -6.98046875,
            "text": "signature in lupus)",
            "probability": 0.0
        },
        {
            "start_logit": -1.7099609375,
            "end_logit": -7.09375,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -1.48046875,
            "text": ".g. interferon",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_5": [
        {
            "start_logit": 9.34375,
            "end_logit": 9.09375,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 9.34375,
            "end_logit": -0.9443359375,
            "text": "interferon",
            "probability": 4.369020462036133e-05
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": 9.09375,
            "text": "signature",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -5.59375,
            "end_logit": 9.09375,
            "text": "type I interferon signature",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -5.9609375,
            "text": "interferon signature and the response to rituximab in rheumatoid arthritis patients.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.34375,
            "text": "interferon signature and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.75390625,
            "text": "interferon signature and the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.82421875,
            "text": "interferon signature and the response to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.9453125,
            "text": "interferon signature and the response",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -6.9765625,
            "text": "interferon signature and the response to rituximab in rheumatoid arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.015625,
            "text": "interferon signature and the response to rituximab in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.0859375,
            "text": "interferon signature and the response to rituximab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 9.09375,
            "text": "I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.11328125,
            "text": "interferon signature and the response to rituximab in rheumatoid arthritis patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.34375,
            "end_logit": -7.125,
            "text": "interferon signature and the response to rituximab in rheumatoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.09375,
            "text": "the type I interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 9.09375,
            "text": "Relationship between the type I interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.59375,
            "end_logit": -0.9443359375,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": -5.9609375,
            "text": "signature and the response to rituximab in rheumatoid arthritis patients.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4248046875,
            "end_logit": -6.34375,
            "text": "signature and",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_6": [
        {
            "start_logit": 9.375,
            "end_logit": 9.0703125,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.837890625,
            "text": "interferon",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -1.46484375,
            "end_logit": 9.0703125,
            "text": "signature",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 9.0703125,
            "text": "type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 9.0703125,
            "text": "I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.84765625,
            "text": "interferon signature in rheumatoid arthritis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.9609375,
            "text": "interferon signature in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.0859375,
            "text": "interferon signature in rheumatoid arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.1484375,
            "text": "interferon signature in rheumatoid",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 9.0703125,
            "text": "the type I interferon signature",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.40625,
            "end_logit": -0.837890625,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -0.837890625,
            "text": "I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -6.84765625,
            "text": "signature in rheumatoid arthritis.",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -6.9609375,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -0.837890625,
            "text": "the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.0859375,
            "text": "signature in rheumatoid arthritis",
            "probability": 0.0
        },
        {
            "start_logit": -1.46484375,
            "end_logit": -7.1484375,
            "text": "signature in rheumatoid",
            "probability": 0.0
        },
        {
            "start_logit": -5.26171875,
            "end_logit": -6.84765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.40625,
            "end_logit": -6.84765625,
            "text": "type I interferon signature in rheumatoid arthritis.",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -6.84765625,
            "text": "I interferon signature in rheumatoid arthritis.",
            "probability": 0.0
        }
    ],
    "517170c48ed59a060a00000d_1": [
        {
            "start_logit": 7.97265625,
            "end_logit": 7.21484375,
            "text": "25",
            "probability": 1.0
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -4.19140625,
            "text": "25 selenoproteins.",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -6.43359375,
            "text": "25 selenoproteins",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.97265625,
            "end_logit": -7.0234375,
            "text": "25 selen",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.21484375,
            "text": "The human selenoproteome consists of 25",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 7.21484375,
            "text": "human selenoproteome consists of 25",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 7.21484375,
            "text": "selenoproteome consists of 25",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.21484375,
            "text": "oproteome consists of 25",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.76171875,
            "end_logit": -4.19140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -4.19140625,
            "text": "The human selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -4.19140625,
            "text": "human selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -4.19140625,
            "text": "selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -4.19140625,
            "text": "selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -4.19140625,
            "text": "oproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.43359375,
            "text": "The human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.51953125,
            "text": "The human selenoproteome consists of",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.57421875,
            "text": "The human selenoproteome consists",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -6.859375,
            "text": "The human selenoproteome",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -6.43359375,
            "text": "human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -6.43359375,
            "text": "selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_1": [
        {
            "start_logit": 8.6015625,
            "end_logit": 9.03125,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": 9.03125,
            "text": "Y",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -2.595703125,
            "text": "XX",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 9.03125,
            "text": "Klinefelter syndrome (XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -7.08984375,
            "text": "XXY)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.515625,
            "end_logit": -7.08984375,
            "text": "Y)",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -2.595703125,
            "text": "Klinefelter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -7.08984375,
            "text": "Klinefelter syndrome (XXY)",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -7.2109375,
            "text": "Klinefelter syndrome",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -7.21875,
            "text": "Klinefelt",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -7.22265625,
            "text": "Klinefe",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -7.26953125,
            "text": "Klinefelter",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -7.28515625,
            "text": "Kline",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_2": [
        {
            "start_logit": 8.7734375,
            "end_logit": 6.0078125,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -5.18359375,
            "text": "X chromosome",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -5.41796875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome).",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.8125,
            "text": "X chromosome (47,XXY",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.86328125,
            "text": "X chromosome (47,XXY or Klinefelter syndrome)",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.0234375,
            "text": "X chromosome (47,XX",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.140625,
            "text": "X chromosome (47",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.171875,
            "text": "X chromosome (",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.24609375,
            "text": "X chromosome (47,XXY or Klinefelter",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -7.2578125,
            "text": "X chromosome (47,XXY or Klinefelter syndrome",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.34375,
            "end_logit": 6.0078125,
            "text": "extra X",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.27734375,
            "end_logit": -5.41796875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -5.18359375,
            "text": "extra X chromosome",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -5.41796875,
            "text": "extra X chromosome (47,XXY or Klinefelter syndrome).",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -6.8125,
            "text": "extra X chromosome (47,XXY",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -6.86328125,
            "text": "extra X chromosome (47,XXY or Klinefelter syndrome)",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -7.0234375,
            "text": "extra X chromosome (47,XX",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -7.140625,
            "text": "extra X chromosome (47",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -7.171875,
            "text": "extra X chromosome (",
            "probability": 0.0
        },
        {
            "start_logit": -6.34375,
            "end_logit": -7.24609375,
            "text": "extra X chromosome (47,XXY or Klinefelter",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_3": [
        {
            "start_logit": 2.876953125,
            "end_logit": 7.8125,
            "text": "additional X chromosome",
            "probability": 0.56103515625
        },
        {
            "start_logit": 2.623046875,
            "end_logit": 7.8125,
            "text": "X chromosome",
            "probability": 0.43701171875
        },
        {
            "start_logit": -3.439453125,
            "end_logit": 7.8125,
            "text": "chromosome",
            "probability": 0.0010175704956054688
        },
        {
            "start_logit": -4.484375,
            "end_logit": 7.8125,
            "text": "an additional X chromosome",
            "probability": 0.0003571510314941406
        },
        {
            "start_logit": -5.68359375,
            "end_logit": 7.8125,
            "text": "On the other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": -6.234375,
            "end_logit": 7.8125,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 7.8125,
            "text": "by an additional X chromosome",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": -6.78125,
            "end_logit": 7.8125,
            "text": "inefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.8125,
            "text": ", Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 7.8125,
            "text": "the other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 7.8125,
            "text": "other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 7.8125,
            "text": "caused by an additional X chromosome",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": 2.876953125,
            "end_logit": -4.19140625,
            "text": "additional X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 2.876953125,
            "end_logit": -4.37109375,
            "text": "additional X chromosome in",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 2.623046875,
            "end_logit": -4.19140625,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 2.623046875,
            "end_logit": -4.37109375,
            "text": "X chromosome in",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 2.876953125,
            "end_logit": -5.0390625,
            "text": "additional X chromosome in males (47,XXY",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 2.623046875,
            "end_logit": -5.0390625,
            "text": "X chromosome in males (47,XXY",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 2.876953125,
            "end_logit": -5.9453125,
            "text": "additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 2.876953125,
            "end_logit": -6.046875,
            "text": "additional X chromosome in males (47,XXY)",
            "probability": 5.364418029785156e-07
        }
    ],
    "5e669e0e1af46fc130000019_4": [
        {
            "start_logit": 9.1015625,
            "end_logit": 9.3125,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.72021484375,
            "end_logit": 9.3125,
            "text": "Y",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.6064453125,
            "text": "47",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -5.17578125,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 9.3125,
            "text": ", XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": 9.3125,
            "text": "XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 9.3125,
            "text": "The formal cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.375,
            "text": "47, XX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.578125,
            "text": "47,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.66015625,
            "text": "47, XXY;",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.03125,
            "end_logit": 9.3125,
            "text": "cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.84375,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.8828125,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 9.3125,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.9375,
            "text": "47, XXY; the extra sex chromosome is due",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.0,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nond",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.046875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.109375,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.13671875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.16015625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondis",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_5": [
        {
            "start_logit": 8.3359375,
            "end_logit": 6.7578125,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -2.212890625,
            "text": "X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 0.00012731552124023438
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.140625,
            "text": "X chromosome",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -4.7265625,
            "end_logit": 6.7578125,
            "text": "additional X",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.375,
            "text": "X chromosome in males leading to",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.3828125,
            "text": "X chromosome in",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.48828125,
            "text": "X chromosome in males leading",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.546875,
            "text": "X chromosome in males leading to a",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.72265625,
            "text": "X chromosome in males",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.83203125,
            "text": "X chromosome in males leading to a karyotype",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.84765625,
            "text": "X chromosome in males leading to a karyotype of",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.859375,
            "text": "X chromosome in males leading to a karyotype of 47,XX",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.91796875,
            "text": "X chromosome in males leading to a karyotype of 47",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.90625,
            "end_logit": 6.7578125,
            "text": "Klinefelter syndrome (KS) is characterized by an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 6.7578125,
            "text": "an additional X",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -2.212890625,
            "text": "additional X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -2.212890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.90625,
            "end_logit": -2.212890625,
            "text": "Klinefelter syndrome (KS) is characterized by an additional X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 0.0
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -2.212890625,
            "text": "an additional X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 0.0
        },
        {
            "start_logit": -4.7265625,
            "end_logit": -5.140625,
            "text": "additional X chromosome",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_6": [
        {
            "start_logit": 8.7734375,
            "end_logit": 9.4140625,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.322509765625,
            "end_logit": 9.4140625,
            "text": "Y",
            "probability": 0.00011235475540161133
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -2.29296875,
            "text": "47",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -4.7578125,
            "end_logit": 9.4140625,
            "text": "a 47,XXY",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -4.42578125,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to date.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -5.1875,
            "text": "47,XXY chromosomal abnormality",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 9.4140625,
            "text": "XXY",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.1875,
            "end_logit": 9.4140625,
            "text": ",XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 9.4140625,
            "text": "Klinefelter syndrome (KS), a 47,XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -5.875,
            "text": "47,XXY chromosomal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.078125,
            "text": "47,XXY chromosomal abnormality,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.09765625,
            "text": "47,XX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.51953125,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 9.4140625,
            "text": ", a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.62890625,
            "text": "47,XXY chromosomal abnormality, has been shown to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.63671875,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.6953125,
            "text": "47,XXY chromosomal abnormality, has been shown",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.72265625,
            "text": "47,XXY chromosomal abnormality, has been shown to be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.80859375,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.87109375,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_7": [
        {
            "start_logit": 9.109375,
            "end_logit": 9.2734375,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.8388671875,
            "end_logit": 9.2734375,
            "text": "Y",
            "probability": 4.83393669128418e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.552734375,
            "text": "47",
            "probability": 1.996755599975586e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -5.828125,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 9.2734375,
            "text": "XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.2734375,
            "text": ", XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.33203125,
            "text": "47, XX",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.54296875,
            "text": "47, XXY;",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.5625,
            "text": "47,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 9.2734375,
            "text": "cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.8984375,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.90625,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.2734375,
            "text": "formal cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.94140625,
            "text": "47, XXY; the extra sex chromosome is due",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.0390625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nond",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 9.2734375,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.09765625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.16796875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.18359375,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.109375,
            "end_logit": -7.1875,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_8": [
        {
            "start_logit": 8.8828125,
            "end_logit": 9.0546875,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": 9.0546875,
            "text": "Y",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -1.90234375,
            "text": "XX",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -3.5078125,
            "text": "XXY chromosomal abnormality may",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -5.94140625,
            "text": "XXY chromosomal abnormality may be more than coincidental.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 9.0546875,
            "text": "the XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -6.6015625,
            "text": "XXY chromosomal abnormality",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 9.0546875,
            "text": "that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 9.0546875,
            "text": "reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -6.9296875,
            "text": "XXY chromosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -6.98828125,
            "text": "XXY chromosomal abnormality may be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 9.0546875,
            "text": "association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.078125,
            "text": "XXY chromosomal abnormality may be more than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.20703125,
            "text": "XXY chromosomal abnormality may be more than coincident",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.26171875,
            "text": "XXY chromosomal abnormality may be more than coincidental",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.8828125,
            "end_logit": -7.26953125,
            "text": "XXY chromosomal abnormality may be more",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": -3.5078125,
            "text": "Y chromosomal abnormality may",
            "probability": 0.0
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": -5.94140625,
            "text": "Y chromosomal abnormality may be more than coincidental.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": -6.6015625,
            "text": "Y chromosomal abnormality",
            "probability": 0.0
        },
        {
            "start_logit": -1.2431640625,
            "end_logit": -6.9296875,
            "text": "Y chromosomal",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_9": [
        {
            "start_logit": 7.5625,
            "end_logit": 5.453125,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 0.9951171875
        },
        {
            "start_logit": 1.5810546875,
            "end_logit": 5.453125,
            "text": "a 47, XXY",
            "probability": 0.0025157928466796875
        },
        {
            "start_logit": 7.5625,
            "end_logit": -0.8466796875,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY karyotype",
            "probability": 0.0018262863159179688
        },
        {
            "start_logit": -0.54931640625,
            "end_logit": 5.453125,
            "text": "47, XXY",
            "probability": 0.00029921531677246094
        },
        {
            "start_logit": 7.5625,
            "end_logit": -3.79296875,
            "text": "Kl",
            "probability": 9.560585021972656e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -4.01171875,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY karyotype associated with hypogonadism",
            "probability": 7.68899917602539e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.62109375,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XX",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.62109375,
            "text": "Klinefelter syndrome (KS) is",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.76171875,
            "text": "Klinefelter syndrome (KS)",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.90234375,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.91796875,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY karyotype associated",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -5.98046875,
            "text": "Klinefelter syndrome (KS) is a",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.1171875,
            "text": "Klinefelter syndrome (",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.23046875,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.2578125,
            "text": "Klinefelter syndrome",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.359375,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.44140625,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.55859375,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY karyotype associated with hypogonadism and infertility",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.640625,
            "text": "Klinefelter",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -6.6484375,
            "text": "Klinefelter syndrome (KS) is a chromosomal",
            "probability": 5.543231964111328e-06
        }
    ],
    "5e669e0e1af46fc130000019_10": [
        {
            "start_logit": 7.87109375,
            "end_logit": 1.9267578125,
            "text": "Y chromosome microdeletions.",
            "probability": 0.7763671875
        },
        {
            "start_logit": 7.87109375,
            "end_logit": 0.62841796875,
            "text": "Y chromosome microdeletions",
            "probability": 0.2122802734375
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -2.673828125,
            "text": "Y",
            "probability": 0.00778961181640625
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -4.00390625,
            "text": "Y chromosome",
            "probability": 0.002063751220703125
        },
        {
            "start_logit": 0.80810546875,
            "end_logit": 1.9267578125,
            "text": "47,XXY) and Y chromosome microdeletions.",
            "probability": 0.0006647109985351562
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.71484375,
            "text": "Y chromosome microd",
            "probability": 0.00037288665771484375
        },
        {
            "start_logit": 7.87109375,
            "end_logit": -5.93359375,
            "text": "Y chromosome microdelet",
            "probability": 0.00029969215393066406
        },
        {
            "start_logit": 0.80810546875,
            "end_logit": 0.62841796875,
            "text": "47,XXY) and Y chromosome microdeletions",
            "probability": 0.0001819133758544922
        },
        {
            "start_logit": 0.80810546875,
            "end_logit": -0.66943359375,
            "text": "47,XXY",
            "probability": 4.971027374267578e-05
        },
        {
            "start_logit": -3.259765625,
            "end_logit": 1.927734375,
            "text": ".",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -3.26171875,
            "end_logit": 1.9267578125,
            "text": ".",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 0.80810546875,
            "end_logit": -2.673828125,
            "text": "47,XXY) and Y",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 0.80810546875,
            "end_logit": -4.00390625,
            "text": "47,XXY) and Y chromosome",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 0.80810546875,
            "end_logit": -4.0390625,
            "text": "47,XXY)",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -5.15625,
            "end_logit": 1.9267578125,
            "text": "numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY) and Y chromosome microdeletions.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -5.25390625,
            "end_logit": 1.9267578125,
            "text": "(47,XXY) and Y chromosome microdeletions.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.359375,
            "end_logit": 1.9267578125,
            "text": "Klinefelter syndrome (47,XXY) and Y chromosome microdeletions.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -3.1640625,
            "end_logit": -0.66943359375,
            "text": "nonobstructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.0859375,
            "end_logit": 1.9267578125,
            "text": ",XXY) and Y chromosome microdeletions.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.15625,
            "end_logit": 0.62841796875,
            "text": "numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY) and Y chromosome microdeletions",
            "probability": 4.76837158203125e-07
        }
    ],
    "5e669e0e1af46fc130000019_11": [
        {
            "start_logit": 3.955078125,
            "end_logit": 7.578125,
            "text": "additional X chromosome",
            "probability": 0.97509765625
        },
        {
            "start_logit": 0.24951171875,
            "end_logit": 7.578125,
            "text": "X chromosome",
            "probability": 0.0240325927734375
        },
        {
            "start_logit": -3.6484375,
            "end_logit": 7.578125,
            "text": "an additional X chromosome",
            "probability": 0.00048732757568359375
        },
        {
            "start_logit": -3.76171875,
            "end_logit": 7.578125,
            "text": "chromosome",
            "probability": 0.00043511390686035156
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 7.578125,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 4.4286251068115234e-05
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 7.578125,
            "text": "by an additional X chromosome",
            "probability": 2.968311309814453e-05
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 7.578125,
            "text": ", Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 2.7239322662353516e-05
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 7.578125,
            "text": "inefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.578125,
            "text": "other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 2.0563602447509766e-05
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.578125,
            "text": "hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X chromosome",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -4.32421875,
            "text": "additional X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -4.5390625,
            "text": "additional X chromosome in",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.234375,
            "text": "additional X chromosome in males",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.26171875,
            "text": "additional X chromosome in males (47,XXY",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.3515625,
            "text": "additional X chromosome in males (47,XXY)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.59765625,
            "text": "additional X chromosome in males (47,XXY),",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.63671875,
            "text": "additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.66015625,
            "text": "additional X chromosome in males (47,XX",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.87890625,
            "text": "additional",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 3.955078125,
            "end_logit": -6.93359375,
            "text": "additional X chromosome in males (47,XXY), and",
            "probability": 4.76837158203125e-07
        }
    ],
    "5e669e0e1af46fc130000019_12": [
        {
            "start_logit": 8.703125,
            "end_logit": 9.1875,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.97314453125,
            "end_logit": 9.1875,
            "text": "Y",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": -1.0302734375,
            "end_logit": 9.1875,
            "text": "Klinefelter's syndrome (47, XXY",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 8.703125,
            "end_logit": -2.373046875,
            "text": "47",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -2.421875,
            "text": "47, XXY) was the most common chromosomal aberration.",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -4.765625,
            "end_logit": 9.1875,
            "text": "(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -4.33203125,
            "text": "47, XXY)",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.703125,
            "end_logit": -4.86328125,
            "text": "47, XXY) was",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.63671875,
            "end_logit": 9.1875,
            "text": "(47, XXY",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.6953125,
            "end_logit": 9.1875,
            "text": "10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.984375,
            "end_logit": 9.1875,
            "text": "XXY",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 9.1875,
            "text": ", XXY",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 9.1875,
            "text": "39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.34765625,
            "end_logit": 9.1875,
            "text": "have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 9.1875,
            "text": "found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -5.96484375,
            "text": "47, XXY) was the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.53125,
            "end_logit": 9.1875,
            "text": "9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.703125,
            "end_logit": -6.08984375,
            "text": "47, XXY) was the most common",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 9.1875,
            "text": "chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.97314453125,
            "end_logit": -2.421875,
            "text": "Y) was the most common chromosomal aberration.",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_13": [
        {
            "start_logit": 8.6015625,
            "end_logit": 5.890625,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 0.59375
        },
        {
            "start_logit": 8.6015625,
            "end_logit": 5.50390625,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 0.405029296875
        },
        {
            "start_logit": 1.9423828125,
            "end_logit": 5.890625,
            "text": "a 47, XXY",
            "probability": 0.0007600784301757812
        },
        {
            "start_logit": 1.9423828125,
            "end_logit": 5.50390625,
            "text": "a 47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 0.0005164146423339844
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -2.51171875,
            "text": "Kl",
            "probability": 0.00013267993927001953
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -2.759765625,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY karyotype",
            "probability": 0.00010406970977783203
        },
        {
            "start_logit": -1.4033203125,
            "end_logit": 5.890625,
            "text": "47, XXY",
            "probability": 2.6941299438476562e-05
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -4.4296875,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY karyotype associated with hypogonadism",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -1.4033203125,
            "end_logit": 5.50390625,
            "text": "47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -1.95703125,
            "end_logit": 5.50390625,
            "text": ".",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.20703125,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.27734375,
            "text": "Klinefelter syndrome (KS) is",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.3125,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XX",
            "probability": 8.106231689453125e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.5546875,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.62890625,
            "text": "Klinefelter syndrome (KS) is a",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.69921875,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.85546875,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -5.88671875,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY karyotype associated",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -6.015625,
            "text": "Klinefelter syndrome (",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 8.6015625,
            "end_logit": -6.078125,
            "text": "Klinefelter syndrome (KS)",
            "probability": 3.7550926208496094e-06
        }
    ],
    "5e669e0e1af46fc130000019_14": [
        {
            "start_logit": 8.4375,
            "end_logit": 3.529296875,
            "text": "sex chromosome anomalies",
            "probability": 0.9111328125
        },
        {
            "start_logit": 8.4375,
            "end_logit": 1.1826171875,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXXXY.",
            "probability": 0.08673095703125
        },
        {
            "start_logit": 8.4375,
            "end_logit": -2.548828125,
            "text": "sex",
            "probability": 0.0020885467529296875
        },
        {
            "start_logit": 8.4375,
            "end_logit": -5.1640625,
            "text": "sex chromosome",
            "probability": 0.00015246868133544922
        },
        {
            "start_logit": -0.79345703125,
            "end_logit": 3.529296875,
            "text": "Klinefelter's syndrome may be associated with a variety of different sex chromosome anomalies",
            "probability": 8.893013000488281e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -5.80859375,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XXXXY",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -5.828125,
            "text": "sex chromosome anomalies including",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.13671875,
            "text": "sex chromosome anomalies including XX",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.3671875,
            "text": "sex chromosome anomalies including XXY",
            "probability": 4.57763671875e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.65234375,
            "text": "sex chromosome anomalies including XXY, XX",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.4375,
            "end_logit": -6.85546875,
            "text": "sex chromosome anomalies including XXY, XXYY, XXXY and XX",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -3.5,
            "end_logit": 1.1826171875,
            "text": ".",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 3.529296875,
            "text": "anomalies",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 3.529296875,
            "text": "inefelter's syndrome may be associated with a variety of different sex chromosome anomalies",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 3.529296875,
            "text": "chromosome anomalies",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.79345703125,
            "end_logit": -2.548828125,
            "text": "Klinefelter's syndrome may be associated with a variety of different sex",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 3.529296875,
            "text": "associated with a variety of different sex chromosome anomalies",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 3.529296875,
            "text": "felter's syndrome may be associated with a variety of different sex chromosome anomalies",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 1.1826171875,
            "text": "anomalies including XXY, XXYY, XXXY and XXXXY.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 1.1826171875,
            "text": "and XXXXY.",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_15": [
        {
            "start_logit": 8.34375,
            "end_logit": 9.3125,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.5810546875,
            "end_logit": 9.3125,
            "text": "Y",
            "probability": 0.00013339519500732422
        },
        {
            "start_logit": 8.34375,
            "end_logit": -1.8681640625,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical abnormalities.",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": 8.34375,
            "end_logit": -2.9765625,
            "text": "47",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -4.265625,
            "end_logit": 9.3125,
            "text": "a 47,XXY",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.984375,
            "end_logit": 9.3125,
            "text": "Klinefelter's syndrome, characterised by a 47,XXY",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.09375,
            "end_logit": 9.3125,
            "text": "XXY",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.296875,
            "end_logit": 9.3125,
            "text": ",XXY",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -5.546875,
            "text": "47,XXY chromosomal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -5.63671875,
            "text": "47,XXY chromosomal pattern",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -5.72265625,
            "text": "47,XX",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 9.3125,
            "text": "by a 47,XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 9.3125,
            "text": "inefelter's syndrome, characterised by a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.17578125,
            "text": "47,XXY chromosomal pattern,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.62890625,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical abnormalities",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.671875,
            "text": "47,XXY chromosomal pattern, has largely been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.6796875,
            "text": "47,XXY chromosomal pattern, has largely",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.6875,
            "text": "47,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.73046875,
            "text": "47,XXY chromosomal pattern, has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.34375,
            "end_logit": -6.93359375,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_16": [
        {
            "start_logit": 8.7578125,
            "end_logit": 4.18359375,
            "text": "t(13q;14q)",
            "probability": 0.9921875
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -0.98486328125,
            "text": "t(13q;14q).",
            "probability": 0.005672454833984375
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -1.900390625,
            "text": "t",
            "probability": 0.0022754669189453125
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -5.80078125,
            "text": "t(13q",
            "probability": 4.57763671875e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.203125,
            "text": "t(13q;14",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.265625,
            "text": "t(13q;",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -6.51171875,
            "text": "t(13q;14q",
            "probability": 2.2649765014648438e-05
        },
        {
            "start_logit": 8.7578125,
            "end_logit": -7.015625,
            "text": "t(13",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": -3.525390625,
            "end_logit": 4.18359375,
            "text": "Klinefelter syndrome associated with 13/14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -4.76953125,
            "end_logit": 4.18359375,
            "text": ",t(13q;14q)",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.13671875,
            "end_logit": 4.18359375,
            "text": "(13q;14q)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.26171875,
            "end_logit": 4.18359375,
            "text": "abnormality 46,XXY,t(13q;14q)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 4.18359375,
            "text": "46,XXY,t(13q;14q)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.859375,
            "end_logit": 4.18359375,
            "text": "translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.9375,
            "end_logit": 4.18359375,
            "text": "13q;14q)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.35546875,
            "end_logit": 4.18359375,
            "text": "with 13/14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 4.18359375,
            "text": "13/14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 4.18359375,
            "text": ")",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 4.18359375,
            "text": "14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6640625,
            "end_logit": 4.18359375,
            "text": "inefelter syndrome associated with 13/14 translocation abnormality 46,XXY,t(13q;14q)",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56c8f4615795f9a73e00001a_1": [
        {
            "start_logit": 9.046875,
            "end_logit": 9.0703125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.62890625,
            "end_logit": 9.0703125,
            "text": "e",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.8603515625,
            "text": "GBs",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -5.34765625,
            "end_logit": 9.0703125,
            "text": "hape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.53125,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.5390625,
            "text": "GBshape:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.9453125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.99609375,
            "text": "GBshape: a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.0703125,
            "text": "GBshape: a genome brow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.07421875,
            "text": "GBshape: a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.09375,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.19921875,
            "text": "GBshape: a genome browser database",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.20703125,
            "text": "GBshape: a genome browser database for DNA shape annotations.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.3046875,
            "text": "GBshape: a genome browser database for DNA shape",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.33984375,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.3671875,
            "text": "GBshape: a genome browser database for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.62890625,
            "end_logit": -6.53125,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.62890625,
            "end_logit": -6.5390625,
            "text": "e:",
            "probability": 0.0
        },
        {
            "start_logit": -1.62890625,
            "end_logit": -6.99609375,
            "text": "e: a genome",
            "probability": 0.0
        },
        {
            "start_logit": -1.62890625,
            "end_logit": -7.0703125,
            "text": "e: a genome brow",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_2": [
        {
            "start_logit": 8.75,
            "end_logit": 9.0625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.5888671875,
            "end_logit": 9.0625,
            "text": "e",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": 8.75,
            "end_logit": -2.34375,
            "text": "GBs",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": -4.8046875,
            "end_logit": 9.0625,
            "text": "hape",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.2734375,
            "end_logit": 9.0625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -5.1328125,
            "text": "GBshape;",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.6875,
            "end_logit": 9.0625,
            "text": "(GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.45703125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.5234375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.5390625,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.546875,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.578125,
            "text": "GBshape; freely available at http:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.671875,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.77734375,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.80078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.86328125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.9765625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.75,
            "end_logit": -6.98046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5888671875,
            "end_logit": -5.1328125,
            "text": "e;",
            "probability": 0.0
        },
        {
            "start_logit": -5.2734375,
            "end_logit": -2.34375,
            "text": "Our Genome Browser for DNA shape annotations (GBs",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_3": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.078125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": 9.078125,
            "text": "e",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.7978515625,
            "text": "GBs",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 9.078125,
            "text": "hape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.61328125,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.87890625,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.0859375,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.12890625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.1640625,
            "text": "GBshape can be used to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.23046875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.24609375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.25,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.25390625,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.28125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "GBshape can be used to visualize",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.35546875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -6.61328125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -6.87890625,
            "text": "e can be",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_4": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.0390625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.63671875,
            "end_logit": 9.0390625,
            "text": "e",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.7802734375,
            "text": "GBs",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 9.0390625,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -5.6484375,
            "text": "GBshape;",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 9.0390625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.53125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5546875,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5546875,
            "text": "GBshape; freely available at http:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.58203125,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.58203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.640625,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.76171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.7734375,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.78125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.91015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.9375,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.0390625,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.05078125,
            "text": "GBshape; freely",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.05859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_5": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.078125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": 9.078125,
            "text": "e",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.7978515625,
            "text": "GBs",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 9.078125,
            "text": "hape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.61328125,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.87890625,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.0859375,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.12890625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.1640625,
            "text": "GBshape can be used to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.23046875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.24609375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.25,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.25390625,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.28125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "GBshape can be used to visualize",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.35546875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -6.61328125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -6.87890625,
            "text": "e can be",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_6": [
        {
            "start_logit": 9.0703125,
            "end_logit": 9.09375,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": 9.09375,
            "text": "e",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.7705078125,
            "text": "GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -4.84765625,
            "end_logit": 9.09375,
            "text": "hape",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.6796875,
            "text": "GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.875,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.1328125,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.203125,
            "text": "GBshape can be used to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.23046875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.25,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.2734375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.296875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.30078125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.31640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.31640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -6.6796875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -6.875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -7.1328125,
            "text": "e can be used",
            "probability": 0.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -7.203125,
            "text": "e can be used to",
            "probability": 0.0
        },
        {
            "start_logit": -1.54296875,
            "end_logit": -7.23046875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_7": [
        {
            "start_logit": 8.7109375,
            "end_logit": 9.03125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.6435546875,
            "end_logit": 9.03125,
            "text": "e",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -2.484375,
            "text": "GBs",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": -3.728515625,
            "end_logit": 9.03125,
            "text": ". Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -4.8828125,
            "end_logit": 9.03125,
            "text": "hape",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -5.0859375,
            "text": "GBshape;",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 9.03125,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.39453125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 9.03125,
            "text": "(GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.5625,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.5859375,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.7109375,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.72265625,
            "text": "GBshape; freely available at http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.7578125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.87109375,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.8828125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7109375,
            "end_logit": -6.984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.03125,
            "text": "DNA shape annotations (GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.728515625,
            "end_logit": -2.484375,
            "text": ". Our Genome Browser for DNA shape annotations (GBs",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_8": [
        {
            "start_logit": 8.7890625,
            "end_logit": 9.078125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.572265625,
            "end_logit": 9.078125,
            "text": "e",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -2.291015625,
            "text": "GBs",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": -4.96875,
            "end_logit": 9.078125,
            "text": "hape",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.48046875,
            "text": "GBshape framework.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.81640625,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.8359375,
            "text": "GBshape framework. GBshape can",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.859375,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.8671875,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.87109375,
            "text": "GBshape framework",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.078125,
            "text": "genomes can easily be added using the GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.92578125,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.9296875,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.94140625,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.94140625,
            "text": "GBshape framework. GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.953125,
            "text": "GBshape framework. GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.953125,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.7890625,
            "end_logit": -6.9609375,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 9.078125,
            "text": "the GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.078125,
            "text": "using the GBshape",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c8f4615795f9a73e00001a_9": [
        {
            "start_logit": 9.0078125,
            "end_logit": 9.0546875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.611328125,
            "end_logit": 9.0546875,
            "text": "e",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -1.8837890625,
            "text": "GBs",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -4.99609375,
            "end_logit": 9.0546875,
            "text": "hape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -5.375,
            "text": "GBshape;",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 9.0546875,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.390625,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.40625,
            "text": "GBshape; freely available at http:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.43359375,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.48046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.48828125,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.5390625,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.65625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.671875,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.6953125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.83984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.875,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.95703125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0078125,
            "end_logit": -6.984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 9.0546875,
            "text": "(GBshape",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c8f4615795f9a73e00001a_10": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.078125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": 9.078125,
            "text": "e",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.7978515625,
            "text": "GBs",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 9.078125,
            "text": "hape",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.61328125,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.87890625,
            "text": "GBshape can be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.0859375,
            "text": "GBshape can be used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.12890625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.1640625,
            "text": "GBshape can be used to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.23046875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.24609375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.25,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.25390625,
            "text": "GBshap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.28125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.3125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browse",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.34375,
            "text": "GBshape can be used to visualize",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.35546875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome brow",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -6.61328125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -1.595703125,
            "end_logit": -6.87890625,
            "text": "e can be",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_11": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.0390625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -1.63671875,
            "end_logit": 9.0390625,
            "text": "e",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.7802734375,
            "text": "GBs",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 9.0390625,
            "text": "hape",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -5.6484375,
            "text": "GBshape;",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 9.0390625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.53125,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5546875,
            "text": "GBshape; freely available at http://rohslab.cm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.5546875,
            "text": "GBshape; freely available at http:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.58203125,
            "text": "GBshape; freely available at http://rohslab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.58203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.640625,
            "text": "GBshape; freely available at http://rohslab.cmb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.76171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.7734375,
            "text": "GBshape; freely available at http://rohslab.cmb.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.78125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.91015625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -6.9375,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.0390625,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.05078125,
            "text": "GBshape; freely",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.05859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e36cf8eb5b409ea53000007_1": [
        {
            "start_logit": 8.5546875,
            "end_logit": 8.578125,
            "text": "melanocyte",
            "probability": 1.0
        },
        {
            "start_logit": -2.212890625,
            "end_logit": 8.578125,
            "text": "ocyte",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -2.19140625,
            "text": "melan",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -2.75390625,
            "end_logit": 8.578125,
            "text": ". Here we show that a melanocyte",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 8.578125,
            "text": "Here we show that a melanocyte",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.0390625,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -2.19140625,
            "text": ". Here we show that a melan",
            "probability": 0.0
        },
        {
            "start_logit": -4.83203125,
            "end_logit": -2.19140625,
            "text": "Here we show that a melan",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -4.73046875,
            "text": ". Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.0
        },
        {
            "start_logit": -2.212890625,
            "end_logit": -6.0390625,
            "text": "ocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish.",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -5.9609375,
            "text": ". Our studies reveal that melanocytes",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -5.9921875,
            "text": ". Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized",
            "probability": 0.0
        },
        {
            "start_logit": -2.751953125,
            "end_logit": -6.0390625,
            "text": ". The location of this niche varies across species, but the evolutionary pressures that drive HSPCs to different microenvironments remain unknown.",
            "probability": 0.0
        },
        {
            "start_logit": -2.751953125,
            "end_logit": -6.0390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -2.751953125,
            "end_logit": -6.0390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -2.751953125,
            "end_logit": -6.0390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -2.751953125,
            "end_logit": -6.0390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -2.751953125,
            "end_logit": -6.0390625,
            "text": ". The umbrella of melanocytes associated with the haematopoietic niche is highly evolutionarily conserved in aquatic animals, including the sea lamprey, a basal vertebrate.",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -6.0390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -2.75390625,
            "end_logit": -6.0390625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_1": [
        {
            "start_logit": 8.328125,
            "end_logit": 8.53125,
            "text": "SPINK5",
            "probability": 1.0
        },
        {
            "start_logit": -2.52734375,
            "end_logit": 8.53125,
            "text": "5",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.328125,
            "end_logit": -3.109375,
            "text": "SPIN",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 8.328125,
            "end_logit": -4.234375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5)",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 8.328125,
            "end_logit": -5.296875,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 8.53125,
            "text": "mutations in the gene SPINK5",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -5.859375,
            "end_logit": 8.53125,
            "text": "gene SPINK5",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 8.53125,
            "text": "Netherton syndrome (NS) is a serious inherited skin disorder caused by mutations in the gene SPINK5",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.125,
            "end_logit": 8.53125,
            "text": "K5",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.07421875,
            "text": "SPINK5 (serine protease inhibitor Kazal type",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.09765625,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.19921875,
            "text": "SPINK5 (serine protease inhibitor Kazal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.30859375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.30859375,
            "text": "SPINK5 (serine protease inhibitor Ka",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.30859375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.35546875,
            "text": "SPINK5 (serine protease inhibitor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.453125,
            "text": "SPINK5 (serine protease inhibitor Kaz",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.4765625,
            "text": "SPINK5 (serine protease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.53515625,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.328125,
            "end_logit": -6.6015625,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a",
            "probability": 2.384185791015625e-07
        }
    ],
    "54ff45966ad7dcbc12000010_2": [
        {
            "start_logit": 2.91015625,
            "end_logit": 4.02734375,
            "text": "SPINK5",
            "probability": 0.435791015625
        },
        {
            "start_logit": 2.568359375,
            "end_logit": 4.02734375,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5",
            "probability": 0.308837890625
        },
        {
            "start_logit": 2.28125,
            "end_logit": 4.02734375,
            "text": "(SPINK5",
            "probability": 0.2322998046875
        },
        {
            "start_logit": 2.91015625,
            "end_logit": -0.26171875,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.005977630615234375
        },
        {
            "start_logit": 2.91015625,
            "end_logit": -0.5302734375,
            "text": "SPINK5)",
            "probability": 0.004566192626953125
        },
        {
            "start_logit": 2.568359375,
            "end_logit": -0.5302734375,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5)",
            "probability": 0.0032501220703125
        },
        {
            "start_logit": 2.28125,
            "end_logit": -0.26171875,
            "text": "(SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0031871795654296875
        },
        {
            "start_logit": 2.28125,
            "end_logit": -0.5302734375,
            "text": "(SPINK5)",
            "probability": 0.00243377685546875
        },
        {
            "start_logit": 2.91015625,
            "end_logit": -1.5947265625,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.",
            "probability": 0.0015773773193359375
        },
        {
            "start_logit": 2.28125,
            "end_logit": -1.5947265625,
            "text": "(SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.",
            "probability": 0.0008411407470703125
        },
        {
            "start_logit": -0.166015625,
            "end_logit": -0.26171875,
            "text": "LEKTI",
            "probability": 0.0002753734588623047
        },
        {
            "start_logit": 2.91015625,
            "end_logit": -4.015625,
            "text": "SPINK5) gene",
            "probability": 0.00013947486877441406
        },
        {
            "start_logit": 2.568359375,
            "end_logit": -4.015625,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5) gene",
            "probability": 9.965896606445312e-05
        },
        {
            "start_logit": 2.28125,
            "end_logit": -4.015625,
            "text": "(SPINK5) gene",
            "probability": 7.462501525878906e-05
        },
        {
            "start_logit": -0.166015625,
            "end_logit": -1.5947265625,
            "text": "LEKTI) deficiency cause NS.",
            "probability": 7.295608520507812e-05
        },
        {
            "start_logit": 2.568359375,
            "end_logit": -4.67578125,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (",
            "probability": 5.131959915161133e-05
        },
        {
            "start_logit": -6.203125,
            "end_logit": 4.02734375,
            "text": "serine protease inhibitor Kazal type 5 (SPINK5",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": 2.91015625,
            "end_logit": -5.15234375,
            "text": "SPINK5) gene leading",
            "probability": 4.494190216064453e-05
        },
        {
            "start_logit": 2.91015625,
            "end_logit": -5.28515625,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency",
            "probability": 3.933906555175781e-05
        },
        {
            "start_logit": 2.28125,
            "end_logit": -4.67578125,
            "text": "(",
            "probability": 3.8743019104003906e-05
        }
    ],
    "54ff45966ad7dcbc12000010_3": [
        {
            "start_logit": 9.0,
            "end_logit": 9.0,
            "text": "SPINK5",
            "probability": 1.0
        },
        {
            "start_logit": -1.6474609375,
            "end_logit": 9.0,
            "text": "5",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.9599609375,
            "text": "SPIN",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -4.16015625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and all stratified epithelial tissues.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -4.640625,
            "text": "SPINK5 gene",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.1953125,
            "text": "SPINK5 gene and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 9.0,
            "text": "K5",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.59765625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.74609375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.75390625,
            "text": "SPINK5 gene and to the consequent lack of expression of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.75390625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.7578125,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.7890625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.79296875,
            "text": "SPINK5 gene and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.83203125,
            "text": "SPINK5 gene and to the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.83984375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.8828125,
            "text": "SPINK5 gene and to the consequent lack of expression of its",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 9.0,
            "text": "the SPINK5",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.0,
            "text": "in the SPINK5",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.0,
            "text": "NS is due to loss-of-function mutations in the SPINK5",
            "probability": 5.960464477539063e-08
        }
    ],
    "54ff45966ad7dcbc12000010_4": [
        {
            "start_logit": 6.87109375,
            "end_logit": 7.8046875,
            "text": "LEKTI",
            "probability": 0.9921875
        },
        {
            "start_logit": 1.9189453125,
            "end_logit": 7.8046875,
            "text": "(LEKTI",
            "probability": 0.0070648193359375
        },
        {
            "start_logit": 6.87109375,
            "end_logit": 0.873046875,
            "text": "LEKTI)",
            "probability": 0.0009708404541015625
        },
        {
            "start_logit": -2.759765625,
            "end_logit": 7.8046875,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 6.55055046081543e-05
        },
        {
            "start_logit": -3.66796875,
            "end_logit": 7.8046875,
            "text": "I",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": 1.9189453125,
            "end_logit": 0.873046875,
            "text": "(LEKTI)",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 7.8046875,
            "text": "KTI",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -4.51171875,
            "text": "LE",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -5.30078125,
            "text": "LEKTI) is the defective protein of the ichthyosiform condition Netherton syndrome (NS).",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -5.41015625,
            "text": "LEKTI) is",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 7.8046875,
            "text": "epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.8046875,
            "text": "-epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.5546875,
            "text": "LEKTI) is the",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.86328125,
            "text": "LEKTI) is the defective protein",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.87109375,
            "end_logit": -6.9921875,
            "text": "LEKTI) is the defective protein of the ichthyosiform condition Netherton syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.759765625,
            "end_logit": 0.873046875,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.9189453125,
            "end_logit": -4.51171875,
            "text": "(LE",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.66796875,
            "end_logit": 0.873046875,
            "text": "I)",
            "probability": 0.0
        },
        {
            "start_logit": 1.9189453125,
            "end_logit": -5.30078125,
            "text": "(LEKTI) is the defective protein of the ichthyosiform condition Netherton syndrome (NS).",
            "probability": 0.0
        },
        {
            "start_logit": 1.9189453125,
            "end_logit": -5.41015625,
            "text": "(LEKTI) is",
            "probability": 0.0
        }
    ],
    "54ff45966ad7dcbc12000010_5": [
        {
            "start_logit": 9.0546875,
            "end_logit": 8.8046875,
            "text": "LEKTI",
            "probability": 1.0
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.7724609375,
            "text": "LE",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -2.111328125,
            "end_logit": 8.8046875,
            "text": "I",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -4.94921875,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.875,
            "end_logit": 8.8046875,
            "text": "KTI",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 8.8046875,
            "text": "Deficiency in the serine protease inhibitor LEKTI",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.45703125,
            "text": "LEKTI is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.66015625,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.7265625,
            "text": "LEKTI is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.89453125,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 8.8046875,
            "text": "serine protease inhibitor LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.94140625,
            "text": "LEKTI is the etiological",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.9921875,
            "text": "LEKTI is the etiological origin of Netherton syndrome,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.99609375,
            "text": "LEKTI is the etiological origin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.01171875,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.09765625,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.8046875,
            "text": "inhibitor LEKTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.8046875,
            "text": "in the serine protease inhibitor LEKTI",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.111328125,
            "end_logit": -4.94921875,
            "text": "I is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.",
            "probability": 0.0
        },
        {
            "start_logit": -5.92578125,
            "end_logit": -1.7724609375,
            "text": "Deficiency in the serine protease inhibitor LE",
            "probability": 0.0
        }
    ],
    "53175e9fb166e2b80600000a_1": [
        {
            "start_logit": 2.25,
            "end_logit": 4.53515625,
            "text": "Wnt-signaling pathway",
            "probability": 0.36083984375
        },
        {
            "start_logit": 2.162109375,
            "end_logit": 4.53515625,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.329833984375
        },
        {
            "start_logit": 1.9697265625,
            "end_logit": 4.53515625,
            "text": "controlling the Wnt-signaling pathway",
            "probability": 0.2724609375
        },
        {
            "start_logit": -1.1416015625,
            "end_logit": 4.53515625,
            "text": "the Wnt-signaling pathway",
            "probability": 0.01215362548828125
        },
        {
            "start_logit": 2.25,
            "end_logit": 0.7958984375,
            "text": "Wnt-signaling pathway and",
            "probability": 0.00858306884765625
        },
        {
            "start_logit": 2.162109375,
            "end_logit": 0.7958984375,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and",
            "probability": 0.007843017578125
        },
        {
            "start_logit": 1.9697265625,
            "end_logit": 0.7958984375,
            "text": "controlling the Wnt-signaling pathway and",
            "probability": 0.006481170654296875
        },
        {
            "start_logit": -4.61328125,
            "end_logit": 4.53515625,
            "text": "LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.0003771781921386719
        },
        {
            "start_logit": -2.83203125,
            "end_logit": 2.666015625,
            "text": ".",
            "probability": 0.0003447532653808594
        },
        {
            "start_logit": -1.1416015625,
            "end_logit": 0.7958984375,
            "text": "the Wnt-signaling pathway and",
            "probability": 0.00028824806213378906
        },
        {
            "start_logit": -5.140625,
            "end_logit": 4.53515625,
            "text": "functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00022268295288085938
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 4.53515625,
            "text": "in controlling the Wnt-signaling pathway",
            "probability": 0.00016736984252929688
        },
        {
            "start_logit": -5.5703125,
            "end_logit": 4.53515625,
            "text": "studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00014483928680419922
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 4.53515625,
            "text": "pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00012433528900146484
        },
        {
            "start_logit": -5.84375,
            "end_logit": 4.53515625,
            "text": "have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.00011020898818969727
        },
        {
            "start_logit": -5.84375,
            "end_logit": 4.53515625,
            "text": "pathway",
            "probability": 0.00011020898818969727
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 4.53515625,
            "text": "B1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 8.064508438110352e-05
        },
        {
            "start_logit": -6.2421875,
            "end_logit": 4.53515625,
            "text": "genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 7.396936416625977e-05
        },
        {
            "start_logit": 2.162109375,
            "end_logit": -4.2109375,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in",
            "probability": 5.245208740234375e-05
        },
        {
            "start_logit": 2.25,
            "end_logit": -4.7265625,
            "text": "Wnt-signaling",
            "probability": 3.415346145629883e-05
        }
    ],
    "5a9d31711d1251d03b00001c_1": [
        {
            "start_logit": 9.2890625,
            "end_logit": 9.1328125,
            "text": "100 nm",
            "probability": 1.0
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -1.05078125,
            "text": "100",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -1.3681640625,
            "end_logit": 9.1328125,
            "text": "nm",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 9.2890625,
            "end_logit": -4.9765625,
            "text": "100 nm.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 9.1328125,
            "text": "diamtere of 100 nm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 9.1328125,
            "text": "maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 9.1328125,
            "text": "number remained relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 9.1328125,
            "text": "attained their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.1328125,
            "text": "their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.1328125,
            "text": "vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34375,
            "end_logit": 9.1328125,
            "text": "they attained their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.1328125,
            "text": "constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.1328125,
            "text": "tere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.1328125,
            "text": "until they attained their maximum diamtere of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 9.1328125,
            "text": "of 100 nm",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3681640625,
            "end_logit": -4.9765625,
            "text": "nm.",
            "probability": 0.0
        },
        {
            "start_logit": -6.890625,
            "end_logit": -1.05078125,
            "text": "diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -1.05078125,
            "text": "maximum diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.1953125,
            "end_logit": -1.05078125,
            "text": "number remained relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -1.05078125,
            "text": "attained their maximum diamtere of 100",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_1": [
        {
            "start_logit": 3.0234375,
            "end_logit": 8.7734375,
            "text": "intravenous drug abuse",
            "probability": 0.63818359375
        },
        {
            "start_logit": 2.4453125,
            "end_logit": 8.7734375,
            "text": "drug abuse",
            "probability": 0.35791015625
        },
        {
            "start_logit": -2.177734375,
            "end_logit": 8.7734375,
            "text": "abuse",
            "probability": 0.003509521484375
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 8.7734375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.00015652179718017578
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.7734375,
            "text": "complication of intravenous drug abuse",
            "probability": 3.4928321838378906e-05
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.7734375,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 2.872943878173828e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.7734375,
            "text": "of intravenous drug abuse",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.7734375,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.7734375,
            "text": "hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.7734375,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 2.0205974578857422e-05
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.7734375,
            "text": "syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.7734375,
            "text": "is an unrecognized complication of intravenous drug abuse",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": 3.0234375,
            "end_logit": -3.828125,
            "text": "intravenous drug abuse.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 2.4453125,
            "end_logit": -3.828125,
            "text": "drug abuse.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 3.0234375,
            "end_logit": -6.328125,
            "text": "intravenous drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.0234375,
            "end_logit": -6.89453125,
            "text": "intravenous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.4453125,
            "end_logit": -6.328125,
            "text": "drug",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.177734375,
            "end_logit": -3.828125,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -3.828125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -6.015625,
            "end_logit": -3.828125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_2": [
        {
            "start_logit": 3.091796875,
            "end_logit": 8.8828125,
            "text": "drug abuse",
            "probability": 0.72119140625
        },
        {
            "start_logit": 2.126953125,
            "end_logit": 8.8828125,
            "text": "intravenous drug abuse",
            "probability": 0.273681640625
        },
        {
            "start_logit": -1.951171875,
            "end_logit": 8.8828125,
            "text": "abuse",
            "probability": 0.004634857177734375
        },
        {
            "start_logit": -5.25390625,
            "end_logit": 8.8828125,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.00017154216766357422
        },
        {
            "start_logit": -6.390625,
            "end_logit": 8.8828125,
            "text": "complication of intravenous drug abuse",
            "probability": 5.4836273193359375e-05
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 8.8828125,
            "text": "BACKGROUND: Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 8.8828125,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.8828125,
            "text": ": Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 8.8828125,
            "text": "of intravenous drug abuse",
            "probability": 2.3186206817626953e-05
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.8828125,
            "text": "hand syndrome is a complication of intravenous drug abuse",
            "probability": 2.002716064453125e-05
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.8828125,
            "text": "a complication of intravenous drug abuse",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -4.27734375,
            "text": "drug abuse, which has no current available treatment.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -4.27734375,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -6.05859375,
            "text": "drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -6.84375,
            "text": "drug abuse,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -6.9765625,
            "text": "drug abuse, which",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.126953125,
            "end_logit": -6.05859375,
            "text": "intravenous drug",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -7.07421875,
            "text": "drug abuse, which has no",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -7.08203125,
            "text": "drug abuse, which has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 3.091796875,
            "end_logit": -7.1953125,
            "text": "drug abuse, which has no current",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7346662dc08e987e00001a_3": [
        {
            "start_logit": 4.33984375,
            "end_logit": 8.875,
            "text": "intravenous drug abuse",
            "probability": 0.97705078125
        },
        {
            "start_logit": 0.499267578125,
            "end_logit": 8.875,
            "text": "drug abuse",
            "probability": 0.0209197998046875
        },
        {
            "start_logit": -1.958984375,
            "end_logit": 8.875,
            "text": "abuse",
            "probability": 0.0017862319946289062
        },
        {
            "start_logit": -3.806640625,
            "end_logit": 8.875,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.00028252601623535156
        },
        {
            "start_logit": -6.28125,
            "end_logit": 8.875,
            "text": "complication of intravenous drug abuse",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": -6.859375,
            "end_logit": 8.875,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -2.474609375,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.875,
            "text": "of intravenous drug abuse",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.875,
            "text": "hand syndrome is a complication of intravenous drug abuse",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.875,
            "text": "a complication of intravenous drug abuse",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.875,
            "text": "syndrome is a complication of intravenous drug abuse",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": 0.499267578125,
            "end_logit": -2.474609375,
            "text": "drug abuse, which has no current available treatment.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -6.39453125,
            "text": "intravenous",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -6.4609375,
            "text": "intravenous drug abuse,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -6.73828125,
            "text": "intravenous drug abuse, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -6.81640625,
            "text": "intravenous drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -6.875,
            "text": "intravenous drug abuse, which has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -6.91015625,
            "text": "intravenous drug abuse, which has no",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -7.00390625,
            "text": "intravenous drug abuse, which has no current",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.33984375,
            "end_logit": -7.1484375,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7346662dc08e987e00001a_4": [
        {
            "start_logit": 3.0234375,
            "end_logit": 8.7734375,
            "text": "intravenous drug abuse",
            "probability": 0.63818359375
        },
        {
            "start_logit": 2.4453125,
            "end_logit": 8.7734375,
            "text": "drug abuse",
            "probability": 0.35791015625
        },
        {
            "start_logit": -2.177734375,
            "end_logit": 8.7734375,
            "text": "abuse",
            "probability": 0.003509521484375
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 8.7734375,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.00015652179718017578
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.7734375,
            "text": "complication of intravenous drug abuse",
            "probability": 3.4928321838378906e-05
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.7734375,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 2.872943878173828e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.7734375,
            "text": "of intravenous drug abuse",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.7734375,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.7734375,
            "text": "hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.7734375,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 2.0205974578857422e-05
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.7734375,
            "text": "syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.7734375,
            "text": "is an unrecognized complication of intravenous drug abuse",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": 3.0234375,
            "end_logit": -3.828125,
            "text": "intravenous drug abuse.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 2.4453125,
            "end_logit": -3.828125,
            "text": "drug abuse.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 3.0234375,
            "end_logit": -6.328125,
            "text": "intravenous drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.0234375,
            "end_logit": -6.89453125,
            "text": "intravenous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.4453125,
            "end_logit": -6.328125,
            "text": "drug",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.177734375,
            "end_logit": -3.828125,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -3.828125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -6.015625,
            "end_logit": -3.828125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_5": [
        {
            "start_logit": 5.203125,
            "end_logit": 8.1015625,
            "text": "drug abuse",
            "probability": 1.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": 8.1015625,
            "text": "abuse",
            "probability": 0.0002378225326538086
        },
        {
            "start_logit": -5.0,
            "end_logit": 8.1015625,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -5.0,
            "end_logit": 8.1015625,
            "text": "intravenous drug abuse",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 5.203125,
            "end_logit": -3.765625,
            "text": "drug",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 8.1015625,
            "text": "complication of intravenous drug abuse",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -7.0625,
            "end_logit": 8.1015625,
            "text": "of intravenous drug abuse",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.1875,
            "text": "drug abuse this",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.984375,
            "text": "drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and sometimes the forearms and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.0,
            "end_logit": -3.765625,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -3.765625,
            "text": "intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -6.1875,
            "text": "abuse this",
            "probability": 0.0
        },
        {
            "start_logit": -3.33203125,
            "end_logit": -6.20703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -3.138671875,
            "end_logit": -6.984375,
            "text": "abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and sometimes the forearms and",
            "probability": 0.0
        },
        {
            "start_logit": -6.90234375,
            "end_logit": -3.765625,
            "text": "complication of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -3.765625,
            "text": "of intravenous drug",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -6.1875,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -6.1875,
            "text": "intravenous drug abuse this",
            "probability": 0.0
        },
        {
            "start_logit": -5.21875,
            "end_logit": -6.02734375,
            "text": "hands and sometimes the forearms and may cause functional aesthetic and social disturbances when the hand volume",
            "probability": 0.0
        },
        {
            "start_logit": -5.21875,
            "end_logit": -6.12890625,
            "text": "hands and sometimes the forearms and may cause functional aesthetic and social disturbances when the hand",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_6": [
        {
            "start_logit": 5.98046875,
            "end_logit": 8.8046875,
            "text": "intravenous drug abuse",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.93359375,
            "end_logit": 8.8046875,
            "text": "drug abuse",
            "probability": 0.00036644935607910156
        },
        {
            "start_logit": -1.943359375,
            "end_logit": 8.8046875,
            "text": "abuse",
            "probability": 0.000362396240234375
        },
        {
            "start_logit": -4.984375,
            "end_logit": 8.8046875,
            "text": "puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -5.625,
            "end_logit": 8.8046875,
            "text": "complication of intravenous drug abuse",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.8046875,
            "text": "of intravenous drug abuse",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 5.98046875,
            "end_logit": -4.43359375,
            "text": "intravenous drug abuse which",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.98046875,
            "end_logit": -5.09765625,
            "text": "intravenous",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.98046875,
            "end_logit": -6.21875,
            "text": "intravenous drug",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -4.43359375,
            "text": "drug abuse which",
            "probability": 0.0
        },
        {
            "start_logit": -1.943359375,
            "end_logit": -4.43359375,
            "text": "abuse which",
            "probability": 0.0
        },
        {
            "start_logit": -1.93359375,
            "end_logit": -6.21875,
            "text": "drug",
            "probability": 0.0
        },
        {
            "start_logit": -2.2265625,
            "end_logit": -6.5078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.984375,
            "end_logit": -4.43359375,
            "text": "puffy hand syndrome is a complication of intravenous drug abuse which",
            "probability": 0.0
        },
        {
            "start_logit": -5.625,
            "end_logit": -4.43359375,
            "text": "complication of intravenous drug abuse which",
            "probability": 0.0
        },
        {
            "start_logit": -4.984375,
            "end_logit": -5.09765625,
            "text": "puffy hand syndrome is a complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -5.8203125,
            "end_logit": -4.81640625,
            "text": "multifactorial venous lymphatic insufficiency",
            "probability": 0.0
        },
        {
            "start_logit": -5.625,
            "end_logit": -5.09765625,
            "text": "complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -5.1171875,
            "text": "intravenous drug users with puffy hand syndrome were hospitalized for 11 days treatment included daily multilayer bandaging",
            "probability": 0.0
        },
        {
            "start_logit": -6.0,
            "end_logit": -4.81640625,
            "text": "venous lymphatic insufficiency",
            "probability": 0.0
        }
    ],
    "56cf236f3975bb303a000002_1": [
        {
            "start_logit": 8.953125,
            "end_logit": 4.05078125,
            "text": "T-type",
            "probability": 0.994140625
        },
        {
            "start_logit": 8.953125,
            "end_logit": -1.6640625,
            "text": "T",
            "probability": 0.0032901763916015625
        },
        {
            "start_logit": 8.953125,
            "end_logit": -2.134765625,
            "text": "T-type calcium channels",
            "probability": 0.0020599365234375
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.39453125,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase",
            "probability": 2.9146671295166016e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.578125,
            "text": "T-type calcium",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.63671875,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase (",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.671875,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel blockers and also inhibitors of cystathionine-\u03b3-lyase (CSE",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.7890625,
            "text": "T-type calcium channels,",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.83984375,
            "text": "T-",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 4.05078125,
            "text": "type",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.1796875,
            "end_logit": 4.05078125,
            "text": "block T-type",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 4.05078125,
            "text": "Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 4.05078125,
            "text": "-type",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 4.05078125,
            "text": "evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -2.134765625,
            "text": "type calcium channels",
            "probability": 0.0
        },
        {
            "start_logit": -6.1796875,
            "end_logit": -1.6640625,
            "text": "block T",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -1.6640625,
            "text": "Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T",
            "probability": 0.0
        },
        {
            "start_logit": -6.1796875,
            "end_logit": -2.134765625,
            "text": "block T-type calcium channels",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -2.134765625,
            "text": "Given evidence that chemotherapy-induced neuropathic pain is blocked by ethosuximide, known to block T-type calcium channels",
            "probability": 0.0
        },
        {
            "start_logit": -6.2890625,
            "end_logit": -2.134765625,
            "text": "calcium channels",
            "probability": 0.0
        }
    ],
    "6026ed981cb411341a0000d2_1": [
        {
            "start_logit": -1.607421875,
            "end_logit": 1.2822265625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.6005859375
        },
        {
            "start_logit": -2.416015625,
            "end_logit": 1.2822265625,
            "text": "the calcitonin gene-related peptide",
            "probability": 0.267578125
        },
        {
            "start_logit": -4.24609375,
            "end_logit": 1.2822265625,
            "text": "targeting the calcitonin gene-related peptide",
            "probability": 0.042816162109375
        },
        {
            "start_logit": -4.73046875,
            "end_logit": 1.2822265625,
            "text": "prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.026397705078125
        },
        {
            "start_logit": -1.607421875,
            "end_logit": -2.189453125,
            "text": "calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.018646240234375
        },
        {
            "start_logit": -2.416015625,
            "end_logit": -2.189453125,
            "text": "the calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.00830078125
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 1.2822265625,
            "text": "the prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.00557708740234375
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 1.2822265625,
            "text": "of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.005153656005859375
        },
        {
            "start_logit": -1.607421875,
            "end_logit": -3.4765625,
            "text": "calcitonin gene-related peptide (",
            "probability": 0.005138397216796875
        },
        {
            "start_logit": -1.607421875,
            "end_logit": -3.626953125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 0.004425048828125
        },
        {
            "start_logit": -1.607421875,
            "end_logit": -3.876953125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.003448486328125
        },
        {
            "start_logit": -2.416015625,
            "end_logit": -3.4765625,
            "text": "the calcitonin gene-related peptide (",
            "probability": 0.00229644775390625
        },
        {
            "start_logit": -2.416015625,
            "end_logit": -3.626953125,
            "text": "the calcitonin gene-related peptide (CGRP)",
            "probability": 0.001972198486328125
        },
        {
            "start_logit": -2.416015625,
            "end_logit": -3.876953125,
            "text": "the calcitonin gene-related peptide (CGRP",
            "probability": 0.0015363693237304688
        },
        {
            "start_logit": -4.24609375,
            "end_logit": -2.189453125,
            "text": "targeting the calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.0013284683227539062
        },
        {
            "start_logit": -2.369140625,
            "end_logit": -4.12890625,
            "text": ".",
            "probability": 0.0012483596801757812
        },
        {
            "start_logit": -1.2900390625,
            "end_logit": -5.3515625,
            "text": "AMG334 (erenumab)",
            "probability": 0.0010852813720703125
        },
        {
            "start_logit": -4.73046875,
            "end_logit": -2.189453125,
            "text": "prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide (CGRP) pathway",
            "probability": 0.0008192062377929688
        },
        {
            "start_logit": -1.607421875,
            "end_logit": -5.3515625,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab)",
            "probability": 0.0007877349853515625
        },
        {
            "start_logit": -4.73046875,
            "end_logit": -2.541015625,
            "text": "prevention of episodic and chronic migraine",
            "probability": 0.000576019287109375
        }
    ],
    "587e0116ae05ffb474000002_1": [
        {
            "start_logit": 9.1328125,
            "end_logit": 8.90625,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.6513671875,
            "text": "Cis",
            "probability": 2.6285648345947266e-05
        },
        {
            "start_logit": -1.96484375,
            "end_logit": 8.90625,
            "text": "per",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 8.90625,
            "text": "Mapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.015625,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.1015625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.12890625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.16015625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.16796875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2109375,
            "text": "CisMap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2265625,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.26953125,
            "text": "CisMapper: predicting regulatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.2734375,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.3125,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.31640625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -7.36328125,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.96484375,
            "end_logit": -7.015625,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -1.96484375,
            "end_logit": -7.1015625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        },
        {
            "start_logit": -1.96484375,
            "end_logit": -7.12890625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -1.96484375,
            "end_logit": -7.16015625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_2": [
        {
            "start_logit": 9.25,
            "end_logit": 9.0859375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.3134765625,
            "text": "Cis",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": 9.0859375,
            "text": "per",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": -5.65625,
            "end_logit": 9.0859375,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.97265625,
            "text": "CisMapper,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.08203125,
            "text": "CisMapper, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.18359375,
            "text": "CisMapper, which predicts the regulatory targets of a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.23828125,
            "text": "CisMapper, which predicts the regulatory targets of a TF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.24609375,
            "text": "CisMap",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.24609375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.25,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.2578125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.265625,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.28515625,
            "text": "CisMapper, which predicts the regulatory",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 9.0859375,
            "text": "present CisMapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 9.0859375,
            "text": "We present CisMapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": -6.97265625,
            "text": "per,",
            "probability": 0.0
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": -7.08203125,
            "text": "per, which",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -1.3134765625,
            "text": "present Cis",
            "probability": 0.0
        },
        {
            "start_logit": -1.5478515625,
            "end_logit": -7.18359375,
            "text": "per, which predicts the regulatory targets of a",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_3": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.046875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.44921875,
            "text": "Cis",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": 9.046875,
            "text": "per",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 9.046875,
            "text": "Mapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.98046875,
            "text": "CisMapper is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.0703125,
            "text": "CisMapper is more",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.13671875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.1796875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.2109375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous for predicting the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.2421875,
            "text": "CisMapper is more accurate at",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.2578125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.046875,
            "text": "that CisMapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -6.98046875,
            "text": "per is",
            "probability": 0.0
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -7.0703125,
            "text": "per is more",
            "probability": 0.0
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -7.13671875,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -7.1796875,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 0.0
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -7.2109375,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous for predicting the",
            "probability": 0.0
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -7.2421875,
            "text": "per is more accurate at",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -1.44921875,
            "text": "that Cis",
            "probability": 0.0
        },
        {
            "start_logit": -1.6298828125,
            "end_logit": -7.2578125,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_4": [
        {
            "start_logit": 9.3125,
            "end_logit": 9.078125,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.3125,
            "end_logit": -1.130859375,
            "text": "Cis",
            "probability": 3.6776065826416016e-05
        },
        {
            "start_logit": -1.541015625,
            "end_logit": 9.078125,
            "text": "per",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -5.53125,
            "end_logit": 9.078125,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.96484375,
            "text": "CisMap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -6.96875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.015625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.0859375,
            "text": "CisMapper also",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.1171875,
            "text": "CisMapper also predicts which TF binding sites regulate a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.17578125,
            "text": "CisMapper also predicts which TF binding sites regulate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.2421875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.24609375,
            "text": "CisMapper also predicts which TF binding sites",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.26953125,
            "text": "CisMapper also predicts which TF binding sites regulate a given",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.28125,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.2890625,
            "text": "CisMapper also predicts",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.30859375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper can",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3125,
            "end_logit": -7.33203125,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.541015625,
            "end_logit": -6.96875,
            "text": "per also predicts which TF binding sites regulate a given gene more",
            "probability": 0.0
        },
        {
            "start_logit": -1.541015625,
            "end_logit": -7.015625,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using genomic distance.",
            "probability": 0.0
        },
        {
            "start_logit": -1.541015625,
            "end_logit": -7.0859375,
            "text": "per also",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_5": [
        {
            "start_logit": 9.21875,
            "end_logit": 8.9921875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.41796875,
            "text": "Cis",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": 8.9921875,
            "text": "per",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 8.9921875,
            "text": "Mapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.9375,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.9921875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.015625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.03125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.046875,
            "text": "CisMap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.0546875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.16015625,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.1640625,
            "text": "CisMapper: predicting regulatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.1796875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.203125,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.234375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.25390625,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.3046875,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -6.9375,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -6.9921875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -7.015625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_6": [
        {
            "start_logit": 9.21875,
            "end_logit": 8.9921875,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.41796875,
            "text": "Cis",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": 8.9921875,
            "text": "per",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 8.9921875,
            "text": "Mapper",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.9375,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.9921875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.015625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.03125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.046875,
            "text": "CisMap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.0546875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.16015625,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.1640625,
            "text": "CisMapper: predicting regulatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.1796875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.203125,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.234375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.25390625,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.3046875,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -6.9375,
            "text": "per:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -6.9921875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -1.7783203125,
            "end_logit": -7.015625,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_7": [
        {
            "start_logit": 9.265625,
            "end_logit": 9.109375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -1.2890625,
            "text": "Cis",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": 9.109375,
            "text": "per",
            "probability": 2.1457672119140625e-05
        },
        {
            "start_logit": -5.609375,
            "end_logit": 9.109375,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.76171875,
            "text": "CisMapper is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.87109375,
            "text": "CisMapper is more",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -6.90625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.01171875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.08984375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous for predicting the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.1015625,
            "text": "CisMapper is more accurate at",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.265625,
            "end_logit": -7.10546875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.109375,
            "text": "that CisMapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 9.109375,
            "text": "Using both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 9.109375,
            "text": "chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -6.76171875,
            "text": "per is",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -6.87109375,
            "text": "per is more",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -6.90625,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -7.01171875,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -7.08984375,
            "text": "per is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and is particularly advantageous for predicting the",
            "probability": 0.0
        },
        {
            "start_logit": -1.4814453125,
            "end_logit": -7.1015625,
            "text": "per is more accurate at",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_1": [
        {
            "start_logit": 8.9609375,
            "end_logit": 7.00390625,
            "text": "inflammation of the aorta",
            "probability": 0.76806640625
        },
        {
            "start_logit": 8.9609375,
            "end_logit": 5.796875,
            "text": "inflammation of the aorta due to various causes.",
            "probability": 0.228759765625
        },
        {
            "start_logit": 3.013671875,
            "end_logit": 7.00390625,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 0.001995086669921875
        },
        {
            "start_logit": 3.013671875,
            "end_logit": 5.796875,
            "text": "Aortitis is the inflammation of the aorta due to various causes.",
            "probability": 0.0005993843078613281
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -1.486328125,
            "text": "inflammation",
            "probability": 0.00015747547149658203
        },
        {
            "start_logit": -2.064453125,
            "end_logit": 7.00390625,
            "text": "the inflammation of the aorta",
            "probability": 1.245737075805664e-05
        },
        {
            "start_logit": -2.064453125,
            "end_logit": 5.796875,
            "text": "the inflammation of the aorta due to various causes.",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -3.330078125,
            "end_logit": 7.00390625,
            "text": "aorta",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -5.42578125,
            "text": "inflammation of the aorta due to",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -5.4296875,
            "text": "inflammation of the aorta due to various",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -5.49609375,
            "text": "inflammation of the aorta due to various causes",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -5.671875,
            "text": "inflammation of the aorta due",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -2.875,
            "end_logit": 5.796875,
            "text": ".",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -3.330078125,
            "end_logit": 5.796875,
            "text": "aorta due to various causes.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -6.8828125,
            "text": "inflammation of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.9609375,
            "end_logit": -7.29296875,
            "text": "inflammation of the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 7.00390625,
            "text": "the aorta",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 3.013671875,
            "end_logit": -1.486328125,
            "text": "Aortitis is the inflammation",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 7.00390625,
            "text": "of the aorta",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.4609375,
            "end_logit": 5.796875,
            "text": "the aorta due to various causes.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60314c361cb411341a00012e_2": [
        {
            "start_logit": 8.6484375,
            "end_logit": 8.28125,
            "text": "inflammation of the aorta",
            "probability": 1.0
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -1.8876953125,
            "text": "inflammation",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": -2.521484375,
            "end_logit": 8.28125,
            "text": "aorta",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": -3.3671875,
            "end_logit": 8.28125,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 8.6484375,
            "end_logit": -4.95703125,
            "text": "inflammation of the aorta due",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.22265625,
            "end_logit": 8.28125,
            "text": "of the aorta",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.515625,
            "end_logit": 8.28125,
            "text": "the inflammation of the aorta",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.546875,
            "end_logit": 8.28125,
            "text": "the aorta",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -3.3671875,
            "end_logit": -1.8876953125,
            "text": "Aortitis is the inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -5.515625,
            "end_logit": -1.8876953125,
            "text": "the inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -2.521484375,
            "end_logit": -4.95703125,
            "text": "aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -3.3671875,
            "end_logit": -4.95703125,
            "text": "Aortitis is the inflammation of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -3.3671875,
            "end_logit": -6.53125,
            "text": "Aortitis is",
            "probability": 0.0
        },
        {
            "start_logit": -5.22265625,
            "end_logit": -4.95703125,
            "text": "of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -3.3671875,
            "end_logit": -7.0078125,
            "text": "Aortitis",
            "probability": 0.0
        },
        {
            "start_logit": -5.515625,
            "end_logit": -4.95703125,
            "text": "the inflammation of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -5.546875,
            "end_logit": -4.95703125,
            "text": "the aorta due",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_3": [
        {
            "start_logit": 6.60546875,
            "end_logit": 5.8671875,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.513671875
        },
        {
            "start_logit": 6.60546875,
            "end_logit": 5.76953125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 0.4677734375
        },
        {
            "start_logit": 2.63671875,
            "end_logit": 5.8671875,
            "text": "inflammation of the aorta",
            "probability": 0.00970458984375
        },
        {
            "start_logit": 2.63671875,
            "end_logit": 5.76953125,
            "text": "inflammation of the aorta.",
            "probability": 0.00884246826171875
        },
        {
            "start_logit": -2.375,
            "end_logit": 5.76953125,
            "text": ".",
            "probability": 5.8591365814208984e-05
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -4.35546875,
            "text": "Aort",
            "probability": 1.8715858459472656e-05
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 5.8671875,
            "text": "aorta",
            "probability": 9.119510650634766e-06
        },
        {
            "start_logit": -4.3359375,
            "end_logit": 5.76953125,
            "text": "aorta.",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.03125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.12109375,
            "text": "Aortitis is",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.234375,
            "text": "Aortitis is the all-encompassing pathological term ascribed",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.3671875,
            "text": "Aortitis is the all-",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.515625,
            "text": "Aortitis is the all-encompassing pathological term",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.5546875,
            "text": "Aortitis is the all-encompassing",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.56640625,
            "text": "Aortitis is the all",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.5859375,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.67578125,
            "text": "Aortitis is the all-encompassing pathological",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.796875,
            "text": "Aortitis",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.8515625,
            "text": "Aortitis is the all-encompassing pathological term ascribed to",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.60546875,
            "end_logit": -6.91796875,
            "text": "Aortitis is the",
            "probability": 1.430511474609375e-06
        }
    ],
    "5891c90949702f2e01000001_1": [
        {
            "start_logit": 8.953125,
            "end_logit": 8.765625,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.953125,
            "end_logit": -2.01953125,
            "text": "INC",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -2.25,
            "end_logit": 8.765625,
            "text": "A",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.97265625,
            "text": "INCA:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.0078125,
            "text": "INCA: synonymous codon usage analysis and clustering by means",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.06640625,
            "text": "INCA: synonymous codon usage analysis and clustering by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.11328125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.12109375,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.12890625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.1328125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.15625,
            "text": "INCA: synonymous codon usage analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.171875,
            "text": "INCA: synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.1796875,
            "text": "INCA: synonymous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.234375,
            "text": "INCA: synonymous codon usage analysis and clustering",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.24609375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.25,
            "end_logit": -6.97265625,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.0078125,
            "text": "A: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.06640625,
            "text": "A: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.11328125,
            "text": "A: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.12109375,
            "text": "A: synonymous codon usage analysis and",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_2": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.7578125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": 8.7578125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": -2.0625,
            "end_logit": 8.7578125,
            "text": "A",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -3.181640625,
            "text": "INC",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.1953125,
            "text": "INCA)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.7578125,
            "text": "Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.65234375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.84765625,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.09375,
            "text": "INCA) provides an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -3.181640625,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -6.08203125,
            "text": "INteractive Codon usage Analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -6.1953125,
            "text": "INteractive Codon usage Analysis (INCA)",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -6.5078125,
            "text": "INteractive Codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -6.65234375,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -6.1953125,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -6.84765625,
            "text": "INteractive Codon usage Analysis (INCA) provides",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -6.9375,
            "text": "INteractive Codon usage Analysis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.5498046875,
            "end_logit": -7.09375,
            "text": "INteractive Codon usage Analysis (INCA) provides an",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -6.65234375,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": -2.0625,
            "end_logit": -6.84765625,
            "text": "A) provides",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_3": [
        {
            "start_logit": 7.53515625,
            "end_logit": 8.578125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -2.453125,
            "end_logit": 8.578125,
            "text": "A",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -3.892578125,
            "text": "INC",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -6.171875,
            "end_logit": 8.578125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.578125,
            "text": "(INCA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.578125,
            "text": ": INteractive Codon usage Analysis (INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.578125,
            "text": "Codon usage Analysis (INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.578125,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -6.8828125,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -6.9453125,
            "text": "INCA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -6.96484375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.12109375,
            "text": "INCA) provides an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.1875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.53515625,
            "end_logit": -7.1875,
            "text": "INCA) provides an array of features useful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.453125,
            "end_logit": -6.8828125,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -2.453125,
            "end_logit": -6.9453125,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -2.453125,
            "end_logit": -6.96484375,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": -2.453125,
            "end_logit": -7.12109375,
            "text": "A) provides an",
            "probability": 0.0
        },
        {
            "start_logit": -2.453125,
            "end_logit": -7.1875,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -2.453125,
            "end_logit": -7.1875,
            "text": "A) provides an array of features useful",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_4": [
        {
            "start_logit": 8.78125,
            "end_logit": 8.6640625,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.78125,
            "end_logit": -2.361328125,
            "text": "INC",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -2.44140625,
            "end_logit": 8.6640625,
            "text": "A",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.046875,
            "text": "INCA: synonymous codon usage analysis and clustering by means",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.15625,
            "text": "INCA: synonymous codon usage analysis and clustering by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.23828125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.23828125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.25,
            "text": "INCA:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.26171875,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.28515625,
            "text": "INCA: synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.296875,
            "text": "INCA: synonymous codon usage analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.30078125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.3359375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.35546875,
            "text": "INCA: synonymous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.78125,
            "end_logit": -7.390625,
            "text": "INCA: synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.44140625,
            "end_logit": -7.046875,
            "text": "A: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": -2.44140625,
            "end_logit": -7.15625,
            "text": "A: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": -2.44140625,
            "end_logit": -7.23828125,
            "text": "A: synonymous codon usage analysis and clustering by means of",
            "probability": 0.0
        },
        {
            "start_logit": -2.44140625,
            "end_logit": -7.23828125,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -2.44140625,
            "end_logit": -7.25,
            "text": "A:",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_5": [
        {
            "start_logit": 8.296875,
            "end_logit": 8.6328125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -2.458984375,
            "end_logit": 8.6328125,
            "text": "A",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -3.05859375,
            "text": "INC",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -6.03125,
            "end_logit": 8.6328125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.6328125,
            "text": "Codon usage Analysis (INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.23046875,
            "text": "INCA) provides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.6328125,
            "text": "(INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.28125,
            "text": "INCA)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.3359375,
            "text": "INCA) provides an array of features useful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.36328125,
            "text": "INCA) provides an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.41015625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.03125,
            "end_logit": -3.05859375,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.23046875,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.28125,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.3359375,
            "text": "A) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.36328125,
            "text": "A) provides an",
            "probability": 0.0
        },
        {
            "start_logit": -2.458984375,
            "end_logit": -7.41015625,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -3.05859375,
            "text": "Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -3.05859375,
            "text": "(INC",
            "probability": 0.0
        },
        {
            "start_logit": -6.03125,
            "end_logit": -7.06640625,
            "text": "INteractive Codon usage Analysis",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_6": [
        {
            "start_logit": 8.828125,
            "end_logit": 8.78125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": 8.78125,
            "text": "A",
            "probability": 1.6570091247558594e-05
        },
        {
            "start_logit": 8.828125,
            "end_logit": -2.236328125,
            "text": "INC",
            "probability": 1.6450881958007812e-05
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 8.78125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.16015625,
            "text": "INCA) provides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.1953125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.2109375,
            "text": "INCA) provides an array of features useful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.25390625,
            "text": "INCA)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.2578125,
            "text": "INCA) provides an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.828125,
            "end_logit": -7.296875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.78125,
            "text": "Codon usage Analysis (INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.6015625,
            "end_logit": -2.236328125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.16015625,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.1953125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.2109375,
            "text": "A) provides an array of features useful",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.25390625,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.2578125,
            "text": "A) provides an",
            "probability": 0.0
        },
        {
            "start_logit": -2.181640625,
            "end_logit": -7.296875,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -2.236328125,
            "text": "Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -4.23828125,
            "end_logit": -7.1953125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_7": [
        {
            "start_logit": 6.4140625,
            "end_logit": 8.765625,
            "text": "INCA",
            "probability": 0.80908203125
        },
        {
            "start_logit": 4.97265625,
            "end_logit": 8.765625,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.190673828125
        },
        {
            "start_logit": -1.8447265625,
            "end_logit": 8.765625,
            "text": "A",
            "probability": 0.00020956993103027344
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 8.765625,
            "text": "Codon usage Analysis (INCA",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.765625,
            "text": "(INCA",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 8.765625,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -4.89453125,
            "text": "INC",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -4.94921875,
            "text": "INCA)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -6.3203125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -4.89453125,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -4.94921875,
            "text": "INteractive Codon usage Analysis (INCA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -6.64453125,
            "text": "INCA) provides",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -5.44140625,
            "text": "INteractive Codon usage Analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -5.62890625,
            "text": "INteractive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -6.24609375,
            "text": "INteractive Codon usage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -6.3203125,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -6.62890625,
            "text": "INteractive Codon usage Analysis (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 4.97265625,
            "end_logit": -6.64453125,
            "text": "INteractive Codon usage Analysis (INCA) provides",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8447265625,
            "end_logit": -4.94921875,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -1.8447265625,
            "end_logit": -6.3203125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_8": [
        {
            "start_logit": 6.5859375,
            "end_logit": 8.6328125,
            "text": "INCA",
            "probability": 0.98388671875
        },
        {
            "start_logit": 2.474609375,
            "end_logit": 8.6328125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 0.016143798828125
        },
        {
            "start_logit": -2.171875,
            "end_logit": 8.6328125,
            "text": "A",
            "probability": 0.00015461444854736328
        },
        {
            "start_logit": -6.703125,
            "end_logit": 8.6328125,
            "text": "Codon usage Analysis (INCA",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -4.734375,
            "text": "INC",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 8.6328125,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.6328125,
            "text": ": INteractive Codon usage Analysis (INCA",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.6328125,
            "text": "(INCA",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -5.79296875,
            "text": "INCA)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -6.66796875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -6.71484375,
            "text": "INCA) provides",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -6.95703125,
            "text": "INCA) provides an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.5859375,
            "end_logit": -7.16015625,
            "text": "INCA) provides an array",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.474609375,
            "end_logit": -4.734375,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": 2.474609375,
            "end_logit": -5.76171875,
            "text": "INteractive Codon usage Analysis",
            "probability": 0.0
        },
        {
            "start_logit": 2.474609375,
            "end_logit": -5.79296875,
            "text": "INteractive Codon usage Analysis (INCA)",
            "probability": 0.0
        },
        {
            "start_logit": 2.474609375,
            "end_logit": -6.390625,
            "text": "INteractive Codon usage",
            "probability": 0.0
        },
        {
            "start_logit": 2.474609375,
            "end_logit": -6.66796875,
            "text": "INteractive Codon usage Analysis (INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 0.0
        },
        {
            "start_logit": 2.474609375,
            "end_logit": -6.71484375,
            "text": "INteractive Codon usage Analysis (INCA) provides",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_9": [
        {
            "start_logit": 8.7265625,
            "end_logit": 8.4609375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -2.44140625,
            "text": "INC",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -2.765625,
            "end_logit": 8.4609375,
            "text": "A",
            "probability": 1.0192394256591797e-05
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -6.60546875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.7265625,
            "end_logit": -7.0546875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.4609375,
            "text": "codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.4609375,
            "text": "'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.4609375,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.4609375,
            "text": "codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.4609375,
            "text": "In addition to computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.4609375,
            "text": "Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.765625,
            "end_logit": -6.60546875,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 0.0
        },
        {
            "start_logit": -3.3984375,
            "end_logit": -6.1796875,
            "text": ". Finally, INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -2.44140625,
            "text": "codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -2.44140625,
            "text": "'codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -2.44140625,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -2.765625,
            "end_logit": -7.0546875,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -2.44140625,
            "text": "codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -2.44140625,
            "text": "In addition to computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INC",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -2.44140625,
            "text": "Nc and CAI, the primary strength of INC",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_10": [
        {
            "start_logit": 9.046875,
            "end_logit": 8.8984375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.791015625,
            "text": "INC",
            "probability": 2.300739288330078e-05
        },
        {
            "start_logit": -1.9609375,
            "end_logit": 8.8984375,
            "text": "A",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.78125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.8671875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.91796875,
            "text": "INCA includes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.96875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.046875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.06640625,
            "text": "INCA includes a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.0859375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1015625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.140625,
            "text": "INCA includes a specific unsupervised neural network algorithm",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.19140625,
            "text": "INCA includes a specific unsupervised neural network algorithm,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1953125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map, used",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.8984375,
            "text": ", INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -6.78125,
            "text": "A includes a specific unsupervised neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -6.8671875,
            "text": "A includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -6.91796875,
            "text": "A includes",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -6.96875,
            "text": "A includes a specific unsupervised neural network algorithm, the",
            "probability": 0.0
        },
        {
            "start_logit": -1.9609375,
            "end_logit": -7.046875,
            "text": "A includes a specific unsupervised neural network algorithm, the self",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_11": [
        {
            "start_logit": 8.953125,
            "end_logit": 8.765625,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.953125,
            "end_logit": -2.01953125,
            "text": "INC",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -2.25,
            "end_logit": 8.765625,
            "text": "A",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.97265625,
            "text": "INCA:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.0078125,
            "text": "INCA: synonymous codon usage analysis and clustering by means",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.06640625,
            "text": "INCA: synonymous codon usage analysis and clustering by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.11328125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.12109375,
            "text": "INCA: synonymous codon usage analysis and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.12890625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.1328125,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.15625,
            "text": "INCA: synonymous codon usage analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.171875,
            "text": "INCA: synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.1796875,
            "text": "INCA: synonymous",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.234375,
            "text": "INCA: synonymous codon usage analysis and clustering",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -7.24609375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.25,
            "end_logit": -6.97265625,
            "text": "A:",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.0078125,
            "text": "A: synonymous codon usage analysis and clustering by means",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.06640625,
            "text": "A: synonymous codon usage analysis and clustering by",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.11328125,
            "text": "A: synonymous codon usage analysis and clustering by means of self",
            "probability": 0.0
        },
        {
            "start_logit": -2.25,
            "end_logit": -7.12109375,
            "text": "A: synonymous codon usage analysis and",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_1": [
        {
            "start_logit": 6.3125,
            "end_logit": 2.61328125,
            "text": "acetaminophen",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.3125,
            "end_logit": -5.14453125,
            "text": "acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.0004286766052246094
        },
        {
            "start_logit": 6.3125,
            "end_logit": -5.8359375,
            "text": "acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs in management of COVID-19 patients until there are enough evidence.",
            "probability": 0.00021469593048095703
        },
        {
            "start_logit": 6.3125,
            "end_logit": -6.43359375,
            "text": "acetaminophen for controlling fever and inflammation and",
            "probability": 0.0001176595687866211
        },
        {
            "start_logit": 6.3125,
            "end_logit": -6.515625,
            "text": "acetaminophen for controlling fever and inflammation",
            "probability": 0.00010877847671508789
        },
        {
            "start_logit": 6.3125,
            "end_logit": -6.8203125,
            "text": "acetaminophen for controlling fever and inflammation and be",
            "probability": 8.022785186767578e-05
        },
        {
            "start_logit": -5.515625,
            "end_logit": 2.61328125,
            "text": "as acetaminophen",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 2.61328125,
            "text": "substitutes such as acetaminophen",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -4.07421875,
            "text": "NSAIDs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.806640625,
            "end_logit": -5.8359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -6.2578125,
            "text": "NSAIDs have",
            "probability": 0.0
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -4.07421875,
            "text": "based on existing evidence, NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -6.3359375,
            "end_logit": -4.07421875,
            "text": ", NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -6.53125,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since there",
            "probability": 0.0
        },
        {
            "start_logit": -5.515625,
            "end_logit": -5.14453125,
            "text": "as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -6.6484375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since there is no",
            "probability": 0.0
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -6.75,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza",
            "probability": 0.0
        },
        {
            "start_logit": -6.71484375,
            "end_logit": -4.07421875,
            "text": "on existing evidence, NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -6.77734375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhinovirus, since there is",
            "probability": 0.0
        },
        {
            "start_logit": -4.01953125,
            "end_logit": -6.78515625,
            "text": "NSAIDs have been",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_2": [
        {
            "start_logit": 0.87548828125,
            "end_logit": 0.41455078125,
            "text": "pain",
            "probability": 0.9052734375
        },
        {
            "start_logit": -2.50390625,
            "end_logit": 0.41455078125,
            "text": "acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0308685302734375
        },
        {
            "start_logit": -3.16796875,
            "end_logit": 0.41455078125,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0158843994140625
        },
        {
            "start_logit": 0.87548828125,
            "end_logit": -3.798828125,
            "text": "pain management in children",
            "probability": 0.0133819580078125
        },
        {
            "start_logit": -3.509765625,
            "end_logit": 0.41455078125,
            "text": ", acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.01126861572265625
        },
        {
            "start_logit": 0.87548828125,
            "end_logit": -4.36328125,
            "text": "pain management in children with COVID-19.",
            "probability": 0.007617950439453125
        },
        {
            "start_logit": 0.87548828125,
            "end_logit": -4.6796875,
            "text": "pain management",
            "probability": 0.00555419921875
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 0.41455078125,
            "text": "ibuprofen can be safely administered for pain",
            "probability": 0.0020904541015625
        },
        {
            "start_logit": -5.40625,
            "end_logit": 0.41455078125,
            "text": "current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0016937255859375
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 0.41455078125,
            "text": "As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.0013933181762695312
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 0.41455078125,
            "text": "for pain",
            "probability": 0.000988006591796875
        },
        {
            "start_logit": -2.50390625,
            "end_logit": -3.111328125,
            "text": "acetaminophen and ibuprofen",
            "probability": 0.0009064674377441406
        },
        {
            "start_logit": -6.21875,
            "end_logit": 0.41455078125,
            "text": "and ibuprofen can be safely administered for pain",
            "probability": 0.000751495361328125
        },
        {
            "start_logit": -6.2890625,
            "end_logit": 0.41455078125,
            "text": "safely administered for pain",
            "probability": 0.0007004737854003906
        },
        {
            "start_logit": -3.16796875,
            "end_logit": -3.111328125,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 0.0004665851593017578
        },
        {
            "start_logit": -2.50390625,
            "end_logit": -3.798828125,
            "text": "acetaminophen and ibuprofen can be safely administered for pain management in children",
            "probability": 0.0004558563232421875
        },
        {
            "start_logit": -3.509765625,
            "end_logit": -3.111328125,
            "text": ", acetaminophen and ibuprofen",
            "probability": 0.00033211708068847656
        },
        {
            "start_logit": -2.50390625,
            "end_logit": -4.36328125,
            "text": "acetaminophen and ibuprofen can be safely administered for pain management in children with COVID-19.",
            "probability": 0.00025963783264160156
        },
        {
            "start_logit": -3.16796875,
            "end_logit": -3.798828125,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain management in children",
            "probability": 0.0002346038818359375
        },
        {
            "start_logit": -2.50390625,
            "end_logit": -4.6796875,
            "text": "acetaminophen and ibuprofen can be safely administered for pain management",
            "probability": 0.00018858909606933594
        }
    ],
    "6277e4ee56bf9aee6f000008_3": [
        {
            "start_logit": 6.30859375,
            "end_logit": 7.20703125,
            "text": "Paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -5.1171875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses.",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.26171875,
            "text": "Paracetamol (acetaminophen) has been proposed",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.3984375,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.44140625,
            "text": "Paracetamol (acetaminophen",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.4453125,
            "text": "Paracetamol (acetaminophen) has",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.49609375,
            "text": "Paracetamol (",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.51171875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -4.703125,
            "text": ". There are clearly COVID-19 cases where NSAIDs should not be used, but there is no strong evidence that NSAIDs must",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -4.8828125,
            "text": ". There are clearly COVID-19 cases where NSAIDs should not be used, but there is no strong evidence that NSAIDs must be avoided",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -4.96875,
            "text": ". There are clearly COVID-19 cases where NSAIDs should",
            "probability": 0.0
        },
        {
            "start_logit": -3.533203125,
            "end_logit": -5.1171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -5.1171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -5.41015625,
            "text": ". There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -5.859375,
            "text": ". There are clearly COVID-19 cases where NSAIDs should not",
            "probability": 0.0
        },
        {
            "start_logit": -4.69921875,
            "end_logit": -4.703125,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -5.96484375,
            "text": ". There are clearly COVID-19 cases where NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 0.0
        },
        {
            "start_logit": -4.69921875,
            "end_logit": -4.8828125,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must be avoided",
            "probability": 0.0
        },
        {
            "start_logit": -4.69921875,
            "end_logit": -4.96875,
            "text": "NSAIDs should",
            "probability": 0.0
        },
        {
            "start_logit": -3.53515625,
            "end_logit": -6.26171875,
            "text": ". There are clearly COVID-19 cases where NSAIDs should not be",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_4": [
        {
            "start_logit": 5.73828125,
            "end_logit": 5.4296875,
            "text": "paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -3.39453125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.00014650821685791016
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -5.4453125,
            "text": "paracetamol can",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -5.71484375,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.16015625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 5.4296875,
            "text": ", paracetamol",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.45703125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.484375,
            "text": "paracetamol can be",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.65234375,
            "text": "paracetamol can be listed as the",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.77734375,
            "text": "paracetamol can be listed",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.84375,
            "text": "paracetamol can be listed as",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.85546875,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 5.73828125,
            "end_logit": -6.85546875,
            "text": "paracetamol can be listed as the first option",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 5.4296875,
            "text": "provide analgesia, paracetamol",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 5.4296875,
            "text": "analgesia, paracetamol",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -4.0234375,
            "end_logit": -3.39453125,
            "text": "pain",
            "probability": 0.0
        },
        {
            "start_logit": -3.658203125,
            "end_logit": -5.7265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.98828125,
            "end_logit": -3.39453125,
            "text": ", paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_5": [
        {
            "start_logit": 6.29296875,
            "end_logit": 8.328125,
            "text": "Paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -4.86328125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.19921875,
            "text": "Paracetamol (acetaminophen) has been proposed",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.2890625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.31640625,
            "text": "Paracetamol (acetaminophen",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.3515625,
            "text": "Paracetamol (acetaminophen) has",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.37109375,
            "text": "Paracetamol (",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.41015625,
            "text": "Paracetamol (acetaminophen) has been proposed as",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.515625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.62890625,
            "text": "Paracetamol (acetaminophen)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.64453125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.71484375,
            "text": "Paracetamol (acetaminophen) has been proposed as an",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.7734375,
            "text": "Paracetamol (acetaminophen) has been",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -6.91796875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -7.01171875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -7.01953125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.53125,
            "end_logit": -4.86328125,
            "text": "liver toxicity",
            "probability": 0.0
        },
        {
            "start_logit": -4.53125,
            "end_logit": -6.515625,
            "text": "liver",
            "probability": 0.0
        },
        {
            "start_logit": -4.53125,
            "end_logit": -6.91796875,
            "text": "liver toxicity at",
            "probability": 0.0
        },
        {
            "start_logit": -6.9765625,
            "end_logit": -4.86328125,
            "text": "with liver toxicity",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_1": [
        {
            "start_logit": 7.3125,
            "end_logit": 7.9453125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.046875,
            "end_logit": 7.9453125,
            "text": "risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.9453125,
            "text": "for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.9453125,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.9453125,
            "text": "antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.9453125,
            "text": "ialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.9453125,
            "text": "anglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.9453125,
            "text": "disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.9453125,
            "text": "improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.9453125,
            "text": "against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.9453125,
            "text": "14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.9453125,
            "text": ".18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.9453125,
            "text": "ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3125,
            "end_logit": -7.3828125,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.0234375,
            "end_logit": -7.3828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.046875,
            "end_logit": -7.3828125,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -7.3828125,
            "text": "for high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.3828125,
            "text": "monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.3828125,
            "text": "antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -7.44140625,
            "text": "monoclonal antibody against disialoganglioside, improved survival as",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_2": [
        {
            "start_logit": 7.03125,
            "end_logit": 8.1796875,
            "text": "Neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.91796875,
            "end_logit": 8.1796875,
            "text": "Risk Neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.1796875,
            "text": "in High-Risk Neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.1796875,
            "text": "Review in High-Risk Neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.1796875,
            "text": "Dinutuximab: A Review in High-Risk Neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.1796875,
            "text": "-Risk Neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.1796875,
            "text": "High-Risk Neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.1796875,
            "text": ": A Review in High-Risk Neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.1796875,
            "text": "A Review in High-Risk Neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.1796875,
            "text": "uximab: A Review in High-Risk Neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.1796875,
            "text": "utuximab: A Review in High-Risk Neuroblastoma",
            "probability": 4.172325134277344e-07
        }
    ],
    "589a247078275d0c4a000035_3": [
        {
            "start_logit": 7.38671875,
            "end_logit": 7.890625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.1953125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.21875,
            "text": "neuroblastoma cells.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.29296875,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.30859375,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.3125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.328125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.36328125,
            "text": "neuroblastoma cells. This intravenous drug is approved",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.36328125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.37109375,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.375,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.38671875,
            "end_logit": -7.37890625,
            "text": "neuroblastoma cells. This intravenous drug is approved in the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.1953125,
            "text": ". This intravenous drug is approved in the EU",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.21875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.21484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.29296875,
            "text": ". This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.30859375,
            "text": ". This intravenous drug is approved in the EU and USA",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.3125,
            "text": ". This intravenous drug is approved in the EU and USA as combination therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.328125,
            "text": ". This intravenous drug is approved in the EU and USA as",
            "probability": 0.0
        },
        {
            "start_logit": -4.28125,
            "end_logit": -7.36328125,
            "text": ". This intravenous drug is approved",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_4": [
        {
            "start_logit": 7.15234375,
            "end_logit": 8.0546875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.0546875,
            "text": "risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.0546875,
            "text": "solidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.0546875,
            "text": "in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.0546875,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.0546875,
            "text": "lidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.0546875,
            "text": "retinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.0546875,
            "text": "treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.0546875,
            "text": "advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.0546875,
            "text": "with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.0546875,
            "text": "dation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.0546875,
            "text": "isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.0546875,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.0546875,
            "text": "oin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.0546875,
            "text": "the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.15234375,
            "end_logit": -7.36328125,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic options.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.15234375,
            "end_logit": -7.43359375,
            "text": "neuroblastoma, with its benefits outweigh",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.15234375,
            "end_logit": -7.44921875,
            "text": "neuroblastoma, with its benefits outweighing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.9609375,
            "end_logit": -7.36328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -7.36328125,
            "text": "risk neuroblastoma, with its benefits outweighing its risks in a patient population with a poor prognosis and limited therapeutic options.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_5": [
        {
            "start_logit": 7.1796875,
            "end_logit": 8.0859375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.0859375,
            "text": "risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.0859375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.0859375,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.0859375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.0859375,
            "text": "for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.0859375,
            "text": "with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.0859375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0859375,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.0859375,
            "text": "uximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.0859375,
            "text": "of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.0859375,
            "text": "-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.0859375,
            "text": "utuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.0859375,
            "text": "high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.35546875,
            "text": "neuroblastoma.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -7.35546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.35546875,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.32421875,
            "text": "treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.32421875,
            "text": "Dinutuximab for the treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.35546875,
            "text": "treatment of pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_6": [
        {
            "start_logit": 6.99609375,
            "end_logit": 8.1328125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.1328125,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.1328125,
            "text": "with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -6.53125,
            "text": "neuroblastoma who",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.03125,
            "text": "neuroblastoma who achieve at least a partial response to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.078125,
            "text": "neuroblastoma who achieve",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.0859375,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.1328125,
            "text": "neuroblastoma who achieve at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.15625,
            "text": "neuroblastoma who achieve at least a partial response",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.15625,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.171875,
            "text": "neuroblastoma who achieve at least a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.2421875,
            "text": "neuroblastoma who achieve at least",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.99609375,
            "end_logit": -7.2421875,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.171875,
            "end_logit": -6.8984375,
            "text": ".<br>",
            "probability": 0.0
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.00390625,
            "text": ".<br><b>",
            "probability": 0.0
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.0859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.0859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.12890625,
            "text": ".<",
            "probability": 0.0
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.1875,
            "text": ".<br><b>CONCLUSIONS",
            "probability": 0.0
        },
        {
            "start_logit": -4.171875,
            "end_logit": -7.28125,
            "text": ".<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal antibody approved",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_7": [
        {
            "start_logit": 7.26171875,
            "end_logit": 7.91015625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.91015625,
            "text": "risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -6.72265625,
            "text": "neuroblastoma who",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.91015625,
            "text": "with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.91015625,
            "text": "]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.15625,
            "text": "neuroblastoma who achieve at least a partial response to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.1640625,
            "text": "neuroblastoma who achieve",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.16796875,
            "text": "neuroblastoma who achieve at",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.26171875,
            "text": "neuroblastoma who achieve at least",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.29296875,
            "text": "neuroblastoma who achieve at least a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.296875,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.30078125,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.3359375,
            "text": "neuroblastoma who achieve at least a partial response",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.35546875,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.37109375,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.140625,
            "end_logit": -7.30078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.72265625,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -6.72265625,
            "text": "with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.72265625,
            "text": "]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.15625,
            "text": "risk neuroblastoma who achieve at least a partial response to",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_8": [
        {
            "start_logit": 6.92578125,
            "end_logit": 8.2109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 8.2109375,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 8.2109375,
            "text": "CONCLUSION</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.2109375,
            "text": "with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.2109375,
            "text": ": Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.2109375,
            "text": "Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.2109375,
            "text": "</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.2109375,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.2109375,
            "text": "immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.2109375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.2109375,
            "text": "combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.92578125,
            "end_logit": -7.2109375,
            "text": "neuroblastoma.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.92578125,
            "end_logit": -7.390625,
            "text": "neuroblastoma.<br>",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -7.2109375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.66015625,
            "end_logit": -7.390625,
            "text": ".<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -7.2109375,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -7.390625,
            "text": "risk neuroblastoma.<br>",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -7.38671875,
            "text": "CONCLUSION</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -7.12890625,
            "text": "5 mg/",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -7.046875,
            "text": "The recommended dosage of dinutuximab is 17",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_9": [
        {
            "start_logit": 7.171875,
            "end_logit": 8.0546875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.0546875,
            "text": "in the treatment of pediatric high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.0546875,
            "text": "risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.0546875,
            "text": "treatment of pediatric high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.0546875,
            "text": ", or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.0546875,
            "text": "the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.0546875,
            "text": ", represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.0546875,
            "text": "uximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.0546875,
            "text": "dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.0546875,
            "text": "GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.0546875,
            "text": "anti-GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.11328125,
            "text": "neuroblastoma and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.23046875,
            "text": "neuroblastoma and is now considered part of standard of care in this patient population.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.4453125,
            "text": "neuroblastoma and is now considered part",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.171875,
            "end_logit": -7.4453125,
            "text": "neuroblastoma and is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.26953125,
            "end_logit": -7.23046875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.11328125,
            "text": "in the treatment of pediatric high-risk neuroblastoma and",
            "probability": 0.0
        },
        {
            "start_logit": -7.34375,
            "end_logit": -7.11328125,
            "text": "risk neuroblastoma and",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.23046875,
            "text": "in the treatment of pediatric high-risk neuroblastoma and is now considered part of standard of care in this patient population.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -7.11328125,
            "text": "treatment of pediatric high-risk neuroblastoma and",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_10": [
        {
            "start_logit": 7.3203125,
            "end_logit": 7.9296875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": 7.9296875,
            "text": ": The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.9296875,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.9296875,
            "text": "pediatric neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.9296875,
            "text": "safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.9296875,
            "text": "dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.9296875,
            "text": "pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.89453125,
            "text": "neuroblastoma are reviewed",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.90234375,
            "text": "neuroblastoma are",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.9296875,
            "text": "treatment of high-risk pediatric neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.9296875,
            "text": "clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.9296875,
            "text": "dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.9296875,
            "text": "administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.12109375,
            "text": "neuroblastoma are reviewed.<br><b>",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.125,
            "text": "neuroblastoma are reviewed.<br>",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.234375,
            "text": "neuroblastoma are reviewed.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.24609375,
            "text": "neuroblastoma are reviewed.<",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.25390625,
            "text": "neuroblastoma are reviewed.<br><",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.27734375,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinutuximab (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.2890625,
            "text": "neuroblastoma are reviewed.<br",
            "probability": 2.384185791015625e-07
        }
    ],
    "589a247078275d0c4a000035_11": [
        {
            "start_logit": 6.98046875,
            "end_logit": 8.1953125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.1953125,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.1953125,
            "text": "with high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -6.953125,
            "text": "neuroblastoma who",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.1796875,
            "text": "neuroblastoma who achieve at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.19921875,
            "text": "neuroblastoma who achieve at least partial response to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.19921875,
            "text": "neuroblastoma who achieve at least partial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.203125,
            "text": "neuroblastoma who achieve at least",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.21875,
            "text": "neuroblastoma who achieve",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.24609375,
            "text": "neuroblastoma who achieve at least partial response to prior",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.26171875,
            "text": "neuroblastoma who achieve at least partial response",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.26953125,
            "text": "neuroblastoma who achieve at least partial response to prior first-line multiagent, multimodality therapy.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.39453125,
            "text": "neuroblastoma who achieve at least partial response to prior first-line multiagent, multimodality therapy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.40625,
            "text": "neuroblastoma who achieve at least partial response to prior first-line multiagent",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.98046875,
            "end_logit": -7.421875,
            "text": "neuroblastoma who achieve at least partial response to prior first-line",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.58203125,
            "end_logit": -7.26953125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.953125,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.1796875,
            "text": "risk neuroblastoma who achieve at",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.19921875,
            "text": "risk neuroblastoma who achieve at least partial response to",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.19921875,
            "text": "risk neuroblastoma who achieve at least partial",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_12": [
        {
            "start_logit": 7.33984375,
            "end_logit": 7.96875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.96875,
            "text": "treatment of high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.96875,
            "text": "risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.96875,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.96875,
            "text": "combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.96875,
            "text": "use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.96875,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.96875,
            "text": "for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.96875,
            "text": "approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.96875,
            "text": "of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.96875,
            "text": "the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.96875,
            "text": "US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.96875,
            "text": "the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.96875,
            "text": "therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.96875,
            "text": "FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.96875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.18359375,
            "text": "neuroblastoma in paediatric patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.34375,
            "text": "neuroblastoma in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.109375,
            "end_logit": -7.18359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -7.18359375,
            "text": "treatment of high-risk neuroblastoma in paediatric patients.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_13": [
        {
            "start_logit": 7.0625,
            "end_logit": 8.078125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.078125,
            "text": "of neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.078125,
            "text": "uxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.078125,
            "text": "treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.078125,
            "text": "ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.078125,
            "text": "targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.078125,
            "text": ".18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.078125,
            "text": "14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.078125,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.078125,
            "text": "18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.078125,
            "text": "monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.078125,
            "text": "in\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.078125,
            "text": "), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.078125,
            "text": ", a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.0625,
            "end_logit": -7.2890625,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -7.2890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -7.20703125,
            "text": "Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -7.29296875,
            "text": "Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.20703125,
            "text": "National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.2890625,
            "text": "of neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_14": [
        {
            "start_logit": 7.1015625,
            "end_logit": 8.125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 8.125,
            "text": "risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.125,
            "text": "Immunotherapy of high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.125,
            "text": ": Immunotherapy of high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.125,
            "text": "PURPOSE: Immunotherapy of high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.125,
            "text": "-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.125,
            "text": "of high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.28515625,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.37890625,
            "text": "neuroblastoma using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.3828125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.39453125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.40234375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.40234375,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -7.28515625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -7.28515625,
            "text": "risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC).",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -7.37890625,
            "text": "risk neuroblastoma using",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -7.3828125,
            "text": "risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -7.39453125,
            "text": "risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -7.40234375,
            "text": "risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -7.40234375,
            "text": "risk neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC)",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_15": [
        {
            "start_logit": 7.26171875,
            "end_logit": 7.91015625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.91015625,
            "text": "risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -6.72265625,
            "text": "neuroblastoma who",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.91015625,
            "text": "with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.91015625,
            "text": "]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.15625,
            "text": "neuroblastoma who achieve at least a partial response to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.1640625,
            "text": "neuroblastoma who achieve",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.16796875,
            "text": "neuroblastoma who achieve at",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.26171875,
            "text": "neuroblastoma who achieve at least",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.29296875,
            "text": "neuroblastoma who achieve at least a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.296875,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.30078125,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.3359375,
            "text": "neuroblastoma who achieve at least a partial response",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.35546875,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -7.37109375,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.140625,
            "end_logit": -7.30078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.72265625,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -6.72265625,
            "text": "with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -6.72265625,
            "text": "]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -7.15625,
            "text": "risk neuroblastoma who achieve at least a partial response to",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_16": [
        {
            "start_logit": 7.1796875,
            "end_logit": 8.0234375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 8.0234375,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.0234375,
            "text": "with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.0234375,
            "text": "-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.0234375,
            "text": "with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.0234375,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.0234375,
            "text": "-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.0234375,
            "text": "GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.0234375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.0234375,
            "text": ", IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -6.921875,
            "text": "neuroblastoma who",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.09375,
            "text": "neuroblastoma who achieve at least a partial response to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.25,
            "text": "neuroblastoma who achieve at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.29296875,
            "text": "neuroblastoma who achieve at least",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.296875,
            "text": "neuroblastoma who achieve at least a partial response",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.31640625,
            "text": "neuroblastoma who achieve at least a partial response to first",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.3203125,
            "text": "neuroblastoma who achieve",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.32421875,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.3359375,
            "text": "neuroblastoma who achieve at least a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.33984375,
            "text": "neuroblastoma who achieve at least a partial",
            "probability": 2.384185791015625e-07
        }
    ],
    "589a247078275d0c4a000035_17": [
        {
            "start_logit": 7.0625,
            "end_logit": 8.078125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.078125,
            "text": "of neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.078125,
            "text": "uxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.078125,
            "text": "treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.078125,
            "text": "ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.078125,
            "text": "targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.078125,
            "text": ".18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.078125,
            "text": "14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.078125,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.078125,
            "text": "18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.078125,
            "text": "monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.078125,
            "text": "in\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.078125,
            "text": "), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.078125,
            "text": ", a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.0625,
            "end_logit": -7.2890625,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.51171875,
            "end_logit": -7.2890625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -7.20703125,
            "text": "Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -7.29296875,
            "text": "Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -7.20703125,
            "text": "National Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.2890625,
            "text": "of neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_18": [
        {
            "start_logit": 7.10546875,
            "end_logit": 8.109375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.109375,
            "text": "risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.109375,
            "text": "with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.109375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.109375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.109375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.109375,
            "text": "of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.109375,
            "text": "retinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.109375,
            "text": "isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.109375,
            "text": "granulocyte- macrophage colony-stimulating factor, interleukin-2, and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.10546875,
            "end_logit": -7.46484375,
            "text": "neuroblastoma.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.9453125,
            "end_logit": -7.46484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -7.46484375,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.38671875,
            "text": "with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.453125,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.44140625,
            "text": "with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.4765625,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics)",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -7.46484375,
            "text": "with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.38671875,
            "text": "pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.38671875,
            "text": "patients with high",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_19": [
        {
            "start_logit": 7.2109375,
            "end_logit": 8.078125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.078125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.078125,
            "text": "Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.078125,
            "text": "with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.078125,
            "text": "immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.078125,
            "text": "monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.078125,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.078125,
            "text": "risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.078125,
            "text": "combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.078125,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.078125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.078125,
            "text": "of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.078125,
            "text": "novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.078125,
            "text": "utuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.078125,
            "text": "is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.078125,
            "text": "that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.078125,
            "text": "antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.2109375,
            "end_logit": -7.296875,
            "text": "neuroblastoma.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -7.296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.296875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_20": [
        {
            "start_logit": 7.27734375,
            "end_logit": 7.97265625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.046875,
            "end_logit": 7.97265625,
            "text": "risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.97265625,
            "text": "improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 7.97265625,
            "text": "with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.97265625,
            "text": "disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.97265625,
            "text": "survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.97265625,
            "text": "in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.97265625,
            "text": "patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.97265625,
            "text": "anglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.97265625,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.97265625,
            "text": "targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.97265625,
            "text": "monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.97265625,
            "text": "antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.97265625,
            "text": "oganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.97265625,
            "text": ", has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.97265625,
            "text": "oside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.27734375,
            "end_logit": -7.15234375,
            "text": "neuroblastoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.125,
            "end_logit": -7.15234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.046875,
            "end_logit": -7.15234375,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.15234375,
            "text": "improve survival rates in patients with high-risk neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_21": [
        {
            "start_logit": 7.23828125,
            "end_logit": 7.984375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.984375,
            "text": "human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.984375,
            "text": "glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.984375,
            "text": "anglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.984375,
            "text": "monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.984375,
            "text": "chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.984375,
            "text": "of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.984375,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.984375,
            "text": "oganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.984375,
            "text": "the surface of neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.23828125,
            "end_logit": -7.34765625,
            "text": "neuroblastoma cells.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.23828125,
            "end_logit": -7.41796875,
            "text": "neuroblastoma cells",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.85546875,
            "end_logit": -7.34765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.43359375,
            "text": "uxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.40625,
            "text": "Din",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.44140625,
            "text": "uxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -7.4453125,
            "text": "uxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.34765625,
            "text": "human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma cells.",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.43359375,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly",
            "probability": 0.0
        },
        {
            "start_logit": -7.515625,
            "end_logit": -7.44140625,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_22": [
        {
            "start_logit": 7.33984375,
            "end_logit": 7.96875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.96875,
            "text": "treatment of high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.96875,
            "text": "risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.96875,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.96875,
            "text": "combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.96875,
            "text": "use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.96875,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.96875,
            "text": "for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.96875,
            "text": "approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.96875,
            "text": "of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.96875,
            "text": "the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.96875,
            "text": "US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.96875,
            "text": "the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.96875,
            "text": "therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.96875,
            "text": "FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.96875,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.18359375,
            "text": "neuroblastoma in paediatric patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.33984375,
            "end_logit": -7.34375,
            "text": "neuroblastoma in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.109375,
            "end_logit": -7.18359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -7.18359375,
            "text": "treatment of high-risk neuroblastoma in paediatric patients.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_23": [
        {
            "start_logit": 7.1796875,
            "end_logit": 8.0859375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.0859375,
            "text": "risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.0859375,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.0859375,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.0859375,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.0859375,
            "text": "for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.0859375,
            "text": "with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.0859375,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0859375,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.0859375,
            "text": "uximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.0859375,
            "text": "of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.0859375,
            "text": "-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.0859375,
            "text": "utuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.0859375,
            "text": "high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.1796875,
            "end_logit": -7.35546875,
            "text": "neuroblastoma.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -7.35546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.35546875,
            "text": "risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.32421875,
            "text": "treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.32421875,
            "text": "Dinutuximab for the treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -7.35546875,
            "text": "treatment of pediatric patients with high-risk neuroblastoma.",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_24": [
        {
            "start_logit": 7.328125,
            "end_logit": 7.95703125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.95703125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.95703125,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.95703125,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 7.95703125,
            "text": "Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.95703125,
            "text": "risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 7.95703125,
            "text": "with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.95703125,
            "text": "treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.95703125,
            "text": "with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.95703125,
            "text": "dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.95703125,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.95703125,
            "text": "uximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.95703125,
            "text": "complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.95703125,
            "text": "unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.95703125,
            "text": "utuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.95703125,
            "text": "following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.95703125,
            "text": "an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -7.26953125,
            "text": "neuroblastoma:",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -7.27734375,
            "text": "neuroblastoma: A case series.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.328125,
            "end_logit": -7.3359375,
            "text": "neuroblastoma: A case series",
            "probability": 2.384185791015625e-07
        }
    ],
    "589a247078275d0c4a000035_25": [
        {
            "start_logit": 7.30859375,
            "end_logit": 7.984375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 7.984375,
            "text": "of the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.984375,
            "text": "treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.984375,
            "text": "BL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.984375,
            "text": "ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.984375,
            "text": "randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.984375,
            "text": "the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.984375,
            "text": "to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 7.984375,
            "text": "(ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.984375,
            "text": "risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.984375,
            "text": "children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.984375,
            "text": "phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.984375,
            "text": "dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.984375,
            "text": "0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.984375,
            "text": "III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.984375,
            "text": "with high-risk neuroblastoma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.30859375,
            "end_logit": -7.05859375,
            "text": "neuroblastoma.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -7.05859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3984375,
            "end_logit": -7.05859375,
            "text": "treatment of children with high-risk neuroblastoma.",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -7.05859375,
            "text": "BL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma.",
            "probability": 0.0
        }
    ],
    "5c8cd26a0101eac870000003_1": [
        {
            "start_logit": 8.0,
            "end_logit": 2.52734375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 0.92822265625
        },
        {
            "start_logit": 8.0,
            "end_logit": -0.72509765625,
            "text": "secreted protein content (exoproteome) revealed",
            "probability": 0.035736083984375
        },
        {
            "start_logit": 8.0,
            "end_logit": -1.3046875,
            "text": "secreted protein content",
            "probability": 0.0200347900390625
        },
        {
            "start_logit": 8.0,
            "end_logit": -2.884765625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis",
            "probability": 0.004131317138671875
        },
        {
            "start_logit": 8.0,
            "end_logit": -3.064453125,
            "text": "secreted protein content (",
            "probability": 0.0034542083740234375
        },
        {
            "start_logit": 8.0,
            "end_logit": -3.1015625,
            "text": "secreted",
            "probability": 0.003322601318359375
        },
        {
            "start_logit": 8.0,
            "end_logit": -3.71875,
            "text": "secreted protein content (exoproteome)",
            "probability": 0.0017919540405273438
        },
        {
            "start_logit": 8.0,
            "end_logit": -4.078125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were",
            "probability": 0.001251220703125
        },
        {
            "start_logit": 8.0,
            "end_logit": -4.9375,
            "text": "secreted protein",
            "probability": 0.0005297660827636719
        },
        {
            "start_logit": 8.0,
            "end_logit": -5.6953125,
            "text": "secreted protein content (exoproteome) revealed that",
            "probability": 0.0002484321594238281
        },
        {
            "start_logit": 8.0,
            "end_logit": -5.796875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate",
            "probability": 0.0002243518829345703
        },
        {
            "start_logit": 8.0,
            "end_logit": -5.90234375,
            "text": "secreted protein content (exoproteome",
            "probability": 0.00020110607147216797
        },
        {
            "start_logit": 8.0,
            "end_logit": -5.94921875,
            "text": "secreted protein content (exoprote",
            "probability": 0.0001919269561767578
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.2265625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated",
            "probability": 0.00014603137969970703
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.23828125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by",
            "probability": 0.00014483928680419922
        },
        {
            "start_logit": 8.0,
            "end_logit": -6.27734375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in",
            "probability": 0.00013828277587890625
        },
        {
            "start_logit": -3.00390625,
            "end_logit": 2.52734375,
            "text": ".",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -4.50390625,
            "end_logit": 2.52734375,
            "text": "enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -1.8330078125,
            "end_logit": -0.72509765625,
            "text": "Comparative analyses of the secreted protein content (exoproteome) revealed",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.296875,
            "end_logit": 2.52734375,
            "text": "(exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 1.5497207641601562e-06
        }
    ],
    "5cb0e4a6ecadf2e73f00005b_1": [
        {
            "start_logit": 7.6640625,
            "end_logit": 8.9453125,
            "text": "surfaceome",
            "probability": 1.0
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -0.03216552734375,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based on machine learning.",
            "probability": 0.00012636184692382812
        },
        {
            "start_logit": -1.650390625,
            "end_logit": 8.9453125,
            "text": "ome",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -3.654296875,
            "text": "surface",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.28515625,
            "end_logit": 8.9453125,
            "text": "o enable analysis of the human surfaceome",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.3828125,
            "end_logit": 8.9453125,
            "text": "enable analysis of the human surfaceome",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -4.359375,
            "text": "surfaceome, we developed the surfaceome predictor",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -4.56640625,
            "text": "surfaceome,",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -4.65234375,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based on machine learning",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -4.83984375,
            "text": "surfaceome, we developed the surfaceome predictor SURFY,",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.328125,
            "end_logit": 8.9453125,
            "text": "analysis of the human surfaceome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.64453125,
            "end_logit": 8.9453125,
            "text": "the human surfaceome",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 8.9453125,
            "text": "human surfaceome",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.484375,
            "text": "surfaceome, we",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 8.9453125,
            "text": "of the human surfaceome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -5.65625,
            "text": "surfaceome, we developed the surfaceome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.2421875,
            "text": "surfaceome, we developed",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.4296875,
            "text": "surfaceome, we developed the surfaceome predictor SURFY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.4375,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6640625,
            "end_logit": -6.80078125,
            "text": "surfaceome, we developed the surfaceome predictor SURF",
            "probability": 1.1920928955078125e-07
        }
    ],
    "550618f58e1671127b000007_1": [
        {
            "start_logit": 7.58203125,
            "end_logit": 6.31640625,
            "text": "protein phosphatase inhibitor-1",
            "probability": 0.9326171875
        },
        {
            "start_logit": 7.58203125,
            "end_logit": 3.64453125,
            "text": "protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 0.06451416015625
        },
        {
            "start_logit": 1.51171875,
            "end_logit": 6.31640625,
            "text": ", protein phosphatase inhibitor-1",
            "probability": 0.0021533966064453125
        },
        {
            "start_logit": 1.51171875,
            "end_logit": 3.64453125,
            "text": ", protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 0.00014901161193847656
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -2.71875,
            "text": "protein phosphatase inhibitor-1 (PPI-1",
            "probability": 0.00011157989501953125
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -2.791015625,
            "text": "protein phosphatase inhibitor",
            "probability": 0.00010317564010620117
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -2.9453125,
            "text": "protein phosphatase inhibitor-",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -3.51953125,
            "text": "protein",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -3.0078125,
            "end_logit": 6.31640625,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1",
            "probability": 2.3424625396728516e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.125,
            "text": "protein phosphatase inhibitor-1 (PPI",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.51171875,
            "text": "protein phosphatase inhibitor-1 (PPI-",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -5.82421875,
            "text": "protein phosphatase inhibitor-1 (",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -4.94921875,
            "end_logit": 6.31640625,
            "text": "1",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 7.58203125,
            "end_logit": -6.23046875,
            "text": "protein phosphatase",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -3.0078125,
            "end_logit": 3.64453125,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -3.15234375,
            "end_logit": 3.64453125,
            "text": "(PPI-1)",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 6.31640625,
            "text": "phosphatase inhibitor-1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 6.31640625,
            "text": "of heart failure. Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.31640625,
            "text": "protein kinase A and phosphatase-1 activities, are hallmarks of heart failure. Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 6.31640625,
            "text": "inhibitor, protein phosphatase inhibitor-1",
            "probability": 3.5762786865234375e-07
        }
    ],
    "550618f58e1671127b000007_2": [
        {
            "start_logit": 9.125,
            "end_logit": 6.125,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.97607421875
        },
        {
            "start_logit": 5.25,
            "end_logit": 6.125,
            "text": "(I-1)",
            "probability": 0.020263671875
        },
        {
            "start_logit": 9.125,
            "end_logit": 0.01514434814453125,
            "text": "Inhibitor 1",
            "probability": 0.0021686553955078125
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.54296875,
            "text": "Inhibitor",
            "probability": 0.0004563331604003906
        },
        {
            "start_logit": 9.125,
            "end_logit": -1.654296875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.0004074573516845703
        },
        {
            "start_logit": 9.125,
            "end_logit": -2.109375,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.0002589225769042969
        },
        {
            "start_logit": 9.125,
            "end_logit": -4.734375,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 9.125,
            "end_logit": -4.8515625,
            "text": "Inhibitor 1 (",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 5.25,
            "end_logit": -1.654296875,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.65625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.75,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.8046875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -5.875,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 5.25,
            "end_logit": -2.109375,
            "text": "(I-1) is",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.0,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 9.125,
            "end_logit": -6.01953125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 6.125,
            "text": "I-1)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 6.125,
            "text": ")",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.25,
            "end_logit": -4.734375,
            "text": "(I-1) is a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.25,
            "end_logit": -4.8515625,
            "text": "(",
            "probability": 3.5762786865234375e-07
        }
    ],
    "550618f58e1671127b000007_3": [
        {
            "start_logit": 8.2421875,
            "end_logit": 5.33984375,
            "text": "inhibitor 1",
            "probability": 0.9716796875
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 1.7587890625,
            "text": "inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.027130126953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.5693359375,
            "text": "inhibitor 1 is",
            "probability": 0.000972747802734375
        },
        {
            "start_logit": 0.348388671875,
            "end_logit": 5.33984375,
            "text": "Ser67-phosphorylated inhibitor 1",
            "probability": 0.0003635883331298828
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -2.943359375,
            "text": "inhibitor",
            "probability": 0.0002460479736328125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.763671875,
            "text": "inhibitor 1 is a",
            "probability": 0.00010836124420166016
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.40234375,
            "text": "inhibitor 1 is a potent",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.1015625,
            "text": "inhibitor 1 is a potent protein phosphatase 1 inhibitor",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": 0.348388671875,
            "end_logit": 1.7587890625,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.5078125,
            "text": "inhibitor 1 is a potent protein phosphatase 1",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.8125,
            "text": "inhibitor 1 is a potent protein phosphatase",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.90625,
            "text": "inhibitor 1 is a potent protein",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -5.39453125,
            "end_logit": 5.33984375,
            "text": "1",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 5.33984375,
            "text": "phosphorylated inhibitor 1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.125,
            "end_logit": 5.33984375,
            "text": "67-phosphorylated inhibitor 1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 0.348388671875,
            "end_logit": -1.5693359375,
            "text": "Ser67-phosphorylated inhibitor 1 is",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 5.33984375,
            "text": "-phosphorylated inhibitor 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.662109375,
            "end_logit": 1.7587890625,
            "text": ".",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.348388671875,
            "end_logit": -2.943359375,
            "text": "Ser67-phosphorylated inhibitor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.348388671875,
            "end_logit": -3.763671875,
            "text": "Ser67-phosphorylated inhibitor 1 is a",
            "probability": 5.960464477539063e-08
        }
    ],
    "550618f58e1671127b000007_4": [
        {
            "start_logit": 9.1953125,
            "end_logit": 8.390625,
            "text": "Inhibitor 1 (I-1)",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.4208984375,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 5.435943603515625e-05
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.4287109375,
            "text": "Inhibitor",
            "probability": 5.3942203521728516e-05
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -2.337890625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 2.1755695343017578e-05
        },
        {
            "start_logit": -2.7734375,
            "end_logit": 8.390625,
            "text": ")",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -4.421875,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -4.3671875,
            "end_logit": 8.390625,
            "text": "(I-1)",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -5.83203125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.015625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.04296875,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.0546875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.1796875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.26171875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.30078125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predom",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.4140625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.453125,
            "text": "Inhibitor 1 (I-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.45703125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.4921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.52734375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein",
            "probability": 3.5762786865234375e-07
        }
    ],
    "550618f58e1671127b000007_5": [
        {
            "start_logit": 9.1640625,
            "end_logit": 8.3828125,
            "text": "Inhibitor 1 (I-1)",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.193359375,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.517578125,
            "text": "Inhibitor",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -2.703125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 1.531839370727539e-05
        },
        {
            "start_logit": -2.77734375,
            "end_logit": 8.3828125,
            "text": ")",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -4.3671875,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -4.4296875,
            "end_logit": 8.3828125,
            "text": "(I-1)",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.69921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.80078125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.859375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -5.97265625,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.046875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.06640625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.21875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.32421875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.3671875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.44140625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.4765625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.4765625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.5078125,
            "text": "Inhibitor 1 (I-",
            "probability": 3.5762786865234375e-07
        }
    ],
    "550618f58e1671127b000007_6": [
        {
            "start_logit": 9.203125,
            "end_logit": 8.59375,
            "text": "Inhibitor 1 (I-1)",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.3935546875,
            "text": "Inhibitor",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": -2.4140625,
            "end_logit": 8.59375,
            "text": ")",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": 9.203125,
            "end_logit": -3.052734375,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": 9.203125,
            "end_logit": -4.59765625,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -4.10546875,
            "end_logit": 8.59375,
            "text": "(I-1)",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.56640625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.78515625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.84765625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -5.98046875,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.109375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.14453125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.28125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.3515625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.4296875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.44140625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.5078125,
            "text": "Inhibitor 1 (I-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.51171875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.54296875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.6328125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the",
            "probability": 2.384185791015625e-07
        }
    ],
    "5881f9b65bf093691f000001_1": [
        {
            "start_logit": 7.203125,
            "end_logit": 8.765625,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": 8.765625,
            "text": "neurons",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": 7.203125,
            "end_logit": -4.23828125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 7.203125,
            "end_logit": -4.28515625,
            "text": "Parasympathetic",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.203125,
            "end_logit": -4.3125,
            "text": "Parasympathetic neurons originate",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.203125,
            "end_logit": -5.55859375,
            "text": "Parasympathetic neurons originate from",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.078125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.60546875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.64453125,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.7109375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.9140625,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.203125,
            "end_logit": -6.97265625,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -4.23828125,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -4.3125,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -5.55859375,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -6.078125,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -6.60546875,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -6.64453125,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -6.7109375,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -1.7314453125,
            "end_logit": -6.9140625,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_2": [
        {
            "start_logit": 6.43359375,
            "end_logit": 8.609375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": 8.609375,
            "text": "neurons",
            "probability": 0.0003936290740966797
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 8.609375,
            "text": ". Parasympathetic neurons",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -3.193359375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -3.416015625,
            "text": "Parasympathetic neurons originate",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -4.89453125,
            "text": "Parasympathetic",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -5.26953125,
            "text": "Parasympathetic neurons originate from",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -5.359375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.4765625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.67578125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.80859375,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.82421875,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.015625,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -3.193359375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -3.416015625,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -5.26953125,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -5.359375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -6.4765625,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -6.67578125,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -4.97265625,
            "end_logit": -3.193359375,
            "text": ". Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_3": [
        {
            "start_logit": 7.32421875,
            "end_logit": 8.6484375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": 8.6484375,
            "text": "neurons",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -4.17578125,
            "text": "Parasympathetic",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -4.8046875,
            "text": "Parasympathetic neurons originate",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -5.8671875,
            "text": "Parasympathetic neurons originate from",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -6.3203125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -6.78515625,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -6.87890625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -6.8828125,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -6.91015625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.32421875,
            "end_logit": -6.97265625,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -4.8046875,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -5.8671875,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -6.3203125,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -6.78515625,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -6.87890625,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -6.8828125,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -6.91015625,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -2.205078125,
            "end_logit": -6.97265625,
            "text": "neurons originate from nerve",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_4": [
        {
            "start_logit": 6.43359375,
            "end_logit": 8.609375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": 8.609375,
            "text": "neurons",
            "probability": 0.0003936290740966797
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 8.609375,
            "text": ". Parasympathetic neurons",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -3.193359375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -3.416015625,
            "text": "Parasympathetic neurons originate",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -4.89453125,
            "text": "Parasympathetic",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -5.26953125,
            "text": "Parasympathetic neurons originate from",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -5.359375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.4765625,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.67578125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.80859375,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -6.82421875,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.015625,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -3.193359375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -3.416015625,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -5.26953125,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -5.359375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -6.4765625,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -1.4013671875,
            "end_logit": -6.67578125,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -4.97265625,
            "end_logit": -3.193359375,
            "text": ". Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_1": [
        {
            "start_logit": 9.046875,
            "end_logit": 8.9609375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.046875,
            "end_logit": -1.8037109375,
            "text": "Clostridium",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": 8.9609375,
            "text": "difficile",
            "probability": 2.1278858184814453e-05
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.2109375,
            "text": "Clostridium difficile,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 8.9609375,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -6.8515625,
            "text": "Clostridium difficile, a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.01953125,
            "text": "Clostridium difficile, a common",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.046875,
            "end_logit": -7.1953125,
            "text": "Clostridium difficile, a common hospital",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.9609375,
            "text": "microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.9609375,
            "text": "patients suffering from recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.9609375,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -6.2109375,
            "text": "difficile,",
            "probability": 0.0
        },
        {
            "start_logit": -6.44140625,
            "end_logit": -1.8037109375,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -6.8515625,
            "text": "difficile, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.01953125,
            "text": "difficile, a common",
            "probability": 0.0
        },
        {
            "start_logit": -1.7177734375,
            "end_logit": -7.1953125,
            "text": "difficile, a common hospital",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -1.8037109375,
            "text": "microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.8037109375,
            "text": "patients suffering from recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.8037109375,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -6.44140625,
            "end_logit": -6.2109375,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile,",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_2": [
        {
            "start_logit": 8.7734375,
            "end_logit": 4.99609375,
            "text": "Clostridium difficile Proctitis",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -2.392578125,
            "text": "Clostridium",
            "probability": 0.0006213188171386719
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -3.73828125,
            "text": "Clostridium difficile",
            "probability": 0.0001608133316040039
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -4.40625,
            "text": "Clostridium difficile Proct",
            "probability": 8.279085159301758e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -4.90234375,
            "text": "Clostridium difficile Proctitis Following Total Colectomy.",
            "probability": 5.060434341430664e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.28515625,
            "text": "Clostridium difficile Proctitis Following Total Colectomy",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.40234375,
            "text": "Clostridium difficile Proctitis Following",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 8.7734375,
            "end_logit": -6.84765625,
            "text": "Clostridium difficile Proctitis Following Total",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 4.99609375,
            "text": "itis",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 4.99609375,
            "text": "difficile Proctitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 4.99609375,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 4.99609375,
            "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 4.99609375,
            "text": "-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 4.99609375,
            "text": "of Clostridium difficile Proctitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 4.99609375,
            "text": "Microbiota Transplantation for Treatment of Clostridium difficile Proctitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 4.99609375,
            "text": "Treatment of Clostridium difficile Proctitis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.09765625,
            "end_logit": -2.392578125,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.23046875,
            "end_logit": -2.392578125,
            "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -2.392578125,
            "text": "-Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -2.392578125,
            "text": "of Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_3": [
        {
            "start_logit": 9.1015625,
            "end_logit": 8.9375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -1.6923828125,
            "text": "Clostridium",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": -1.76171875,
            "end_logit": 8.9375,
            "text": "difficile",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.7890625,
            "text": "Clostridium difficile carriage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -6.98046875,
            "text": "Clostridium difficile carriage rates following",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.0703125,
            "text": "Clostridium difficile carriage rates",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.11328125,
            "text": "Clostridium difficile carriage rates following fecal microbiota transplantation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.2109375,
            "text": "Clostridium difficile carriage rates following fecal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1015625,
            "end_logit": -7.25390625,
            "text": "Clostridium difficile carriage rates following fecal microbiota",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.9375,
            "text": "asymptomatic Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.9375,
            "text": "We aimed to assess the asymptomatic Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.9375,
            "text": "assess the asymptomatic Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.9375,
            "text": "the asymptomatic Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.9375,
            "text": "to assess the asymptomatic Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -6.7890625,
            "text": "difficile carriage",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -6.98046875,
            "text": "difficile carriage rates following",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.0703125,
            "text": "difficile carriage rates",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.11328125,
            "text": "difficile carriage rates following fecal microbiota transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.2109375,
            "text": "difficile carriage rates following fecal",
            "probability": 0.0
        },
        {
            "start_logit": -1.76171875,
            "end_logit": -7.25390625,
            "text": "difficile carriage rates following fecal microbiota",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_4": [
        {
            "start_logit": 9.1640625,
            "end_logit": 8.921875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.5361328125,
            "text": "Clostridium",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.787109375,
            "end_logit": 8.921875,
            "text": "difficile",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -4.13671875,
            "text": "Clostridium difficile infection",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.4140625,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.05078125,
            "text": "Clostridium difficile infection,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.1875,
            "text": "Clostridium difficile infection, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.921875,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.921875,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.921875,
            "text": "the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.921875,
            "text": "of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.921875,
            "text": ", the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.921875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.921875,
            "text": "used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.921875,
            "text": "intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.921875,
            "text": "into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.921875,
            "text": "donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.921875,
            "text": "for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.921875,
            "text": "decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.787109375,
            "end_logit": -4.13671875,
            "text": "difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_5": [
        {
            "start_logit": 9.03125,
            "end_logit": 6.26171875,
            "text": "Clostridium difficile",
            "probability": 0.5390625
        },
        {
            "start_logit": 9.03125,
            "end_logit": 6.10546875,
            "text": "Clostridium difficile Infection",
            "probability": 0.4609375
        },
        {
            "start_logit": 9.03125,
            "end_logit": -1.82421875,
            "text": "Clostridium",
            "probability": 0.0001646280288696289
        },
        {
            "start_logit": 9.03125,
            "end_logit": -5.9921875,
            "text": "Clostridium difficile Infection in",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.29296875,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.53125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT)",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.65234375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.83984375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.85546875,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.87890625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.9375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.953125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as a",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 9.03125,
            "end_logit": -6.98046875,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 6.26171875,
            "text": "difficile",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 6.10546875,
            "text": "difficile Infection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.91015625,
            "end_logit": 6.10546875,
            "text": "Infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 6.26171875,
            "text": "Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 6.10546875,
            "text": "Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 6.26171875,
            "text": "Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.26171875,
            "text": "Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c71d6d27c78d6947100006a_6": [
        {
            "start_logit": 9.1953125,
            "end_logit": 8.96875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.4794921875,
            "text": "Clostridium",
            "probability": 2.9325485229492188e-05
        },
        {
            "start_logit": -1.73828125,
            "end_logit": 8.96875,
            "text": "difficile",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.6015625,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.640625,
            "text": "Clostridium difficile Infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.15234375,
            "text": "Clostridium difficile Infection following",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.171875,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.2421875,
            "text": "Clostridium difficile Infection following Fecal Microbiota",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.3203125,
            "text": "Clostridium difficile Infection following Fecal",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 8.96875,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.96875,
            "text": "Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.96875,
            "text": "from Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.96875,
            "text": "Recovery from Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.96875,
            "text": "Recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.73828125,
            "end_logit": -6.6015625,
            "text": "difficile Infection following Fecal Microbiota Transplantation.",
            "probability": 0.0
        },
        {
            "start_logit": -1.73828125,
            "end_logit": -6.640625,
            "text": "difficile Infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -1.4794921875,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.73828125,
            "end_logit": -7.15234375,
            "text": "difficile Infection following",
            "probability": 0.0
        },
        {
            "start_logit": -1.73828125,
            "end_logit": -7.171875,
            "text": "difficile Infection following Fecal Microbiota Transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -1.73828125,
            "end_logit": -7.2421875,
            "text": "difficile Infection following Fecal Microbiota",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_7": [
        {
            "start_logit": 9.1640625,
            "end_logit": 8.921875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.5361328125,
            "text": "Clostridium",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -1.787109375,
            "end_logit": 8.921875,
            "text": "difficile",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -4.13671875,
            "text": "Clostridium difficile infection",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.4140625,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.05078125,
            "text": "Clostridium difficile infection,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.1875,
            "text": "Clostridium difficile infection, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.921875,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.921875,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.921875,
            "text": "the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.921875,
            "text": "of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.921875,
            "text": ", the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.921875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.921875,
            "text": "used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.921875,
            "text": "intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.921875,
            "text": "into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.921875,
            "text": "donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.921875,
            "text": "for decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.921875,
            "text": "decades to treat recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.787109375,
            "end_logit": -4.13671875,
            "text": "difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_8": [
        {
            "start_logit": 9.0,
            "end_logit": 8.0546875,
            "text": "Clostridium difficile infection",
            "probability": 0.96533203125
        },
        {
            "start_logit": 9.0,
            "end_logit": 4.73046875,
            "text": "Clostridium difficile",
            "probability": 0.03460693359375
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.951171875,
            "text": "Clostridium",
            "probability": 4.315376281738281e-05
        },
        {
            "start_logit": -2.912109375,
            "end_logit": 8.0546875,
            "text": "infection",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -5.23828125,
            "end_logit": 8.0546875,
            "text": "difficile infection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.421875,
            "text": "Clostridium difficile infection, with near 90% of success.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.91796875,
            "end_logit": 8.0546875,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.9609375,
            "text": "Clostridium difficile infection, with near 90",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.0390625,
            "text": "Clostridium difficile infection,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.04296875,
            "text": "Clostridium difficile infection, with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.04296875,
            "text": "Clostridium difficile infection, with near 90%",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.046875,
            "text": "Clostridium difficile infection, with near",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.0546875,
            "text": "recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.0546875,
            "text": "microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.0546875,
            "text": "treat recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.23828125,
            "end_logit": 4.73046875,
            "text": "difficile",
            "probability": 0.0
        },
        {
            "start_logit": -5.91796875,
            "end_logit": 4.73046875,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 4.73046875,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 4.73046875,
            "text": "microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 4.73046875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_9": [
        {
            "start_logit": 9.109375,
            "end_logit": 8.609375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.109375,
            "end_logit": 0.46435546875,
            "text": "Clostridium difficile infection",
            "probability": 0.0002892017364501953
        },
        {
            "start_logit": 9.109375,
            "end_logit": -1.6884765625,
            "text": "Clostridium",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": -2.34765625,
            "end_logit": 8.609375,
            "text": "difficile",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 9.109375,
            "end_logit": -5.8359375,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.51953125,
            "end_logit": 8.609375,
            "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.59765625,
            "text": "Clostridium difficile infection,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.78125,
            "text": "Clostridium difficile infection, has emerged",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.85546875,
            "text": "Clostridium difficile infection, has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.8828125,
            "text": "Clostridium difficile infection, has emerged as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.109375,
            "end_logit": -6.9765625,
            "text": "Clostridium difficile infection, has emerged as a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.609375,
            "text": "microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.609375,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.609375,
            "text": "treatment for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.609375,
            "text": "for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.609375,
            "text": "highly effective treatment for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.609375,
            "text": "effective treatment for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -2.34765625,
            "end_logit": 0.46435546875,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -5.51953125,
            "end_logit": 0.46435546875,
            "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 0.46435546875,
            "text": "microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile infection",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_10": [
        {
            "start_logit": 9.0,
            "end_logit": 8.171875,
            "text": "Clostridium difficile infection",
            "probability": 0.98193359375
        },
        {
            "start_logit": 9.0,
            "end_logit": 4.19921875,
            "text": "Clostridium difficile",
            "probability": 0.0185394287109375
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.8955078125,
            "text": "Clostridium",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -2.6875,
            "end_logit": 8.171875,
            "text": "infection",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.109375,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -4.8515625,
            "end_logit": 8.171875,
            "text": "Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.07421875,
            "end_logit": 8.171875,
            "text": "difficile infection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.60546875,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.69921875,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.74609375,
            "text": "Clostridium difficile infection (R-CDI) that cannot be",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.84765625,
            "text": "Clostridium difficile infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.875,
            "text": "Clostridium difficile infection (R-CDI) that cann",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.89453125,
            "text": "Clostridium difficile infection (R",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.89453125,
            "text": "Clostridium difficile infection (R-CDI) that cannot",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 8.171875,
            "text": "recurrent Clostridium difficile infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.171875,
            "text": "microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.171875,
            "text": "OBJECTIVES Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.171875,
            "text": "treatment of recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.171875,
            "text": "FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.8515625,
            "end_logit": 4.19921875,
            "text": "Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_11": [
        {
            "start_logit": 9.0,
            "end_logit": 8.734375,
            "text": "Clostridium difficile infection",
            "probability": 0.9990234375
        },
        {
            "start_logit": 9.0,
            "end_logit": 1.080078125,
            "text": "Clostridium difficile",
            "probability": 0.0004725456237792969
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.91796875,
            "text": "Clostridium",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -1.8076171875,
            "end_logit": 8.734375,
            "text": "infection",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -3.33203125,
            "text": "Clostridium difficile infection (CDI).",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 8.734375,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.6328125,
            "text": "Clostridium difficile infection (CDI",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.25390625,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.32421875,
            "text": "Clostridium difficile infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 8.734375,
            "text": "difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.734375,
            "text": "with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.734375,
            "text": "microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.734375,
            "text": "BACKGROUND Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.734375,
            "text": "to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.734375,
            "text": "patients with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.734375,
            "text": "gastrointestinal tract and may effectively treat patients with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.734375,
            "text": "treat patients with Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.09765625,
            "end_logit": 1.080078125,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -1.8076171875,
            "end_logit": -3.33203125,
            "text": "infection (CDI).",
            "probability": 0.0
        },
        {
            "start_logit": -6.2578125,
            "end_logit": 1.080078125,
            "text": "difficile",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_12": [
        {
            "start_logit": 9.09375,
            "end_logit": 8.90625,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.09375,
            "end_logit": -0.708984375,
            "text": "Clostridium difficile infection",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": 9.09375,
            "end_logit": -1.70703125,
            "text": "Clostridium",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -1.7890625,
            "end_logit": 8.90625,
            "text": "difficile",
            "probability": 1.8775463104248047e-05
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.41796875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.70703125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.8984375,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -6.99609375,
            "text": "Clostridium difficile infection (rCDI) by fecal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.015625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.09375,
            "text": "Clostridium difficile infection (rC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.1328125,
            "text": "Clostridium difficile infection (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.1328125,
            "text": "Clostridium difficile infection (rCDI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.15625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.15625,
            "text": "Clostridium difficile infection (rCDI)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.1796875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples, were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.09375,
            "end_logit": -7.19921875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 8.90625,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 8.90625,
            "text": "for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.90625,
            "text": "subjects treated for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.90625,
            "text": "treated for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c71d6d27c78d6947100006a_13": [
        {
            "start_logit": 9.1640625,
            "end_logit": 8.9375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -1.55078125,
            "text": "Clostridium",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": -1.7939453125,
            "end_logit": 8.9375,
            "text": "difficile",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.640625,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.890625,
            "text": "Clostridium difficile infections, with potential",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.9140625,
            "text": "Clostridium difficile infections,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -6.984375,
            "text": "Clostridium difficile infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.05078125,
            "text": "Clostridium difficile infections, with potential applications",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.09375,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.1328125,
            "text": "Clostridium difficile infections, with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.140625,
            "text": "Clostridium difficile infections, with potential applications against other",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 8.9375,
            "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1640625,
            "end_logit": -7.25390625,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.9375,
            "text": "recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.9375,
            "text": "microbiota transplantation is a compelling treatment for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.9375,
            "text": "treatment for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7939453125,
            "end_logit": -6.640625,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 0.0
        },
        {
            "start_logit": -6.953125,
            "end_logit": -1.55078125,
            "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -1.7939453125,
            "end_logit": -6.890625,
            "text": "difficile infections, with potential",
            "probability": 0.0
        },
        {
            "start_logit": -1.7939453125,
            "end_logit": -6.9140625,
            "text": "difficile infections,",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_14": [
        {
            "start_logit": 9.0703125,
            "end_logit": 8.0859375,
            "text": "Clostridium difficile infection",
            "probability": 0.84423828125
        },
        {
            "start_logit": 9.0703125,
            "end_logit": 6.39453125,
            "text": "Clostridium difficile",
            "probability": 0.1561279296875
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -1.798828125,
            "text": "Clostridium",
            "probability": 4.309415817260742e-05
        },
        {
            "start_logit": -2.91015625,
            "end_logit": 8.0859375,
            "text": "infection",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 8.0859375,
            "text": "difficile infection",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.078125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -6.8359375,
            "text": "Clostridium difficile infection, but",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.96875,
            "end_logit": 8.0859375,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.0234375,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 6.39453125,
            "text": "difficile",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0703125,
            "end_logit": -7.13671875,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.0859375,
            "text": "recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.0859375,
            "text": "microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.96875,
            "end_logit": 6.39453125,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.39453125,
            "text": "recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.39453125,
            "text": "microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 0.0
        },
        {
            "start_logit": -5.96875,
            "end_logit": -1.798828125,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -2.91015625,
            "end_logit": -6.078125,
            "text": "infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required.",
            "probability": 0.0
        },
        {
            "start_logit": -7.46875,
            "end_logit": -1.798828125,
            "text": "recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -1.798828125,
            "text": "microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_15": [
        {
            "start_logit": 8.953125,
            "end_logit": 7.64453125,
            "text": "Clostridium difficile infection",
            "probability": 1.0
        },
        {
            "start_logit": 8.953125,
            "end_logit": -0.908203125,
            "text": "Clostridium difficile",
            "probability": 0.00019419193267822266
        },
        {
            "start_logit": 8.953125,
            "end_logit": -2.0234375,
            "text": "Clostridium",
            "probability": 6.35385513305664e-05
        },
        {
            "start_logit": 8.953125,
            "end_logit": -4.71484375,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases.",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -3.529296875,
            "end_logit": 7.64453125,
            "text": "infection",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 8.953125,
            "end_logit": -5.6875,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -4.3828125,
            "end_logit": 7.64453125,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.953125,
            "end_logit": -5.83984375,
            "text": "Clostridium difficile infection (CDI",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.18359375,
            "text": "Clostridium difficile infection (CDI) and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.359375,
            "text": "Clostridium difficile infection (",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.546875,
            "text": "Clostridium difficile infection (CDI) and is considered",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.62890625,
            "text": "Clostridium difficile infection (CDI) and is considered as",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.703125,
            "text": "Clostridium difficile infection (CDI) and is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.953125,
            "end_logit": -6.7734375,
            "text": "Clostridium difficile infection (CDI) and is considered as a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.64453125,
            "text": "difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.64453125,
            "text": "recurrent Clostridium difficile infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 7.64453125,
            "text": "microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.64453125,
            "text": "treatment for recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 7.64453125,
            "text": "FMT) is an effective treatment for recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.3828125,
            "end_logit": -0.908203125,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_16": [
        {
            "start_logit": 9.0546875,
            "end_logit": 6.984375,
            "text": "Clostridium difficile infection",
            "probability": 0.60400390625
        },
        {
            "start_logit": 9.0546875,
            "end_logit": 6.55078125,
            "text": "Clostridium difficile",
            "probability": 0.39599609375
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -1.8369140625,
            "text": "Clostridium",
            "probability": 8.988380432128906e-05
        },
        {
            "start_logit": -4.171875,
            "end_logit": 6.984375,
            "text": "infection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -4.21875,
            "end_logit": 6.984375,
            "text": "difficile infection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -4.21875,
            "end_logit": 6.55078125,
            "text": "difficile",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -6.98046875,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.14453125,
            "text": "Clostridium difficile infection with",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.21875,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.28125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.28125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.2890625,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.30859375,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0546875,
            "end_logit": -7.32421875,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 6.984375,
            "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.984375,
            "text": "recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 6.55078125,
            "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.984375,
            "text": "in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.984375,
            "text": "perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.984375,
            "text": "simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c71d6d27c78d6947100006a_17": [
        {
            "start_logit": 9.1171875,
            "end_logit": 8.84375,
            "text": "Clostridium difficile infection",
            "probability": 1.0
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.6728515625,
            "text": "Clostridium",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": -1.8515625,
            "end_logit": 8.84375,
            "text": "infection",
            "probability": 1.710653305053711e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -3.33203125,
            "text": "Clostridium difficile",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.65234375,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 8.84375,
            "text": "difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -6.9453125,
            "text": "Clostridium difficile infection and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.1875,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.1875,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.23828125,
            "text": "Clostridium difficile infection and coexist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.28125,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 8.84375,
            "text": "recurrent Clostridium difficile infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.30859375,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -7.34375,
            "text": "Clostridium difficile infection and coexistent",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.84375,
            "text": "fecal microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.84375,
            "text": "in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.84375,
            "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.84375,
            "text": "microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.84375,
            "text": "use of fecal microbiota transplantation in recurrent Clostridium difficile infection",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8515625,
            "end_logit": -6.65234375,
            "text": "infection and coexistent inflammatory bowel disease remains unclear.",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_1": [
        {
            "start_logit": 7.08984375,
            "end_logit": 6.91796875,
            "text": "histone deacetylase",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.2396240234375,
            "end_logit": 6.91796875,
            "text": "proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 0.0006561279296875
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -3.302734375,
            "text": "histone",
            "probability": 3.641843795776367e-05
        },
        {
            "start_logit": -3.6171875,
            "end_logit": 6.91796875,
            "text": "deacetylase",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -4.9453125,
            "end_logit": 6.91796875,
            "text": ", histone deacetylase",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.625,
            "text": "histone deacetylase (",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.7109375,
            "text": "histone deacetylase (HDAC",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.75390625,
            "text": "histone deacetylase (HDAC) inhibitors",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -5.8984375,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinostat).",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -6.73046875,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinostat",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.08984375,
            "end_logit": -6.96875,
            "text": "histone deacetylase (HDAC)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 6.91796875,
            "text": "filzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 6.91796875,
            "text": "daratumumab and elotuzumab), histone deacetylase",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 6.91796875,
            "text": "carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.91796875,
            "text": "otuzumab), histone deacetylase",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.91796875,
            "text": "), histone deacetylase",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.91796875,
            "text": "uzumab), histone deacetylase",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -0.2396240234375,
            "end_logit": -0.89404296875,
            "text": "proteasome inhibitors",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.2396240234375,
            "end_logit": -3.302734375,
            "text": "proteasome inhibitors (bortezomib, carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone",
            "probability": 0.0
        },
        {
            "start_logit": -0.2396240234375,
            "end_logit": -4.40625,
            "text": "proteasome",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_2": [
        {
            "start_logit": 7.4375,
            "end_logit": 7.734375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.10546875,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated in phase I studies.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.15234375,
            "text": "proteasome inhibitor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.734375,
            "text": "N2238), the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.734375,
            "text": "the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.734375,
            "text": "generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.734375,
            "text": ", the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.26953125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 7.734375,
            "text": "MLN9708-MLN2238), the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.2890625,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 7.734375,
            "text": "MLN2238), the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.734375,
            "text": "azomib (MLN9708-MLN2238), the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.734375,
            "text": "N9708-MLN2238), the second-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.296875,
            "text": "proteasome inhibitor, selectivity and potency were similar to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.30859375,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.3125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.31640625,
            "text": "proteasome inhibitor, selectivity and potency were",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.33984375,
            "text": "proteasome inhibitor, selectivity and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.35546875,
            "text": "proteasome inhibitor, selectivity and potency were similar",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4375,
            "end_logit": -7.36328125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated",
            "probability": 2.980232238769531e-07
        }
    ],
    "589630f378275d0c4a000007_3": [
        {
            "start_logit": 8.0234375,
            "end_logit": 6.828125,
            "text": "CD38",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.279296875,
            "end_logit": 6.828125,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.001178741455078125
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.65625,
            "text": "CD38 and SLAMF7, respectively.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.90625,
            "end_logit": 6.828125,
            "text": "oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.140625,
            "text": "CD38 and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.1953125,
            "text": "CD38 and SLAMF7, respectively",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 6.828125,
            "text": "first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.828125,
            "text": ", the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 6.828125,
            "text": "target CD38",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 6.828125,
            "text": "multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.279296875,
            "end_logit": -1.8193359375,
            "text": "proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.828125,
            "text": "for multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.828125,
            "text": "the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 6.828125,
            "text": ": ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.828125,
            "text": "ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.279296875,
            "end_logit": -5.546875,
            "text": "proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": 1.279296875,
            "end_logit": -6.65625,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7, respectively.",
            "probability": 0.0
        },
        {
            "start_logit": 1.279296875,
            "end_logit": -6.8359375,
            "text": "proteasome inhibitor;",
            "probability": 0.0
        },
        {
            "start_logit": 1.279296875,
            "end_logit": -7.140625,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and",
            "probability": 0.0
        },
        {
            "start_logit": 1.279296875,
            "end_logit": -7.1953125,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7, respectively",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_4": [
        {
            "start_logit": 7.6484375,
            "end_logit": 7.61328125,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -6.51953125,
            "text": "proteasome inhibitor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 7.61328125,
            "text": "oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.04296875,
            "text": "proteasome inhibitor to",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.15625,
            "text": "proteasome inhibitor to be evaluated",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.18359375,
            "text": "proteasome inhibitor to be",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.1953125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.234375,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.23828125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.26171875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.26953125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.27734375,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.28125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination with immunomodulatory drugs and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.30078125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.3046875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.3125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination with immunomodulatory drugs and it may",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6484375,
            "end_logit": -7.3125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.61328125,
            "text": "first oral proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 7.61328125,
            "text": "the first oral proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 7.61328125,
            "text": ", the first oral proteasome",
            "probability": 2.980232238769531e-07
        }
    ],
    "589630f378275d0c4a000007_5": [
        {
            "start_logit": 7.59375,
            "end_logit": 5.81640625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 7.59375,
            "end_logit": -5.94140625,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanzomib.",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -6.3671875,
            "text": "proteasome inhibitors",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.04296875,
            "text": "proteasome inhibitors have",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.05859375,
            "text": "proteasome inhibitors have also",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.10546875,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.13671875,
            "text": "proteasome inhibitors have also been used clinically",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.18359375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ix",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.19921875,
            "text": "proteasome inhibitors have also been",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.59375,
            "end_logit": -7.203125,
            "text": "proteasome inhibitors have also been used clinically,",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -7.0625,
            "end_logit": 5.81640625,
            "text": "generation proteasome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 5.81640625,
            "text": "the introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 5.81640625,
            "text": "introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 5.81640625,
            "text": "Since the introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 5.81640625,
            "text": "in 2003, several next-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 5.81640625,
            "text": "bortezomib in 2003, several next-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 5.81640625,
            "text": "of bortezomib in 2003, several next-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 5.81640625,
            "text": ", several next-generation proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.38671875,
            "end_logit": -5.94140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.0625,
            "end_logit": -5.94140625,
            "text": "generation proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanzomib.",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_6": [
        {
            "start_logit": 8.2578125,
            "end_logit": 6.76953125,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -4.65234375,
            "text": "proteasome inhibitor",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.4375,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment, to provide posology recommendations.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.0078125,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.04296875,
            "text": "proteasome inhibitor,",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.2109375,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.23046875,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.23046875,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.27734375,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment, to",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.28515625,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.3359375,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.3359375,
            "text": "proteasome inhibitor, ix",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 6.76953125,
            "text": "oral proteasome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 6.76953125,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 6.76953125,
            "text": "The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 6.76953125,
            "text": "study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 6.76953125,
            "text": "pharmacokinetics of the oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.76953125,
            "text": "aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 6.76953125,
            "text": "characterize the pharmacokinetics of the oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.76953125,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 1.7881393432617188e-07
        }
    ],
    "589630f378275d0c4a000007_7": [
        {
            "start_logit": 7.8203125,
            "end_logit": 7.41796875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -5.90234375,
            "text": "proteasome inhibitor",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -6.6171875,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -6.71484375,
            "text": "proteasome inhibitor, in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -6.9296875,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -6.99609375,
            "text": "proteasome inhibitor, in solid tumour patients",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.02734375,
            "text": "proteasome inhibitor, in solid tumour patients with moderate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.02734375,
            "text": "proteasome inhibitor, in solid tumour patients with",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.03515625,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.03515625,
            "text": "proteasome inhibitor,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.09765625,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.15234375,
            "text": "proteasome inhibitor, in solid tumour",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.15625,
            "text": "proteasome inhibitor, in solid",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.8203125,
            "end_logit": -7.19140625,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 7.41796875,
            "text": "oral proteasome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.41796875,
            "text": "an oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.41796875,
            "text": ", an oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.390625,
            "end_logit": -6.6171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.85546875,
            "end_logit": -5.90234375,
            "text": "oral proteasome inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -5.90234375,
            "text": "an oral proteasome inhibitor",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_8": [
        {
            "start_logit": 7.8515625,
            "end_logit": 7.12109375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -6.171875,
            "text": "proteasome inhibitor to reach phase III trials.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -6.37109375,
            "text": "proteasome inhibitor",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 7.12109375,
            "text": ", proteasome",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -6.765625,
            "text": "proteasome inhibitor to",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.12109375,
            "text": "proteasome inhibitor to reach",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.1875,
            "text": "proteasome inhibitor to reach phase III trials",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.1953125,
            "text": "proteasome inhibitor to reach phase",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.8515625,
            "end_logit": -7.2109375,
            "text": "proteasome inhibitor to reach phase III",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 7.12109375,
            "text": "oral, proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.12109375,
            "text": "Ixazomib is the first oral, proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.12109375,
            "text": "first oral, proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.12109375,
            "text": "azomib is the first oral, proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.12109375,
            "text": "is the first oral, proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.12109375,
            "text": "mib is the first oral, proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.12109375,
            "text": "b is the first oral, proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.12109375,
            "text": "the first oral, proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.1328125,
            "end_logit": -6.171875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -6.171875,
            "text": ", proteasome inhibitor to reach phase III trials.",
            "probability": 0.0
        },
        {
            "start_logit": -5.7734375,
            "end_logit": -6.37109375,
            "text": ", proteasome inhibitor",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_9": [
        {
            "start_logit": 7.69140625,
            "end_logit": 7.3671875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -6.046875,
            "end_logit": 7.3671875,
            "text": "oral proteasome",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -6.41796875,
            "text": "proteasome inhibitor",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -6.6484375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -6.98828125,
            "text": "proteasome inhibitor,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.16015625,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.171875,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.1875,
            "text": "proteasome inhibitor, has",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.203125,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.3828125,
            "text": "proteasome inhibitor, has improved",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.69140625,
            "end_logit": -7.38671875,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.3671875,
            "text": "an oral proteasome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.3671875,
            "text": "MLN2238 (ixazomib), an oral proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.3671875,
            "text": "(ixazomib), an oral proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.3671875,
            "text": ", an oral proteasome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.3671875,
            "text": "N2238 (ixazomib), an oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.3671875,
            "text": "azomib), an oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.3671875,
            "text": "b), an oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.3671875,
            "text": "8 (ixazomib), an oral proteasome",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 7.3671875,
            "text": "), an oral proteasome",
            "probability": 2.384185791015625e-07
        }
    ],
    "589630f378275d0c4a000007_10": [
        {
            "start_logit": 8.0390625,
            "end_logit": 7.03125,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.22265625,
            "text": "proteasome inhibitor",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.92578125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.0,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.05859375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.08984375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.09765625,
            "text": "proteasome inhibitor ix",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.12890625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.171875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.1796875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.19921875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.203125,
            "text": "proteasome inhibitor ixazomi",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.21875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.234375,
            "text": "proteasome inhibitor ixazomib assessed the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 7.03125,
            "text": "This population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.5,
            "end_logit": 7.03125,
            "text": "oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.03125,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.03125,
            "text": "investigational oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.03125,
            "text": "of the investigational oral proteasome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.03125,
            "text": "pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55201a316b348bb82c000019_1": [
        {
            "start_logit": 9.53125,
            "end_logit": 8.8359375,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 9.53125,
            "end_logit": 0.68994140625,
            "text": "55",
            "probability": 0.0002868175506591797
        },
        {
            "start_logit": -1.3125,
            "end_logit": 8.8359375,
            "text": "S",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 9.53125,
            "end_logit": -2.248046875,
            "text": "55 S, consisting of 39 S large and 28 S small subunits.",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": 9.53125,
            "end_logit": -5.765625,
            "text": "55 S,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.1875,
            "end_logit": 8.8359375,
            "text": "The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.3046875,
            "end_logit": 8.8359375,
            "text": "small sedimentation coefficient of 55 S",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.53125,
            "end_logit": -6.51953125,
            "text": "55 S, consisting",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 8.8359375,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.8359375,
            "text": "ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.09375,
            "end_logit": 8.8359375,
            "text": "(mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.109375,
            "end_logit": 8.8359375,
            "text": "a small sedimentation coefficient of 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.8359375,
            "text": "of 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 8.8359375,
            "text": "sedimentation coefficient of 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3125,
            "end_logit": -2.248046875,
            "text": "S, consisting of 39 S large and 28 S small subunits.",
            "probability": 0.0
        },
        {
            "start_logit": -5.1875,
            "end_logit": 0.68994140625,
            "text": "The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -5.3046875,
            "end_logit": 0.68994140625,
            "text": "small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -6.0703125,
            "end_logit": 0.68994140625,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 0.68994140625,
            "text": "ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": 0.68994140625,
            "text": "(mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_2": [
        {
            "start_logit": 9.625,
            "end_logit": 3.955078125,
            "text": "55 S",
            "probability": 0.8173828125
        },
        {
            "start_logit": 9.625,
            "end_logit": 2.451171875,
            "text": "55",
            "probability": 0.182373046875
        },
        {
            "start_logit": 9.625,
            "end_logit": -5.63671875,
            "text": "55 S mammalian mitochondrial ribosome",
            "probability": 5.5670738220214844e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -5.8359375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\")",
            "probability": 4.583597183227539e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.25390625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter",
            "probability": 3.0279159545898438e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.265625,
            "text": "55 S mammalian mitochondrial ribosome (referred to",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.3203125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\"",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.328125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.34375,
            "text": "55 S mammalian mitochondrial ribosome (",
            "probability": 2.759695053100586e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.453125,
            "text": "55 S mammalian mitochondrial ribosome (referred to here",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.453125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.4921875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich,",
            "probability": 2.378225326538086e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.52734375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.546875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as",
            "probability": 2.2530555725097656e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.58203125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein",
            "probability": 2.181529998779297e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.5859375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.60546875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome",
            "probability": 2.1159648895263672e-05
        },
        {
            "start_logit": 9.625,
            "end_logit": -6.6171875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-",
            "probability": 2.09808349609375e-05
        },
        {
            "start_logit": -5.390625,
            "end_logit": 3.955078125,
            "text": "The 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 3.955078125,
            "text": "S",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55201a316b348bb82c000019_3": [
        {
            "start_logit": 9.265625,
            "end_logit": 8.9453125,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 9.265625,
            "end_logit": -0.7919921875,
            "text": "55",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -1.373046875,
            "end_logit": 8.9453125,
            "text": "S",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 9.265625,
            "end_logit": -4.07421875,
            "text": "55 S.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -4.45703125,
            "end_logit": 8.9453125,
            "text": "The sedimentation coefficient of the intact monosome was about 55 S",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 8.9453125,
            "text": "about 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.9453125,
            "text": "intact monosome was about 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.9453125,
            "text": "monosome was about 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.9453125,
            "text": "ome was about 55 S",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.45703125,
            "end_logit": -0.7919921875,
            "text": "The sedimentation coefficient of the intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -1.373046875,
            "end_logit": -4.07421875,
            "text": "S.",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -0.7919921875,
            "text": "about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -0.7919921875,
            "text": "intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -0.7919921875,
            "text": "monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -0.7919921875,
            "text": "ome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -4.45703125,
            "end_logit": -4.07421875,
            "text": "The sedimentation coefficient of the intact monosome was about 55 S.",
            "probability": 0.0
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -4.07421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.45703125,
            "end_logit": -6.0390625,
            "text": "The sedimentation coefficient of the intact monosome was",
            "probability": 0.0
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -4.07421875,
            "text": "about 55 S.",
            "probability": 0.0
        },
        {
            "start_logit": -4.45703125,
            "end_logit": -6.625,
            "text": "The sedimentation coefficient of",
            "probability": 0.0
        }
    ],
    "5e2a1096aa19d7443100000e_1": [
        {
            "start_logit": 8.53125,
            "end_logit": 9.15625,
            "text": "vascular endothelial growth factor A",
            "probability": 1.0
        },
        {
            "start_logit": -1.044921875,
            "end_logit": 9.15625,
            "text": "A",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 8.53125,
            "end_logit": -1.05078125,
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": -1.7392578125,
            "end_logit": 9.15625,
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 3.4809112548828125e-05
        },
        {
            "start_logit": 8.53125,
            "end_logit": -1.3671875,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo.",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": 8.53125,
            "end_logit": -2.478515625,
            "text": "vascular",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 8.53125,
            "end_logit": -2.71484375,
            "text": "vascular endothelial growth factor A (VEGF-A",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 8.53125,
            "end_logit": -3.033203125,
            "text": "vascular endothelial growth factor A (VEGF-A),",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 9.15625,
            "text": "a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -4.421875,
            "end_logit": 9.15625,
            "text": "endothelial growth factor A",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.3515625,
            "end_logit": 9.15625,
            "text": "factor A",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -4.80078125,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.546875,
            "end_logit": 9.15625,
            "text": "encoding vascular endothelial growth factor A",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -4.97265625,
            "text": "vascular endothelial growth factor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -5.984375,
            "end_logit": 9.15625,
            "text": "Here, we longitudinally and comprehensively characterize microvascular responses to AZD8601, a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 9.15625,
            "text": "growth factor A",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -5.796875,
            "text": "vascular endothelial growth",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -6.00390625,
            "text": "vascular endothelial growth factor A (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -6.13671875,
            "text": "vascular endothelial growth factor A (VEGF",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 9.15625,
            "text": "mRNA encoding vascular endothelial growth factor A",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5caa0247ecadf2e73f000055_1": [
        {
            "start_logit": 7.703125,
            "end_logit": 5.43359375,
            "text": "moesin",
            "probability": 0.916015625
        },
        {
            "start_logit": 7.703125,
            "end_logit": 3.025390625,
            "text": "moesin (Moe)",
            "probability": 0.08197021484375
        },
        {
            "start_logit": 7.703125,
            "end_logit": -0.66796875,
            "text": "moesin (Moe).",
            "probability": 0.0020427703857421875
        },
        {
            "start_logit": 7.703125,
            "end_logit": -3.12890625,
            "text": "mo",
            "probability": 0.00017499923706054688
        },
        {
            "start_logit": 7.703125,
            "end_logit": -4.2109375,
            "text": "moesin (Moe",
            "probability": 5.91278076171875e-05
        },
        {
            "start_logit": 7.703125,
            "end_logit": -5.38671875,
            "text": "moesin (",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": 7.703125,
            "end_logit": -5.39453125,
            "text": "moesin (Mo",
            "probability": 1.817941665649414e-05
        },
        {
            "start_logit": -3.28515625,
            "end_logit": 5.43359375,
            "text": "of moesin",
            "probability": 1.537799835205078e-05
        },
        {
            "start_logit": -4.5078125,
            "end_logit": 5.43359375,
            "text": "by Crb recruitment of moesin",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": -5.15625,
            "end_logit": 5.43359375,
            "text": "esin",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 5.43359375,
            "text": "propose is mediated by Crb recruitment of moesin",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -3.28515625,
            "end_logit": 3.025390625,
            "text": "of moesin (Moe)",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 2.634765625,
            "end_logit": -3.16015625,
            "text": "epidermal growth factor receptor (Egfr) pathway,",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -4.5078125,
            "end_logit": 3.025390625,
            "text": "by Crb recruitment of moesin (Moe)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 5.43359375,
            "text": "we propose is mediated by Crb recruitment of moesin",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 2.634765625,
            "end_logit": -4.53515625,
            "text": "epidermal growth factor receptor (Egfr) pathway, is required for tracheal cell apical constriction",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.15625,
            "end_logit": 3.025390625,
            "text": "esin (Moe)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.634765625,
            "end_logit": -5.20703125,
            "text": "epidermal growth factor receptor (Egfr) pathway, is required",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 3.025390625,
            "text": "propose is mediated by Crb recruitment of moesin (Moe)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.634765625,
            "end_logit": -5.31640625,
            "text": "epidermal growth factor receptor (Egfr) pathway, is required for tracheal cell apical",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4604d83f54159529000003_1": [
        {
            "start_logit": 8.5390625,
            "end_logit": 9.078125,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.8603515625
        },
        {
            "start_logit": 6.7265625,
            "end_logit": 9.078125,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.139404296875
        },
        {
            "start_logit": -1.4736328125,
            "end_logit": 9.078125,
            "text": "dissection",
            "probability": 3.844499588012695e-05
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -2.708984375,
            "text": "carotid",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 6.7265625,
            "end_logit": -2.708984375,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -5.8828125,
            "end_logit": 9.078125,
            "text": "artery dissection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.94921875,
            "end_logit": 9.078125,
            "text": ") carotid and vertebral artery dissection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.01171875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 9.078125,
            "text": "and vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.7265625,
            "end_logit": -4.46484375,
            "text": "acute",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 9.078125,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 9.078125,
            "text": "vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -6.7109375,
            "text": "carotid and vertebral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 9.078125,
            "text": "AIMS: CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.078125,
            "text": ": CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 9.078125,
            "text": "(within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.5390625,
            "end_logit": -7.0078125,
            "text": "carotid and vertebral artery",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 9.078125,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 9.078125,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.078125,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4604d83f54159529000003_2": [
        {
            "start_logit": 8.53125,
            "end_logit": 9.09375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9462890625
        },
        {
            "start_logit": 5.6640625,
            "end_logit": 9.09375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.053802490234375
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": 9.09375,
            "text": "dissection",
            "probability": 4.500150680541992e-05
        },
        {
            "start_logit": 8.53125,
            "end_logit": -2.6875,
            "text": "carotid",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 9.09375,
            "text": "artery dissection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 9.09375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -2.6875,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 9.09375,
            "text": "and vertebral artery dissection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -5.96875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 9.09375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.09375,
            "text": "vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -6.734375,
            "text": "carotid and vertebral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.09375,
            "text": "AIMS  CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.09375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.09375,
            "text": "(within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.015625,
            "text": "carotid and vertebral artery",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.09375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.16015625,
            "text": "carotid and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.2109375,
            "text": "acute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.96875,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_3": [
        {
            "start_logit": 8.53125,
            "end_logit": 9.09375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9462890625
        },
        {
            "start_logit": 5.6640625,
            "end_logit": 9.09375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.053802490234375
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": 9.09375,
            "text": "dissection",
            "probability": 4.500150680541992e-05
        },
        {
            "start_logit": 8.53125,
            "end_logit": -2.6875,
            "text": "carotid",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 9.09375,
            "text": "artery dissection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 9.09375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -2.6875,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 9.09375,
            "text": "and vertebral artery dissection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -5.96875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 9.09375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.09375,
            "text": "vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -6.734375,
            "text": "carotid and vertebral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.09375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.09375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.09375,
            "text": "(within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.015625,
            "text": "carotid and vertebral artery",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.09375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.16015625,
            "text": "carotid and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.2109375,
            "text": "acute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.96875,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_4": [
        {
            "start_logit": 8.53125,
            "end_logit": 9.09375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9462890625
        },
        {
            "start_logit": 5.6640625,
            "end_logit": 9.09375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.053802490234375
        },
        {
            "start_logit": -1.4267578125,
            "end_logit": 9.09375,
            "text": "dissection",
            "probability": 4.500150680541992e-05
        },
        {
            "start_logit": 8.53125,
            "end_logit": -2.6875,
            "text": "carotid",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -5.7421875,
            "end_logit": 9.09375,
            "text": "artery dissection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 9.09375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -2.6875,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 9.09375,
            "text": "and vertebral artery dissection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -5.96875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 9.09375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 9.09375,
            "text": "vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -6.734375,
            "text": "carotid and vertebral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 9.09375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.09375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.09375,
            "text": "(within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.015625,
            "text": "carotid and vertebral artery",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 9.09375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.53125,
            "end_logit": -7.16015625,
            "text": "carotid and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.2109375,
            "text": "acute",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.6640625,
            "end_logit": -5.96875,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_5": [
        {
            "start_logit": 8.421875,
            "end_logit": 9.109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.5703125,
            "end_logit": 9.109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 0.001056671142578125
        },
        {
            "start_logit": -1.365234375,
            "end_logit": 9.109375,
            "text": "dissection",
            "probability": 5.602836608886719e-05
        },
        {
            "start_logit": 8.421875,
            "end_logit": -2.810546875,
            "text": "carotid",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -5.36328125,
            "end_logit": 9.109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.4296875,
            "end_logit": 9.109375,
            "text": "artery dissection",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.140625,
            "end_logit": 9.109375,
            "text": "and vertebral artery dissection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -5.77734375,
            "text": "carotid and vertebral artery dissection.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 9.109375,
            "text": "vertebral artery dissection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 9.109375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 9.109375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 9.109375,
            "text": "(within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -6.80078125,
            "text": "carotid and vertebral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.109375,
            "text": "onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 9.109375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 9.109375,
            "text": "days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 9.109375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.421875,
            "end_logit": -7.12109375,
            "text": "carotid and vertebral artery",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.5703125,
            "end_logit": -2.810546875,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": 1.5703125,
            "end_logit": -5.77734375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection.",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_1": [
        {
            "start_logit": 5.51171875,
            "end_logit": 4.64453125,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity.",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.689453125,
            "end_logit": 4.64453125,
            "text": ".",
            "probability": 0.0002734661102294922
        },
        {
            "start_logit": -3.359375,
            "end_logit": 4.64453125,
            "text": "protects against \u03b1-synuclein neurotoxicity.",
            "probability": 0.00013971328735351562
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -5.078125,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 6.008148193359375e-05
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -5.33203125,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 4.64320182800293e-05
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -5.4140625,
            "text": "Spermidine",
            "probability": 4.26173210144043e-05
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -5.92578125,
            "text": "Spermidine protects against \u03b1-",
            "probability": 2.568960189819336e-05
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -6.19140625,
            "text": "Spermidine protects against",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": -5.76953125,
            "end_logit": 4.64453125,
            "text": "against \u03b1-synuclein neurotoxicity.",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -6.75,
            "text": "Spermidine protects against \u03b1",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": 5.51171875,
            "end_logit": -7.0703125,
            "text": "Spermidine protects",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -6.40625,
            "end_logit": 4.64453125,
            "text": "\u03b1-synuclein neurotoxicity.",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -3.359375,
            "end_logit": -5.078125,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -5.33203125,
            "text": "protects against \u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -5.92578125,
            "text": "protects against \u03b1-",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -6.19140625,
            "text": "protects against",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -6.75,
            "text": "protects against \u03b1",
            "probability": 0.0
        },
        {
            "start_logit": -3.359375,
            "end_logit": -7.0703125,
            "text": "protects",
            "probability": 0.0
        },
        {
            "start_logit": -5.76953125,
            "end_logit": -5.078125,
            "text": "against \u03b1-synuclein neurotoxicity",
            "probability": 0.0
        },
        {
            "start_logit": -5.76953125,
            "end_logit": -5.33203125,
            "text": "against \u03b1-synuclein",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_2": [
        {
            "start_logit": 3.39453125,
            "end_logit": -1.681640625,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.916015625
        },
        {
            "start_logit": 3.39453125,
            "end_logit": -5.1171875,
            "text": "Spermidine protects against",
            "probability": 0.0294952392578125
        },
        {
            "start_logit": 3.39453125,
            "end_logit": -5.4375,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 0.0214080810546875
        },
        {
            "start_logit": 3.39453125,
            "end_logit": -6.0703125,
            "text": "Spermidine protects against \u03b1-",
            "probability": 0.01134490966796875
        },
        {
            "start_logit": 3.39453125,
            "end_logit": -6.3359375,
            "text": "Spermidine",
            "probability": 0.008697509765625
        },
        {
            "start_logit": 3.39453125,
            "end_logit": -6.55859375,
            "text": "Spermidine protects against \u03b1",
            "probability": 0.006992340087890625
        },
        {
            "start_logit": 3.39453125,
            "end_logit": -6.75,
            "text": "Spermidine protects",
            "probability": 0.0057525634765625
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -1.681640625,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.00012218952178955078
        },
        {
            "start_logit": -6.71875,
            "end_logit": -1.681640625,
            "text": "against \u03b1-synuclein neurotoxicity",
            "probability": 3.731250762939453e-05
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -1.681640625,
            "text": "\u03b1-synuclein neurotoxicity",
            "probability": 3.266334533691406e-05
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -5.1171875,
            "text": "protects against",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -5.4375,
            "text": "protects against \u03b1-synuclein",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -6.0703125,
            "text": "protects against \u03b1-",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.71875,
            "end_logit": -5.1171875,
            "text": "against",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -6.55859375,
            "text": "protects against \u03b1",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": -5.4375,
            "text": "against \u03b1-synuclein",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.52734375,
            "end_logit": -6.75,
            "text": "protects",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -5.4375,
            "text": "\u03b1-synuclein",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": -6.0703125,
            "text": "against \u03b1-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": -6.0703125,
            "text": "\u03b1-",
            "probability": 3.5762786865234375e-07
        }
    ],
    "606074ab94d57fd87900003e_1": [
        {
            "start_logit": 9.0,
            "end_logit": 9.0,
            "text": "Rtpca",
            "probability": 1.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": 9.0,
            "text": "a",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.90234375,
            "text": "Rt",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.0,
            "end_logit": -5.41796875,
            "text": "Rtpca:",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 9.0,
            "text": "pca",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.140625,
            "text": "Rtpca: an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.28515625,
            "text": "Rtpca: an R package",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.43359375,
            "text": "Rtpca: an R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.859375,
            "text": "Rtpc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.9765625,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation analysis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.125,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.1796875,
            "text": "Rtpca: an R package for differential thermal proximity coaggreg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.234375,
            "text": "Rtpca: an R package for",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.25390625,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation analysis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.26171875,
            "text": "Rtpca: an R package for differential",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.2734375,
            "text": "Rtpca: an R package for differential thermal proximity coag",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -5.41796875,
            "text": "a:",
            "probability": 0.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -6.140625,
            "text": "a: an",
            "probability": 0.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -6.28515625,
            "text": "a: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -1.7158203125,
            "end_logit": -6.43359375,
            "text": "a: an R",
            "probability": 0.0
        }
    ],
    "606074ab94d57fd87900003e_2": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.078125,
            "text": "Rtpca",
            "probability": 1.0
        },
        {
            "start_logit": -1.5234375,
            "end_logit": 9.078125,
            "text": "a",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.7060546875,
            "text": "Rt",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -5.13671875,
            "text": "Rtpca is",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.46875,
            "end_logit": 9.078125,
            "text": "pca",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.48046875,
            "text": "Rtpca is an R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.61328125,
            "text": "Rtpca is an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.66796875,
            "text": "Rtpca is an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.828125,
            "text": "Rtpc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5234375,
            "end_logit": -5.13671875,
            "text": "a is",
            "probability": 0.0
        },
        {
            "start_logit": -1.5234375,
            "end_logit": -6.48046875,
            "text": "a is an R package",
            "probability": 0.0
        },
        {
            "start_logit": -1.5234375,
            "end_logit": -6.61328125,
            "text": "a is an",
            "probability": 0.0
        },
        {
            "start_logit": -1.5234375,
            "end_logit": -6.66796875,
            "text": "a is an R",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.28515625,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.69140625,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https:/",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.703125,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioc",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.71875,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconduc",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.78515625,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor.",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.84375,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor.org/packages",
            "probability": 0.0
        },
        {
            "start_logit": -3.57421875,
            "end_logit": -6.9140625,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca).",
            "probability": 0.0
        }
    ],
    "513ce494bee46bd34c000009_1": [
        {
            "start_logit": 9.0625,
            "end_logit": 9.21875,
            "text": "polycystic kidney disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.078125,
            "end_logit": 9.21875,
            "text": "disease",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -1.6865234375,
            "text": "polycystic",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": 9.0625,
            "end_logit": -4.0703125,
            "text": "polycystic kidney disease (PKD",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 9.21875,
            "text": "kidney disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -5.9765625,
            "text": "polycystic kidney disease (PK",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 9.21875,
            "text": "autosomal recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 9.21875,
            "text": "in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.06640625,
            "text": "polycystic kidney disease (PKD)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 9.21875,
            "text": "of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0625,
            "end_logit": -7.1875,
            "text": "polycystic kidney disease (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34375,
            "end_logit": 9.21875,
            "text": "and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 9.21875,
            "text": "development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 9.21875,
            "text": "recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.21875,
            "text": "of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 9.21875,
            "text": "is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 9.21875,
            "text": "malformation of primary cilia, and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 9.21875,
            "text": "collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 9.21875,
            "text": "primary cilia, and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.078125,
            "end_logit": -4.0703125,
            "text": "disease (PKD",
            "probability": 0.0
        }
    ],
    "5a885daa61bb38fb24000018_1": [
        {
            "start_logit": 7.1953125,
            "end_logit": 0.57568359375,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif.",
            "probability": 0.8125
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -1.1728515625,
            "text": "Asp",
            "probability": 0.1417236328125
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -3.486328125,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif",
            "probability": 0.01398468017578125
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -4.0390625,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D) which",
            "probability": 0.00806427001953125
        },
        {
            "start_logit": 1.8662109375,
            "end_logit": 0.57568359375,
            "text": "including Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif.",
            "probability": 0.00394439697265625
        },
        {
            "start_logit": 1.3984375,
            "end_logit": 0.57568359375,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.002468109130859375
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.2578125,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D)",
            "probability": 0.0023822784423828125
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.41015625,
            "text": "Asp(D)-Glu",
            "probability": 0.0020465850830078125
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.4140625,
            "text": "Asp(D",
            "probability": 0.0020389556884765625
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.5625,
            "text": "Asp(D)",
            "probability": 0.0017576217651367188
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.71484375,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp",
            "probability": 0.0015087127685546875
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.74609375,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D",
            "probability": 0.0014629364013671875
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.7890625,
            "text": "Asp(",
            "probability": 0.0014009475708007812
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.80078125,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part",
            "probability": 0.0013837814331054688
        },
        {
            "start_logit": 7.1953125,
            "end_logit": -5.8671875,
            "text": "Asp(D)-Glu-(E)",
            "probability": 0.0012960433959960938
        },
        {
            "start_logit": 1.8662109375,
            "end_logit": -1.1728515625,
            "text": "including Asp",
            "probability": 0.0006856918334960938
        },
        {
            "start_logit": 1.3984375,
            "end_logit": -1.5673828125,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 0.00029015541076660156
        },
        {
            "start_logit": 1.3984375,
            "end_logit": -1.572265625,
            "text": "RNA helicase",
            "probability": 0.0002880096435546875
        },
        {
            "start_logit": -1.07421875,
            "end_logit": 0.57568359375,
            "text": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.0002090930938720703
        },
        {
            "start_logit": 1.8662109375,
            "end_logit": -3.486328125,
            "text": "including Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif",
            "probability": 6.788969039916992e-05
        }
    ],
    "52b2e409f828ad283c00000e_1": [
        {
            "start_logit": 7.48046875,
            "end_logit": 7.8125,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -6.66015625,
            "text": "schizophrenia in Canada from 2005 to 2009.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -6.80859375,
            "text": "schizophrenia in Canada",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -6.875,
            "text": "schizophrenia in Canada from",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.8125,
            "text": "with schizophrenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -6.98046875,
            "text": "schizophrenia in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.8125,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.0859375,
            "text": "schizophrenia in Canada from 2005 to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.08984375,
            "text": "schizophrenia in Canada from 2005",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.48046875,
            "end_logit": -7.1015625,
            "text": "schizophrenia in Canada from 2005 to 2009",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 7.8125,
            "text": "in the use of antipsychotics for adults with schizophrenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.8125,
            "text": "antipsychotics for adults with schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.8125,
            "text": "use of antipsychotics for adults with schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.8125,
            "text": "for adults with schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19140625,
            "end_logit": -6.66015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -6.66015625,
            "text": "with schizophrenia in Canada from 2005 to 2009.",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -6.66015625,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in Canada from 2005 to 2009.",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -6.66015625,
            "text": "in the use of antipsychotics for adults with schizophrenia in Canada from 2005 to 2009.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -6.80859375,
            "text": "with schizophrenia in Canada",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -6.66015625,
            "text": "to 2009.",
            "probability": 0.0
        }
    ],
    "52b2e409f828ad283c00000e_2": [
        {
            "start_logit": 7.69921875,
            "end_logit": 7.6328125,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.0625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.12109375,
            "text": "schizophrenia was listed as the indication.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.1640625,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.203125,
            "text": "schizophrenia was",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.23046875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.25,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.25390625,
            "text": "schizophrenia was listed as the",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.26171875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005 and 2009",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.30859375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.69921875,
            "end_logit": -7.31640625,
            "text": "schizophrenia was listed as",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 7.6328125,
            "text": "which schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.6328125,
            "text": "I data in which schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.6328125,
            "text": "in which schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.6328125,
            "text": "Antipsychotic recommendations were estimated using CDTI data in which schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.6328125,
            "text": "using CDTI data in which schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.6328125,
            "text": "CDTI data in which schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -6.9609375,
            "text": ". RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38% between 2005 and 2009, from 329 380 to",
            "probability": 0.0
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -7.0625,
            "text": ". RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 0.0
        },
        {
            "start_logit": -4.64453125,
            "end_logit": -7.12109375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "52b2e409f828ad283c00000e_3": [
        {
            "start_logit": 7.4609375,
            "end_logit": 7.78515625,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": 7.78515625,
            "text": ". Its best indication seems to be paranoid schizophrenia",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -6.71875,
            "end_logit": 7.78515625,
            "text": "oid schizophrenia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.09375,
            "text": "schizophrenia, although some data suggest bipolar action.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.78515625,
            "text": "indication seems to be paranoid schizophrenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.16796875,
            "text": "schizophrenia, although",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 7.78515625,
            "text": "be paranoid schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.78515625,
            "text": "best indication seems to be paranoid schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.78515625,
            "text": "Its best indication seems to be paranoid schizophrenia",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.26171875,
            "text": "schizophrenia,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.296875,
            "text": "schizophrenia, although some",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.30078125,
            "text": "schizophrenia, although some data",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.30859375,
            "text": "schizophrenia, although some data suggest",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.09375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.09375,
            "text": ". Its best indication seems to be paranoid schizophrenia, although some data suggest bipolar action.",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.09375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.09375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.16796875,
            "text": ". Its best indication seems to be paranoid schizophrenia, although",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.26171875,
            "text": ". Its best indication seems to be paranoid schizophrenia,",
            "probability": 0.0
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -7.29296875,
            "text": ". Its pharmacological profile is close",
            "probability": 0.0
        }
    ],
    "6252f496e764a53204000020_1": [
        {
            "start_logit": 9.1328125,
            "end_logit": 7.59375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 0.9970703125
        },
        {
            "start_logit": 9.1328125,
            "end_logit": 1.4990234375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter",
            "probability": 0.002269744873046875
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -1.5390625,
            "text": "ABC",
            "probability": 0.00010859966278076172
        },
        {
            "start_logit": -0.677734375,
            "end_logit": 7.59375,
            "text": ".",
            "probability": 5.501508712768555e-05
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.01171875,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -2.65234375,
            "end_logit": 7.59375,
            "text": "ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.4765625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.51171875,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -4.88671875,
            "text": "ABCG1 is an ATP binding cassette (",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -3.560546875,
            "end_logit": 7.59375,
            "text": "transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.109375,
            "text": "ABCG1 is an ATP binding cassette (ABC",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.11328125,
            "text": "ABCG1 is an ATP binding cassette (ABC)",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.46484375,
            "text": "ABCG1 is",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.52734375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.8046875,
            "text": "ABCG1 is an ATP binding cassette",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -5.9921875,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 7.59375,
            "text": "that removes excess cholesterol from peripheral tissues.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 9.1328125,
            "end_logit": -6.49609375,
            "text": "ABCG1 is an ATP binding",
            "probability": 7.748603820800781e-07
        }
    ],
    "601ee4c61cb411341a000066_1": [
        {
            "start_logit": 9.21875,
            "end_logit": 9.09375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.21875,
            "end_logit": -1.1474609375,
            "text": "196",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": -1.421875,
            "end_logit": 9.09375,
            "text": "7",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.76953125,
            "text": "1967 was",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -6.96875,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 9.09375,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.06640625,
            "text": "1967 was performed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.19140625,
            "text": "1967 was performed using a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.24609375,
            "text": "1967 was performed using a deceased",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.2578125,
            "text": "1967 was performed using",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.265625,
            "text": "1967 was performed using a deceased donor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.21875,
            "end_logit": -7.296875,
            "text": "1967 was performed using a deceased donor heart",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 9.09375,
            "text": "human heart transplant in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.90625,
            "end_logit": -1.1474609375,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": -6.76953125,
            "text": "7 was",
            "probability": 0.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": -6.96875,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": -7.06640625,
            "text": "7 was performed",
            "probability": 0.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": -7.19140625,
            "text": "7 was performed using a",
            "probability": 0.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": -7.24609375,
            "text": "7 was performed using a deceased",
            "probability": 0.0
        },
        {
            "start_logit": -1.421875,
            "end_logit": -7.2578125,
            "text": "7 was performed using",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_2": [
        {
            "start_logit": 9.0,
            "end_logit": 8.9140625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.0,
            "end_logit": -1.6044921875,
            "text": "196",
            "probability": 2.7120113372802734e-05
        },
        {
            "start_logit": -1.7802734375,
            "end_logit": 8.9140625,
            "text": "7",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": -3.708984375,
            "end_logit": 8.9140625,
            "text": "In 1967",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.1796875,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.30078125,
            "text": "1967, Christian Barnard",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.68359375,
            "text": "1967, Christian Barnar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.7265625,
            "text": "1967, Christian Barnard performed the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.75,
            "text": "1967, Christian Bar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.84765625,
            "text": "1967, Christian Barnard performed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.86328125,
            "text": "1967, Christian",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -6.9453125,
            "text": "1967, Christian Barnard performed the first",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.0390625,
            "text": "1967, Christ",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.07421875,
            "text": "1967, Christian Barnard performed the first successful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.09375,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.21875,
            "text": "1967,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.25,
            "text": "1967, Christian Barnard performed the first successful human-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.28125,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0,
            "end_logit": -7.33203125,
            "text": "1967, Chr",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.708984375,
            "end_logit": -1.6044921875,
            "text": "In 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_3": [
        {
            "start_logit": 9.3984375,
            "end_logit": 9.1953125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -0.383056640625,
            "text": "196",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -0.99365234375,
            "end_logit": 9.1953125,
            "text": "7",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -5.3125,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 9.1953125,
            "text": "Christiaan Barnard in 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.8828125,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.8984375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.91015625,
            "text": "1967,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -6.99609375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.015625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.015625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.04296875,
            "text": "1967, there has been substantial progress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.0625,
            "text": "1967, there has been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.3984375,
            "end_logit": -7.06640625,
            "text": "1967, there has been substantial progress in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 9.1953125,
            "text": "Since the first successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 9.1953125,
            "text": "by Christiaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 9.1953125,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 9.1953125,
            "text": "istiaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.1953125,
            "text": "iaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 9.1953125,
            "text": "n Barnard in 1967",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_4": [
        {
            "start_logit": 5.01171875,
            "end_logit": 8.4453125,
            "text": "1967",
            "probability": 0.98828125
        },
        {
            "start_logit": 8.5546875,
            "end_logit": 0.275390625,
            "text": "50th",
            "probability": 0.0096893310546875
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -1.892578125,
            "text": "50",
            "probability": 0.0011129379272460938
        },
        {
            "start_logit": -2.44140625,
            "end_logit": 8.4453125,
            "text": "7",
            "probability": 0.0005750656127929688
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -2.662109375,
            "text": "50th anniversary",
            "probability": 0.0005135536193847656
        },
        {
            "start_logit": -5.5078125,
            "end_logit": 8.4453125,
            "text": "December 3rd, 1967",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": -5.82421875,
            "end_logit": 8.4453125,
            "text": "on December 3rd, 1967",
            "probability": 1.9609928131103516e-05
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.1328125,
            "text": "50th anniversary of",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 8.4453125,
            "text": ", 1967",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.62890625,
            "text": "50th annivers",
            "probability": 9.715557098388672e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.671875,
            "text": "50th anniversary of the",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -6.8359375,
            "text": "50th anniversary of the first human heart transplant that had",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.03515625,
            "text": "50th anniversary of the first human heart transplant that",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 8.5546875,
            "end_logit": -7.046875,
            "text": "50th anniversary of the first human heart transplant that had been carried out by the South African surgeon, Christiaa",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": 5.01171875,
            "end_logit": -5.54296875,
            "text": "196",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -0.95751953125,
            "end_logit": 0.275390625,
            "text": "In 2017, we celebrated the 50th",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.01171875,
            "end_logit": -6.10546875,
            "text": "1967.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.95751953125,
            "end_logit": -1.892578125,
            "text": "In 2017, we celebrated the 50",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.95751953125,
            "end_logit": -2.662109375,
            "text": "In 2017, we celebrated the 50th anniversary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 0.275390625,
            "text": "2017, we celebrated the 50th",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_5": [
        {
            "start_logit": 4.2421875,
            "end_logit": 8.890625,
            "text": "1967",
            "probability": 0.9931640625
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.890625,
            "text": "December 1967",
            "probability": 0.0044403076171875
        },
        {
            "start_logit": -1.822265625,
            "end_logit": 8.890625,
            "text": "7",
            "probability": 0.0023136138916015625
        },
        {
            "start_logit": -5.0,
            "end_logit": 8.890625,
            "text": "40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 9.620189666748047e-05
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 8.890625,
            "text": "years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 8.890625,
            "text": "been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 8.890625,
            "text": "Christiaan Barnard in December 1967",
            "probability": 1.3113021850585938e-05
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.890625,
            "text": "in December 1967",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": -7.234375,
            "end_logit": 8.890625,
            "text": "by Christiaan Barnard in December 1967",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.890625,
            "text": "has been 40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 8.890625,
            "text": "human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.890625,
            "text": "-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": 4.2421875,
            "end_logit": -5.921875,
            "text": "196",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.16796875,
            "end_logit": -5.921875,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -5.48046875,
            "text": "40 years",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -5.921875,
            "text": "40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -6.02734375,
            "text": "40 years since",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -6.609375,
            "text": "40",
            "probability": 0.0
        },
        {
            "start_logit": -5.0,
            "end_logit": -6.70703125,
            "text": "40 years since the",
            "probability": 0.0
        },
        {
            "start_logit": -6.29296875,
            "end_logit": -5.48046875,
            "text": "It has been 40 years",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_6": [
        {
            "start_logit": 9.234375,
            "end_logit": 9.125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -0.9609375,
            "text": "196",
            "probability": 4.166364669799805e-05
        },
        {
            "start_logit": -1.248046875,
            "end_logit": 9.125,
            "text": "7",
            "probability": 2.7954578399658203e-05
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.34375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 9.125,
            "text": "Christiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.953125,
            "text": "1967,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.09375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.1015625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.15625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.1640625,
            "text": "1967, there",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.16796875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.171875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.18359375,
            "text": "1967, there has been substantial progress",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.20703125,
            "text": "1967, there has been substantial progress in the field of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.20703125,
            "text": "1967, there has been substantial progress in the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.23046875,
            "text": "1967, there has been",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 9.125,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 9.125,
            "text": "by Christiaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.125,
            "text": "istiaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.125,
            "text": "the first successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_7": [
        {
            "start_logit": 9.375,
            "end_logit": 9.125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.375,
            "end_logit": -0.595703125,
            "text": "196",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -1.2734375,
            "end_logit": 9.125,
            "text": "7",
            "probability": 2.372264862060547e-05
        },
        {
            "start_logit": 9.375,
            "end_logit": -6.5234375,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are commonplace.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 9.125,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.515625,
            "end_logit": 9.125,
            "text": "Since the first human heart transplantation was performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.08203125,
            "text": "1967, the field of heart transplantation has advanced",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.17578125,
            "text": "1967, the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.19921875,
            "text": "1967,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.19921875,
            "text": "1967, the field of heart transplantation has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.2265625,
            "text": "1967, the field of heart transplantation has advanced to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.26953125,
            "text": "1967, the field",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.36328125,
            "text": "1967, the field of heart transplantation has advanced to the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.36328125,
            "text": "1967, the field of heart transplantation has advanced to the point",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 9.125,
            "text": "human heart transplantation was performed in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.375,
            "end_logit": -7.37890625,
            "text": "1967, the field of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.234375,
            "end_logit": 9.125,
            "text": "the first human heart transplantation was performed in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 9.125,
            "text": "first human heart transplantation was performed in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.31640625,
            "end_logit": -0.595703125,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.515625,
            "end_logit": -0.595703125,
            "text": "Since the first human heart transplantation was performed in 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_8": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.78125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -2.11328125,
            "end_logit": 8.78125,
            "text": "7",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -3.009765625,
            "text": "196",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 8.78125,
            "text": "in 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.78125,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.78125,
            "text": "50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -3.009765625,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -3.009765625,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -3.009765625,
            "text": "50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -6.61328125,
            "text": "The first human-to-human heart transplant was performed 50 years ago",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -6.61328125,
            "text": "50 years ago",
            "probability": 0.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -7.23046875,
            "text": "in",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.05859375,
            "text": "The first human-to-human heart transplant was",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.07421875,
            "text": "The first human-to-human heart transplant was performed 50 years",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -7.07421875,
            "text": "50 years",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.1875,
            "text": "The",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.19921875,
            "text": "The first human-to-human heart transplant was performed 50",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.2265625,
            "text": "The first human-to-human heart transplant was performed",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.23046875,
            "text": "The first human-to-human heart transplant was performed 50 years ago in",
            "probability": 0.0
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -7.2578125,
            "text": "The first human-to",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_9": [
        {
            "start_logit": 9.25,
            "end_logit": 8.9921875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.1162109375,
            "text": "196",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": 8.9921875,
            "text": "7",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 8.9921875,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.375,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1875,
            "end_logit": 8.9921875,
            "text": "Since the first human-to-human heart transplantation, performed in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.484375,
            "text": "1967,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.9921875,
            "text": "human heart transplantation, performed in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.9921875,
            "text": "human-to-human heart transplantation, performed in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.48828125,
            "end_logit": -1.1162109375,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -1.1162109375,
            "text": "Since the first human-to-human heart transplantation, performed in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -1.1162109375,
            "text": "human heart transplantation, performed in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -1.1162109375,
            "text": "human-to-human heart transplantation, performed in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -7.375,
            "text": "7, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and",
            "probability": 0.0
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -7.484375,
            "text": "7,",
            "probability": 0.0
        },
        {
            "start_logit": -1.6787109375,
            "end_logit": -7.5234375,
            "text": "7, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and surveillance of",
            "probability": 0.0
        },
        {
            "start_logit": -4.84765625,
            "end_logit": -7.05078125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.48828125,
            "end_logit": -7.375,
            "text": "in 1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and",
            "probability": 0.0
        },
        {
            "start_logit": -6.48828125,
            "end_logit": -7.484375,
            "text": "in 1967,",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.0234375,
            "text": "Since",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_10": [
        {
            "start_logit": 9.203125,
            "end_logit": 9.125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.203125,
            "end_logit": -1.1591796875,
            "text": "196",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": -1.302734375,
            "end_logit": 9.125,
            "text": "7",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 9.203125,
            "end_logit": -6.46875,
            "text": "1967 was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 9.125,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.25390625,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.3359375,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.203125,
            "end_logit": -7.33984375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.125,
            "text": "the first human heart transplant in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.125,
            "text": "human heart transplant in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 9.125,
            "text": "heart transplant in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.302734375,
            "end_logit": -6.46875,
            "text": "7 was",
            "probability": 0.0
        },
        {
            "start_logit": -6.82421875,
            "end_logit": -1.1591796875,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.302734375,
            "end_logit": -7.06640625,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death (",
            "probability": 0.0
        },
        {
            "start_logit": -7.37890625,
            "end_logit": -1.1591796875,
            "text": "the first human heart transplant in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.302734375,
            "end_logit": -7.25390625,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": -7.40625,
            "end_logit": -1.1591796875,
            "text": "human heart transplant in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.302734375,
            "end_logit": -7.3359375,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -1.302734375,
            "end_logit": -7.33984375,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac",
            "probability": 0.0
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -1.1591796875,
            "text": "heart transplant in 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_11": [
        {
            "start_logit": 3.783203125,
            "end_logit": 8.734375,
            "text": "1967",
            "probability": 0.9951171875
        },
        {
            "start_logit": -2.0078125,
            "end_logit": 8.734375,
            "text": "7",
            "probability": 0.0030460357666015625
        },
        {
            "start_logit": -2.35546875,
            "end_logit": 8.734375,
            "text": "December 1967",
            "probability": 0.0021514892578125
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 8.734375,
            "text": "in December 1967",
            "probability": 2.872943878173828e-05
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.734375,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 2.3424625396728516e-05
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 8.734375,
            "text": "Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.734375,
            "text": "in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.734375,
            "text": "or Christiaan Barnard and his team in December 1967",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.734375,
            "text": "Christiaan Barnard and his team in December 1967",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.734375,
            "text": "origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": 3.783203125,
            "end_logit": -6.17578125,
            "text": "196",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.35546875,
            "end_logit": -6.17578125,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -6.17578125,
            "text": "in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -6.17578125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -6.5,
            "text": "The Human Tissue Act of 1983",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -6.6640625,
            "text": "The Human Tissue Act",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -6.76953125,
            "text": "The Human Tissue Act of",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -6.5,
            "text": "1983",
            "probability": 0.0
        },
        {
            "start_logit": -7.2421875,
            "end_logit": -6.17578125,
            "text": "Professor Christiaan Barnard and his team in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -6.8984375,
            "text": "The Human Tissue Act of 1983 had its origin in the first successful heart transplant operation performed",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_12": [
        {
            "start_logit": 5.34375,
            "end_logit": 9.03125,
            "text": "1967",
            "probability": 0.97705078125
        },
        {
            "start_logit": 1.5361328125,
            "end_logit": 9.03125,
            "text": "December 1967",
            "probability": 0.021759033203125
        },
        {
            "start_logit": -1.458984375,
            "end_logit": 9.03125,
            "text": "7",
            "probability": 0.0010824203491210938
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 9.03125,
            "text": "It has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 9.03125,
            "text": "Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 9.03125,
            "text": "50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.03125,
            "text": ". Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.1875,
            "end_logit": 9.03125,
            "text": "in December 1967",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 9.03125,
            "text": "human-to-human heart transplant in December 1967",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 9.03125,
            "text": "human heart transplant in December 1967",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.03125,
            "text": "istiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 9.03125,
            "text": "years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.03125,
            "text": "been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.03125,
            "text": "-to-human heart transplant in December 1967",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 9.03125,
            "text": "to-human heart transplant in December 1967",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 9.03125,
            "text": "-human heart transplant in December 1967",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 5.34375,
            "end_logit": -5.37890625,
            "text": "196",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.34375,
            "end_logit": -7.1171875,
            "text": "1967 in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.34375,
            "end_logit": -7.25,
            "text": "1967 in South",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.34375,
            "end_logit": -7.33984375,
            "text": "1967 in South Africa",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_13": [
        {
            "start_logit": 2.79296875,
            "end_logit": 9.1015625,
            "text": "3 December 1967",
            "probability": 0.75
        },
        {
            "start_logit": 1.6376953125,
            "end_logit": 9.1015625,
            "text": "1967",
            "probability": 0.2379150390625
        },
        {
            "start_logit": -1.3837890625,
            "end_logit": 9.1015625,
            "text": "7",
            "probability": 0.01157379150390625
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 9.1015625,
            "text": "December 1967",
            "probability": 5.614757537841797e-05
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 9.1015625,
            "text": "on 3 December 1967",
            "probability": 4.4405460357666016e-05
        },
        {
            "start_logit": -6.96875,
            "end_logit": 9.1015625,
            "text": "The first successful human heart transplantation was reported on 3 December 1967",
            "probability": 4.3392181396484375e-05
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.1015625,
            "text": "human heart transplantation was reported on 3 December 1967",
            "probability": 3.123283386230469e-05
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.1015625,
            "text": "reported on 3 December 1967",
            "probability": 3.0517578125e-05
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 9.1015625,
            "text": "successful human heart transplantation was reported on 3 December 1967",
            "probability": 2.962350845336914e-05
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.1015625,
            "text": "heart transplantation was reported on 3 December 1967",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.1015625,
            "text": "first successful human heart transplantation was reported on 3 December 1967",
            "probability": 2.759695053100586e-05
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -5.3671875,
            "text": "3",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -6.49609375,
            "text": "3 December",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -6.57421875,
            "text": "3 December 196",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -6.67578125,
            "text": "3 December 1967, by Christiaan Barnard in South Africa.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -7.234375,
            "text": "3 December 1967,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -7.28515625,
            "text": "3 December 1967, by Christiaan",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -7.29296875,
            "text": "3 December 1967, by Christiaan Barnard",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -7.30078125,
            "text": "3 December 1967, by",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.79296875,
            "end_logit": -7.30859375,
            "text": "3 December 1967, by Christiaan Bar",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_14": [
        {
            "start_logit": 8.8515625,
            "end_logit": 9.1328125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.2412109375,
            "end_logit": 9.1328125,
            "text": "7",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -1.7099609375,
            "text": "196",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.8515625,
            "end_logit": -5.6796875,
            "text": "1967.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.41796875,
            "end_logit": 9.1328125,
            "text": "December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 9.1328125,
            "text": "on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 9.1328125,
            "text": "Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 9.1328125,
            "text": "at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 9.1328125,
            "text": "The world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 9.1328125,
            "text": "2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 9.1328125,
            "text": "human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 9.1328125,
            "text": "ote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 9.1328125,
            "text": "the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 9.1328125,
            "text": "human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.1328125,
            "text": "-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 9.1328125,
            "text": "heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 9.1328125,
            "text": "first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.1328125,
            "text": "world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.2412109375,
            "end_logit": -5.6796875,
            "text": "7.",
            "probability": 0.0
        },
        {
            "start_logit": -6.41796875,
            "end_logit": -1.7099609375,
            "text": "December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_15": [
        {
            "start_logit": 9.1171875,
            "end_logit": 9.109375,
            "text": "1967",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": 9.109375,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 0.0005311965942382812
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -1.220703125,
            "text": "196",
            "probability": 3.2901763916015625e-05
        },
        {
            "start_logit": -1.2509765625,
            "end_logit": 9.109375,
            "text": "7",
            "probability": 3.165006637573242e-05
        },
        {
            "start_logit": 9.1171875,
            "end_logit": -5.96875,
            "text": "1967.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.890625,
            "end_logit": 9.109375,
            "text": "Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 9.109375,
            "text": "by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 9.109375,
            "text": "3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 9.109375,
            "text": "December 3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.109375,
            "text": "istiaan Barnard in Cape Town December 3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46875,
            "end_logit": 9.109375,
            "text": "Town December 3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 9.109375,
            "text": "years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -1.220703125,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 196",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -5.41015625,
            "text": "50 years",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -5.5625,
            "text": "50",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -5.96875,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967.",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -6.00390625,
            "text": "50 years have passed since",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -6.53515625,
            "text": "50 years have",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -6.5546875,
            "text": "50 years have passed",
            "probability": 0.0
        },
        {
            "start_logit": 1.5732421875,
            "end_logit": -6.9921875,
            "text": "50 years have passed since the",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_16": [
        {
            "start_logit": 9.2265625,
            "end_logit": 9.109375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.1591796875,
            "text": "196",
            "probability": 3.451108932495117e-05
        },
        {
            "start_logit": -1.3662109375,
            "end_logit": 9.109375,
            "text": "7",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 9.109375,
            "text": "In 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.4453125,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.8359375,
            "text": "1967, he led the team that performed the world's",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.84765625,
            "text": "1967, he led the team that performed the world'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.88671875,
            "text": "1967, he led the team that performed the world",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.0,
            "text": "1967, he led the team that performed the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.0625,
            "text": "1967,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.0625,
            "text": "1967, he led the team that",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.06640625,
            "text": "1967, he led the team that performed the world's first",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.078125,
            "text": "1967, he led the team",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.09765625,
            "text": "1967, he led the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.16015625,
            "text": "1967, he led",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.1640625,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.19140625,
            "text": "1967, he led the team that performed",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.23046875,
            "text": "1967, he led the team that performed the world's first human-to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.28125,
            "text": "1967, he led the team that performed the world's first human-to-human heart",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -7.3359375,
            "text": "1967, he",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_17": [
        {
            "start_logit": 9.234375,
            "end_logit": 9.109375,
            "text": "1967",
            "probability": 0.9990234375
        },
        {
            "start_logit": 1.4638671875,
            "end_logit": 9.109375,
            "text": "1953, followed by the first successful heart transplant in 1967",
            "probability": 0.0004203319549560547
        },
        {
            "start_logit": 9.234375,
            "end_logit": -0.50390625,
            "text": "196",
            "probability": 6.705522537231445e-05
        },
        {
            "start_logit": -1.0205078125,
            "end_logit": 9.109375,
            "text": "7",
            "probability": 3.504753112792969e-05
        },
        {
            "start_logit": -4.89453125,
            "end_logit": 9.109375,
            "text": ". From the repair of the first septal defect in 1953, followed by the first successful heart transplant in 1967",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 1.4638671875,
            "end_logit": 1.6904296875,
            "text": "1953",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.4296875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 9.109375,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 9.109375,
            "text": "From the repair of the first septal defect in 1953, followed by the first successful heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.8671875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.90234375,
            "text": "1967,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.9140625,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.99609375,
            "text": "1967, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.0234375,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.125,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made in h",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.1796875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.109375,
            "text": "successful heart transplant in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.40625,
            "end_logit": 9.109375,
            "text": "first successful heart transplant in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 9.109375,
            "text": "heart transplant in 1967",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_18": [
        {
            "start_logit": 8.453125,
            "end_logit": 9.078125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": 9.078125,
            "text": "7",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": 8.453125,
            "end_logit": -2.380859375,
            "text": "196",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -3.9375,
            "end_logit": 9.078125,
            "text": "3 December 1967",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 9.078125,
            "text": "December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 9.078125,
            "text": "on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.453125,
            "end_logit": -6.5,
            "text": "1967.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 9.078125,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 9.078125,
            "text": "at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 9.078125,
            "text": "Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 9.078125,
            "text": "on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 9.078125,
            "text": "ote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 9.078125,
            "text": ", on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 9.078125,
            "text": "Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.9375,
            "end_logit": -2.380859375,
            "text": "3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": -6.5,
            "text": "7.",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -2.380859375,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -2.380859375,
            "text": "on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -2.380859375,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -2.380859375,
            "text": "at Groote Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_19": [
        {
            "start_logit": 5.3125,
            "end_logit": 9.2109375,
            "text": "1967",
            "probability": 0.998046875
        },
        {
            "start_logit": -0.97705078125,
            "end_logit": 9.2109375,
            "text": "7",
            "probability": 0.0018529891967773438
        },
        {
            "start_logit": -4.63671875,
            "end_logit": 9.2109375,
            "text": "December 3, 1967",
            "probability": 4.744529724121094e-05
        },
        {
            "start_logit": -5.25,
            "end_logit": 9.2109375,
            "text": "On December 3, 1967",
            "probability": 2.580881118774414e-05
        },
        {
            "start_logit": -7.125,
            "end_logit": 9.2109375,
            "text": ", 1967",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.2109375,
            "text": "3, 1967",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 5.3125,
            "end_logit": -5.1640625,
            "text": "196",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -5.71875,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart transplant.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.76953125,
            "text": "1967, in Cape Town, South Africa",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.8828125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolution",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.91015625,
            "text": "1967, in Cape Town",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.921875,
            "text": "1967, in Cape Town, South",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.921875,
            "text": "1967, in Cape Town,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.96484375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -6.98828125,
            "text": "1967, in Cape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 5.3125,
            "end_logit": -7.08203125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3125,
            "end_logit": -7.140625,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3125,
            "end_logit": -7.15625,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3125,
            "end_logit": -7.171875,
            "text": "1967, in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 5.3125,
            "end_logit": -7.17578125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation",
            "probability": 5.960464477539063e-08
        }
    ],
    "601ee4c61cb411341a000066_20": [
        {
            "start_logit": 9.0859375,
            "end_logit": 9.0703125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -1.3232421875,
            "text": "196",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.337890625,
            "end_logit": 9.0703125,
            "text": "7",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -5.81640625,
            "text": "1967 and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.1328125,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.26171875,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.87109375,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.92578125,
            "text": "1967 and followed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -6.9296875,
            "text": "1967 and followed this by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 9.0703125,
            "text": "Barnard performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.1171875,
            "text": "1967 and followed this by introducing the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.13671875,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.1796875,
            "text": "1967 and followed this by introducing the technique of heterotopic heart",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.19140625,
            "text": "1967 and followed this",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.19921875,
            "text": "1967 and followed this by introducing the technique of heterotopic",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.0859375,
            "end_logit": -7.203125,
            "text": "1967 and followed this by introducing the technique of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 9.0703125,
            "text": "in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 9.0703125,
            "text": "human-to-human orthotopic heart transplantation in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4375,
            "end_logit": 9.0703125,
            "text": "orthotopic heart transplantation in 1967",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 9.0703125,
            "text": "1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fdb2e23a43ad3127800000a_1": [
        {
            "start_logit": 6.0859375,
            "end_logit": 3.552734375,
            "text": "cis-regulatory elements",
            "probability": 0.53466796875
        },
        {
            "start_logit": 6.0859375,
            "end_logit": 3.408203125,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.460693359375
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -2.21484375,
            "text": "cis",
            "probability": 0.0016679763793945312
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -2.916015625,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.0008292198181152344
        },
        {
            "start_logit": -0.476806640625,
            "end_logit": 3.41015625,
            "text": "gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0006532669067382812
        },
        {
            "start_logit": -0.476806640625,
            "end_logit": 3.408203125,
            "text": "gene transcription.",
            "probability": 0.0006508827209472656
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -4.37109375,
            "text": "cis-regulatory elements is",
            "probability": 0.00019299983978271484
        },
        {
            "start_logit": -2.46875,
            "end_logit": 3.41015625,
            "text": ". Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 8.875131607055664e-05
        },
        {
            "start_logit": -2.46875,
            "end_logit": 3.41015625,
            "text": ".",
            "probability": 8.875131607055664e-05
        },
        {
            "start_logit": -2.46875,
            "end_logit": 3.408203125,
            "text": ".",
            "probability": 8.875131607055664e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -5.3671875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains",
            "probability": 7.128715515136719e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -5.51171875,
            "text": "cis-regulatory elements is central to",
            "probability": 6.192922592163086e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -5.515625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements",
            "probability": 6.145238876342773e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -5.63671875,
            "text": "cis-regulatory elements is central",
            "probability": 5.46574592590332e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -5.7890625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 4.678964614868164e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -5.97265625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to",
            "probability": 3.8743019104003906e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.15625,
            "text": "cis-regulatory elements is central to understanding gene",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.26171875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach",
            "probability": 2.9265880584716797e-05
        },
        {
            "start_logit": -3.798828125,
            "end_logit": 3.552734375,
            "text": "The identification of cis-regulatory elements",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.42578125,
            "text": "cis-regulatory",
            "probability": 2.467632293701172e-05
        }
    ],
    "5fdb2e23a43ad3127800000a_2": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.5546875,
            "text": "cis-regulatory elements",
            "probability": 0.9951171875
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 3.142578125,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.004428863525390625
        },
        {
            "start_logit": 0.85986328125,
            "end_logit": 8.5546875,
            "text": "Hypersensitivity of cis-regulatory elements",
            "probability": 0.0005903244018554688
        },
        {
            "start_logit": -1.984375,
            "end_logit": 8.5546875,
            "text": "elements",
            "probability": 3.4332275390625e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -2.15234375,
            "text": "cis",
            "probability": 2.2351741790771484e-05
        },
        {
            "start_logit": 0.85986328125,
            "end_logit": 3.142578125,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 8.5546875,
            "text": "regulatory elements",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.20703125,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.453125,
            "text": "cis-regulatory elements to digestion with DNaseI remains",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.55859375,
            "text": "cis-regulatory elements to",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.6015625,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.67578125,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 8.5546875,
            "text": "of cis-regulatory elements",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.89453125,
            "text": "cis-regulatory elements to digestion",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.05078125,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.234375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.453125,
            "text": "cis-regulatory elements to digestion with DNaseI remains the",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.5546875,
            "text": "-regulatory elements",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.61328125,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.6484375,
            "text": "cis-",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fdb2e23a43ad3127800000a_3": [
        {
            "start_logit": 1.77734375,
            "end_logit": 5.32421875,
            "text": "gene transcription.",
            "probability": 0.83740234375
        },
        {
            "start_logit": -0.258544921875,
            "end_logit": 5.32421875,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.109375
        },
        {
            "start_logit": -2.033203125,
            "end_logit": 5.32421875,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0185394287109375
        },
        {
            "start_logit": -2.625,
            "end_logit": 5.32421875,
            "text": ".",
            "probability": 0.01025390625
        },
        {
            "start_logit": -3.0703125,
            "end_logit": 5.32421875,
            "text": "understanding gene transcription.",
            "probability": 0.006565093994140625
        },
        {
            "start_logit": -0.258544921875,
            "end_logit": 2.451171875,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.006195068359375
        },
        {
            "start_logit": 1.77734375,
            "end_logit": -0.17578125,
            "text": "gene transcription",
            "probability": 0.0034198760986328125
        },
        {
            "start_logit": -4.0390625,
            "end_logit": 5.32421875,
            "text": "central to understanding gene transcription.",
            "probability": 0.0024929046630859375
        },
        {
            "start_logit": -2.033203125,
            "end_logit": 2.451171875,
            "text": "cis-regulatory elements",
            "probability": 0.0010480880737304688
        },
        {
            "start_logit": -4.921875,
            "end_logit": 5.32421875,
            "text": "elements is central to understanding gene transcription.",
            "probability": 0.0010318756103515625
        },
        {
            "start_logit": -4.9375,
            "end_logit": 5.32421875,
            "text": "identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0010156631469726562
        },
        {
            "start_logit": -5.01953125,
            "end_logit": 5.32421875,
            "text": "to understanding gene transcription.",
            "probability": 0.0009360313415527344
        },
        {
            "start_logit": -5.65625,
            "end_logit": 5.32421875,
            "text": "is central to understanding gene transcription.",
            "probability": 0.0004949569702148438
        },
        {
            "start_logit": -0.258544921875,
            "end_logit": -0.17578125,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.00044727325439453125
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 5.32421875,
            "text": "of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.00026798248291015625
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 5.32421875,
            "text": "regulatory elements is central to understanding gene transcription.",
            "probability": 0.00025582313537597656
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 5.32421875,
            "text": "-regulatory elements is central to understanding gene transcription.",
            "probability": 0.00010830163955688477
        },
        {
            "start_logit": -0.258544921875,
            "end_logit": -1.69140625,
            "text": "The identification of cis-regulatory elements is",
            "probability": 9.781122207641602e-05
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 5.32421875,
            "text": "transcription.",
            "probability": 9.262561798095703e-05
        },
        {
            "start_logit": -2.033203125,
            "end_logit": -0.17578125,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 7.557868957519531e-05
        }
    ],
    "53318685d6d3ac6a3400003d_1": [
        {
            "start_logit": 9.234375,
            "end_logit": 8.9453125,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 9.234375,
            "end_logit": -1.3720703125,
            "text": "autosomal",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -1.8046875,
            "end_logit": 8.9453125,
            "text": "dominant",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.33203125,
            "text": "autosomal dominant mode",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.3515625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -6.76171875,
            "text": "autosomal dominant mode of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.23046875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.23046875,
            "text": "autosomal dominant mode of inheritance,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.296875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.40234375,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.41015625,
            "text": "autosomal dominant mode of inheritance, distinct",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.4453125,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.484375,
            "text": "autosomal dominant mode of inheritance, distinct facial and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.48828125,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.234375,
            "end_logit": -7.5,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.8046875,
            "end_logit": -6.33203125,
            "text": "dominant mode",
            "probability": 0.0
        },
        {
            "start_logit": -1.8046875,
            "end_logit": -6.3515625,
            "text": "dominant mode of inheritance",
            "probability": 0.0
        },
        {
            "start_logit": -1.8046875,
            "end_logit": -6.76171875,
            "text": "dominant mode of",
            "probability": 0.0
        },
        {
            "start_logit": -1.8046875,
            "end_logit": -7.23046875,
            "text": "dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).",
            "probability": 0.0
        },
        {
            "start_logit": -1.8046875,
            "end_logit": -7.23046875,
            "text": "dominant mode of inheritance,",
            "probability": 0.0
        }
    ],
    "53318685d6d3ac6a3400003d_2": [
        {
            "start_logit": 8.984375,
            "end_logit": 8.84375,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 8.984375,
            "end_logit": -1.947265625,
            "text": "autosomal",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": -1.9541015625,
            "end_logit": 8.84375,
            "text": "dominant",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 8.984375,
            "end_logit": -5.9140625,
            "text": "autosomal dominant or",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.77734375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.8515625,
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.88671875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.9296875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.953125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -6.99609375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.0078125,
            "text": "autosomal dominant or an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.01171875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.01953125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.03515625,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.0546875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.984375,
            "end_logit": -7.05859375,
            "text": "autosomal dominant or an autosomal recessive (AR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 8.84375,
            "text": "by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.84375,
            "text": "WMS is transmitted either by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.84375,
            "text": "an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 8.84375,
            "text": "S is transmitted either by an autosomal dominant",
            "probability": 5.960464477539063e-08
        }
    ],
    "53318685d6d3ac6a3400003d_3": [
        {
            "start_logit": 9.2265625,
            "end_logit": 8.984375,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -1.40625,
            "text": "autosomal",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -1.7041015625,
            "end_logit": 8.984375,
            "text": "dominant",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -5.578125,
            "text": "autosomal dominant mode of inheritance.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.51171875,
            "text": "autosomal dominant mode",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.65234375,
            "text": "autosomal dominant mode of inheritance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.2265625,
            "end_logit": -6.76953125,
            "text": "autosomal dominant mode of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 8.984375,
            "text": "The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.984375,
            "text": "condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 8.984375,
            "text": "vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 8.984375,
            "text": "in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.984375,
            "text": "the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.28125,
            "end_logit": 8.984375,
            "text": "an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.984375,
            "text": "families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.984375,
            "text": "of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.984375,
            "text": "observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 8.984375,
            "text": "three families was consistent with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.984375,
            "text": "with an autosomal dominant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.7041015625,
            "end_logit": -5.578125,
            "text": "dominant mode of inheritance.",
            "probability": 0.0
        },
        {
            "start_logit": -1.7041015625,
            "end_logit": -6.51171875,
            "text": "dominant mode",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_1": [
        {
            "start_logit": 9.25,
            "end_logit": 8.921875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.1962890625,
            "text": "Oh",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -1.78125,
            "end_logit": 8.921875,
            "text": "io",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.36328125,
            "text": "Ohio,",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.046875,
            "end_logit": 8.921875,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.921875,
            "text": "2014 measles outbreak in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.921875,
            "text": "in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.046875,
            "end_logit": -1.1962890625,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -1.1962890625,
            "text": "2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -1.1962890625,
            "text": "in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -1.78125,
            "end_logit": -7.36328125,
            "text": "io,",
            "probability": 0.0
        },
        {
            "start_logit": -5.07421875,
            "end_logit": -7.36328125,
            "text": ",",
            "probability": 0.0
        },
        {
            "start_logit": -7.046875,
            "end_logit": -7.36328125,
            "text": "in Ohio,",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.3203125,
            "text": "2014 measles",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.328125,
            "text": "2014 measles outbreak",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.36328125,
            "text": "2014 measles outbreak in Ohio,",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.2265625,
            "text": "in Amish communities include a",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.265625,
            "text": "in Ami",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -7.28515625,
            "text": "in Amish",
            "probability": 0.0
        },
        {
            "start_logit": -7.5234375,
            "end_logit": -7.44140625,
            "text": "2014",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_2": [
        {
            "start_logit": 9.1484375,
            "end_logit": 8.6328125,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.1484375,
            "end_logit": -1.380859375,
            "text": "Oh",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": -2.35546875,
            "end_logit": 8.6328125,
            "text": "io",
            "probability": 1.0132789611816406e-05
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.6328125,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.6328125,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.6328125,
            "text": "with a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.6328125,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.6328125,
            "text": ", with a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1171875,
            "end_logit": -1.380859375,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.375,
            "end_logit": -1.380859375,
            "text": "2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -1.380859375,
            "text": "with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -1.380859375,
            "text": "a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -1.380859375,
            "text": ", with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.04296875,
            "text": "with a",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -7.04296875,
            "text": "a",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.04296875,
            "text": ", with a",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.2890625,
            "text": "with",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.2890625,
            "text": ", with",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_3": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.9765625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.21484375,
            "text": "Oh",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -1.6845703125,
            "end_logit": 8.9765625,
            "text": "io",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.22265625,
            "text": "Ohio were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.23046875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.265625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.28125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Ami",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.30859375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Ohio were transmission primarily",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Ohio were transmission primarily within households, the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 8.9765625,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.9765625,
            "text": "CONCLUSIONS The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.9765625,
            "text": "The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.9765625,
            "text": "a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.9765625,
            "text": "key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.9765625,
            "text": "features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.9765625,
            "text": "of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.9765625,
            "text": "epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5312097e3cb0e231000011_4": [
        {
            "start_logit": 9.25,
            "end_logit": 8.8125,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.25,
            "end_logit": -1.21875,
            "text": "Oh",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -2.029296875,
            "end_logit": 8.8125,
            "text": "io",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": 9.25,
            "end_logit": -6.77734375,
            "text": "Ohio push",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.10546875,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20 years.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.109375,
            "text": "Ohio pushing the annual cases to the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.1796875,
            "text": "Ohio pushing the annual cases to the highest",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.2265625,
            "text": "Ohio pushing the annual cases to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.26171875,
            "text": "Ohio pushing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.29296875,
            "text": "Ohio pushing the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.25,
            "end_logit": -7.296875,
            "text": "Ohio pushing the annual cases to the highest national number reported in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 8.8125,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 8.8125,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.8125,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.8125,
            "text": ", with a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.109375,
            "end_logit": -1.21875,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -1.21875,
            "text": "2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -1.21875,
            "text": "a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -1.21875,
            "text": ", with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -2.029296875,
            "end_logit": -6.77734375,
            "text": "io push",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_5": [
        {
            "start_logit": 9.296875,
            "end_logit": 8.9609375,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.296875,
            "end_logit": -1.1181640625,
            "text": "Oh",
            "probability": 4.2319297790527344e-05
        },
        {
            "start_logit": -1.69921875,
            "end_logit": 8.9609375,
            "text": "io",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.22265625,
            "text": "Ohio,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.25390625,
            "text": "Ohio, resulting in 368 cases reported.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.30859375,
            "text": "Ohio, resulting",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 8.9609375,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.296875,
            "end_logit": -7.4765625,
            "text": "Ohio, resulting in 368 cases reported",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.9609375,
            "text": "2014 measles outbreak in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.9609375,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.9609375,
            "text": "measles outbreak in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -1.1181640625,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -1.1181640625,
            "text": "2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -1.1181640625,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -1.1181640625,
            "text": "measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -1.69921875,
            "end_logit": -7.22265625,
            "text": "io,",
            "probability": 0.0
        },
        {
            "start_logit": -1.69921875,
            "end_logit": -7.25390625,
            "text": "io, resulting in 368 cases reported.",
            "probability": 0.0
        },
        {
            "start_logit": -1.69921875,
            "end_logit": -7.30859375,
            "text": "io, resulting",
            "probability": 0.0
        },
        {
            "start_logit": -1.69921875,
            "end_logit": -7.4765625,
            "text": "io, resulting in 368 cases reported",
            "probability": 0.0
        },
        {
            "start_logit": -5.1015625,
            "end_logit": -7.25390625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_6": [
        {
            "start_logit": 9.2578125,
            "end_logit": 8.9765625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -1.21484375,
            "text": "Oh",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -1.6845703125,
            "end_logit": 8.9765625,
            "text": "io",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.22265625,
            "text": "Ohio were",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.23046875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.265625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.28125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Ami",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.30859375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.390625,
            "text": "Ohio were transmission primarily",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 9.2578125,
            "end_logit": -7.3984375,
            "text": "Ohio were transmission primarily within households, the",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 8.9765625,
            "text": "in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.9765625,
            "text": "CONCLUSIONS The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.9765625,
            "text": "The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.9765625,
            "text": "a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.9765625,
            "text": "key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.9765625,
            "text": "features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.9765625,
            "text": "of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.9765625,
            "text": "epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5312097e3cb0e231000011_7": [
        {
            "start_logit": 9.1953125,
            "end_logit": 8.75,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.36328125,
            "text": "Oh",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -2.1875,
            "end_logit": 8.75,
            "text": "io",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.76953125,
            "text": "Ohio push",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.36328125,
            "end_logit": 8.75,
            "text": "in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.1328125,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20 years.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.23828125,
            "text": "Ohio pushing the annual cases to the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 8.75,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.75,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.75,
            "text": "in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.75,
            "text": "outbreak in Amish communities in Ohio",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.36328125,
            "end_logit": -1.36328125,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -1.36328125,
            "text": "2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -1.36328125,
            "text": "a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.484375,
            "end_logit": -1.36328125,
            "text": "in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -1.36328125,
            "text": "outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -2.1875,
            "end_logit": -6.76953125,
            "text": "io push",
            "probability": 0.0
        },
        {
            "start_logit": -2.1875,
            "end_logit": -7.1328125,
            "text": "io pushing the annual cases to the highest national number reported in the last 20 years.",
            "probability": 0.0
        },
        {
            "start_logit": -2.1875,
            "end_logit": -7.23828125,
            "text": "io pushing the annual cases to the",
            "probability": 0.0
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -6.9453125,
            "text": ".Measles outbreaks in the United States",
            "probability": 0.0
        }
    ],
    "61f95f9f882a024a1000004e_1": [
        {
            "start_logit": 9.1953125,
            "end_logit": 9.109375,
            "text": "Oguchi disease",
            "probability": 1.0
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -1.439453125,
            "text": "Og",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -1.4208984375,
            "end_logit": 9.109375,
            "text": "disease",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -4.65234375,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB).",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -5.6875,
            "text": "Oguchi disease,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -5.73828125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -5.828125,
            "text": "Oguchi disease, a",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 9.109375,
            "text": "uchi disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.28125,
            "end_logit": 9.109375,
            "text": "i disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.390625,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.40625,
            "text": "Oguchi disease, a rare subtype",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 9.109375,
            "text": "cause Oguchi disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.5703125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.58203125,
            "text": "Oguchi",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.82421875,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CS",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.8359375,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.8515625,
            "text": "Oguchi disease, a rare",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.94921875,
            "text": "Oguch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -6.98046875,
            "text": "Oguchi disease, a rare subtype of congenital stationary",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 9.1953125,
            "end_logit": -7.0703125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night",
            "probability": 1.1920928955078125e-07
        }
    ]
}
